{
  "category": "Anatomic Pathology",
  "subject": {
    "name": "Neuropathology",
    "url": "https://app.pathprimer.com/curriculum/5d826dda-9fd3-462c-b99d-030b2a7cc5bd",
    "lessons": {
      "CNS Nonneoplastic Lesions": {
        "name": "CNS Nonneoplastic Lesions",
        "url": "https://app.pathprimer.com/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
        "topics": {
          "Abscess and Cerebritis": {
            "name": "Abscess and Cerebritis",
            "url": "https://app.pathprimer.com/document/0efe73fe-112c-47df-aea3-60c912d121a6/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Cerebritis: Ill-defined area of inflammation without capsule"
                  },
                  {
                    "text": "Brain abscess: Later stage of localized purulent infection with fibrous capsule"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Enhancing rim, often uniform but may be thinner on medial, deeper aspect"
                  },
                  {
                    "text": "Hypointense (dark) rim corresponding to fibrous tissue in capsule on T2WI MR"
                  },
                  {
                    "text": "Bright (restricted diffusion)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Proliferation of perithelial fibroblasts and leptomeningeal fibroblasts serves as source for collagenous capsule"
                  },
                  {
                    "text": "Fibroblasts form granulation tissue, but prominent nucleoli, cytoplasmic basophilia, mitoses may falsely suggest neoplasm"
                  },
                  {
                    "text": "Organisms found on special stains within necrotic areas, not capsule or surrounding gliotic brainMay be difficult to find organisms on Gram stain even on careful reviewAlways correlate histologic results with intraoperative Gram/acid-fast stains and subsequent cultures",
                    "sub_points": [
                      "May be difficult to find organisms on Gram stain even on careful review",
                      "Always correlate histologic results with intraoperative Gram/acid-fast stains and subsequent cultures"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Culture necessary to document specific organism(s)"
                  },
                  {
                    "text": "Culture negative in some instances, but diagnosis may be possible with molecular techniques"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Majority of cerebritis is caused by bacteria, often polymicrobial"
                  },
                  {
                    "text": "Always perform battery of organism stains to include at least Gram, Fite, Grocott methenamine silver (GMS), PAS on suspected bacterial abscess to capture filamentous bacteria, possible fungi"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Focal pyogenic infection with (abscess) or without (cerebritis) well-formed surrounding fibrous capsule"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "Hematogenous dissemination of bacteria from distant site (endocarditis, pulmonary, abdominal, skin infection)"
                  },
                  {
                    "text": "Direct extension from contiguous site (sinusitis, otitis, mastoiditis), recent dental workOverall incidence of brain abscesses has declined, in part because of fewer brain abscesses associated with otogenic infections",
                    "sub_points": [
                      "Overall incidence of brain abscesses has declined, in part because of fewer brain abscesses associated with otogenic infections"
                    ]
                  },
                  {
                    "text": "Penetrating head trauma, neurosurgery responsible for growing proportion of brain abscesses"
                  },
                  {
                    "text": "Up to 25-33% of cases cryptogenic with no source of infection identified"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 1,500-2,000 cases of brain abscess diagnosed annually in USA"
                  },
                  {
                    "text": "Brain abscess relatively rare in developed countries, more common in developing countries"
                  },
                  {
                    "text": "Frequently polymicrobial (up to 50%)Streptococcussp. (e.g.,S. anginosus,S. intermedius,S. viridans,S. pneumoniae) are most frequently identified organisms in brain abscesses, comprising up to 50%S. anginosusgroup includesS. anginosus,S. intermedius,S. constellatus(formerly considered single group calledS. milleri)Anaerobes: 20-25% of casesStaphylococcussp. (e.g.,S. aureus,S. epidermidis) are often isolated from postsurgical abscessesEnterobacteriaceae(e.g.,Klebsiella pneumoniae,Escherichia coli,Proteusspp.)Anaerobic infections from oropharyngeal, gastrointestinal organisms (e.g.,Fusobacterium,Actinomyces,Bacteroidesspp.)",
                    "sub_points": [
                      "Streptococcussp. (e.g.,S. anginosus,S. intermedius,S. viridans,S. pneumoniae) are most frequently identified organisms in brain abscesses, comprising up to 50%S. anginosusgroup includesS. anginosus,S. intermedius,S. constellatus(formerly considered single group calledS. milleri)",
                      "S. anginosusgroup includesS. anginosus,S. intermedius,S. constellatus(formerly considered single group calledS. milleri)",
                      "Anaerobes: 20-25% of cases",
                      "Staphylococcussp. (e.g.,S. aureus,S. epidermidis) are often isolated from postsurgical abscesses",
                      "Enterobacteriaceae(e.g.,Klebsiella pneumoniae,Escherichia coli,Proteusspp.)",
                      "Anaerobic infections from oropharyngeal, gastrointestinal organisms (e.g.,Fusobacterium,Actinomyces,Bacteroidesspp.)"
                    ]
                  },
                  {
                    "text": "Nocardiabrain abscess relatively rareMore common in immunocompromised patients (> 50% cases, corticosteroid use particularly significant risk factor)",
                    "sub_points": [
                      "More common in immunocompromised patients (> 50% cases, corticosteroid use particularly significant risk factor)"
                    ]
                  },
                  {
                    "text": "Persons with comorbid conditions, congenital heart disease, diabetes mellitus, alcohol use, corticosteroid use, may be at higher risk of brain abscess"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Headache/vomiting"
                  },
                  {
                    "text": "Focal neurologic deficits"
                  },
                  {
                    "text": "Confusion/disorientation"
                  },
                  {
                    "text": "Fever in some casesTriad of headache, fever, focal neurologic deficits in 20% of patients on admission",
                    "sub_points": [
                      "Triad of headache, fever, focal neurologic deficits in 20% of patients on admission"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical drainage and culture"
                  },
                  {
                    "text": "Antibiotic choice dependent on organism(s)"
                  },
                  {
                    "text": "Empiric therapy prior to receipt of culture results should cover oral streptococci (includingmillerigroup), methicillin-susceptible staphylococci, anaerobes,Enterobacteriaceae"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Mortality variable but has decreased in recent reports to 5-15% in immunocompetent hostsConsiderably higher withNocardiaabscesses if not promptly diagnosed and treated (> 30%)",
                    "sub_points": [
                      "Considerably higher withNocardiaabscesses if not promptly diagnosed and treated (> 30%)"
                    ]
                  },
                  {
                    "text": "Spillage into ventricular system with ventriculitis associated with increased mortality, neurological sequelaeIn 1 series, ventriculitis associated with brain abscess (32.7%), bacterial meningitis (27.6%), or intraventricular catheter (17.3%)Main pathogens were streptococci (44.9%), Gram-negative bacilli (27.6%), and staphylococci (15.3%)Prognosis poor, with in-hospital mortality rates of 30%; 62% of survivors left with long-term neurological sequelae",
                    "sub_points": [
                      "In 1 series, ventriculitis associated with brain abscess (32.7%), bacterial meningitis (27.6%), or intraventricular catheter (17.3%)",
                      "Main pathogens were streptococci (44.9%), Gram-negative bacilli (27.6%), and staphylococci (15.3%)",
                      "Prognosis poor, with in-hospital mortality rates of 30%; 62% of survivors left with long-term neurological sequelae"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "T1WI with contrastEnhancing rim, often uniform but may be thinner on deeper aspectUnlike irregular, shaggy profile of high-grade gliomasDark, nonenhancing core",
                    "sub_points": [
                      "Enhancing rim, often uniform but may be thinner on deeper aspect",
                      "Unlike irregular, shaggy profile of high-grade gliomas",
                      "Dark, nonenhancing core"
                    ]
                  },
                  {
                    "text": "T2WI: Hypointense (dark) rim corresponding to fibrous tissue in capsule"
                  },
                  {
                    "text": "Perilesional edema, usually pronounced, and mass effect"
                  },
                  {
                    "text": "DWIBright (restricted diffusion)Dark on ADC map",
                    "sub_points": [
                      "Bright (restricted diffusion)",
                      "Dark on ADC map"
                    ]
                  },
                  {
                    "text": "Hematogenous infection often results in multiple abscesses, commonly at gray-white junction and border zone vascular territories"
                  },
                  {
                    "text": "Contiguous site source more often solitary brain abscessFrontal, temporal lobe locations associated with sinusitisTemporal lobe, cerebellum locations associated with otitis media, mastoiditis",
                    "sub_points": [
                      "Frontal, temporal lobe locations associated with sinusitis",
                      "Temporal lobe, cerebellum locations associated with otitis media, mastoiditis"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Liquified, greenish, purulent center"
                  },
                  {
                    "text": "CapsuleHyperemicFirm and gray when matureThinner on deep aspect near ventricle",
                    "sub_points": [
                      "Hyperemic",
                      "Firm and gray when mature",
                      "Thinner on deep aspect near ventricle"
                    ]
                  },
                  {
                    "text": "Cerebritis hyperemic, more poorly defined than abscess"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Central necrosis"
                  },
                  {
                    "text": "Central neutrophils and neutrophilic debris"
                  },
                  {
                    "text": "Fibrous capsule formed by reticulin fibers and collagen"
                  },
                  {
                    "text": "Source of collagen is fibroblasts in leptomeninges and blood vessels"
                  },
                  {
                    "text": "Thickness of capsule often greatest near leptomeninges or cortex"
                  },
                  {
                    "text": "Mitoses and high Ki-67 index in evolving capsule"
                  },
                  {
                    "text": "Lymphoplasmacytic infiltrate"
                  },
                  {
                    "text": "Macrophages may be prominent"
                  },
                  {
                    "text": "OrganismsWithin necrotic areas, not capsule or surrounding gliotic brainBacteria usually not visible on H&E, except filamentous bacteriaIdentification of bacteria requires Gram stain, sometimes still difficult to findFilamentous bacteria also seen with Fite and Grocott methenamine silver (GMS) stains",
                    "sub_points": [
                      "Within necrotic areas, not capsule or surrounding gliotic brain",
                      "Bacteria usually not visible on H&E, except filamentous bacteria",
                      "Identification of bacteria requires Gram stain, sometimes still difficult to find",
                      "Filamentous bacteria also seen with Fite and Grocott methenamine silver (GMS) stains"
                    ]
                  },
                  {
                    "text": "Edema and gliosis in surrounding brain"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Inflammatory cells"
                  },
                  {
                    "text": "Plump fibroblasts, sometimes with mitoses, from granulation tissue; may suggest neoplasm"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Culture": [
                  {
                    "text": "20-25% of abscess cultures may be negativeYield of abscess culture declines if empiric therapy is initiated before surgery",
                    "sub_points": [
                      "Yield of abscess culture declines if empiric therapy is initiated before surgery"
                    ]
                  },
                  {
                    "text": "Close communication between microbiology laboratory, surgeon, pathologist may be necessary to optimize resultsMay need anaerobic transport, timely plating of abscess material onto appropriate culture media",
                    "sub_points": [
                      "May need anaerobic transport, timely plating of abscess material onto appropriate culture media"
                    ]
                  },
                  {
                    "text": "Optimally, purulent centrally necrotic debris should be sent to both microbiology laboratory for intraoperative organism stains and culture and pathologist for organism stains on tissue"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Necrotic Primary Brain Tumor": [
                  {
                    "text": "Highly necrotic glioblastomaNeoplastic cellsTumor cells may be difficult to identify histologically, especially on single frozen section at time of intraoperative consultationNeed to identify cytologic atypiaNo collagenous capsule",
                    "sub_points": [
                      "Neoplastic cellsTumor cells may be difficult to identify histologically, especially on single frozen section at time of intraoperative consultationNeed to identify cytologic atypia",
                      "Tumor cells may be difficult to identify histologically, especially on single frozen section at time of intraoperative consultation",
                      "Need to identify cytologic atypia",
                      "No collagenous capsule"
                    ]
                  },
                  {
                    "text": "Highly necrotic glioblastoma with mesenchymal differentiation (gliosarcoma)GFAP(+) tumorMore atypia, more mitoses in mesenchymal tumor tissue than in abscess capsule, less polymorphous inflammatory infiltrates",
                    "sub_points": [
                      "GFAP(+) tumor",
                      "More atypia, more mitoses in mesenchymal tumor tissue than in abscess capsule, less polymorphous inflammatory infiltrates"
                    ]
                  }
                ],
                "Metastatic Tumor": [
                  {
                    "text": "Tumor cells with cytologic atypia"
                  },
                  {
                    "text": "Little admixed acute inflammation"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Less thick capsule formation on deeper aspect of abscess"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Highly necrotic glioblastomas with acute necrosis may mimic cerebritis, especially on frozen sections"
                  },
                  {
                    "text": "Cannot determine causative organism, or even if bacterial at all, based on gross appearance of cerebritis or abscess"
                  },
                  {
                    "text": "Organisms most likely to be identified on special stains in areas of acute necrosis, not surrounding capsule"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Fungal Infections": {
            "name": "Fungal Infections",
            "url": "https://app.pathprimer.com/document/4d3d02ee-a9c2-42d6-affc-c37e923dfd42/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "CNS infection by pathogenic or opportunistic fungi"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "CommonBasal meningitisHydrocephalusSpace-occupying lesions (abscesses, granulomas)Stroke",
                    "sub_points": [
                      "Basal meningitis",
                      "Hydrocephalus",
                      "Space-occupying lesions (abscesses, granulomas)",
                      "Stroke"
                    ]
                  },
                  {
                    "text": "Less commonOrbito-rhino-cerebral syndromesSpinal infection",
                    "sub_points": [
                      "Orbito-rhino-cerebral syndromes",
                      "Spinal infection"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Yeasts:Blastomyces,Histoplasma,Cryptococcus"
                  },
                  {
                    "text": "Yeast and pseudohyphae:Candida"
                  },
                  {
                    "text": "Hyphae:Aspergillus,Zygomycetes"
                  },
                  {
                    "text": "Sporangium and endospores:Coccidioides"
                  },
                  {
                    "text": "Yeasts not vasoinvasiveUsually do not cause infarctions, hemorrhages",
                    "sub_points": [
                      "Usually do not cause infarctions, hemorrhages"
                    ]
                  },
                  {
                    "text": "Hyphae and pseudohyphae vasoinvasiveMay cause infarctions, hemorrhages",
                    "sub_points": [
                      "May cause infarctions, hemorrhages"
                    ]
                  },
                  {
                    "text": "Focal confined infections [granuloma(s)] if host relatively immunocompetent"
                  },
                  {
                    "text": "Meningitis more common if host immunocompromised"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Do not mistake normal corpora amylacea for fungal formsCorpora amylacea also PAS(+)Corporal amylacea also GMS(+)Corpora amylacea usually not within macrophagesCorpora amylacea often congregate in subpial, perivascular locations",
                    "sub_points": [
                      "Corpora amylacea also PAS(+)",
                      "Corporal amylacea also GMS(+)",
                      "Corpora amylacea usually not within macrophages",
                      "Corpora amylacea often congregate in subpial, perivascular locations"
                    ]
                  },
                  {
                    "text": "Necrotic fungi within tissue do not show as pristine morphologic features as they do in culture"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Blastomycosis: Gilchrist disease, Chicago disease"
                  },
                  {
                    "text": "Coccidioidomycosis: Valley fever"
                  },
                  {
                    "text": "Cryptococcosis: Torulosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "CNS infection by opportunistic or pathogenic fungi"
                  },
                  {
                    "text": "Most common fungi include dimorphic fungi (Blastomyces dermatitidis,Coccidioidesspp.,Histoplasma capsulatum), yeasts (Cryptococcus neoformans,Candidaspp.,Trichosporonspp.), moniliaceous molds (Aspergillusspp.,Fusariumspp.), Mucoromycetes (Mucorspp.,Rhizopusspp.), and dematiaceous fungi (Cladophialophora bantiana)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Most fungi acquired through inhalationMost present in soilException isCandidasp.,which is normal constituent of human gut floraSeveral related to bird feces (e.g., Cryptococcus,Histoplasma)Most ubiquitous in environment; worldwide occurrenceCoccidioidomycosis occurs in areas with low rainfall and high summer temperaturesCoccidioidomycosis endemic in southern California, Arizona, New Mexico, southwestern Texas, Mexico, Central and parts of South AmericaHistoplasmosis and blastomycosis occur in watershed areas with moist soil, often containing rich organic materialHistoplasmosis: Endemic in Ohio and Mississippi river valleys but worldwide distributionBlastomycosis:B. dermatitidisisolates throughout North America, esp. Great Lakes;Blastomyces gilchristiistrains restricted to Canada, some of northern USAMycelia forms in environment; disrupted mycelia release conidia that can be inhaled by animals and humans; conidia rapidly change to yeast form in vivo in lungs in temperature-dependent transformation, resulting in clinical infection",
                    "sub_points": [
                      "Most present in soilException isCandidasp.,which is normal constituent of human gut floraSeveral related to bird feces (e.g., Cryptococcus,Histoplasma)",
                      "Exception isCandidasp.,which is normal constituent of human gut flora",
                      "Several related to bird feces (e.g., Cryptococcus,Histoplasma)",
                      "Most ubiquitous in environment; worldwide occurrenceCoccidioidomycosis occurs in areas with low rainfall and high summer temperaturesCoccidioidomycosis endemic in southern California, Arizona, New Mexico, southwestern Texas, Mexico, Central and parts of South AmericaHistoplasmosis and blastomycosis occur in watershed areas with moist soil, often containing rich organic materialHistoplasmosis: Endemic in Ohio and Mississippi river valleys but worldwide distributionBlastomycosis:B. dermatitidisisolates throughout North America, esp. Great Lakes;Blastomyces gilchristiistrains restricted to Canada, some of northern USAMycelia forms in environment; disrupted mycelia release conidia that can be inhaled by animals and humans; conidia rapidly change to yeast form in vivo in lungs in temperature-dependent transformation, resulting in clinical infection",
                      "Coccidioidomycosis occurs in areas with low rainfall and high summer temperaturesCoccidioidomycosis endemic in southern California, Arizona, New Mexico, southwestern Texas, Mexico, Central and parts of South America",
                      "Coccidioidomycosis endemic in southern California, Arizona, New Mexico, southwestern Texas, Mexico, Central and parts of South America",
                      "Histoplasmosis and blastomycosis occur in watershed areas with moist soil, often containing rich organic materialHistoplasmosis: Endemic in Ohio and Mississippi river valleys but worldwide distributionBlastomycosis:B. dermatitidisisolates throughout North America, esp. Great Lakes;Blastomyces gilchristiistrains restricted to Canada, some of northern USA",
                      "Histoplasmosis: Endemic in Ohio and Mississippi river valleys but worldwide distribution",
                      "Blastomycosis:B. dermatitidisisolates throughout North America, esp. Great Lakes;Blastomyces gilchristiistrains restricted to Canada, some of northern USA",
                      "Mycelia forms in environment; disrupted mycelia release conidia that can be inhaled by animals and humans; conidia rapidly change to yeast form in vivo in lungs in temperature-dependent transformation, resulting in clinical infection"
                    ]
                  },
                  {
                    "text": "Many CNS infections preceded by pulmonary infectionMay be dominant type of infection (e.g., blastomycosis, histoplasmosis)May be clinically overlooked or absent at time of CNS disease (e.g., cryptococcosis)",
                    "sub_points": [
                      "May be dominant type of infection (e.g., blastomycosis, histoplasmosis)",
                      "May be clinically overlooked or absent at time of CNS disease (e.g., cryptococcosis)"
                    ]
                  },
                  {
                    "text": "Fungi reach CNS via hematogenous route, usually from lung"
                  },
                  {
                    "text": "Pathogenic infections: Organism has capability of producing disease in any individual following exposure to sufficient numbers of fungiBlastomycosis, histoplasmosis usually pathogenic and infection usually confined to lungFocal granulomatous disease in immunocompetent hostsDisseminated disease, including CNS involvement, occurs in immunocompromised hosts (e.g., AIDS)",
                    "sub_points": [
                      "Blastomycosis, histoplasmosis usually pathogenic and infection usually confined to lung",
                      "Focal granulomatous disease in immunocompetent hosts",
                      "Disseminated disease, including CNS involvement, occurs in immunocompromised hosts (e.g., AIDS)"
                    ]
                  },
                  {
                    "text": "Opportunistic infections: Organism causes disease in patients with lowered resistanceCandidiasis, Mucoromycetes, cryptococcal infections usually opportunisticCoccidioidomycosis, aspergillosis in both immunocompetent and immunocompromised hosts",
                    "sub_points": [
                      "Candidiasis, Mucoromycetes, cryptococcal infections usually opportunistic",
                      "Coccidioidomycosis, aspergillosis in both immunocompetent and immunocompromised hosts"
                    ]
                  },
                  {
                    "text": "Risk factors that lower host resistanceNeutropeniaSteroidsImpaired cell-mediated immunityImpaired integument (e.g.,Candidaspp.)Diabetic ketoacidosis (e.g., Mucoromycetes)",
                    "sub_points": [
                      "Neutropenia",
                      "Steroids",
                      "Impaired cell-mediated immunity",
                      "Impaired integument (e.g.,Candidaspp.)",
                      "Diabetic ketoacidosis (e.g., Mucoromycetes)"
                    ]
                  },
                  {
                    "text": "Occasionally acquired through direct inoculation from trauma or surgery"
                  },
                  {
                    "text": "\"Phaeohyphomycosis\" refers to infections due to large group of heterogenous organisms called \"dematiaceous\" or \"melanized\" fungiFungi ubiquitous in environment, although development of infection is extremely uncommonCan cause serious disease in both immunocompetent and immunocompromised hosts",
                    "sub_points": [
                      "Fungi ubiquitous in environment, although development of infection is extremely uncommon",
                      "Can cause serious disease in both immunocompetent and immunocompromised hosts"
                    ]
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "B. dermatitidis"
                  },
                  {
                    "text": "H. capsulatum"
                  },
                  {
                    "text": "Coccidioides immitis"
                  },
                  {
                    "text": "Aspergillosis fumigatus"
                  },
                  {
                    "text": "C. neoformans"
                  },
                  {
                    "text": "Mucoromycetes (Mucorspp.,Rhizopusspp.)"
                  },
                  {
                    "text": "Candida albicans"
                  },
                  {
                    "text": "Rare dematiaceous (pigmented) fungi are emerging agents for cerebral mycosisCladophialophora, Exophiala, Alternariaspp.",
                    "sub_points": [
                      "Cladophialophora, Exophiala, Alternariaspp."
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Between 1999 and 2004,Cryptococcusgattiicaused outbreaks of human cryptococcosis in unexpected, nonendemic, nontropical regions on Vancouver Island, Canada, USA Pacific Northwest, and CaliforniaC. gattiirecognized as emerging species with several genotypes + unique environmental relationship with trees often encountered in wilderness and landscaped parksHigh fatality rateOccurred in both immunocompetent and immunocompromised hostsOriginally thought to be restricted to highly exposed individuals in tropics before this outbreak",
                    "sub_points": [
                      "C. gattiirecognized as emerging species with several genotypes + unique environmental relationship with trees often encountered in wilderness and landscaped parks",
                      "High fatality rate",
                      "Occurred in both immunocompetent and immunocompromised hosts",
                      "Originally thought to be restricted to highly exposed individuals in tropics before this outbreak"
                    ]
                  }
                ],
                "Incidence": [
                  {
                    "text": "Most common CNS fungal infection worldwide is cryptococcal meningoencephalitisDisseminated mycosis often associated with CNS involvementEstimated 67-84% of patients with invasive cryptococcosis develop CNS mycosis",
                    "sub_points": [
                      "Disseminated mycosis often associated with CNS involvement",
                      "Estimated 67-84% of patients with invasive cryptococcosis develop CNS mycosis"
                    ]
                  },
                  {
                    "text": "Certain conditions predispose patient to infection with specific fungal infectionCandida: Disease/treatment-associated and genetic factors (prolonged antibiotic therapy, neutropenia, steroid therapy, transplantation, chronic granulomatous disease, CARD9 deficiency, neurosurgery, contaminated devices, and prematurity in infants)Mucoromycetes: Diabetic ketoacidosis, necrotic burns, renal failure, intravenous drug use, deferoxamine therapy/iron overloadCryptococcus, histoplasmosis: Contact with birdsBlastomyces,Histoplasma,Coccidioides,Paracoccidioides[dimorphic fungi = mold (mycelial form) in environment (25 °C), yeast in tissue (37 °C)]: Specific endemic geographic areas",
                    "sub_points": [
                      "Candida: Disease/treatment-associated and genetic factors (prolonged antibiotic therapy, neutropenia, steroid therapy, transplantation, chronic granulomatous disease, CARD9 deficiency, neurosurgery, contaminated devices, and prematurity in infants)",
                      "Mucoromycetes: Diabetic ketoacidosis, necrotic burns, renal failure, intravenous drug use, deferoxamine therapy/iron overload",
                      "Cryptococcus, histoplasmosis: Contact with birds",
                      "Blastomyces,Histoplasma,Coccidioides,Paracoccidioides[dimorphic fungi = mold (mycelial form) in environment (25 °C), yeast in tissue (37 °C)]: Specific endemic geographic areas"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "CNS mycoses present as focal parenchymal or diffuse meningeal diseaseFocal infections: Discrete granulomasSeizures, focal neurologic deficits, variable feverDiffuse infections: MeningitisHeadache, meningeal irritation signs, mental status changesHydrocephalus",
                    "sub_points": [
                      "Focal infections: Discrete granulomasSeizures, focal neurologic deficits, variable fever",
                      "Seizures, focal neurologic deficits, variable fever",
                      "Diffuse infections: MeningitisHeadache, meningeal irritation signs, mental status changesHydrocephalus",
                      "Headache, meningeal irritation signs, mental status changes",
                      "Hydrocephalus"
                    ]
                  },
                  {
                    "text": "Fungi variably vasoinvasive; may cause strokeYeasts not vasoinvasive, e.g.,Histoplasma,Blastomyces,CryptococcusHyphal and pseudohyphal fungi vasoinvasive, e.g.,Candida,Aspergillus,Zygomycetes, occasionallyCoccidioides",
                    "sub_points": [
                      "Yeasts not vasoinvasive, e.g.,Histoplasma,Blastomyces,Cryptococcus",
                      "Hyphal and pseudohyphal fungi vasoinvasive, e.g.,Candida,Aspergillus,Zygomycetes, occasionallyCoccidioides"
                    ]
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Amphotericin BPharmaceutical formulations of amphotericin B (AmB) (deoxycholate-AmBd and liposomal L-AmB) have limited distribution in cerebrospinal fluidBut detectable therapeutic concentrations in CNS make them recommended drugs for cryptococcal meningoencephalitis (AmBd with flucytosine), CNS candidiasis (L-AmB), mucormycosis (L-AmB)",
                    "sub_points": [
                      "Pharmaceutical formulations of amphotericin B (AmB) (deoxycholate-AmBd and liposomal L-AmB) have limited distribution in cerebrospinal fluid",
                      "But detectable therapeutic concentrations in CNS make them recommended drugs for cryptococcal meningoencephalitis (AmBd with flucytosine), CNS candidiasis (L-AmB), mucormycosis (L-AmB)"
                    ]
                  },
                  {
                    "text": "Voriconazole1st-line drug of choice for CNSAspergillusspp. infection",
                    "sub_points": [
                      "1st-line drug of choice for CNSAspergillusspp. infection"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Dependent on prompt diagnosis and treatment, degree of underlying immunosuppression"
                  },
                  {
                    "text": "Outcome poor in many patients, even with treatment"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Basilar meningitis, focal granulomatous parenchymal lesion, hemorrhagic infarction(s), hemorrhage: Depending on type of fungus, degree of host immunocompetency"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "B. dermatitidisUncommon CNS infection, even in endemic areasUsually pathogenic infectionMost infections pulmonary, not CNSRare CNS examples, usually localized granulomaIn recent study, CNS blastomycosis manifested as epidural abscess (1 of 22), meningitis (7 of 22), intracranial mass lesions (10 of 22), concomitant intracranial mass lesions and meningitis (4 of 22)Yeast, 8-15 μm with broad-based budMultiple nuclei seen in well-fixed tissuesMucicarmine (-) or shows thin outline, contrasting with thick (+) capsule inCryptococcusFontana-Masson (-)GMS, PAS (+)B. gilchristiireported to be most common cause of blastomycosis in children",
                    "sub_points": [
                      "Uncommon CNS infection, even in endemic areasUsually pathogenic infectionMost infections pulmonary, not CNSRare CNS examples, usually localized granulomaIn recent study, CNS blastomycosis manifested as epidural abscess (1 of 22), meningitis (7 of 22), intracranial mass lesions (10 of 22), concomitant intracranial mass lesions and meningitis (4 of 22)",
                      "Usually pathogenic infection",
                      "Most infections pulmonary, not CNS",
                      "Rare CNS examples, usually localized granuloma",
                      "In recent study, CNS blastomycosis manifested as epidural abscess (1 of 22), meningitis (7 of 22), intracranial mass lesions (10 of 22), concomitant intracranial mass lesions and meningitis (4 of 22)",
                      "Yeast, 8-15 μm with broad-based budMultiple nuclei seen in well-fixed tissuesMucicarmine (-) or shows thin outline, contrasting with thick (+) capsule inCryptococcusFontana-Masson (-)GMS, PAS (+)",
                      "Multiple nuclei seen in well-fixed tissues",
                      "Mucicarmine (-) or shows thin outline, contrasting with thick (+) capsule inCryptococcus",
                      "Fontana-Masson (-)",
                      "GMS, PAS (+)",
                      "B. gilchristiireported to be most common cause of blastomycosis in children"
                    ]
                  },
                  {
                    "text": "H. capsulatumUncommon CNS infection in endemic areasMost infections in reticuloendothelial systemInfection usually confined to lung; yields small, discrete, localized granulomasDissemination usually limited to spleen and liverDissemination in immunocompromised hosts (e.g., AIDS patients); may produce CNS diseaseCNS disease manifests as meningitis, sometimes with secondary CNS infarction due to vasculitis in leptomeningesLocalizing granulomas in immunocompetent patientsDisseminated disease in AIDS patientsYeast (difficult to identify in H&E sections)2-4 μm, intracellular within macrophagesNot encapsulatedAppear much smaller on H&E than on PAS or GMSFixation causes retraction of protoplasm from rigid cell wall, leaving clear spaceRetraction artifact can produce \"pseudocapsule\"Uninucleate, contrasting with multinucleateB. dermatitidis",
                    "sub_points": [
                      "Uncommon CNS infection in endemic areas",
                      "Most infections in reticuloendothelial systemInfection usually confined to lung; yields small, discrete, localized granulomasDissemination usually limited to spleen and liverDissemination in immunocompromised hosts (e.g., AIDS patients); may produce CNS diseaseCNS disease manifests as meningitis, sometimes with secondary CNS infarction due to vasculitis in leptomeninges",
                      "Infection usually confined to lung; yields small, discrete, localized granulomas",
                      "Dissemination usually limited to spleen and liver",
                      "Dissemination in immunocompromised hosts (e.g., AIDS patients); may produce CNS disease",
                      "CNS disease manifests as meningitis, sometimes with secondary CNS infarction due to vasculitis in leptomeninges",
                      "Localizing granulomas in immunocompetent patients",
                      "Disseminated disease in AIDS patients",
                      "Yeast (difficult to identify in H&E sections)",
                      "2-4 μm, intracellular within macrophages",
                      "Not encapsulated",
                      "Appear much smaller on H&E than on PAS or GMSFixation causes retraction of protoplasm from rigid cell wall, leaving clear spaceRetraction artifact can produce \"pseudocapsule\"Uninucleate, contrasting with multinucleateB. dermatitidis",
                      "Fixation causes retraction of protoplasm from rigid cell wall, leaving clear space",
                      "Retraction artifact can produce \"pseudocapsule\"",
                      "Uninucleate, contrasting with multinucleateB. dermatitidis"
                    ]
                  },
                  {
                    "text": "C. immitisUsually occurs as meningitis in both immunocompetent and AIDS patientsSubacute, granulomatous meningitisOften basilar meningitisBrain abscesses less commonDisseminated disease in minority of immunocompetent patients but predilection for CNSSystemic organ involvement possible in addition to CNS: Skin, bones, jointsHistiocytes, multinucleated giant cellsCaseous material more common in lung than CNS lesions30- to 60-μm sporangia contain 1- to 5-μm sporangiospores (endospores)Term \"spherule\" used for intermediate forms between released endospores and sporangiumIntact sporangia elicit granulomatous reactionSpherules may lie within multinucleated giant cellsHyphae and arthroconidia only rarely encountered in tissue sections",
                    "sub_points": [
                      "Usually occurs as meningitis in both immunocompetent and AIDS patientsSubacute, granulomatous meningitisOften basilar meningitis",
                      "Subacute, granulomatous meningitis",
                      "Often basilar meningitis",
                      "Brain abscesses less common",
                      "Disseminated disease in minority of immunocompetent patients but predilection for CNS",
                      "Systemic organ involvement possible in addition to CNS: Skin, bones, joints",
                      "Histiocytes, multinucleated giant cells",
                      "Caseous material more common in lung than CNS lesions",
                      "30- to 60-μm sporangia contain 1- to 5-μm sporangiospores (endospores)Term \"spherule\" used for intermediate forms between released endospores and sporangiumIntact sporangia elicit granulomatous reactionSpherules may lie within multinucleated giant cells",
                      "Term \"spherule\" used for intermediate forms between released endospores and sporangium",
                      "Intact sporangia elicit granulomatous reaction",
                      "Spherules may lie within multinucleated giant cells",
                      "Hyphae and arthroconidia only rarely encountered in tissue sections"
                    ]
                  },
                  {
                    "text": "A. fumigatusUncommon infection in healthy individualsIn farmers exposed to silageIn some relatively healthy patients with only risk factor such as steroid use for asthmaOrbitorhinal infectionsIn immunocompromised patients, most commonly in debilitated patientsSteroids, neutropenia principal risk factorsImpaired integumentChronic pulmonary disease, hematologic malignancies, bone marrow transplantation recipients, burn victimsUncommon in AIDS patientsA. fumigatusuncommon in patients with solid systemic organ neoplasmsOther species:Aspergillosisflavus,AspergillosisnigerAspergillosisterreusmay be more common pathogen in metastatic, primary brain tumor patients with lymphopeniaDichotomous, branching hyphaeAcute angle branchingHyphae permeate vessel wallSeptate hyphae radiate from center of thrombosed vesselHyphae (+) with PAS, GMSHyphae may be bulbous, distorted in tissue sectionsNeutrophilic reaction in acute infections, uncommon in immunocompetent hostGranulomatous to absent reaction in immunocompromised hostThrombosis leads to hemorrhagic infarction, overt hemorrhageCannot distinguishAspergillusspp. on tissue features; culture required",
                    "sub_points": [
                      "Uncommon infection in healthy individualsIn farmers exposed to silageIn some relatively healthy patients with only risk factor such as steroid use for asthmaOrbitorhinal infections",
                      "In farmers exposed to silage",
                      "In some relatively healthy patients with only risk factor such as steroid use for asthma",
                      "Orbitorhinal infections",
                      "In immunocompromised patients, most commonly in debilitated patientsSteroids, neutropenia principal risk factorsImpaired integumentChronic pulmonary disease, hematologic malignancies, bone marrow transplantation recipients, burn victimsUncommon in AIDS patientsA. fumigatusuncommon in patients with solid systemic organ neoplasmsOther species:Aspergillosisflavus,AspergillosisnigerAspergillosisterreusmay be more common pathogen in metastatic, primary brain tumor patients with lymphopenia",
                      "Steroids, neutropenia principal risk factors",
                      "Impaired integument",
                      "Chronic pulmonary disease, hematologic malignancies, bone marrow transplantation recipients, burn victims",
                      "Uncommon in AIDS patients",
                      "A. fumigatusuncommon in patients with solid systemic organ neoplasms",
                      "Other species:Aspergillosisflavus,Aspergillosisniger",
                      "Aspergillosisterreusmay be more common pathogen in metastatic, primary brain tumor patients with lymphopenia",
                      "Dichotomous, branching hyphae",
                      "Acute angle branching",
                      "Hyphae permeate vessel wall",
                      "Septate hyphae radiate from center of thrombosed vessel",
                      "Hyphae (+) with PAS, GMS",
                      "Hyphae may be bulbous, distorted in tissue sections",
                      "Neutrophilic reaction in acute infections, uncommon in immunocompetent host",
                      "Granulomatous to absent reaction in immunocompromised host",
                      "Thrombosis leads to hemorrhagic infarction, overt hemorrhage",
                      "Cannot distinguishAspergillusspp. on tissue features; culture required"
                    ]
                  },
                  {
                    "text": "C. neoformansUsually opportunistic infectionMost common fungal CNS infection in AIDS patientsPrimary infection thought to be pulmonary but rarely clinically recognizedWidely disseminated disease may affect multiple organs, CNS most severelyMeningitis, often with minimal host inflammatory responseOccasional focal granulomatous responseYeast, 4-7 μmMucinous capsule, mucicarmine stain (+) (carminophilic); Alcian blue (+)Capsule 3-5 μm thickYeast in old fibrotic, caseous lesions have diminished carminophiliaYeast PAS, GMS (+)",
                    "sub_points": [
                      "Usually opportunistic infection",
                      "Most common fungal CNS infection in AIDS patients",
                      "Primary infection thought to be pulmonary but rarely clinically recognized",
                      "Widely disseminated disease may affect multiple organs, CNS most severely",
                      "Meningitis, often with minimal host inflammatory response",
                      "Occasional focal granulomatous response",
                      "Yeast, 4-7 μm",
                      "Mucinous capsule, mucicarmine stain (+) (carminophilic); Alcian blue (+)",
                      "Capsule 3-5 μm thick",
                      "Yeast in old fibrotic, caseous lesions have diminished carminophilia",
                      "Yeast PAS, GMS (+)"
                    ]
                  },
                  {
                    "text": "Zygomycetesspp. (Rhizopus,Mucor,Absidia)Usually opportunistic infectionDiabetic ketoacidosisPatients with malignancyBroad hyphae10- to 15-μm diameterBranching irregular compared toAspergillusspp.Only rare septations; folds may mimic septationsVasoinvasive, leads to infarctionClassic is vasoinvasion large vessels at base of brain with rhinocerebral diseaseMost infections due toRhizopusspp. but cannot distinguish types in tissue sections; culture requiredOften minimal inflammatory host responseSometimes seen better on H&E than PAS, GMS",
                    "sub_points": [
                      "Usually opportunistic infection",
                      "Diabetic ketoacidosis",
                      "Patients with malignancy",
                      "Broad hyphae10- to 15-μm diameterBranching irregular compared toAspergillusspp.Only rare septations; folds may mimic septationsVasoinvasive, leads to infarctionClassic is vasoinvasion large vessels at base of brain with rhinocerebral disease",
                      "10- to 15-μm diameter",
                      "Branching irregular compared toAspergillusspp.",
                      "Only rare septations; folds may mimic septations",
                      "Vasoinvasive, leads to infarction",
                      "Classic is vasoinvasion large vessels at base of brain with rhinocerebral disease",
                      "Most infections due toRhizopusspp. but cannot distinguish types in tissue sections; culture required",
                      "Often minimal inflammatory host response",
                      "Sometimes seen better on H&E than PAS, GMS"
                    ]
                  },
                  {
                    "text": "Candidaspp.Opportunistic infectionPatients often with prolonged antibiotic therapy, abdominal operations, catheters, etc.CNS involvement usually late in disseminated diseaseHigher incidence of CNS fungal infection byCandidaspp. at autopsyYeast (+) pseudohyphae (\"noodles and eggs\")3-4 μmVasoinvasive: Hemorrhagic infarctionsUsually minimal inflammatory host response",
                    "sub_points": [
                      "Opportunistic infection",
                      "Patients often with prolonged antibiotic therapy, abdominal operations, catheters, etc.",
                      "CNS involvement usually late in disseminated disease",
                      "Higher incidence of CNS fungal infection byCandidaspp. at autopsy",
                      "Yeast (+) pseudohyphae (\"noodles and eggs\")3-4 μmVasoinvasive: Hemorrhagic infarctions",
                      "3-4 μm",
                      "Vasoinvasive: Hemorrhagic infarctions",
                      "Usually minimal inflammatory host response"
                    ]
                  },
                  {
                    "text": "Dematiaceous fungiBlack-brown pigment on H&E due to melanin in fungal wallMelanin in fungus not incidental: Promotes survival under harsh conditions, aids in fungal virulence",
                    "sub_points": [
                      "Black-brown pigment on H&E due to melanin in fungal wall",
                      "Melanin in fungus not incidental: Promotes survival under harsh conditions, aids in fungal virulence"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cryptococci may abound in CSF but is easy to overlook if not specifically sought"
                  },
                  {
                    "text": "Some cases with fungal meningitis, ventriculitis may have histiocytes, lymphocytes, multinucleated giant cells in CSF"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cultures": [
                  {
                    "text": "Necessary to document species, sometimes type of fungal infection"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "HistoplasmaFromToxoplasma": [
                  {
                    "text": "Toxoplasmasmaller, not in macrophages"
                  },
                  {
                    "text": "Toxoplasma(-) for PAS, GMS fungal stains"
                  },
                  {
                    "text": "Immunohistochemistry forToxoplasma(+)"
                  }
                ],
                "HistoplasmaFromPneumocystis carinii": [
                  {
                    "text": "Pneumocystis(+) on GMS, butP. cariniiinfection does not affect CNS"
                  }
                ],
                "CryptococcusFromBlastomyces": [
                  {
                    "text": "Blastomycesslightly carminophilic but contains multiple nuclei"
                  },
                  {
                    "text": "Cryptococcusthicker carminophilic, Alcian blue (+), capsule"
                  },
                  {
                    "text": "CryptococcusFontana-Masson (+),BlastomycesFontana-Masson (-)"
                  }
                ],
                "HistoplasmaFromCryptococcus": [
                  {
                    "text": "Histoplasmasmaller; pseudocapsule due to retraction artifact, not true capsule"
                  },
                  {
                    "text": "Histoplasmausually nearly invisible on H&E,Cryptococcusis gray-blue in H&E sections, more visible due to thick capsule"
                  },
                  {
                    "text": "Histoplasmamucicarmine (-)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Hyphal forms often vasoinvasive with risk for infarction"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Histoplasmasmaller on H&E than on PAS, GMS fungal stains due to fixation-induced retraction of protoplasm from rigid wallHistoplasmanearly invisible on H&E",
                    "sub_points": [
                      "Histoplasmanearly invisible on H&E"
                    ]
                  },
                  {
                    "text": "Cryptococcusspp. Fontana-Masson (+) and stronger mucicarmine (+);Blastomycesspp. Fontana-Masson (-)"
                  },
                  {
                    "text": "Rare true septations in hyphae do not exclude diagnosis ofRhizopusspp.; exclude folds in broad hyphae"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Herpes Simplex Encephalitis": {
            "name": "Herpes Simplex Encephalitis",
            "url": "https://app.pathprimer.com/document/b49068ac-c46c-4545-a5d9-f28066a4ea2c/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Herpes simplex virus (HSV); types 1 or 2 (HSV1 or HSV2)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common cause of sporadic fatal encephalitis"
                  },
                  {
                    "text": "Fever, focal neurologic deficits, psychiatric symptoms, altered mental status, cognitive defects"
                  },
                  {
                    "text": "Most patients immunocompetent"
                  }
                ],
                "Imaging": [
                  {
                    "text": "MR more sensitive than CT, shows hyperintense medial temporal, inferior frontal lobe involvement"
                  },
                  {
                    "text": "Limbic system involved, including cingulate gyri, insular cortex, with basal ganglia sparing"
                  },
                  {
                    "text": "Bilateral involvement is typical but may be asymmetric"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Hemorrhagic, necrotizing encephalitis"
                  },
                  {
                    "text": "Neutrophilic, lymphocytic, microglial influx with tissue destruction"
                  },
                  {
                    "text": "Cowdry A owl's eye viral inclusions, classic"
                  },
                  {
                    "text": "Later stages of disease: Mostly macrophages, rare viral inclusions"
                  },
                  {
                    "text": "End stages of disease: Rarefaction, cavitation of tissue"
                  },
                  {
                    "text": "Pseudoischemic form seen in overwhelming infections in immunocompromised individuals"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CSF PCR diagnostic gold standard for diagnosisTest may be negative early in course of HSV; repeat testing should be considered if HSV suspected",
                    "sub_points": [
                      "Test may be negative early in course of HSV; repeat testing should be considered if HSV suspected"
                    ]
                  },
                  {
                    "text": "Use of CNS biopsy largely obviated by CSF PCR testing"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Other types of viral encephalitis"
                  },
                  {
                    "text": "Patients with relapsing HSV encephalitis or prolonged atypical symptoms, with negative CSF PCR for HSV should routinely be tested for NR1 N-methyl-D-aspartate receptor (NMDAR) IgG antibodies in CSF and serum"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Herpes simplex virus (HSV) encephalitis (HSVE)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Hemorrhagic, necrotizing CNS infection by HSV"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "HSV type 1 (HSV1): Most common cause of HSVE"
                  },
                  {
                    "text": "Disease typically caused by reactivation of virus in immunocompetent patients"
                  },
                  {
                    "text": "HSV type 2 (HSV2): HSV meningitis in adults, fetal intrauterine/perinatal infection"
                  },
                  {
                    "text": "HSV relatively uncommon in HIV(+) population"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "HSV most frequent cause of sporadic viral encephalitisHerpes simplex encephalitis is most common cause of encephalitis hospitalizations",
                    "sub_points": [
                      "Herpes simplex encephalitis is most common cause of encephalitis hospitalizations"
                    ]
                  },
                  {
                    "text": "No seasonal predilection; no animal or insect vector"
                  },
                  {
                    "text": "Patients usually not immunocompromised, although more severe forms of HSV occur in severely immunocompromised patients, including those with HIV"
                  }
                ],
                "Site": [
                  {
                    "text": "HSV shows predilection for frontal/temporal lobes and limbic system, including cingulate gyri and insular cortex"
                  },
                  {
                    "text": "Disease usually bilateral but may be asymmetricAsymmetric or atypical locations more likely to prompt biopsy",
                    "sub_points": [
                      "Asymmetric or atypical locations more likely to prompt biopsy"
                    ]
                  },
                  {
                    "text": "Brainstem predominance uncommon"
                  }
                ],
                "Presentation": [
                  {
                    "text": "HSVEEncephalopathy or focal neurologic symptoms + feverEncephalitis shows more significant alterations in level of consciousness, more psychiatric symptoms and cognitive defects than viral meningitisUsually caused by HSV1Classic HSVE is acute viral infection that usually follows monophasic disease courseAtypical presentations in immunocompromised patients: Fewer focal neurologic deficits, diffuse nonnecrotizing encephalitis involving hemispheres and brainstem",
                    "sub_points": [
                      "Encephalopathy or focal neurologic symptoms + fever",
                      "Encephalitis shows more significant alterations in level of consciousness, more psychiatric symptoms and cognitive defects than viral meningitis",
                      "Usually caused by HSV1",
                      "Classic HSVE is acute viral infection that usually follows monophasic disease course",
                      "Atypical presentations in immunocompromised patients: Fewer focal neurologic deficits, diffuse nonnecrotizing encephalitis involving hemispheres and brainstem"
                    ]
                  },
                  {
                    "text": "Brainstem infectionNeuroophthalmologic findings in most patientsCranial nerve deficits in majorityFever in majorityQuadriplegia unusualUsually caused by HSV1 but much less frequent than frontal/temporal lobe type",
                    "sub_points": [
                      "Neuroophthalmologic findings in most patients",
                      "Cranial nerve deficits in majority",
                      "Fever in majority",
                      "Quadriplegia unusual",
                      "Usually caused by HSV1 but much less frequent than frontal/temporal lobe type"
                    ]
                  },
                  {
                    "text": "Herpes simplex meningitis (formerly recurrent Mollaret meningitis)Infection due to HSV2Usually in adultsAseptic meningitis occurs in ~ 1/3 of females with primary HSV2 genital infection",
                    "sub_points": [
                      "Infection due to HSV2",
                      "Usually in adults",
                      "Aseptic meningitis occurs in ~ 1/3 of females with primary HSV2 genital infection"
                    ]
                  },
                  {
                    "text": "Fetal intrauterine or perinatal infectionHSV2 genital herpetic infection transmitted during vaginal birthRisk to fetus reduced with cesarean sectionRare, but devastatingMay be disseminated systemic infection or encephalitis onlyRisk only 1% if mother is HSV2 seropositive but without genital infection",
                    "sub_points": [
                      "HSV2 genital herpetic infection transmitted during vaginal birthRisk to fetus reduced with cesarean section",
                      "Risk to fetus reduced with cesarean section",
                      "Rare, but devastating",
                      "May be disseminated systemic infection or encephalitis only",
                      "Risk only 1% if mother is HSV2 seropositive but without genital infection"
                    ]
                  },
                  {
                    "text": "Very rare chronic granulomatous form of HSV infection"
                  },
                  {
                    "text": "Rare post-HSVE development of N-methyl-D-aspartate receptor (NMDAR) antibodies resulting in autoimmune encephalitisPatients with relapsing HSVE or prolonged atypical symptoms, who have negative CSF PCR for HSV should routinely be tested for NMDAR IgG antibodies in CSF and serumAnti-NMDAR develops 1-4 weeks after HSVE, manifests as choreoathetosis &/or orofacial dyskinesia in children, psychiatric symptoms in young adults",
                    "sub_points": [
                      "Patients with relapsing HSVE or prolonged atypical symptoms, who have negative CSF PCR for HSV should routinely be tested for NMDAR IgG antibodies in CSF and serum",
                      "Anti-NMDAR develops 1-4 weeks after HSVE, manifests as choreoathetosis &/or orofacial dyskinesia in children, psychiatric symptoms in young adults"
                    ]
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "AcyclovirShould be started immediately if HSV suspected",
                    "sub_points": [
                      "Should be started immediately if HSV suspected"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "HSVE devastating disorder1/2 of patients either die or left with major neurologic deficits",
                    "sub_points": [
                      "1/2 of patients either die or left with major neurologic deficits"
                    ]
                  },
                  {
                    "text": "HSV aseptic meningitis mild, self-limitedMinority of patients require hospitalization",
                    "sub_points": [
                      "Minority of patients require hospitalization"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Best imaging tool; positive 24-48 hours earlier than CT"
                  },
                  {
                    "text": "Hyperintense medial temporal, inferior frontal cortex involvement"
                  },
                  {
                    "text": "Involvement of other limbic areas, such as cingulate gyrus, insular region highly suggestive of diagnosis"
                  },
                  {
                    "text": "Involvement of contralateral temporal lobe highly suggestive of diagnosis"
                  },
                  {
                    "text": "Disease may be asymmetric"
                  },
                  {
                    "text": "Basal ganglia sparing is typical"
                  },
                  {
                    "text": "Subacute blood products may be seen in later stages of infection"
                  },
                  {
                    "text": "Neonatal encephalitis may be focal or multifocal, involving any lobe(s)"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Often normal early in disease course"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Temporal lobe necrosis, hemorrhage"
                  },
                  {
                    "text": "Temporal lobe rarefaction, cavitation in advanced cases"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "HSVE: Hemorrhagic, necrotizing parenchymal infection"
                  },
                  {
                    "text": "Parenchymal necrosisImmunocompromised patients: Widespread \"red-dead\" neurons with scant/absent inflammation simulate infarction (pseudoischemic form)",
                    "sub_points": [
                      "Immunocompromised patients: Widespread \"red-dead\" neurons with scant/absent inflammation simulate infarction (pseudoischemic form)"
                    ]
                  },
                  {
                    "text": "Profuse microglial influx in response to tissue damageNeuronophagiaNeuronal apoptosis results from direct viral injury, not dependent on inflammatory T-cell responses",
                    "sub_points": [
                      "Neuronophagia",
                      "Neuronal apoptosis results from direct viral injury, not dependent on inflammatory T-cell responses"
                    ]
                  },
                  {
                    "text": "Inflammation and tissue destruction predominantly cortical but may extend into subgyral white matter"
                  },
                  {
                    "text": "Neutrophilic and lymphocytic meningeal infiltrates, may be intensePerivascular lymphocytes, some highly activatedDiffuse permeation of necrotic parenchyma by neutrophils",
                    "sub_points": [
                      "Perivascular lymphocytes, some highly activated",
                      "Diffuse permeation of necrotic parenchyma by neutrophils"
                    ]
                  },
                  {
                    "text": "Viral inclusions in neurons, astrocytes, oligodendrocytes"
                  },
                  {
                    "text": "Viral inclusions confined to acute and subacute phasesRemote stages of disease with loss of viral inclusions",
                    "sub_points": [
                      "Remote stages of disease with loss of viral inclusions"
                    ]
                  },
                  {
                    "text": "Subset of larger cells show Cowdry A, owl's eye herpetic inclusions without cell enlargement (i.e., without cytomegaly as in cytomegalovirus infections)"
                  },
                  {
                    "text": "Infected oligodendrocytes show violaceous viral inclusions with beading of nuclear membrane and virus filling nucleus without discrete inclusions"
                  },
                  {
                    "text": "Cavitation in late stages of disease with variably persistent lymphocytic inflammation"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Viral inclusions yield nuclear enlargement and eosinophilic owl's eye Cowdry A herpetic inclusions"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Usually positive for HSV1Significantly larger numbers of cells immunopositive than those with viral inclusionsMost immunoreactivity in inclusions and nucleus but some in cytoplasm as cell lysis begins",
                    "sub_points": [
                      "Significantly larger numbers of cells immunopositive than those with viral inclusions",
                      "Most immunoreactivity in inclusions and nucleus but some in cytoplasm as cell lysis begins"
                    ]
                  },
                  {
                    "text": "Many commercial antibodies are directed against HSV1 or HSV2, not both; recognize this when ordering immunostain"
                  }
                ],
                "PCR": [
                  {
                    "text": "Diagnostic gold standard is CSF HSV PCR"
                  },
                  {
                    "text": "In CSF: 96-98% sensitive"
                  },
                  {
                    "text": "In cases with negative results but high clinical suspicion, should be repeated in CSF after 3-7 days, since testing may be negative in 1st days of illness"
                  },
                  {
                    "text": "In 1 large study, 7.6% of 1,224 CSF specimens were positive for HSV-DNACSF HSV-DNA(+) patients had meningitis (52%), encephalitis (26%), neonatal infection (17%), or nonclassifiable disease (5%)17% of HSV patients had mild or atypical disease characterized by absence of focal findings and slow progression in absence of antiviral therapy",
                    "sub_points": [
                      "CSF HSV-DNA(+) patients had meningitis (52%), encephalitis (26%), neonatal infection (17%), or nonclassifiable disease (5%)",
                      "17% of HSV patients had mild or atypical disease characterized by absence of focal findings and slow progression in absence of antiviral therapy"
                    ]
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "HSV serology may help define whether HSV is primary or reactivated infection, although clinical features, therapy, and prognosis are similar"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Paraneoplastic Limbic Encephalitis": [
                  {
                    "text": "Usually neuronal antibodies in serum and CSF"
                  },
                  {
                    "text": "More protracted clinical course than HSV, less fever"
                  },
                  {
                    "text": "Usually seen with carcinoma of lung in adult patients"
                  }
                ],
                "Other Viral Encephalitides": [
                  {
                    "text": "Usually lack frontal/temporal, limbic distribution"
                  },
                  {
                    "text": "CSF HSV PCR (-)"
                  },
                  {
                    "text": "HSV1/2 immunohistochemistry (-)"
                  }
                ],
                "Acute Infarction": [
                  {
                    "text": "Lacks intense leptomeningeal, perivascular inflammation"
                  },
                  {
                    "text": "CSF HSV PCR (-)"
                  },
                  {
                    "text": "HSV1/2 immunohistochemistry (-)"
                  },
                  {
                    "text": "Vascular distribution of involvement (i.e., in territory of middle, posterior cerebral artery or branches)"
                  },
                  {
                    "text": "No fever or flu-like illness"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Especially in immunocompromised patients, HSV can present with pseudoischemic appearance due to widespread \"red-dead\" neuronsInflammation in such cases can be limited",
                    "sub_points": [
                      "Inflammation in such cases can be limited"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Toxoplasmosis": {
            "name": "Toxoplasmosis",
            "url": "https://app.pathprimer.com/document/9aada460-70c9-4f9f-b015-f83382869ee7/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "CNS infection caused by intracellular protozoal parasite,Toxoplasma gondii"
                  },
                  {
                    "text": "Symptomatic infection usually in immunocompromised patient"
                  },
                  {
                    "text": "Congenital toxoplasmosis: Wide spectrum of lesions from extensive necrotizing lesions to intraparenchymal calcifications"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most frequent mass lesion in AIDS patients prior to advent of highly effective antiretroviral therapy (HAART)"
                  },
                  {
                    "text": "Diminished frequency with advent of HAART"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Ring-enhancing lesions, often multiple, often in basal ganglia"
                  },
                  {
                    "text": "Acute lesions with surrounding edema and mass effect"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Acute necrotizing, organizing, chronic abscesses"
                  },
                  {
                    "text": "Different stages of disease may coexist in same patient"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Classic lesion: Coagulation necrosis of vessels and parenchyma with little, if any, inflammation"
                  },
                  {
                    "text": "Necrotizing lesions of varying sizes (dirty necrosis)"
                  },
                  {
                    "text": "Fibrinoid vascular necrosis"
                  },
                  {
                    "text": "Limited or absent lymphocytic inflammation"
                  },
                  {
                    "text": "Ventriculitis (uncommon)"
                  },
                  {
                    "text": "Diffuse encephalitic form (uncommon)"
                  },
                  {
                    "text": "Recognition of organisms is importantTachyzoites, most suggestive of active infectionTissue cysts containing bradyzoites, mostly along periphery of necrotizing abscesses",
                    "sub_points": [
                      "Tachyzoites, most suggestive of active infection",
                      "Tissue cysts containing bradyzoites, mostly along periphery of necrotizing abscesses"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "IHC for organisms valuable in diagnosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "CNS infection byToxoplasma gondii, almost always in immunocompromised patients"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "T.gondiiis found in almost all geographic areas; cysts can be identified in most warm-blooded animals"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "T.gondiiis intracellular protozoal parasite"
                  },
                  {
                    "text": "Humans infected by ingestion of oocysts or tissue cysts (bradyzoites)Consumption of cysts in undercooked meat, particularly pork and lamb, is major risk factorIngestion of oocysts in contaminated soil and water; oocytes shed in cat feces",
                    "sub_points": [
                      "Consumption of cysts in undercooked meat, particularly pork and lamb, is major risk factor",
                      "Ingestion of oocysts in contaminated soil and water; oocytes shed in cat feces"
                    ]
                  },
                  {
                    "text": "Only definitive host (source of infectious oocysts) is catLife cycle of parasite: Sexual phase occurs in cat; oocysts secreted in cat feces survive 1 or more yearsAfter oocyst ingestion by human or animal, sporozoites released in intestine enter circulatory system and spread hematogenouslyOnce sporozoite gains access to cell, transforms into tachyzoitesTachyzoites form tissue cysts containing bradyzoites",
                    "sub_points": [
                      "Life cycle of parasite: Sexual phase occurs in cat; oocysts secreted in cat feces survive 1 or more years",
                      "After oocyst ingestion by human or animal, sporozoites released in intestine enter circulatory system and spread hematogenously",
                      "Once sporozoite gains access to cell, transforms into tachyzoites",
                      "Tachyzoites form tissue cysts containing bradyzoites"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Neurologic diseaseFocal lesions in immunocompromised patients~ 1/2 ofToxoplasma-seropositive patientsMarkedly decreased incidence after highly active antiretroviral therapy (HAART)Prior to HAART, most common cause of focal lesions in AIDS patients was toxoplasmosisFocal neurologic deficits (e.g., seizures, hemiparesis)FeverDiffuse encephalitic formMental status changes, rapid global neurologic deteriorationNonlocalizing symptomsMild to subclinical meningoencephalitis in immunocompetent patientDisease usually resolves spontaneously without clinical sequelaeSymptomatic disease: Infectious mononucleosis-type illness with adenopathy &/or fever with maculopapular rashIdentifiable structural CNS lesions uncommon; presents as mild meningoencephalitisVentriculitisSymptoms referable to hydrocephalus",
                    "sub_points": [
                      "Focal lesions in immunocompromised patients~ 1/2 ofToxoplasma-seropositive patientsMarkedly decreased incidence after highly active antiretroviral therapy (HAART)Prior to HAART, most common cause of focal lesions in AIDS patients was toxoplasmosisFocal neurologic deficits (e.g., seizures, hemiparesis)Fever",
                      "~ 1/2 ofToxoplasma-seropositive patients",
                      "Markedly decreased incidence after highly active antiretroviral therapy (HAART)",
                      "Prior to HAART, most common cause of focal lesions in AIDS patients was toxoplasmosis",
                      "Focal neurologic deficits (e.g., seizures, hemiparesis)",
                      "Fever",
                      "Diffuse encephalitic formMental status changes, rapid global neurologic deteriorationNonlocalizing symptoms",
                      "Mental status changes, rapid global neurologic deterioration",
                      "Nonlocalizing symptoms",
                      "Mild to subclinical meningoencephalitis in immunocompetent patientDisease usually resolves spontaneously without clinical sequelaeSymptomatic disease: Infectious mononucleosis-type illness with adenopathy &/or fever with maculopapular rashIdentifiable structural CNS lesions uncommon; presents as mild meningoencephalitis",
                      "Disease usually resolves spontaneously without clinical sequelae",
                      "Symptomatic disease: Infectious mononucleosis-type illness with adenopathy &/or fever with maculopapular rash",
                      "Identifiable structural CNS lesions uncommon; presents as mild meningoencephalitis",
                      "VentriculitisSymptoms referable to hydrocephalus",
                      "Symptoms referable to hydrocephalus"
                    ]
                  },
                  {
                    "text": "Congenital toxoplasmosisFrequently with ocular involvementAcquired in utero, damage to fetus maximal in midterm infections, minimal effects in late gestationMicrocephaly in severe cases",
                    "sub_points": [
                      "Frequently with ocular involvement",
                      "Acquired in utero, damage to fetus maximal in midterm infections, minimal effects in late gestation",
                      "Microcephaly in severe cases"
                    ]
                  },
                  {
                    "text": "ChorioretinitisAcute chorioretinitis can be de novoIf reactivation, pigmented chorioretinal scar is also present",
                    "sub_points": [
                      "Acute chorioretinitis can be de novo",
                      "If reactivation, pigmented chorioretinal scar is also present"
                    ]
                  },
                  {
                    "text": "Immune reconstitution syndrome (IRIS) may develop after HAART therapy (rare)"
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Pyrimethamine plus sulfadiazine (P+S)"
                  },
                  {
                    "text": "Trimethoprim-sulfamethoxazole in resource-poor settings where P+S not available"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Prior to introduction of HAART, median survival < 1 year"
                  },
                  {
                    "text": "Infections withToxoplasmanot currently preventable by immunization"
                  },
                  {
                    "text": "Postnatal therapy of infected neonates substantially improves outcome"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Smooth rim enhancement"
                  },
                  {
                    "text": "Central targetoid, low-density area corresponding to necrosis"
                  },
                  {
                    "text": "Perilesional edema"
                  },
                  {
                    "text": "Often multifocal"
                  },
                  {
                    "text": "Bilateral lesions in basal ganglia especially characteristic"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Ring-enhancing hypodense lesions in basal ganglia or cortical gray matter"
                  },
                  {
                    "text": "CT often underrepresents number of lesions found pathologically"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Multifocal abscesses with appearance dependent on stageUsually involve cerebral hemisphere, especially basal gangliaMost prominent near cortical gray-white junctionAlso in cerebellumBrainstem and spinal cord involvement infrequent and usually in association with heavy disease burden in cerebral hemispheres",
                    "sub_points": [
                      "Usually involve cerebral hemisphere, especially basal ganglia",
                      "Most prominent near cortical gray-white junction",
                      "Also in cerebellum",
                      "Brainstem and spinal cord involvement infrequent and usually in association with heavy disease burden in cerebral hemispheres"
                    ]
                  },
                  {
                    "text": "Necrotizing abscess: Poorly circumscribed, softened necrotic tissue, petechiae, surrounding edema"
                  },
                  {
                    "text": "Organizing abscess: Better demarcated, central yellow necrosis, hyperemic border, peripheral yellow capsule"
                  },
                  {
                    "text": "Chronic abscess: Well-demarcated, central yellow necrosis, minimal edema"
                  },
                  {
                    "text": "Ventriculitis with necrotic yellow exudate, periventricular petechiae"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Multifocal discrete abscess lesions3 morphologic stages (different stages and sizes of lesions can coexist in same patient)Necrotizing: Coagulative necrosis,Toxoplasmacysts, and numerous free tachyzoites, usually minimal host inflammatory response, small arteries with fibrinoid necrosis, endothelial damage, thrombosisOrganizing: Central eosinophilic, acellular, coagulative necrosis, periphery with histiocytes containing lipid and hemosiderin, variable inflammation, astrocytosis, microglial proliferationChronic: More demarcated capsule, often hemosiderin and intense reactive gliosis at periphery; organisms may not be found, especially after treatment (burnt-out cases)",
                    "sub_points": [
                      "3 morphologic stages (different stages and sizes of lesions can coexist in same patient)Necrotizing: Coagulative necrosis,Toxoplasmacysts, and numerous free tachyzoites, usually minimal host inflammatory response, small arteries with fibrinoid necrosis, endothelial damage, thrombosisOrganizing: Central eosinophilic, acellular, coagulative necrosis, periphery with histiocytes containing lipid and hemosiderin, variable inflammation, astrocytosis, microglial proliferationChronic: More demarcated capsule, often hemosiderin and intense reactive gliosis at periphery; organisms may not be found, especially after treatment (burnt-out cases)",
                      "Necrotizing: Coagulative necrosis,Toxoplasmacysts, and numerous free tachyzoites, usually minimal host inflammatory response, small arteries with fibrinoid necrosis, endothelial damage, thrombosis",
                      "Organizing: Central eosinophilic, acellular, coagulative necrosis, periphery with histiocytes containing lipid and hemosiderin, variable inflammation, astrocytosis, microglial proliferation",
                      "Chronic: More demarcated capsule, often hemosiderin and intense reactive gliosis at periphery; organisms may not be found, especially after treatment (burnt-out cases)"
                    ]
                  },
                  {
                    "text": "VentriculitisPeriventricular necrosis, petechial hemorrhages or hemosiderin, usually minimal patient inflammatory response, numerous free tachyzoites",
                    "sub_points": [
                      "Periventricular necrosis, petechial hemorrhages or hemosiderin, usually minimal patient inflammatory response, numerous free tachyzoites"
                    ]
                  },
                  {
                    "text": "Diffuse encephalitic formMultifocal cysts and free tachyzoitesDiffuse cortical microglial nodulesNo necrosis",
                    "sub_points": [
                      "Multifocal cysts and free tachyzoites",
                      "Diffuse cortical microglial nodules",
                      "No necrosis"
                    ]
                  },
                  {
                    "text": "Acute chorioretinitisRetinal necrosis, histiocytes, organisms",
                    "sub_points": [
                      "Retinal necrosis, histiocytes, organisms"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Monoclonal antibodies specific for organism"
                  },
                  {
                    "text": "IHC for organism diagnostic and especially highlights free tachyzoitesOrganisms may be difficult or impossible to identify post treatment with antibiotics",
                    "sub_points": [
                      "Organisms may be difficult or impossible to identify post treatment with antibiotics"
                    ]
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "Toxoplasmaserum antibodies"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Dystrophic Microcalcifications/Mineralizations": [
                  {
                    "text": "Basophilic structures lack substructure ofToxoplasmacysts"
                  },
                  {
                    "text": "ToxoplasmaIHC(-)"
                  }
                ],
                "Trypanosomacruzi": [
                  {
                    "text": "Cysts identical to those of toxoplasmosis"
                  },
                  {
                    "text": "ToxoplasmaIHC(-)"
                  }
                ],
                "Histoplasmacapsulatum": [
                  {
                    "text": "Small yeasts similar in size to free Toxoplasma tachyzoites but lack elongate shape"
                  },
                  {
                    "text": "Organisms intracellular (histiocytes)"
                  },
                  {
                    "text": "Positive for fungal histochemical stains (Grocott methenamine silver, periodic acid-Schiff)"
                  },
                  {
                    "text": "ToxoplasmaIHC(-)"
                  }
                ],
                "Other TORCH Infections": [
                  {
                    "text": "TORCH: Toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes"
                  },
                  {
                    "text": "Viral inclusions in congenital CMV"
                  },
                  {
                    "text": "Congenital toxoplasmosis may cause extensive brain destruction, calcification, few residual organisms"
                  },
                  {
                    "text": "Examine eye for organisms"
                  }
                ],
                "Necrotizing Vasculitis": [
                  {
                    "text": "Fibrinoid necrosis of blood vessels"
                  },
                  {
                    "text": "Perivascular inflammation"
                  },
                  {
                    "text": "No organisms or focal abscesses"
                  }
                ],
                "Radiation Necrosis": [
                  {
                    "text": "History of irradiation"
                  },
                  {
                    "text": "White matter localization"
                  },
                  {
                    "text": "Telangiectatic vessels"
                  },
                  {
                    "text": "No organisms"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Organisms most frequent at periphery of necrotic areas and near blood vessels"
                  },
                  {
                    "text": "Necrotizing vasculitis may be most eye-catching feature"
                  },
                  {
                    "text": "Fulminant cases contain more tachyzoites than cysts"
                  },
                  {
                    "text": "Few if any organisms post treatment"
                  },
                  {
                    "text": "Look for other opportunistic organisms; coinfection may be present"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Progressive Multifocal Leukoencephalopathy": {
            "name": "Progressive Multifocal Leukoencephalopathy",
            "url": "https://app.pathprimer.com/document/2e22f9e8-2cef-4ab1-b2aa-b4a396aeb2da/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "CNS demyelinating disorder caused by lytic viral infection of oligodendrocytes by John Cunningham (JC) polyomavirus"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Due to reactivation of latent infection by JC virus, usually in immunocompromised host"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Sensory deficits, hemianopsia, cognitive dysfunction, aphasia, gait disturbance"
                  },
                  {
                    "text": "Seizures less common"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Multifocal white matter lesions predominantly in subcortical cerebral white matter, cerebellar peduncles"
                  },
                  {
                    "text": "Gray matter lesions in basal ganglia, thalamus"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Small, ovoid, yellow-tan lesions maximal near cortical gray-white junction"
                  },
                  {
                    "text": "Later lesions coalescent, large, depressed"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Demyelination, oligodendrocyte loss, nuclear oligodendrocyte inclusions"
                  },
                  {
                    "text": "Cytologically bizarre, enlarged astrocytes in context of high Ki-67 and p53 staining indices can suggest high-grade glioma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Infected oligodendrocytes, but less so atypical astrocytes, positive for JC or SV40 virus"
                  },
                  {
                    "text": "Virally infected cells often Ki-67, p53 (+)"
                  },
                  {
                    "text": "Detection of JC virus DNA in CSF establishes diagnosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Progressive multifocal leukoencephalopathy (PML)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Opportunistic viral infection of oligodendrocytes by John Cunningham (JC) polyomavirus, resulting in CNS demyelination due to oligodendroglial cell lysis"
                  },
                  {
                    "text": "JC virus granule cell neuronopathy due to viral infection of granule cells of cerebellum, with neuronal lysis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Archetype virusCirculates widely in environmentFound in sewageMay transform to neurotropic virus via deletion or duplication gene event(s)",
                    "sub_points": [
                      "Circulates widely in environmentFound in sewage",
                      "Found in sewage",
                      "May transform to neurotropic virus via deletion or duplication gene event(s)"
                    ]
                  },
                  {
                    "text": "Asymptomatic primary viral infection in childhood"
                  },
                  {
                    "text": "After initial viral infection, virus thought to be latent in kidneys, bone marrow, lymphoid tissue"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Disease caused by reactivation of latent virus, usually in immunocompromised host"
                  },
                  {
                    "text": "JC virus named after 1971 isolation of virus from autopsied brain of patient John Cunningham"
                  }
                ],
                "Impaired Immune Status": [
                  {
                    "text": "PML most frequently identified in patients with AIDSJC virus neuronopathy also occurs in HIV-infected patients",
                    "sub_points": [
                      "JC virus neuronopathy also occurs in HIV-infected patients"
                    ]
                  },
                  {
                    "text": "Patients on immunosuppressant medications that cause CD4 T-cell lymphopeniaNatalizumab (α4β1 and α4β7 integrin inhibitor)Commonly used in setting of MS, which may complicate differential diagnosisPML can occur with monotherapyRisk of PML increases with duration of exposure to natalizumab over first 3 years of treatmentRituximab, usually in combination with other medications",
                    "sub_points": [
                      "Natalizumab (α4β1 and α4β7 integrin inhibitor)Commonly used in setting of MS, which may complicate differential diagnosisPML can occur with monotherapyRisk of PML increases with duration of exposure to natalizumab over first 3 years of treatment",
                      "Commonly used in setting of MS, which may complicate differential diagnosis",
                      "PML can occur with monotherapy",
                      "Risk of PML increases with duration of exposure to natalizumab over first 3 years of treatment",
                      "Rituximab, usually in combination with other medications"
                    ]
                  },
                  {
                    "text": "Rheumatologic disordersMost commonly reported in patients with SLE, most subjected to, or are under, immunosuppressant therapyOther conditions, often with therapy &/or CD4 lymphopenia: Granulomatous polyangiitis, dermatomyositis, scleroderma, rheumatoid arthritis",
                    "sub_points": [
                      "Most commonly reported in patients with SLE, most subjected to, or are under, immunosuppressant therapy",
                      "Other conditions, often with therapy &/or CD4 lymphopenia: Granulomatous polyangiitis, dermatomyositis, scleroderma, rheumatoid arthritis"
                    ]
                  },
                  {
                    "text": "CancerOriginally recognized in patients with hematologic malignancies, especially chronic lymphocytic leukemia (CLL), Hodgkin disease",
                    "sub_points": [
                      "Originally recognized in patients with hematologic malignancies, especially chronic lymphocytic leukemia (CLL), Hodgkin disease"
                    ]
                  },
                  {
                    "text": "TransplantationPatients on immunosuppressant therapy to prevent graft rejectionSolid organ, bone marrow recipients; autologous or allogenic stem cell transplant recipients",
                    "sub_points": [
                      "Patients on immunosuppressant therapy to prevent graft rejection",
                      "Solid organ, bone marrow recipients; autologous or allogenic stem cell transplant recipients"
                    ]
                  }
                ],
                "Immunocompetent Patient": [
                  {
                    "text": "Rare in this context, but individuals can develop PML with minimal or occult immunosuppression, including hepatic cirrhosis, renal failure, age-related immunosuppression"
                  },
                  {
                    "text": "> 15 cases of PML in male patients with idiopathic CD4(+) T-cell lymphopenia"
                  }
                ],
                "Virus Now Known to Infect Oligodendrocytes and Neurons": [
                  {
                    "text": "Granule cell neurons infected in JC virus granule cell neuronopathy, cortical pyramidal neurons in JC virus encephalopathy"
                  },
                  {
                    "text": "Infection may be abortive/restrictive in some neuronal groups"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "PMLChanges in cognition, personalityMotor deficits, aphasia, gait difficulties, homonymous hemianopsiaSeizures in small percentage of patients",
                    "sub_points": [
                      "Changes in cognition, personality",
                      "Motor deficits, aphasia, gait difficulties, homonymous hemianopsia",
                      "Seizures in small percentage of patients"
                    ]
                  },
                  {
                    "text": "JC virus granule cell neuropathyAtaxia",
                    "sub_points": [
                      "Ataxia"
                    ]
                  },
                  {
                    "text": "PML-immune reconstitution inflammatory syndrome (PML-IRIS)Neurologic symptoms can worsen with PML-IRISOften difficult to distinguish between PML and neurologic symptoms due to PML-IRIS",
                    "sub_points": [
                      "Neurologic symptoms can worsen with PML-IRIS",
                      "Often difficult to distinguish between PML and neurologic symptoms due to PML-IRIS"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Some advocate plasma exchange or immunoabsorption to hasten clearance of natalizumab in cases that develop PML; others prefer simply stopping drug, i.e., slow taperIRISMay develop days to weeks after plasma exchange, may be severePML-IRIS treated with steroids",
                    "sub_points": [
                      "IRISMay develop days to weeks after plasma exchange, may be severePML-IRIS treated with steroids",
                      "May develop days to weeks after plasma exchange, may be severe",
                      "PML-IRIS treated with steroids"
                    ]
                  },
                  {
                    "text": "Some studies suggest efficacy of PML treatment with immune checkpoint inhibitorsAnti-PD-1-antibody pembrolizumab utilized",
                    "sub_points": [
                      "Anti-PD-1-antibody pembrolizumab utilized"
                    ]
                  },
                  {
                    "text": "Case reports of successful PML treatment with combination mefloquine and mirtazapine, anti-5HT2A receptor agents, and antiviral therapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Patients with AIDSPML fatal prior to advent of highly active antiretroviral therapy (HAART) for AIDSSubstantial incidence of stability or improvement after HAARTPatients with AIDS and IRIS (after AIDS drugs) may survive decade(s) without PML recurrence",
                    "sub_points": [
                      "PML fatal prior to advent of highly active antiretroviral therapy (HAART) for AIDSSubstantial incidence of stability or improvement after HAART",
                      "Substantial incidence of stability or improvement after HAART",
                      "Patients with AIDS and IRIS (after AIDS drugs) may survive decade(s) without PML recurrence"
                    ]
                  },
                  {
                    "text": "Majority of patients with PML from natalizumab surviveNeed drug withdrawal &/or plasma exchange therapySurvivors potentially left with residual defects dependent on lesion location",
                    "sub_points": [
                      "Need drug withdrawal &/or plasma exchange therapy",
                      "Survivors potentially left with residual defects dependent on lesion location"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Multiple lesions common"
                  },
                  {
                    "text": "Subcortical hemispheric white matter or cerebellar peduncle involvement frequent"
                  },
                  {
                    "text": "Multifocal white matter lesions predominantly in subcortical cerebral white matter, cerebellar peduncles"
                  },
                  {
                    "text": "Gray matter lesions seen in basal ganglia, thalamus"
                  },
                  {
                    "text": "Distributions of lesions do not correspond to vascular territories"
                  },
                  {
                    "text": "Small subset of patients have lesions limited to cerebellum and brainstem"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Hyperintensities on T2-weighted and FLAIR images"
                  },
                  {
                    "text": "Hypointensities on T1-weighted images"
                  },
                  {
                    "text": "Classic lesions devoid of edema, mass effect, contrast enhancement"
                  },
                  {
                    "text": "Contrast enhancement, edema, mass effect with immune reconstitution syndrome"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Early Stage": [
                  {
                    "text": "Small, ovoid, yellow-tan demyelinating lesion maximal at cortical gray-white junction"
                  }
                ],
                "Intermediate Stage": [
                  {
                    "text": "Small lesions coalesce, occupy large volumes of white matter"
                  },
                  {
                    "text": "Demyelination, preferentially in frontal and parietooccipital regions"
                  },
                  {
                    "text": "Lesions sometimes in cerebellum, brainstem"
                  }
                ],
                "Late Stage": [
                  {
                    "text": "Large, depressed lesions in white matter"
                  },
                  {
                    "text": "Seldom fully cavitated as infarcts"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "DemyelinationRanges from myelin pallor to severe lossVariably visible on H&E, histochemical stains (e.g., Luxol fast blue), IHC preparations (e.g., antimyelin basic protein)Associated with loss of oligodendrocytes",
                    "sub_points": [
                      "Ranges from myelin pallor to severe loss",
                      "Variably visible on H&E, histochemical stains (e.g., Luxol fast blue), IHC preparations (e.g., antimyelin basic protein)",
                      "Associated with loss of oligodendrocytes"
                    ]
                  },
                  {
                    "text": "Axonal injuryAxonal swellings in severe, early examplesAxonal loss (Bielschowsky stain, neurofilament IHC) < myelin lossNo cavitation as in infarct",
                    "sub_points": [
                      "Axonal swellings in severe, early examples",
                      "Axonal loss (Bielschowsky stain, neurofilament IHC) < myelin loss",
                      "No cavitation as in infarct"
                    ]
                  },
                  {
                    "text": "MacrophagesIn areas with marked myelin lossDispersed throughout areas of active myelin breakdown, perivascular in later stagesMay be subtle background feature",
                    "sub_points": [
                      "In areas with marked myelin loss",
                      "Dispersed throughout areas of active myelin breakdown, perivascular in later stages",
                      "May be subtle background feature"
                    ]
                  },
                  {
                    "text": "Viral inclusionsLarge, round, infected oligodendrocytes with violaceous nuclear inclusionsViral inclusion fills nucleusSome oligodendrocytes manifest cleared nucleoplasm centrally, marginated chromatin, nuclear enlargementNo cytoplasmic inclusionsInclusion-bearing cells maximal at periphery of demyelinating lesions, fewer centrallyInclusions may be lacking in burnt-out cases, or posttreatment with IRISVirally infected cells often Ki-67, p53 (+)",
                    "sub_points": [
                      "Large, round, infected oligodendrocytes with violaceous nuclear inclusionsViral inclusion fills nucleusSome oligodendrocytes manifest cleared nucleoplasm centrally, marginated chromatin, nuclear enlargementNo cytoplasmic inclusions",
                      "Viral inclusion fills nucleus",
                      "Some oligodendrocytes manifest cleared nucleoplasm centrally, marginated chromatin, nuclear enlargement",
                      "No cytoplasmic inclusions",
                      "Inclusion-bearing cells maximal at periphery of demyelinating lesions, fewer centrally",
                      "Inclusions may be lacking in burnt-out cases, or posttreatment with IRIS",
                      "Virally infected cells often Ki-67, p53 (+)"
                    ]
                  },
                  {
                    "text": "Some large oligodendrocytes with hyperchromatic nuclei with little homogenization"
                  },
                  {
                    "text": "Bizarre astrocytesMarkedly pleomorphic pseudoneoplastic astrocytesHyperchromasia, multinucleation",
                    "sub_points": [
                      "Markedly pleomorphic pseudoneoplastic astrocytes",
                      "Hyperchromasia, multinucleation"
                    ]
                  },
                  {
                    "text": "Lymphocytic inflammationLimited in patients with severe immunocompromiseSevere inflammation with few viral inclusions in patients with IRIS",
                    "sub_points": [
                      "Limited in patients with severe immunocompromise",
                      "Severe inflammation with few viral inclusions in patients with IRIS"
                    ]
                  },
                  {
                    "text": "Neuronal infection (rare)Cerebellar granular neuronsCerebral neuronsFulminant JC virus encephalopathy",
                    "sub_points": [
                      "Cerebellar granular neurons",
                      "Cerebral neuronsFulminant JC virus encephalopathy",
                      "Fulminant JC virus encephalopathy"
                    ]
                  },
                  {
                    "text": "PML-IRISCD8(+) T-cell infiltratesMay show extensive tissue damage",
                    "sub_points": [
                      "CD8(+) T-cell infiltrates",
                      "May show extensive tissue damage"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Purple ground-glass intranuclear inclusions in oligodendrocytes"
                  },
                  {
                    "text": "Some large oligodendrocytes with hyperchromatic nuclei with little homogenization"
                  },
                  {
                    "text": "Large, bizarre nuclei of astrocytes"
                  },
                  {
                    "text": "Macrophages"
                  },
                  {
                    "text": "Creutzfeldt cellsReactive astrocytes that look like atypical mitosis",
                    "sub_points": [
                      "Reactive astrocytes that look like atypical mitosis"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Infected oligodendrocytes but less so atypical astrocytes, positive for JC or SV40 virus"
                  },
                  {
                    "text": "Virally infected cells with high Ki-67(+) and p53(+) index"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "Viral inclusions, and to lesser extent atypical astrocytes, positive for JC virus probes"
                  }
                ],
                "PCR": [
                  {
                    "text": "Detection of JC virus DNA in CSF establishes diagnosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Multiple Sclerosis": [
                  {
                    "text": "No viral inclusions"
                  },
                  {
                    "text": "IHC and in situ hybridization negative for JC virus"
                  },
                  {
                    "text": "Burnt-out cases of PML may be difficult to distinguish from MSMS not preferentially seen in immunocompromised patients",
                    "sub_points": [
                      "MS not preferentially seen in immunocompromised patients"
                    ]
                  },
                  {
                    "text": "MS more likely to affect certain anatomical sitesSpinal cordOptic nervePeriventricular regionsGray matter, with lesions at gray-white junction (leukocortical) and within gray matter as perivenular or subpial bands of demyelinationImmunostaining for myelin basic protein, proteolipid protein necessary to identify most intracortical demyelinative lesionsPerivenular and subpial plaques characteristic in most anatomical sites",
                    "sub_points": [
                      "Spinal cord",
                      "Optic nerve",
                      "Periventricular regions",
                      "Gray matter, with lesions at gray-white junction (leukocortical) and within gray matter as perivenular or subpial bands of demyelinationImmunostaining for myelin basic protein, proteolipid protein necessary to identify most intracortical demyelinative lesions",
                      "Immunostaining for myelin basic protein, proteolipid protein necessary to identify most intracortical demyelinative lesions",
                      "Perivenular and subpial plaques characteristic in most anatomical sites"
                    ]
                  }
                ],
                "Infarct": [
                  {
                    "text": "No viral inclusions"
                  },
                  {
                    "text": "Ischemic, red-dead neurons in acute phase"
                  },
                  {
                    "text": "Loss of both axons and myelin"
                  },
                  {
                    "text": "Cavitation in chronic phase"
                  },
                  {
                    "text": "More cortical based"
                  }
                ],
                "High-Grade Glioma": [
                  {
                    "text": "No viral inclusions"
                  },
                  {
                    "text": "Extensive myelin destruction with macrophage influx rare in untreated tumor"
                  },
                  {
                    "text": "Cytologically bizarre cells more numerous and associated with other cytologically atypical glial cells"
                  }
                ],
                "Post Natalizumab Immune Reconstitution Inflammatory Syndrome": [
                  {
                    "text": "Occurs in patient receiving natalizumab who develops PML, then receives plasma exchange or other therapy to clear drug"
                  },
                  {
                    "text": "Occasionally reported in patients after natalizumab discontinued"
                  },
                  {
                    "text": "IRIS develops with clearing of virus but can leave large, destructive areas of tissue damage"
                  },
                  {
                    "text": "Large areas of demyelination may be devoid of residual viral inclusions"
                  },
                  {
                    "text": "Residual viral inclusions often difficult to identifyUtilize IHC for JC virus or SV40",
                    "sub_points": [
                      "Utilize IHC for JC virus or SV40"
                    ]
                  }
                ],
                "Other Virally Mediated Demyelinating Disorders": [
                  {
                    "text": "Varicella-zoster virus (VZV) encephalitisViral inclusions in multiple cell typesImmunopositive for VZVImmunonegative for SV40, JC virusUsually smaller, less coalescent areas of demyelination",
                    "sub_points": [
                      "Viral inclusions in multiple cell types",
                      "Immunopositive for VZV",
                      "Immunonegative for SV40, JC virus",
                      "Usually smaller, less coalescent areas of demyelination"
                    ]
                  },
                  {
                    "text": "HIV-related demyelination"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Deep white matter or gray matter location of lesions may lead to negative CSF JC virus on PCR testing in some patients"
                  },
                  {
                    "text": "PML has been associated with therapy using several different specific monoclonal antibodies, includingNatalizumabEfalizumabRituximab",
                    "sub_points": [
                      "Natalizumab",
                      "Efalizumab",
                      "Rituximab"
                    ]
                  },
                  {
                    "text": "CD4(+) T-cell lymphopenia is preponderant risk factor for PML"
                  },
                  {
                    "text": "Newer checkpoint inhibitor therapy for PML"
                  },
                  {
                    "text": "Treatment consists of attempts to reconstitute immune functionPML-IRIS may result after drug withdrawalExtensive CD8(+) T-cell infiltrates, numerous macrophages within, few or no virally infected cells seen in IRIS lesions",
                    "sub_points": [
                      "PML-IRIS may result after drug withdrawal",
                      "Extensive CD8(+) T-cell infiltrates, numerous macrophages within, few or no virally infected cells seen in IRIS lesions"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "High Ki-67 and p53 indices, cytologically bizarre astrocytes can simulate high-grade astrocytoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Demyelinating Disease (Multiple Sclerosis-Tumefactive Demyelination)": {
            "name": "Demyelinating Disease (Multiple Sclerosis-Tumefactive Demyelination)",
            "url": "https://app.pathprimer.com/document/3f60cb5e-e2b7-4f9e-bf56-5942a47d839d/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Acute demyelinating disease prompting biopsy due to enhancement, prominent surrounding edema, &/or tumor or abscess-like appearance"
                  },
                  {
                    "text": "Most, but not all, patients with demyelinating disease prompting biopsy eventually develop relapsing-remitting multiple sclerosis (MS)"
                  },
                  {
                    "text": "Pathologists should not diagnose MS or tumefactive MS on acute demyelinating lesions prompting biopsy"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Open ring sign is characteristic MR enhancement feature"
                  },
                  {
                    "text": "Inconsistent with pathologic diagnosis of WHO grade 2 infiltrating gliomas"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Sharp border"
                  },
                  {
                    "text": "Numerous foamy macrophages"
                  },
                  {
                    "text": "Admixed reactive astrocytes with long processes"
                  },
                  {
                    "text": "Loss of myelin on special stains"
                  },
                  {
                    "text": "Relatively greater preservation of axons than myelin"
                  },
                  {
                    "text": "Variable perivascular lymphocytic cuffing"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Astrocytoma, oligodendroglioma"
                  },
                  {
                    "text": "Glioblastoma"
                  },
                  {
                    "text": "Lymphocytic vasculitis"
                  },
                  {
                    "text": "Infarct"
                  },
                  {
                    "text": "Acute disseminated encephalomyelitis"
                  },
                  {
                    "text": "Steroid-treated CNS lymphoma"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "May closely resemble astrocytoma or oligodendroglioma in H&E sections"
                  },
                  {
                    "text": "Recognition of macrophages on touch and smear preparations during intraoperative consultation aids in diagnosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Multiple sclerosis (MS)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Large, usually solitary, lesion > 2 cm in size or lesion with significant mass effect, edema, or ring enhancementMay be mistaken for tumor or abscess on neuroimagingSometimes called tumefactive MS, but term should be avoided since not all acute demyelinating lesions prompting biopsy are MS; some are other demyelinating conditions, including neuromyelitis optica (NMO)",
                    "sub_points": [
                      "May be mistaken for tumor or abscess on neuroimaging",
                      "Sometimes called tumefactive MS, but term should be avoided since not all acute demyelinating lesions prompting biopsy are MS; some are other demyelinating conditions, including neuromyelitis optica (NMO)"
                    ]
                  },
                  {
                    "text": "Most, but not all, patients with acute demyelinating disease/lesion prompting biopsy eventually develop relapsing-remitting MSDisease course in most patients, once MS diagnosis is made by clinical/neuroimaging criteria, similar to, or even better, than that of \"ordinary\" MSOne study demonstrated average interval of ≥ 4 years between acute demyelinating lesion and further MS diagnosis",
                    "sub_points": [
                      "Disease course in most patients, once MS diagnosis is made by clinical/neuroimaging criteria, similar to, or even better, than that of \"ordinary\" MS",
                      "One study demonstrated average interval of ≥ 4 years between acute demyelinating lesion and further MS diagnosis"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Median age at onset: 30-40 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Slightly more common in females"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Patients polysymptomaticMotor, cognitive, sensory symptoms",
                    "sub_points": [
                      "Motor, cognitive, sensory symptoms"
                    ]
                  },
                  {
                    "text": "Symptom onset-biopsy interval usually about 2 months"
                  },
                  {
                    "text": "Prior history of relapsing-remitting MS (in some cases)"
                  },
                  {
                    "text": "History of progressive disease (rare)"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Stereotactic biopsy (most cases)"
                  },
                  {
                    "text": "Open biopsyAggressive resection potentially associated with new or increased neurologic deficit",
                    "sub_points": [
                      "Aggressive resection potentially associated with new or increased neurologic deficit"
                    ]
                  }
                ],
                "Adjuvant therapy": [
                  {
                    "text": "Plasma exchange (PLEX)Ring-enhancing lesions &/or mass effect associated with beneficial response to PLEX",
                    "sub_points": [
                      "Ring-enhancing lesions &/or mass effect associated with beneficial response to PLEX"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Good but variable"
                  },
                  {
                    "text": "Does not portend subsequent aggressive clinical course"
                  },
                  {
                    "text": "Median time to 2nd attack of demyelination ~ 5 years"
                  },
                  {
                    "text": "Large lesions (> 5 cm) associated with slightly more clinical dysfunction"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Large, confluent lesion(s), often periventricular or subcortical"
                  },
                  {
                    "text": "Contrast enhancementCommon in acute phaseOpen ring or horseshoe-shaped configuration highly suggestiveInconsistent with pathologic diagnosis of WHO grade 2 infiltrating gliomas",
                    "sub_points": [
                      "Common in acute phase",
                      "Open ring or horseshoe-shaped configuration highly suggestive",
                      "Inconsistent with pathologic diagnosis of WHO grade 2 infiltrating gliomas"
                    ]
                  },
                  {
                    "text": "Perilesional edemaVariable but may be prominent with larger lesions",
                    "sub_points": [
                      "Variable but may be prominent with larger lesions"
                    ]
                  },
                  {
                    "text": "Multiple lesions on prebiopsy scan in ~ 70%"
                  },
                  {
                    "text": "Rare variant, Balo sclerosis, shows concentric globe appearance with alternating bands of myelin loss and preservation"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Acute plaques with somewhat ill-defined margins, tan-yellow, granular"
                  },
                  {
                    "text": "Chronic inactive plaques usually have sharply defined margins, gray, glistening, depressed"
                  },
                  {
                    "text": "Often periventricular, gray-white junction, or deep white matter (WM)Perivenular orientation at angles of lateral ventricles, with extension along veins: \"Dawson fingers\"",
                    "sub_points": [
                      "Perivenular orientation at angles of lateral ventricles, with extension along veins: \"Dawson fingers\""
                    ]
                  },
                  {
                    "text": "Balo sclerosis not easily detected on gross examinationDiagnosis requires correlation with MR imaging",
                    "sub_points": [
                      "Diagnosis requires correlation with MR imaging"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "BordersUsually discrete in chronic/inactive plaquesSomewhat more irregular, but still microscopically well defined, in acute/active plaques",
                    "sub_points": [
                      "Usually discrete in chronic/inactive plaques",
                      "Somewhat more irregular, but still microscopically well defined, in acute/active plaques"
                    ]
                  },
                  {
                    "text": "Perivenular orientationMore obvious in autopsy specimens",
                    "sub_points": [
                      "More obvious in autopsy specimens"
                    ]
                  },
                  {
                    "text": "MacrophagesPrincipal componentFrequent perivascular concentrationContentsFoamy to granularLuxol fast blue (LFB) (+), acutePeriodic acid-Schiff (PAS) (+), subacute to chronic",
                    "sub_points": [
                      "Principal component",
                      "Frequent perivascular concentration",
                      "ContentsFoamy to granularLuxol fast blue (LFB) (+), acutePeriodic acid-Schiff (PAS) (+), subacute to chronic",
                      "Foamy to granular",
                      "Luxol fast blue (LFB) (+), acute",
                      "Periodic acid-Schiff (PAS) (+), subacute to chronic"
                    ]
                  },
                  {
                    "text": "Reactive astrocytesEvenly dispersedLong, tapering cytoplasmic processesLarge nuclei, prominent nucleoli, and vesicular nuclei when highly reactiveMultinucleate (Creutzfeldt cell)Common but not specific",
                    "sub_points": [
                      "Evenly dispersed",
                      "Long, tapering cytoplasmic processes",
                      "Large nuclei, prominent nucleoli, and vesicular nuclei when highly reactive",
                      "Multinucleate (Creutzfeldt cell)Common but not specific",
                      "Common but not specific"
                    ]
                  },
                  {
                    "text": "Loss of myelin"
                  },
                  {
                    "text": "Axonal lossAxonal swellings in acute examplesProportionally less than that of myelin",
                    "sub_points": [
                      "Axonal swellings in acute examples",
                      "Proportionally less than that of myelin"
                    ]
                  },
                  {
                    "text": "Perivascular inflammationVariable; not always presentT cells predominate",
                    "sub_points": [
                      "Variable; not always present",
                      "T cells predominate"
                    ]
                  },
                  {
                    "text": "Little, if any, cavitation"
                  },
                  {
                    "text": "MitosesGranularExploding pattern of chromosomes in cells with copious cytoplasmPresumed precursor of Creutzfeldt cellConventional, occasional",
                    "sub_points": [
                      "GranularExploding pattern of chromosomes in cells with copious cytoplasmPresumed precursor of Creutzfeldt cell",
                      "Exploding pattern of chromosomes in cells with copious cytoplasm",
                      "Presumed precursor of Creutzfeldt cell",
                      "Conventional, occasional"
                    ]
                  },
                  {
                    "text": "RemyelinationFrequently, but not exclusively, located at lesion borderRemyelination identified by thinner myelin sheaths resulting in paler staining intensityShadow plaques now mostly accepted to be remyelination, not partial demyelinationRemyelination can be extensive, seen in ~ 20% of lesions; can vary from lesion to lesion at autopsy",
                    "sub_points": [
                      "Frequently, but not exclusively, located at lesion border",
                      "Remyelination identified by thinner myelin sheaths resulting in paler staining intensity",
                      "Shadow plaques now mostly accepted to be remyelination, not partial demyelination",
                      "Remyelination can be extensive, seen in ~ 20% of lesions; can vary from lesion to lesion at autopsy"
                    ]
                  },
                  {
                    "text": "Normal-appearing WM (NAWM), periplaque WM (PPWM) not fully normalDiffuse, sometimes extensive microglial activationAstrocytic hyperplasia especially in PPWMMay represent wallerian degeneration or prelesional change",
                    "sub_points": [
                      "Diffuse, sometimes extensive microglial activation",
                      "Astrocytic hyperplasia especially in PPWM",
                      "May represent wallerian degeneration or prelesional change"
                    ]
                  },
                  {
                    "text": "Cortical demyelinative lesionsCortical gray matter (GM) lesions correlate better with physical disability and cognitive impairment than WM lesionsRemyelination can be extensive in cortical lesionsMore remyelination shown in some studies in GM than WM in MS patient brainsMore oligodendrocyte precursor cells (OPCs) found in remyelinated and nonremyelinated cortical lesions vs. remyelinated WM lesions and nonremyelinated WM lesionsOPC assessment via Olig2 IHC (Olig2 strongly expressed in OPCs, weakly expressed in mature oligodendrocytes)Cortical demyelination, neuronal loss, meningeal inflammation can be found in brains from patients with short-duration (< 2 years) MSCortical lesions of subpial, full-thickness, intracortical, leukocortical types; subpial most frequent",
                    "sub_points": [
                      "Cortical gray matter (GM) lesions correlate better with physical disability and cognitive impairment than WM lesions",
                      "Remyelination can be extensive in cortical lesions",
                      "More remyelination shown in some studies in GM than WM in MS patient brains",
                      "More oligodendrocyte precursor cells (OPCs) found in remyelinated and nonremyelinated cortical lesions vs. remyelinated WM lesions and nonremyelinated WM lesionsOPC assessment via Olig2 IHC (Olig2 strongly expressed in OPCs, weakly expressed in mature oligodendrocytes)",
                      "OPC assessment via Olig2 IHC (Olig2 strongly expressed in OPCs, weakly expressed in mature oligodendrocytes)",
                      "Cortical demyelination, neuronal loss, meningeal inflammation can be found in brains from patients with short-duration (< 2 years) MS",
                      "Cortical lesions of subpial, full-thickness, intracortical, leukocortical types; subpial most frequent"
                    ]
                  }
                ],
                "Updated Classification System for Multiple Sclerosis Lesions": [
                  {
                    "text": "Active lesions characterized by macrophages/microglia throughout lesion areaThis is lesion type seen most commonly in acute demyelinating lesions prompting biopsyFurther subdivided into early and late active demyelinatingEarly active: Presence in macrophages of minor myelin proteins, such as cyclic nucleotide diphosphoesterase (CNP), myelin oligodendrocyte glycoprotein (MOG), or myelin-associated protein (MAG) &/or LFB(+) debris (major myelin proteins, [MBP(+) or PLP] may also be present)Late active: Macrophages contain only major myelin proteins MBP or PLPLess abundant myelin proteins, such as MOG, cleared faster by phagocytic cells than more abundant myelin proteins, such as PLP or MBPUncommon to encounter active stage at autopsy",
                    "sub_points": [
                      "This is lesion type seen most commonly in acute demyelinating lesions prompting biopsy",
                      "Further subdivided into early and late active demyelinating",
                      "Early active: Presence in macrophages of minor myelin proteins, such as cyclic nucleotide diphosphoesterase (CNP), myelin oligodendrocyte glycoprotein (MOG), or myelin-associated protein (MAG) &/or LFB(+) debris (major myelin proteins, [MBP(+) or PLP] may also be present)",
                      "Late active: Macrophages contain only major myelin proteins MBP or PLPLess abundant myelin proteins, such as MOG, cleared faster by phagocytic cells than more abundant myelin proteins, such as PLP or MBP",
                      "Less abundant myelin proteins, such as MOG, cleared faster by phagocytic cells than more abundant myelin proteins, such as PLP or MBP",
                      "Uncommon to encounter active stage at autopsy"
                    ]
                  },
                  {
                    "text": "Mixed active/inactive lesions have hypocellular center with macrophages/microglia limited to lesion borderFurther subdividedLesions with ongoing myelin destruction (demyelinating lesions)Lesions where destruction of myelin has ceased, but macrophages are still present (postdemyelinating lesions)Distinction based on presence or absence of early [LFB(+), CNP, MOG, MAG] vs. late [PAS(+), MBP, PLP only] myelin degradation products within cytoplasm of macrophages/microgliaMicroglia/macrophage rim does not need to completely surround lesion to classify it as mixed active/inactiveThickness of microglial/macrophage rim highly variableHypertrophied astrocytes, moderate T-cell infiltrates present perivascularly or diffusely distributed throughout lesion centerAt autopsy, mixed active/inactive lesions rare or absent in MS brain from patients with short disease durationAt autopsy, mixed active/inactive lesions increased in patients with MS duration > 10 years &/or progressive courseMixed active/inactive lesions formerly called \"smoldering\" lesionsMixed active/inactive lesions likely reflect ongoing, slowly expanding demyelinating activity",
                    "sub_points": [
                      "Further subdividedLesions with ongoing myelin destruction (demyelinating lesions)Lesions where destruction of myelin has ceased, but macrophages are still present (postdemyelinating lesions)",
                      "Lesions with ongoing myelin destruction (demyelinating lesions)",
                      "Lesions where destruction of myelin has ceased, but macrophages are still present (postdemyelinating lesions)",
                      "Distinction based on presence or absence of early [LFB(+), CNP, MOG, MAG] vs. late [PAS(+), MBP, PLP only] myelin degradation products within cytoplasm of macrophages/microglia",
                      "Microglia/macrophage rim does not need to completely surround lesion to classify it as mixed active/inactive",
                      "Thickness of microglial/macrophage rim highly variable",
                      "Hypertrophied astrocytes, moderate T-cell infiltrates present perivascularly or diffusely distributed throughout lesion center",
                      "At autopsy, mixed active/inactive lesions rare or absent in MS brain from patients with short disease duration",
                      "At autopsy, mixed active/inactive lesions increased in patients with MS duration > 10 years &/or progressive course",
                      "Mixed active/inactive lesions formerly called \"smoldering\" lesions",
                      "Mixed active/inactive lesions likely reflect ongoing, slowly expanding demyelinating activity"
                    ]
                  },
                  {
                    "text": "Inactive lesions are almost completely lacking macrophages/microgliaMost common stage of lesions encountered at autopsyPredominant plaque type in MS patients with disease duration > 15 years &/or secondary progressive MS without attacksMay see marked axonal loss, infrequent axonal swellings possibleAstrocytes form gliosis; lesion hypocellular due to oligodendrocyte lossFew, if any, T cells or microglia/macrophages present",
                    "sub_points": [
                      "Most common stage of lesions encountered at autopsy",
                      "Predominant plaque type in MS patients with disease duration > 15 years &/or secondary progressive MS without attacks",
                      "May see marked axonal loss, infrequent axonal swellings possible",
                      "Astrocytes form gliosis; lesion hypocellular due to oligodendrocyte loss",
                      "Few, if any, T cells or microglia/macrophages present"
                    ]
                  },
                  {
                    "text": "Numbers and distribution of macrophages/microglia change more dynamically than numbers of lymphocytes"
                  },
                  {
                    "text": "T cells or B cells present in lower numbers than macrophages/microglia in all lesion types, independent of inflammatory or demyelinating activity"
                  },
                  {
                    "text": "Dating age of lesions most useful for researchers studying in pathobiology/underlying mechanisms of MS"
                  },
                  {
                    "text": "Older classification systems: Bö/Trapp system, De Groot/van der Valk modification, Lucchinetti/Lassmann/Brück system, Vienna consensus systemBö/Trapp system aims at characterization of postmortem tissue samples: Active (hypercellular lesions), chronic active lesions (hypocellular lesion center with hypercellular rim), inactive lesions (hypocellular lesion); focuses on cellularity of lesions, especially macrophages/microgliaLucchinetti et al subdivide active and early demyelinating lesions further into 4 different histologic patterns (I, II, III, and IV)Pattern I lesions: Demyelination associated only with activated macrophages/microgliaPattern II lesions: Complement activation prominent, suggesting involvement of antibodiesPattern III lesions: Oligodendrocytes with nuclear condensation and fragmentation, resembling apoptotic cell deathAssociated with selective loss of MAG, myelin antigen located in most distal (periaxonal) oligodendrocyte processesPattern IV: Very rareExtensive nonapoptotic oligodendrocyte degeneration in PPWM adjacent to active lesionLimited repair, no complement deposition or MAG lossIn each patient, single type of lesion consistently foundControversial whether different patterns represent different etiologies",
                    "sub_points": [
                      "Bö/Trapp system aims at characterization of postmortem tissue samples: Active (hypercellular lesions), chronic active lesions (hypocellular lesion center with hypercellular rim), inactive lesions (hypocellular lesion); focuses on cellularity of lesions, especially macrophages/microglia",
                      "Lucchinetti et al subdivide active and early demyelinating lesions further into 4 different histologic patterns (I, II, III, and IV)Pattern I lesions: Demyelination associated only with activated macrophages/microgliaPattern II lesions: Complement activation prominent, suggesting involvement of antibodiesPattern III lesions: Oligodendrocytes with nuclear condensation and fragmentation, resembling apoptotic cell deathAssociated with selective loss of MAG, myelin antigen located in most distal (periaxonal) oligodendrocyte processesPattern IV: Very rareExtensive nonapoptotic oligodendrocyte degeneration in PPWM adjacent to active lesionLimited repair, no complement deposition or MAG lossIn each patient, single type of lesion consistently foundControversial whether different patterns represent different etiologies",
                      "Pattern I lesions: Demyelination associated only with activated macrophages/microglia",
                      "Pattern II lesions: Complement activation prominent, suggesting involvement of antibodies",
                      "Pattern III lesions: Oligodendrocytes with nuclear condensation and fragmentation, resembling apoptotic cell deathAssociated with selective loss of MAG, myelin antigen located in most distal (periaxonal) oligodendrocyte processes",
                      "Associated with selective loss of MAG, myelin antigen located in most distal (periaxonal) oligodendrocyte processes",
                      "Pattern IV: Very rareExtensive nonapoptotic oligodendrocyte degeneration in PPWM adjacent to active lesionLimited repair, no complement deposition or MAG loss",
                      "Extensive nonapoptotic oligodendrocyte degeneration in PPWM adjacent to active lesion",
                      "Limited repair, no complement deposition or MAG loss",
                      "In each patient, single type of lesion consistently found",
                      "Controversial whether different patterns represent different etiologies"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "MacrophagesSharp cell bordersFoamy or granular cytoplasmCytologically bland",
                    "sub_points": [
                      "Sharp cell borders",
                      "Foamy or granular cytoplasm",
                      "Cytologically bland"
                    ]
                  },
                  {
                    "text": "Reactive astrocytesConventional; can simulate astrocytomaMultinucleated (Creutzfeldt cell)",
                    "sub_points": [
                      "Conventional; can simulate astrocytoma",
                      "Multinucleated (Creutzfeldt cell)"
                    ]
                  },
                  {
                    "text": "Granular mitoses"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "Modified Bielschowsky, Bodian stainsReactivity: AxonsStaining pattern: Preservation relative to myelin loss",
                    "sub_points": [
                      "Reactivity: Axons",
                      "Staining pattern: Preservation relative to myelin loss"
                    ]
                  },
                  {
                    "text": "LFB/H&E, LFB/PASReactivity: Myelin (LFB)Staining pattern: Loss of myelinMacrophages: LFB(+) in early PAS(+) in chronic lesions",
                    "sub_points": [
                      "Reactivity: Myelin (LFB)",
                      "Staining pattern: Loss of myelinMacrophages: LFB(+) in early PAS(+) in chronic lesions",
                      "Macrophages: LFB(+) in early PAS(+) in chronic lesions"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "GFAPReactive astrocytes strongly (+)",
                    "sub_points": [
                      "Reactive astrocytes strongly (+)"
                    ]
                  },
                  {
                    "text": "Olig2Strong (+) in OPCs, weaker in oligodendrocytes",
                    "sub_points": [
                      "Strong (+) in OPCs, weaker in oligodendrocytes"
                    ]
                  },
                  {
                    "text": "Macrophage markersHAM56, CD163Specific macrophage markersQualitatively and quantitatively may show less staining than with CD68CD68Lysosomal, rather than specific macrophage, markerAll phagocytes (+)",
                    "sub_points": [
                      "HAM56, CD163Specific macrophage markersQualitatively and quantitatively may show less staining than with CD68",
                      "Specific macrophage markers",
                      "Qualitatively and quantitatively may show less staining than with CD68",
                      "CD68Lysosomal, rather than specific macrophage, markerAll phagocytes (+)",
                      "Lysosomal, rather than specific macrophage, marker",
                      "All phagocytes (+)"
                    ]
                  },
                  {
                    "text": "Axonal markersNeurofilament protein, especially phosphorylated, e.g., SMI-31Axons generally preservedSome reduction and fragmentation but less than in infarcts",
                    "sub_points": [
                      "Neurofilament protein, especially phosphorylated, e.g., SMI-31Axons generally preservedSome reduction and fragmentation but less than in infarcts",
                      "Axons generally preserved",
                      "Some reduction and fragmentation but less than in infarcts"
                    ]
                  },
                  {
                    "text": "Antibodies directed against major myelin basic protein (MBP), proteolipid protein (PLP) (commercially available)Antibodies against minor myelin proteins less availableExtensive cortical demyelination revealed on MBP, PLP not H&E (and poorly on LFB-PAS)Cortical demyelinative lesions almost exclusively appreciated with MBP or PLP IHC markers",
                    "sub_points": [
                      "Antibodies against minor myelin proteins less available",
                      "Extensive cortical demyelination revealed on MBP, PLP not H&E (and poorly on LFB-PAS)",
                      "Cortical demyelinative lesions almost exclusively appreciated with MBP or PLP IHC markers"
                    ]
                  },
                  {
                    "text": "AQP4 IHC recently recognized as method to identify acute demyelinative lesions related to NMO/NMO spectrum disorder (NMOSD)Should be followed up with subsequent AQP4-IgG testing to confirm NMO/NMOSD",
                    "sub_points": [
                      "Should be followed up with subsequent AQP4-IgG testing to confirm NMO/NMOSD"
                    ]
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "Serum neurofilament light chain (NfL), serum GFAP, serum tau levels utilizedNfL levels linked with MS disease course, future disability score",
                    "sub_points": [
                      "NfL levels linked with MS disease course, future disability score"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Astrocytoma, Oligodendroglioma": [
                  {
                    "text": "Few, if any, macrophages in untreated tumor"
                  },
                  {
                    "text": "Cytoplasm of neoplastic oligodendrocytes artifactually clear, not foamy or granular"
                  },
                  {
                    "text": "Little, if any, perivascular inflammation, except for gemistocytic astrocytomas"
                  },
                  {
                    "text": "IDH1 R132H(+) in most lower grade tumors"
                  },
                  {
                    "text": "Olig2(+) irregular &/or large nuclei, almost all casesOPCs are also positive in nonneoplastic brain (pitfall)",
                    "sub_points": [
                      "OPCs are also positive in nonneoplastic brain (pitfall)"
                    ]
                  },
                  {
                    "text": "p53(+) in majority of IDH-mutant astrocytomasSlight increase with increased cell cycle in OPCs (pitfall)",
                    "sub_points": [
                      "Slight increase with increased cell cycle in OPCs (pitfall)"
                    ]
                  }
                ],
                "Glioblastoma": [
                  {
                    "text": "More variable nuclear size, shape, and hyperchromatism"
                  },
                  {
                    "text": "Often more variable cell distribution, greater cellularity"
                  },
                  {
                    "text": "Pseudopalisading necrosis"
                  },
                  {
                    "text": "Microvascular proliferation"
                  },
                  {
                    "text": "Macrophages and microglia but not in large numbers or sheets of cells"
                  }
                ],
                "Lymphocytic Vasculitis": [
                  {
                    "text": "Transmural, not perivascular, lymphocytes"
                  },
                  {
                    "text": "Vessel wall distortion, destruction"
                  },
                  {
                    "text": "Associated infarction in some cases"
                  },
                  {
                    "text": "Angiographic features of vasculitis in some cases, but often absent"
                  }
                ],
                "Infarct": [
                  {
                    "text": "Loss of axons and myelin in near equal proportions"
                  },
                  {
                    "text": "Cavitation in subacute and chronic phases"
                  },
                  {
                    "text": "Lesions in vascular territory distribution"
                  },
                  {
                    "text": "Little, if any, perivascular chronic inflammation"
                  }
                ],
                "Acute Disseminated Encephalomyelitis": [
                  {
                    "text": "Perivenous, rather than confluent, demyelination"
                  },
                  {
                    "text": "Microglial activation and aggregation without cortical demyelination"
                  },
                  {
                    "text": "Depressed level of consciousness, headache, meningismus, CSF pleocytosis, or multifocal enhancing MR abnormalities more common"
                  }
                ],
                "Steroid-Treated CNS Lymphoma": [
                  {
                    "text": "Sheets of macrophages, reactive astrocytes, variable numbers of nonneoplastic lymphocytesResidual lymphocytes often nonneoplastic CD3(+) T cellsGreater disruption of background neuropil, \"empty bed\"",
                    "sub_points": [
                      "Residual lymphocytes often nonneoplastic CD3(+) T cells",
                      "Greater disruption of background neuropil, \"empty bed\""
                    ]
                  },
                  {
                    "text": "Apoptosis, acutely prominent post steroids"
                  }
                ],
                "Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorder": [
                  {
                    "text": "Disorder often abbreviated to NMOSD"
                  },
                  {
                    "text": "AQP4-IgG (+) NMOSD"
                  },
                  {
                    "text": "Can present as acute demyelinative lesion"
                  },
                  {
                    "text": "AQP4-IgG serum test (+), unlike MS"
                  },
                  {
                    "text": "AQP4 immunoreactivity lost even in areas where GFAP and myelin loss are not seen"
                  },
                  {
                    "text": "May have eosinophils, neutrophils in biopsy (rare in MS)"
                  },
                  {
                    "text": "Myelin vacuolization, vascular hyalinization, macrophages containing GFAP(+) debris may be present"
                  },
                  {
                    "text": "Dystrophic astrocytes: Massively enlarged cytoplasm, beading/clumping/disintegrated cell processes"
                  },
                  {
                    "text": "Chronic lesions show gliosis, cavitation, fibrotic thickened vessel walls, atrophy of spinal cord, optic nerve"
                  }
                ],
                "Balo Sclerosis": [
                  {
                    "text": "Considered rare variant of MS, not fully separate disorder"
                  },
                  {
                    "text": "May present acutely, prompting biopsy"
                  },
                  {
                    "text": "Diagnosis requires correlation with MR imaging of concentric globe appearance"
                  },
                  {
                    "text": "Requires histochemistry for LFB/PAS or IHC for MBP, PLP to detect concentric myelin loss and preservation"
                  }
                ],
                "Myelin Oligodendrocyte Glycoprotein Encephalomyelitis/Myelin Oligodendrocyte Glycoprotein Antibody Disease": [
                  {
                    "text": "MOG-IgG-associated encephalomyelitis (MOG-EM) considered distinct disease entityAutoimmune disease of CNS associated with serologic antibody against MOG, myelin oligodendrocyte glycoproteinMOG is glycoprotein expressed on outer membrane of myelin; only found in CNS (brain, optic nerves, and spinal cord)Many patients diagnosed with AQP4-IgG (-) NMOSD are MOG-EM, but cases not restricted to this groupClinically resembles NMOSD due to relapses of optic neuritis, transverse myelitisUp to 42% of NMOSD patients who test seronegative for tAQP4 antibody test positive for MOG antibodiesIndications for MOG-IgG testing in children not as rigorous as in adults, since MOG-IgG thought to be much more common in children with acquired demyelinating disease (up to 70% depending on age) than in their adult counterparts (≤ 1% in Western countries)",
                    "sub_points": [
                      "Autoimmune disease of CNS associated with serologic antibody against MOG, myelin oligodendrocyte glycoproteinMOG is glycoprotein expressed on outer membrane of myelin; only found in CNS (brain, optic nerves, and spinal cord)",
                      "MOG is glycoprotein expressed on outer membrane of myelin; only found in CNS (brain, optic nerves, and spinal cord)",
                      "Many patients diagnosed with AQP4-IgG (-) NMOSD are MOG-EM, but cases not restricted to this groupClinically resembles NMOSD due to relapses of optic neuritis, transverse myelitisUp to 42% of NMOSD patients who test seronegative for tAQP4 antibody test positive for MOG antibodies",
                      "Clinically resembles NMOSD due to relapses of optic neuritis, transverse myelitis",
                      "Up to 42% of NMOSD patients who test seronegative for tAQP4 antibody test positive for MOG antibodies",
                      "Indications for MOG-IgG testing in children not as rigorous as in adults, since MOG-IgG thought to be much more common in children with acquired demyelinating disease (up to 70% depending on age) than in their adult counterparts (≤ 1% in Western countries)"
                    ]
                  },
                  {
                    "text": "Immunopathogenetically distinct from MS or AQP4-IgG (+) NMOSD, although overlap in clinical phenotypesSerologic studies show lack of AQP4-IgG in almost all MOG-IgG (+) patients",
                    "sub_points": [
                      "Serologic studies show lack of AQP4-IgG in almost all MOG-IgG (+) patients"
                    ]
                  },
                  {
                    "text": "Often misdiagnosed as MS in past"
                  },
                  {
                    "text": "3 clinical, MR criteria for diagnosis establishedMonophasic or relapsing acute optic neuritis (ON), myelitis, brainstem encephalitis, or encephalitis, or any combinationMRI or electrophysiologic (visual evoked potentials in patients with isolated ON) findings compatible with CNS demyelinationSeropositivity for MOG-IgG as detected by means of cell-based assay employing full-length human MOG as target antigen",
                    "sub_points": [
                      "Monophasic or relapsing acute optic neuritis (ON), myelitis, brainstem encephalitis, or encephalitis, or any combination",
                      "MRI or electrophysiologic (visual evoked potentials in patients with isolated ON) findings compatible with CNS demyelination",
                      "Seropositivity for MOG-IgG as detected by means of cell-based assay employing full-length human MOG as target antigen"
                    ]
                  },
                  {
                    "text": "Positive MOG-IgG test result should be challenged with certain red flagsChronic progressive disease course (i.e., SPMS without relapses, PPMS)Sudden onset of symptoms or continuous worsening of symptoms over weeksMR lesions adjacent to lateral ventricle or Dawson finger type lesions",
                    "sub_points": [
                      "Chronic progressive disease course (i.e., SPMS without relapses, PPMS)",
                      "Sudden onset of symptoms or continuous worsening of symptoms over weeks",
                      "MR lesions adjacent to lateral ventricle or Dawson finger type lesions"
                    ]
                  },
                  {
                    "text": "Important to diagnose/distinguish since associated with high risk of flare-ups after cessation of steroid treatment for acute attacks"
                  },
                  {
                    "text": "May be more responsive to PLEX, immunoadsorption, rituximab, intravenous immunoglobulins, immunosuppressive treatments"
                  },
                  {
                    "text": "Histologic features dominated by coexistence of both perivenous and confluent WM demyelinationMore intracortical demyelinated lesions compared to typical MSSlowly expanding smoldering WM lesions as seen in MS not presentCD4(+) T-cell-dominated inflammatory reaction with granulocytic infiltration predominatesAQP4 preserved; no preferential loss of MOGNo dystrophic astrocytesVariable oligodendrocyte and axonal destruction",
                    "sub_points": [
                      "More intracortical demyelinated lesions compared to typical MS",
                      "Slowly expanding smoldering WM lesions as seen in MS not present",
                      "CD4(+) T-cell-dominated inflammatory reaction with granulocytic infiltration predominates",
                      "AQP4 preserved; no preferential loss of MOG",
                      "No dystrophic astrocytes",
                      "Variable oligodendrocyte and axonal destruction"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "May closely resemble astrocytoma or oligodendroglioma in H&E sections due to hypercellularity"
                  },
                  {
                    "text": "Recognition of macrophages on touch and smear preparations during intraoperative consultation aids in diagnosis"
                  },
                  {
                    "text": "Absence of inflammation does not negate diagnosis"
                  },
                  {
                    "text": "Periventricular, perivenular location typical"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Amyloid (Congophilic) Angiopathy": {
            "name": "Amyloid (Congophilic) Angiopathy",
            "url": "https://app.pathprimer.com/document/230f77e0-66b4-4fcc-a523-c65e0d86c0a8/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "SynonymsCerebral amyloid angiopathy (CAA)Congophilic angiopathy",
                    "sub_points": [
                      "Cerebral amyloid angiopathy (CAA)",
                      "Congophilic angiopathy"
                    ]
                  },
                  {
                    "text": "Amyloid isolated to CNS"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Lobar and microhemorrhages, small infarctions, differing ages and sizes"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Amyloid deposition earliest/maximal in leptomeningeal and superficial cortical blood vessels"
                  },
                  {
                    "text": "Medium to small arteries, arterioles preferentially affected"
                  },
                  {
                    "text": "Amyloid could be difficult to appreciate on routine sections, and special stains may be needed"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Vessels with electrocautery artifact can appear smudgy, eosinophilic, congophilicElectrocauterized vessels do not polarize on Congo red stain",
                    "sub_points": [
                      "Electrocauterized vessels do not polarize on Congo red stain"
                    ]
                  },
                  {
                    "text": "CAA often incidental finding in Alzheimer disease patients without cerebral hemorrhage(s)"
                  },
                  {
                    "text": "Rule out other causes of hemorrhageHypertensionCoagulopathyThrombocytopeniaNeoplasm",
                    "sub_points": [
                      "Hypertension",
                      "Coagulopathy",
                      "Thrombocytopenia",
                      "Neoplasm"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Use Congo red or β-A4-amyloid IHC to rule out presence of amyloid in all cases of clot evacuation in older adults if fragments of cortex &/or leptomeninges are present"
                  },
                  {
                    "text": "Assess surgical specimens with CAA for additional presence of neuritic plaques and tangles by modified Bielschowsky silver stain or TAU IHC"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Cerebral amyloid angiopathy (CAA)"
                  },
                  {
                    "text": "Congophilic angiopathy"
                  },
                  {
                    "text": "Rare inflammatory forms of CAAAβ-related angiitis (Aβ-angiitis, ABRA)Cerebral amyloid-related inflammation (CAA-RI)",
                    "sub_points": [
                      "Aβ-related angiitis (Aβ-angiitis, ABRA)",
                      "Cerebral amyloid-related inflammation (CAA-RI)"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Amyloid deposition in wall of leptomeningeal and cortical vessels, preferentially medium to small arteries and arterioles, without associated amyloid deposition in blood vessels of systemic organs"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Sporadic Cerebral Amyloid Angiopathy": [
                  {
                    "text": "Precursor proteinAmyloid precursor protein (APP)Protein is amyloid-β peptide (Aβ, β-A4-amyloid)",
                    "sub_points": [
                      "Amyloid precursor protein (APP)Protein is amyloid-β peptide (Aβ, β-A4-amyloid)",
                      "Protein is amyloid-β peptide (Aβ, β-A4-amyloid)"
                    ]
                  },
                  {
                    "text": "Amyloid also present in cores of neuritic plaques in Alzheimer disease (AD)AD has strong etiologic correlation with CAA",
                    "sub_points": [
                      "AD has strong etiologic correlation with CAA"
                    ]
                  },
                  {
                    "text": "Most common form of cerebral amyloid"
                  },
                  {
                    "text": "Novel locus,LINC-PINT, recently identified as being associated with lower CAA amongstAPOEε4-negative individuals"
                  },
                  {
                    "text": "Association of male sex, AD neuropathology, andAPOEε4with increased CAA"
                  }
                ],
                "Cerebral Amyloid Angiopathy in Down Syndrome": [
                  {
                    "text": "Precursor proteinAPP",
                    "sub_points": [
                      "APP"
                    ]
                  }
                ],
                "Hereditary Forms": [
                  {
                    "text": "Hereditary cerebral hemorrhage with amyloid (HCHWA)Dutch, Italian, Flemish/British, Icelandic typesOnly Dutch type has β-amyloid deposition",
                    "sub_points": [
                      "Dutch, Italian, Flemish/British, Icelandic typesOnly Dutch type has β-amyloid deposition",
                      "Only Dutch type has β-amyloid deposition"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "CAA lobar hemorrhages5-20% of all nontraumatic cerebral hemorrhages in older adult patients",
                    "sub_points": [
                      "5-20% of all nontraumatic cerebral hemorrhages in older adult patients"
                    ]
                  },
                  {
                    "text": "APOE4 genotype influences risk of CAA-related hemorrhage"
                  },
                  {
                    "text": "Most patients with AD have some degree of CAA"
                  },
                  {
                    "text": "Meta-analysis showed that in patients with AD, CAA prevalence based on pathology (48%) is twice that based on MRI presence of strictly lobar cerebral microbleeds (22%)Meta-analysis showed that pathology and MRI yield similar estimated prevalences of CAA in cognitively normal elderly (5% to 7%), in patients with intracerebral hemorrhage (19% to 24%), and in patients with lobar intracerebral hemorrhage (50% to 57%)",
                    "sub_points": [
                      "Meta-analysis showed that pathology and MRI yield similar estimated prevalences of CAA in cognitively normal elderly (5% to 7%), in patients with intracerebral hemorrhage (19% to 24%), and in patients with lobar intracerebral hemorrhage (50% to 57%)"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Sporadic CAAUsually patients > 55 years",
                    "sub_points": [
                      "Usually patients > 55 years"
                    ]
                  },
                  {
                    "text": "CAA in Down syndromeMay be seen by 40-50 years",
                    "sub_points": [
                      "May be seen by 40-50 years"
                    ]
                  },
                  {
                    "text": "Hereditary formsOnset usually between 45-50 years",
                    "sub_points": [
                      "Onset usually between 45-50 years"
                    ]
                  },
                  {
                    "text": "Hereditary Icelandic form related to cystatin COnset between 20-30 years",
                    "sub_points": [
                      "Onset between 20-30 years"
                    ]
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Hereditary formsSmall numbers of families affected within ethnic group bearing disorder name",
                    "sub_points": [
                      "Small numbers of families affected within ethnic group bearing disorder name"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Supratentorial, all lobes"
                  },
                  {
                    "text": "Subarachnoid bleeds"
                  },
                  {
                    "text": "Superficial cortical bleedsBleeds spare deep gray matter (basal ganglia, thalamus), rarely involve cerebellum",
                    "sub_points": [
                      "Bleeds spare deep gray matter (basal ganglia, thalamus), rarely involve cerebellum"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Recurrent lobar hemorrhages"
                  },
                  {
                    "text": "Focal neurologic deficits"
                  }
                ],
                "Treatment": [
                  {
                    "text": "No specific treatment"
                  },
                  {
                    "text": "Intracranial surgical procedures carry risk of rebleeding"
                  },
                  {
                    "text": "Treatment with anti-AD medication, such as memantine, is reported to reduce severity of CAA"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Guarded, due to risk for repeated hemorrhage"
                  },
                  {
                    "text": "CAA in setting of AD is often clinically silent"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Recurrent, large lobar and microhemorrhages of varying ages"
                  },
                  {
                    "text": "Small infarction(s)"
                  },
                  {
                    "text": "Ischemic white matter damage"
                  },
                  {
                    "text": "On MR, leptomeningeal disease alone significantly more frequent at presentation in patients with Aβ-angiitis or CAA-RI compared with those with CAA"
                  },
                  {
                    "text": "Lobar hemorrhage more frequent in patients with CAA without inflammation than with Aβ-angiitis or CAA-RI"
                  },
                  {
                    "text": "Microbleeds found at presentation in 70% of patients with either type of inflammatory CAA"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Surgical specimenAcute clot with small fragments of admixed brain parenchyma",
                    "sub_points": [
                      "Acute clot with small fragments of admixed brain parenchyma"
                    ]
                  },
                  {
                    "text": "AutopsyMajor lobar hemorrhages in frontal or frontoparietal areasCortical petechial hemorrhagesSmall infarctsWhite matter ischemic lesions",
                    "sub_points": [
                      "Major lobar hemorrhages in frontal or frontoparietal areas",
                      "Cortical petechial hemorrhages",
                      "Small infarcts",
                      "White matter ischemic lesions"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Smudgy, eosinophilic thickening of leptomeningeal and cortical vesselsFull circumferential or segmental vascular amyloid depositionSevere examples haveVessel splitting (\"lumen within lumen\")ThrombosisAneurysmal changeLobar hemorrhage correlates with severity of CAAMild CAA focally distributed, most often seen as incidental findingInitial amyloid deposition appears 1st in meningeal vesselsOne study of >100 cases demonstrated no example where CAA was limited only to cerebral cortical blood vesselsSame study of >100 cases showed CAA in white matter vessels was seen in 10 cases; 9 severe, 1 mildAffects cerebral cortical vessels, much less frequently than white matter vesselsWhite matter may show pallor, rarefaction, so-called leukoaraiosis",
                    "sub_points": [
                      "Full circumferential or segmental vascular amyloid deposition",
                      "Severe examples haveVessel splitting (\"lumen within lumen\")ThrombosisAneurysmal change",
                      "Vessel splitting (\"lumen within lumen\")",
                      "Thrombosis",
                      "Aneurysmal change",
                      "Lobar hemorrhage correlates with severity of CAA",
                      "Mild CAA focally distributed, most often seen as incidental finding",
                      "Initial amyloid deposition appears 1st in meningeal vesselsOne study of >100 cases demonstrated no example where CAA was limited only to cerebral cortical blood vesselsSame study of >100 cases showed CAA in white matter vessels was seen in 10 cases; 9 severe, 1 mild",
                      "One study of >100 cases demonstrated no example where CAA was limited only to cerebral cortical blood vessels",
                      "Same study of >100 cases showed CAA in white matter vessels was seen in 10 cases; 9 severe, 1 mild",
                      "Affects cerebral cortical vessels, much less frequently than white matter vessels",
                      "White matter may show pallor, rarefaction, so-called leukoaraiosis"
                    ]
                  },
                  {
                    "text": "On Congo red, CAA vessels congophilic with birefringence after polarization"
                  },
                  {
                    "text": "Sporadic, Down-, and AD-associated CAAAβ(+) by immunohistochemistry",
                    "sub_points": [
                      "Aβ(+) by immunohistochemistry"
                    ]
                  },
                  {
                    "text": "Variable amounts parenchymal amyloid, neuritic plaques, neurofibrillary tangles, dystrophic neurites"
                  },
                  {
                    "text": "CAA with granulomatous inflammation/Aβ-related angiitis (ABRA); uncommonMultinucleated giant cells with intracytoplasmic Aβ(+) amyloidEpithelioid histiocytes, lymphocytesRequires presence of inflammation within vessel wall, \"angiodestructive inflammation\"Fibrinoid vascular necrosis in some casesABRA more closely related to primary CNS vasculitis than to CAANeurologic manifestations of CAA with inflammatory vascular or perivascular infiltration respond to immunosuppressive treatment",
                    "sub_points": [
                      "Multinucleated giant cells with intracytoplasmic Aβ(+) amyloid",
                      "Epithelioid histiocytes, lymphocytes",
                      "Requires presence of inflammation within vessel wall, \"angiodestructive inflammation\"",
                      "Fibrinoid vascular necrosis in some cases",
                      "ABRA more closely related to primary CNS vasculitis than to CAA",
                      "Neurologic manifestations of CAA with inflammatory vascular or perivascular infiltration respond to immunosuppressive treatment"
                    ]
                  },
                  {
                    "text": "Cerebral amyloid-related inflammationa.k.a. CAA-related inflammation or CAA-RIPerivascular inflammationOccurs in spectrum with true Aβ-angiitisCAA-RI more closely related to primary CNS vasculitis than to CAACognitive, behavioral manifestations; seizures are most common symptomsAPOEε4 allele and ε4/ε4 genotype overrepresented in CAA-RI",
                    "sub_points": [
                      "a.k.a. CAA-related inflammation or CAA-RI",
                      "Perivascular inflammation",
                      "Occurs in spectrum with true Aβ-angiitis",
                      "CAA-RI more closely related to primary CNS vasculitis than to CAACognitive, behavioral manifestations; seizures are most common symptoms",
                      "Cognitive, behavioral manifestations; seizures are most common symptoms",
                      "APOEε4 allele and ε4/ε4 genotype overrepresented in CAA-RI"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hemorrhages Due to Other Causes": [
                  {
                    "text": "Neoplasm (primary or metastatic)No amyloid, unless incidental finding",
                    "sub_points": [
                      "No amyloid, unless incidental finding"
                    ]
                  },
                  {
                    "text": "Chronic hypertensionBleeds usually involve basal ganglia, thalamus, basis pontis, cerebellar white matterArteriolosclerosis",
                    "sub_points": [
                      "Bleeds usually involve basal ganglia, thalamus, basis pontis, cerebellar white matter",
                      "Arteriolosclerosis"
                    ]
                  },
                  {
                    "text": "Coagulopathy relatedOften associated with systemic organ hemorrhages",
                    "sub_points": [
                      "Often associated with systemic organ hemorrhages"
                    ]
                  }
                ],
                "Primary CNS Angiitis": [
                  {
                    "text": "No amyloid"
                  }
                ],
                "Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy": [
                  {
                    "text": "No amyloid"
                  },
                  {
                    "text": "Today almost always diagnosed by blood test for mutation inNOTCH3, not by brain biopsy"
                  },
                  {
                    "text": "Tends to affect white matter and deep gray matter vessels; not leptomeningeal and superficial cortical vessels, as in CAA"
                  },
                  {
                    "text": "Vessel walls PAS(+) due to accumulation of granular osmophilic material (GOM)GOM best identified on electron microscopy",
                    "sub_points": [
                      "GOM best identified on electron microscopy"
                    ]
                  }
                ],
                "Cerebral Autosomal Recessive Arteriopathy With Subcortical Infarcts and Leukoencephalopathy": [
                  {
                    "text": "No amyloid"
                  },
                  {
                    "text": "Caused by mutations inHTRA1"
                  }
                ],
                "Small Vessel Disease WithCOL4A1Mutations": [
                  {
                    "text": "No amyloid"
                  }
                ],
                "Hypertensive Vasculopathy": [
                  {
                    "text": "Vessels show trichrome (+) thickening, no amyloid"
                  },
                  {
                    "text": "Tends to affect white matter and deep gray matter vessels, not leptomeningeal and superficial cortical vessels, as does CAA"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Recurrent lobar hemorrhages"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "CAA maximal in meningeal, cerebral cortical vessels; rare in white matter vessels"
                  },
                  {
                    "text": "Recognized as 1 of morphologic hallmarks of AD"
                  },
                  {
                    "text": "Systemic forms of amyloidosis do not cause amyloid deposits in CNS blood vessels or parenchyma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Arteriovenous Malformation": {
            "name": "Arteriovenous Malformation",
            "url": "https://app.pathprimer.com/document/882017d5-5cb4-4840-ac02-4f89082fecc7/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most sporadic"
                  },
                  {
                    "text": "ActivatingKRASmutations in sporadic AVMs"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Usually present with brain hemorrhage in patients aged 20-40 years"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Flow voids (high flow) on T1WI and, especially, T2WI"
                  },
                  {
                    "text": "Enlarged arterial feeders, nidus of tight-packed vessels, dilated draining veins, shunting (angiography)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Superficial AVMs: Wedge-shaped aggregate of closely juxtaposed, abnormal, dilated veins; fewer arteries"
                  },
                  {
                    "text": "Most supratentorial"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Combination of arteries and veins"
                  },
                  {
                    "text": "Arteries with duplicated elastic lamina"
                  },
                  {
                    "text": "Veins dilated, hyalinized, calcified, but infrequently thrombosed"
                  },
                  {
                    "text": "Usually many more veins than arteries"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Trichrome stain shows hyalinization of veins, loss of muscularis"
                  },
                  {
                    "text": "Elastic stain highlights arterial component"
                  },
                  {
                    "text": "Elastic stain may also show duplicated elastic lamina in arteries"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Do not confuse artifactually compacted normal leptomeningeal vessels with AVM"
                  },
                  {
                    "text": "Clinically, radiologically, pathologically distinct from cavernous angioma"
                  },
                  {
                    "text": "Check surgically resected brain clots for entrapped abnormal vessels to rule out ruptured AVM"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Arteriovenous malformation (AVM)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Brain arteriovenous malformation (BAVM)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Vascular malformation with arteries shunting directly into tangle of veins, without intervening capillary bed"
                  },
                  {
                    "text": "\"Fast-flow vascular anomaly consisting of arteriovenous connections through a nidus or fistula of malformed arteries and veins instead of a normal capillary bed. AVMs are typically sporadic, show intervening brain parenchyma with gliosis between malformed vessels, with frequent somaticKRASorBRAFmutations\" (WHO CNS Classification 2021)"
                  },
                  {
                    "text": "Focal abnormal conglomeration of dilated arteries and veins within brain parenchymaLack of intervening capillary bed results in abnormal, fast-flow, arteriovenous shuntingRelatively well-circumscribed center of lesion known as nidus",
                    "sub_points": [
                      "Lack of intervening capillary bed results in abnormal, fast-flow, arteriovenous shunting",
                      "Relatively well-circumscribed center of lesion known as nidus"
                    ]
                  },
                  {
                    "text": "Foix-Alajouanine: Dural arteriovenous fistula causing spinal cord chronic ischemic damage, progressive myelopathy"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Traditionally viewed as congenital, but acquired AVMs also reported"
                  },
                  {
                    "text": "Typically sporadicIncidence ~ 1 per 100,000 (0.69-1.32)",
                    "sub_points": [
                      "Incidence ~ 1 per 100,000 (0.69-1.32)"
                    ]
                  },
                  {
                    "text": "Small percentage associated with hereditary hemorrhagic telangiectasia (HHT) syndrome (Rendu-Osler-Weber)HHT systemic disorder characterized by mucocutaneous telangiectasias, epistaxis, AVMsCaused by mutations in transforming growth factor-β signaling genes [ENG,ACVRL1(ALK1),SMAD4]Patients often have multiple brain AVMs, which is highly predictive of diagnosis of HHTRisk of AVM rupture similar in HHT (< 2.5% per year) and sporadic brain AVM (2.3% per year) patients",
                    "sub_points": [
                      "HHT systemic disorder characterized by mucocutaneous telangiectasias, epistaxis, AVMs",
                      "Caused by mutations in transforming growth factor-β signaling genes [ENG,ACVRL1(ALK1),SMAD4]",
                      "Patients often have multiple brain AVMs, which is highly predictive of diagnosis of HHT",
                      "Risk of AVM rupture similar in HHT (< 2.5% per year) and sporadic brain AVM (2.3% per year) patients"
                    ]
                  },
                  {
                    "text": "Vein of Galen malformation uniquely pediatric vascular malformation"
                  }
                ],
                "Genetics": [
                  {
                    "text": "Activating somaticKRASmutations (KRASG12V,KRASG12D) in large percentage of sporadic AVMsMetaanalysis found frequency ofKRASmutations in 1,726 patients with AVM was 55% (48-62%)No difference in age, sex, presenting symptom, AVM location, or AVM size between patients with confirmed mutation and those withoutNo association between specificKRASmutation and patient age at resection, at first hemorrhage, or lesion sizeMetaanalysis found prevalence ofBRAFmutation was 7.5% (0.8-14.1%)",
                    "sub_points": [
                      "Metaanalysis found frequency ofKRASmutations in 1,726 patients with AVM was 55% (48-62%)",
                      "No difference in age, sex, presenting symptom, AVM location, or AVM size between patients with confirmed mutation and those without",
                      "No association between specificKRASmutation and patient age at resection, at first hemorrhage, or lesion size",
                      "Metaanalysis found prevalence ofBRAFmutation was 7.5% (0.8-14.1%)"
                    ]
                  },
                  {
                    "text": "Mutations inRASA1associated with capillary malformation AVM in childrenRASA1mutations also associated with Parkes Weber syndrome, vein of Galen malformation, spinal arteriovenous lesions, pial arteriovenous fistulae in children",
                    "sub_points": [
                      "RASA1mutations also associated with Parkes Weber syndrome, vein of Galen malformation, spinal arteriovenous lesions, pial arteriovenous fistulae in children"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "< 1% of population (0.1-0.2%)"
                  },
                  {
                    "text": "1-4% of brain masses"
                  },
                  {
                    "text": "Majority sporadic"
                  },
                  {
                    "text": "Hemorrhage of AVM accounts for 1-2% of all strokesBrain AVMs in children present far more often with hemorrhage than in adults: Up to 80% hemorrhagic at presentation",
                    "sub_points": [
                      "Brain AVMs in children present far more often with hemorrhage than in adults: Up to 80% hemorrhagic at presentation"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Peak clinical presentation of AVM: 20-40 years old"
                  },
                  {
                    "text": "Mean age of AVM presentation in children: 11 yearsAVMs less common in children, but many intracerebral bleeds in childhood due to ruptured AVM",
                    "sub_points": [
                      "AVMs less common in children, but many intracerebral bleeds in childhood due to ruptured AVM"
                    ]
                  },
                  {
                    "text": "Vein of Galen malformation most frequent type AVM found in neonates, children < 1 yearsPresents with high-output cardiac failure due to shunting or hydrocephalusCan be life-threatening if not diagnosed and treated early",
                    "sub_points": [
                      "Presents with high-output cardiac failure due to shunting or hydrocephalus",
                      "Can be life-threatening if not diagnosed and treated early"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "No strong sex predilection"
                  }
                ],
                "Site": [
                  {
                    "text": "Intracranial"
                  },
                  {
                    "text": "Intraspinal"
                  },
                  {
                    "text": "Extradural shunting nidus in some cases"
                  },
                  {
                    "text": "Dural arteriovenous fistula with venous portion in spinal cord (Foix-Alajouanine syndrome)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Cerebral hemorrhageOnce AVM has presented with bleed, much higher incidence of bleeding recurrence",
                    "sub_points": [
                      "Once AVM has presented with bleed, much higher incidence of bleeding recurrence"
                    ]
                  },
                  {
                    "text": "Seizures"
                  },
                  {
                    "text": "Mass effect/headache"
                  },
                  {
                    "text": "Ischemic tissue damage due to steal of blood flow and hypoperfusion of adjacent brain"
                  },
                  {
                    "text": "Foix-Alajouanine syndrome with progressive myelopathy"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Microsurgery, surgery, embolization, radiosurgery options for unruptured AVMs"
                  },
                  {
                    "text": "Surgical decompression ± hematoma and nidus resection may be required in patients with rapid clinical deterioration"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Risk of hemorrhage2-4% per year",
                    "sub_points": [
                      "2-4% per year"
                    ]
                  },
                  {
                    "text": "Hemorrhage associated with5-10% chance of death30-50% chance of permanent neurologic deficits",
                    "sub_points": [
                      "5-10% chance of death",
                      "30-50% chance of permanent neurologic deficits"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Can be obscured by hematoma"
                  }
                ],
                "Radiographic Findings": [
                  {
                    "text": "Enlarged arterial feeders, nidus of tight packed vessels, dilated draining veins, shunting (angiography)"
                  },
                  {
                    "text": "May be coassociated saccular aneurysm of feeding vessels"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Highly vascular"
                  },
                  {
                    "text": "Larger, less compact than cavernous angioma"
                  },
                  {
                    "text": "Flow voids (high flow) on T1WI and, especially, T2WI"
                  },
                  {
                    "text": "Hemorrhage (some cases)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Superficial AVMs often wedge-shaped"
                  },
                  {
                    "text": "Deep AVMs often drain into deep venous system"
                  },
                  {
                    "text": "Aggregate of tangled blood vessels of varying sizes"
                  },
                  {
                    "text": "Hemosiderin usually absent in adjacent brain tissue"
                  },
                  {
                    "text": "May see intravascular embolization material or coils in gross specimenSearch gross specimen carefully to avoid putting specimen through tissue processing without first removing coils",
                    "sub_points": [
                      "Search gross specimen carefully to avoid putting specimen through tissue processing without first removing coils"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Multiple abnormal vessels"
                  },
                  {
                    "text": "Veins more numerous and larger than arteries"
                  },
                  {
                    "text": "Veins hyalinized, calcified, less frequently thrombosed than cavernous angioma vessels due to high arterial flow"
                  },
                  {
                    "text": "Duplication of arterial internal elastic lamina"
                  },
                  {
                    "text": "Gliotic brain in and around lesion due to ischemic \"steal\""
                  },
                  {
                    "text": "Generally little parenchymal hemosiderin"
                  },
                  {
                    "text": "Occasional examples present de novo with large obliterating hemorrhageSearch surgically resected brain clot diligently for abnormal vessels of AVM",
                    "sub_points": [
                      "Search surgically resected brain clot diligently for abnormal vessels of AVM"
                    ]
                  },
                  {
                    "text": "Eosinophilic, neutrophilic, mononuclear, and multinucleated giant cell reaction in some embolized AVMsEmbolization material may be amorphous gray-blue color or jet-black",
                    "sub_points": [
                      "Embolization material may be amorphous gray-blue color or jet-black"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal, Artifactually Compacted Vessels": [
                  {
                    "text": "Confined to leptomeninges"
                  },
                  {
                    "text": "Vessels individually normal"
                  },
                  {
                    "text": "Calcification absent in vessel walls"
                  },
                  {
                    "text": "Vessels even with arteriosclerosis usually not as severely hyalinized as in AVM"
                  }
                ],
                "Cavernous Angioma": [
                  {
                    "text": "Well-circumscribed compact mass"
                  },
                  {
                    "text": "Abnormal vessels, no normal arteries or veinsHyalinizedUsually more closely packed than in AVM",
                    "sub_points": [
                      "Hyalinized",
                      "Usually more closely packed than in AVM"
                    ]
                  },
                  {
                    "text": "Almost always with surrounding hemosiderin"
                  }
                ],
                "Aneurysm": [
                  {
                    "text": "Dilatation of single vessel, usually arteries on circle of Willis"
                  },
                  {
                    "text": "No venous component"
                  }
                ],
                "Leptomeningeal Angiomatosis in Sturge-Weber Syndrome": [
                  {
                    "text": "Capillary or capillary-venous malformation"
                  },
                  {
                    "text": "No arterial component"
                  },
                  {
                    "text": "Dystrophic mineralization in small arterioles in underlying cortex"
                  },
                  {
                    "text": "SomaticGNAQmutations"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Intervening parenchyma and varying caliber of vessels, plus arteries and veins, rules out cavernous malformation"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Clinically, radiologically, and pathologically distinct from cavernous angioma"
                  },
                  {
                    "text": "Recognize intraluminal embolization materialMay occasionally see inflammation in tissue from previously embolized AVMs",
                    "sub_points": [
                      "May occasionally see inflammation in tissue from previously embolized AVMs"
                    ]
                  },
                  {
                    "text": "Arteries are less frequent than veins in AVMsVeins hyalinized, calcified, occasionally thrombosed",
                    "sub_points": [
                      "Veins hyalinized, calcified, occasionally thrombosed"
                    ]
                  },
                  {
                    "text": "Either unruptured or embolized AVMs may be surrounded by tissue rarefaction, gliosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Infarct at Autopsy and Biopsy": {
            "name": "Infarct at Autopsy and Biopsy",
            "url": "https://app.pathprimer.com/document/1d1dd6d5-9777-4809-85b3-e5d3c778e82b/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Uncommon as surgical specimenUnusual clinical features in some casesYoung age, absence of sudden onset of symptoms, atypical vascular distributionWhen acute, can simulate tumor, especially in posterior fossa",
                    "sub_points": [
                      "Unusual clinical features in some casesYoung age, absence of sudden onset of symptoms, atypical vascular distribution",
                      "Young age, absence of sudden onset of symptoms, atypical vascular distribution",
                      "When acute, can simulate tumor, especially in posterior fossa"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "Diffusion-weighted imagingHyperacute, within 6 hoursHyperintense (bright) in contrast to dark signal with most malignant gliomas and metastases",
                    "sub_points": [
                      "Hyperacute, within 6 hours",
                      "Hyperintense (bright) in contrast to dark signal with most malignant gliomas and metastases"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "No definite gross changes until 6-8 hours"
                  },
                  {
                    "text": "\"Cracking away\" of gray matter from white matter due to advanced tissue necrosis, 3-4 days"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Acute (12-24 hours)\"Red-dead,\" acutely ischemic neurons",
                    "sub_points": [
                      "\"Red-dead,\" acutely ischemic neurons"
                    ]
                  },
                  {
                    "text": "SubacuteProgressive influx of microglia and macrophages; progressive capillary proliferation",
                    "sub_points": [
                      "Progressive influx of microglia and macrophages; progressive capillary proliferation"
                    ]
                  },
                  {
                    "text": "Chronic (weeks to months)Progressive removal of necrotic debris by macrophages, cavitation",
                    "sub_points": [
                      "Progressive removal of necrotic debris by macrophages, cavitation"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Contracted \"red-dead\" neurons may be inconspicuous"
                  },
                  {
                    "text": "Vascular thrombi common to both high-grade gliomas and infarcts; look for cytologically atypical glial cells for tumor"
                  },
                  {
                    "text": "Macrophages conspicuous in subacute stages of infarct; rule out demyelinating lesionIn difficult cases, perform axonal stains/immunostains to show severe axonal loss in infarct vs. relative preservation of axons in demyelination",
                    "sub_points": [
                      "In difficult cases, perform axonal stains/immunostains to show severe axonal loss in infarct vs. relative preservation of axons in demyelination"
                    ]
                  },
                  {
                    "text": "Chronic gliosis surrounding remote stroke, especially perinatal stroke, may simulate glioma in specimens resected for seizures"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Cerebrovascular accident (CVA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Loss of blood supply, and hence oxygen and nutrients, to given area of brain due to blood vessel occlusion, resulting in tissue necrosis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Nonmodifiable Risk Factors": [
                  {
                    "text": "Increasing age; M > F"
                  },
                  {
                    "text": "Race (lower risk for White North Americans/Europeans), family history"
                  }
                ],
                "Treatable Risk Factors": [
                  {
                    "text": "Hypertension (most important risk)"
                  },
                  {
                    "text": "Lipid disorders [high total cholesterol, low-density lipoprotein (LDL)]"
                  },
                  {
                    "text": "Smoking, diabetes mellitus, obesity (relatively small risk after correction of other problems)"
                  },
                  {
                    "text": "Alcoholism (low intake decreases risk, high intake increases risk)"
                  },
                  {
                    "text": "Stimulant use/abuse"
                  }
                ],
                "Common Proximate Causes": [
                  {
                    "text": "Atherosclerosis with thrombosis"
                  },
                  {
                    "text": "Embolic occlusionSource of embolism often heart or atherosclerotic carotid arteriesCardiac disease: Atrial fibrillation, valvular defects, patent foramen ovale, atrial septal defect",
                    "sub_points": [
                      "Source of embolism often heart or atherosclerotic carotid arteries",
                      "Cardiac disease: Atrial fibrillation, valvular defects, patent foramen ovale, atrial septal defect"
                    ]
                  },
                  {
                    "text": "Hypoperfusion (profound systemic hypotension, shock)May combine with regional atherosclerosis to produce lesion in single vessel distribution",
                    "sub_points": [
                      "May combine with regional atherosclerosis to produce lesion in single vessel distribution"
                    ]
                  },
                  {
                    "text": "Herniation due to edema with compression of posterior cerebral arteries by swollen uncus/mesial temporal lobe or anterior cerebral artery by cingulate gyrus with falcine herniation"
                  }
                ],
                "Uncommon Proximate Causes": [
                  {
                    "text": "Fibromuscular dysplasiaWomen in 30s and 40s; associated with arterial dissection, aneurysms",
                    "sub_points": [
                      "Women in 30s and 40s; associated with arterial dissection, aneurysms"
                    ]
                  },
                  {
                    "text": "Moyamoya diseaseFocal occlusion of middle cerebral artery, nonatherosclerotic,Usually in children or women in 30s and 40s",
                    "sub_points": [
                      "Focal occlusion of middle cerebral artery, nonatherosclerotic,",
                      "Usually in children or women in 30s and 40s"
                    ]
                  },
                  {
                    "text": "Spontaneous arterial dissection (traumatic or nontraumatic, including fibromuscular dysplasia)"
                  },
                  {
                    "text": "Hematologic disorders (more associated with venous infarction than arterial)Protein C, protein S, factor V, Leiden, prothrombin gene (F2), antithrombin (formerly antithrombin III) gene (SERPINC1)Sickle cell anemia, coagulopathies associated with malignanciesOral contraceptivesPost partum (usually venous infarction, day 3-5)Antiphospholipid syndrome",
                    "sub_points": [
                      "Protein C, protein S, factor V, Leiden, prothrombin gene (F2), antithrombin (formerly antithrombin III) gene (SERPINC1)",
                      "Sickle cell anemia, coagulopathies associated with malignancies",
                      "Oral contraceptives",
                      "Post partum (usually venous infarction, day 3-5)",
                      "Antiphospholipid syndrome"
                    ]
                  },
                  {
                    "text": "Vasospasm after subarachnoid hemorrhage"
                  },
                  {
                    "text": "Posterior reversible encephalopathy syndrome (reversible posterior leukoencephalopathy syndrome, reversible posterior leukoencephalopathy)"
                  }
                ],
                "Rare Causes": [
                  {
                    "text": "Intravascular lymphoma"
                  },
                  {
                    "text": "Emboli from atrial myxoma"
                  },
                  {
                    "text": "Primary CNS angiitis (PACNS, CNS vasculitis)Different size of vessels involvedLeptomeningeal vs. cerebral intraparenchymalPACNS overall diagnosed more often by angiogram than by biopsyIn one of largest studies, patients diagnosed by biopsy presented more frequently with cognitive dysfunction, greater CSF total protein concentrations, less frequent cerebral infarcts, more frequent leptomeningeal gadolinium-enhanced lesions on MR; also had less mortality and disabilityIn same study, patients diagnosed by angiogram presented more frequently with hemiparesis or persistent neurologic deficit or stroke, had more frequent infarcts on MR; had increased mortalityAngiography more likely positive with larger caliber vessel involvement by PACNS",
                    "sub_points": [
                      "Different size of vessels involvedLeptomeningeal vs. cerebral intraparenchymal",
                      "Leptomeningeal vs. cerebral intraparenchymal",
                      "PACNS overall diagnosed more often by angiogram than by biopsyIn one of largest studies, patients diagnosed by biopsy presented more frequently with cognitive dysfunction, greater CSF total protein concentrations, less frequent cerebral infarcts, more frequent leptomeningeal gadolinium-enhanced lesions on MR; also had less mortality and disabilityIn same study, patients diagnosed by angiogram presented more frequently with hemiparesis or persistent neurologic deficit or stroke, had more frequent infarcts on MR; had increased mortalityAngiography more likely positive with larger caliber vessel involvement by PACNS",
                      "In one of largest studies, patients diagnosed by biopsy presented more frequently with cognitive dysfunction, greater CSF total protein concentrations, less frequent cerebral infarcts, more frequent leptomeningeal gadolinium-enhanced lesions on MR; also had less mortality and disability",
                      "In same study, patients diagnosed by angiogram presented more frequently with hemiparesis or persistent neurologic deficit or stroke, had more frequent infarcts on MR; had increased mortality",
                      "Angiography more likely positive with larger caliber vessel involvement by PACNS"
                    ]
                  },
                  {
                    "text": "Radiation vasculopathy"
                  },
                  {
                    "text": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)"
                  },
                  {
                    "text": "Fat embolism"
                  },
                  {
                    "text": "Venous thrombosis"
                  }
                ],
                "Infectious Causes": [
                  {
                    "text": "Septic emboli, infected cardiac valve"
                  },
                  {
                    "text": "Vasoinvasive fungi,Aspergillus,Rhizopus(mucormycosis)"
                  },
                  {
                    "text": "Meningovascular syphilis (usually smaller vessel infarcts)"
                  },
                  {
                    "text": "COVID-19 (SARS-CoV-2)-associated ischemic, hemorrhagic conditionsThrombotic disorders: Ischemic stroke, venous thrombosesStrokes: Large vessel occlusion, embolic stroke, lacunar strokeIn recent review, ischemic stroke was most frequently reported neuroradiologic abnormality of COVID-19Ischemic strokes may be more frequent in vertebrobasilar territoryExtracted arterial thrombi mainly composed of fibrin and RBCs in variable proportions but with predominance of fibrin and different quantities of plateletsOne report identified clots containing apoptotic cells and some endothelial cells, along with atypical lymphocytesEndothelial damage disorders: Intracranial hemorrhage, posterior reversible encephalopathy syndromeHemorrhages: Subarachnoid, subdural > epidural, intraventricularHypoxia and hypoperfusion disordersWatershed infarction, leukoencephalopathyNervous system manifestations more common in patients with severe infections compared with nonsevere infections (45% vs. 30% in one study)",
                    "sub_points": [
                      "Thrombotic disorders: Ischemic stroke, venous thrombosesStrokes: Large vessel occlusion, embolic stroke, lacunar strokeIn recent review, ischemic stroke was most frequently reported neuroradiologic abnormality of COVID-19Ischemic strokes may be more frequent in vertebrobasilar territoryExtracted arterial thrombi mainly composed of fibrin and RBCs in variable proportions but with predominance of fibrin and different quantities of plateletsOne report identified clots containing apoptotic cells and some endothelial cells, along with atypical lymphocytes",
                      "Strokes: Large vessel occlusion, embolic stroke, lacunar stroke",
                      "In recent review, ischemic stroke was most frequently reported neuroradiologic abnormality of COVID-19Ischemic strokes may be more frequent in vertebrobasilar territoryExtracted arterial thrombi mainly composed of fibrin and RBCs in variable proportions but with predominance of fibrin and different quantities of plateletsOne report identified clots containing apoptotic cells and some endothelial cells, along with atypical lymphocytes",
                      "Ischemic strokes may be more frequent in vertebrobasilar territory",
                      "Extracted arterial thrombi mainly composed of fibrin and RBCs in variable proportions but with predominance of fibrin and different quantities of platelets",
                      "One report identified clots containing apoptotic cells and some endothelial cells, along with atypical lymphocytes",
                      "Endothelial damage disorders: Intracranial hemorrhage, posterior reversible encephalopathy syndromeHemorrhages: Subarachnoid, subdural > epidural, intraventricular",
                      "Hemorrhages: Subarachnoid, subdural > epidural, intraventricular",
                      "Hypoxia and hypoperfusion disordersWatershed infarction, leukoencephalopathy",
                      "Watershed infarction, leukoencephalopathy",
                      "Nervous system manifestations more common in patients with severe infections compared with nonsevere infections (45% vs. 30% in one study)"
                    ]
                  }
                ],
                "Infarct as Surgical Specimen": [
                  {
                    "text": "Uncommon"
                  },
                  {
                    "text": "Unusual features: Young patient age, absence of sudden onset of symptoms, atypical vascular distribution"
                  },
                  {
                    "text": "When acute, can simulate tumor, especially in posterior fossa"
                  },
                  {
                    "text": "Exclude primary or secondary CNS angiitis, intravascular lymphoma, vasculopathy"
                  },
                  {
                    "text": "Not true infarct: Subacute superficial tissue necrosis in epilepsy patients due to grid placement"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare between ages 45-55 years; more common in older adults"
                  },
                  {
                    "text": "~ 800,000 cases per year in USA"
                  },
                  {
                    "text": "Major cause of adult disability in USA"
                  },
                  {
                    "text": "3rd leading cause of mortality"
                  },
                  {
                    "text": "Increasing incidence in resource-limited world"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Sudden onset of neurologic deficitLarge vessel infarct in middle cerebral artery may cause hemiparesis, hemisensory loss, homonymous hemianopsia contralateral to vessel occlusionSmall vessel infarct (e.g., lacunar infarction) yields more isolated motor or sensory deficit",
                    "sub_points": [
                      "Large vessel infarct in middle cerebral artery may cause hemiparesis, hemisensory loss, homonymous hemianopsia contralateral to vessel occlusion",
                      "Small vessel infarct (e.g., lacunar infarction) yields more isolated motor or sensory deficit"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "1st few hours: Recombinant tissue plasminogen activator (TPA)"
                  },
                  {
                    "text": "Risk reduction: Aspirin, antiplatelet drugs, anticoagulants"
                  },
                  {
                    "text": "Endarterectomy for high-grade (70-90%) carotid stenosis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Tissue damage irreversible"
                  },
                  {
                    "text": "Outcome/residual neurologic deficits dependent on size and location of lesion"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Diffusion-weighted imagingHyperacute, within 6 hoursHyperintense (bright) with diffusion-weighted imaging, in contrast to dark signal with most malignant gliomas and metastases",
                    "sub_points": [
                      "Hyperacute, within 6 hours",
                      "Hyperintense (bright) with diffusion-weighted imaging, in contrast to dark signal with most malignant gliomas and metastases"
                    ]
                  },
                  {
                    "text": "Mild to moderate FLAIR hyperintensity, especially gray matter, acute"
                  },
                  {
                    "text": "Wedge shape in cortical infarcts, after 1-2 days"
                  },
                  {
                    "text": "Enhancement, cortical gyriform, develops within 1 week, persists as long as infarction undergoing resolution"
                  },
                  {
                    "text": "Cystic, chronic state"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Unremarkable in 1st few hours after stroke unless hemorrhagic"
                  },
                  {
                    "text": "Hypodense beginning at 24 hours"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "AcuteNo definite gross changes until 6-8 hours1st feature: Blurring of gray matter-white matter junction, congested vessels, tissue softening, 1-2 days\"Cracking away\" of gray matter from white matter due to tissue necrosis, 3-4 daysProgressive softening and cavitation during subacute resolving stageBland ischemic infarct: Little or no blood or blood pigmentsHemorrhagic infarct, often embolic or due to herniation: Blood or blood pigments, especially in gray matterVenous infarct may show hemorrhage in leptomeninges, cortex, venous thrombosisIn herniation hemorrhages, reperfusion of necrotic gray matter blood vessels causes gray matter petechial hemorrhages",
                    "sub_points": [
                      "No definite gross changes until 6-8 hours",
                      "1st feature: Blurring of gray matter-white matter junction, congested vessels, tissue softening, 1-2 days",
                      "\"Cracking away\" of gray matter from white matter due to tissue necrosis, 3-4 days",
                      "Progressive softening and cavitation during subacute resolving stage",
                      "Bland ischemic infarct: Little or no blood or blood pigments",
                      "Hemorrhagic infarct, often embolic or due to herniation: Blood or blood pigments, especially in gray matterVenous infarct may show hemorrhage in leptomeninges, cortex, venous thrombosisIn herniation hemorrhages, reperfusion of necrotic gray matter blood vessels causes gray matter petechial hemorrhages",
                      "Venous infarct may show hemorrhage in leptomeninges, cortex, venous thrombosis",
                      "In herniation hemorrhages, reperfusion of necrotic gray matter blood vessels causes gray matter petechial hemorrhages"
                    ]
                  },
                  {
                    "text": "RemoteCavity with variable degree of collapseCavitation follows territory of supply for occluded vessel",
                    "sub_points": [
                      "Cavity with variable degree of collapse",
                      "Cavitation follows territory of supply for occluded vessel"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Acute, 8-12 hoursNeurons histologically normal",
                    "sub_points": [
                      "Neurons histologically normal"
                    ]
                  },
                  {
                    "text": "Acute, 12-24 hours\"Red-dead,\" acutely ischemic neuronsShrunken, sometimes extremely soHypereosinophilic cytoplasmPyknosis, eventual karyorrhexisBackground fragmentation, vacuolization of neuropilOccluded vessel in some cases",
                    "sub_points": [
                      "\"Red-dead,\" acutely ischemic neuronsShrunken, sometimes extremely soHypereosinophilic cytoplasmPyknosis, eventual karyorrhexis",
                      "Shrunken, sometimes extremely so",
                      "Hypereosinophilic cytoplasm",
                      "Pyknosis, eventual karyorrhexis",
                      "Background fragmentation, vacuolization of neuropil",
                      "Occluded vessel in some cases"
                    ]
                  },
                  {
                    "text": "Subacute, 5-30 daysProgressive influx of microglia and macrophages, few, if any, residual \"red-dead\" neuronsHypertrophy and hyperplasia of capillary vascular cellsScattered mitosesPlump reactive astrocytes at perimeterMarked loss of axons centrally with axonal fragmentation; axonal spheroids at peripherySevere axonal loss contrasts with \"relative\" axonal preservation in demyelinating diseasesSubacute infarct at biopsy may show macrophages on smear/touch preparations at intraoperative consultationExclude demyelinating disease",
                    "sub_points": [
                      "Progressive influx of microglia and macrophages, few, if any, residual \"red-dead\" neurons",
                      "Hypertrophy and hyperplasia of capillary vascular cellsScattered mitoses",
                      "Scattered mitoses",
                      "Plump reactive astrocytes at perimeter",
                      "Marked loss of axons centrally with axonal fragmentation; axonal spheroids at peripherySevere axonal loss contrasts with \"relative\" axonal preservation in demyelinating diseases",
                      "Severe axonal loss contrasts with \"relative\" axonal preservation in demyelinating diseases",
                      "Subacute infarct at biopsy may show macrophages on smear/touch preparations at intraoperative consultationExclude demyelinating disease",
                      "Exclude demyelinating disease"
                    ]
                  },
                  {
                    "text": "Chronic, weeks to monthsProgressive removal of necrotic debris by macrophagesStrands of residual glial tissue and traversing blood vesselsCavitation",
                    "sub_points": [
                      "Progressive removal of necrotic debris by macrophages",
                      "Strands of residual glial tissue and traversing blood vessels",
                      "Cavitation"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Reactive proliferative capillaries"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Malignant Glioma": [
                  {
                    "text": "Cytologically neoplastic glial cellsMay be few viable in extensively necrotic glioblastoma",
                    "sub_points": [
                      "May be few viable in extensively necrotic glioblastoma"
                    ]
                  },
                  {
                    "text": "Microvascular proliferation more common in high-grade gliomas than infarcts"
                  },
                  {
                    "text": "Palisading necrosis, tumor cells surrounding zonal necrosis"
                  },
                  {
                    "text": "Coagulative necrosis in gliomas also usually affects vessels; vessels within infarct are usually spared"
                  }
                ],
                "Demyelinating Disease": [
                  {
                    "text": "Relative preservation of axons compared to myelin loss"
                  },
                  {
                    "text": "No ischemic \"red-dead\" neurons"
                  }
                ],
                "Herpes Simplex Encephalitis": [
                  {
                    "text": "Inferofrontal-temporal location, not in territory of vascular supply, often bilateral"
                  },
                  {
                    "text": "Intranuclear viral inclusions"
                  },
                  {
                    "text": "Immunohistochemistry for HSV(+)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "\"Red-dead\" neurons may be inconspicuous, especially in subacute phases of stroke"
                  },
                  {
                    "text": "Hypertrophic/hyperplastic vessels should not be misinterpreted as microvascular proliferation of high-grade glioma"
                  },
                  {
                    "text": "Remote infarcts, especially site of perinatal stroke resected for seizures, can show hypercellularity due to chronic gliosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Subdural Hematoma": {
            "name": "Subdural Hematoma",
            "url": "https://app.pathprimer.com/document/b0c3b34f-ea48-4829-a504-fee1941a448a/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Subdural hematoma (SDH)Acute (aSDH), subacute (sSDH), chronic (cSDH)",
                    "sub_points": [
                      "Acute (aSDH), subacute (sSDH), chronic (cSDH)"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Tearing of bridging veins traversing subdural space"
                  },
                  {
                    "text": "Capillaries in granulation tissue can rebleed with little or no additional trauma"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "aSDH: 6 hours to 3 days old"
                  },
                  {
                    "text": "sSDH: ± 3 days to 3 weeks old"
                  },
                  {
                    "text": "cSDH: ± > 3 weeks old"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Crescentic extraaxial collections by CT"
                  },
                  {
                    "text": "Varying signal characteristics depending on age of blood"
                  },
                  {
                    "text": "Dural neoplasms can mimic SDH"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Acute clot in aSDH"
                  },
                  {
                    "text": "Neomembranes in cSDH"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Granulation tissue can appear highly vascular and reactive"
                  },
                  {
                    "text": "Eosinophils, basophils, or extramedullary hematopoiesis in granulation tissue"
                  },
                  {
                    "text": "Rare primary brain tumors, brain cysts associated with SDH"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Angiosarcoma: Higher cellularity, more cytologic atypia, neoplastic cells line vascular channels"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Examine hematoma carefully for occult tumor cells in cancer patients, especially hematopoietic tumors"
                  },
                  {
                    "text": "Plump, mitotically active fibroblasts can erroneously suggest neoplasm"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Subdural hematoma (SDH)Acute (aSDH), subacute (sSDH), chronic (cSDH)",
                    "sub_points": [
                      "Acute (aSDH), subacute (sSDH), chronic (cSDH)"
                    ]
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Subdural bleed"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Collection of acute, subacute, or chronic blood and blood products in subdural space"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Acute head traumaSDH in young children raises suspicion of nonaccidental trauma",
                    "sub_points": [
                      "SDH in young children raises suspicion of nonaccidental trauma"
                    ]
                  }
                ],
                "Cancer Patients": [
                  {
                    "text": "Dural metastases may coexist with SDHProstate, breast carcinomas, especially hematologic malignancies",
                    "sub_points": [
                      "Prostate, breast carcinomas, especially hematologic malignancies"
                    ]
                  },
                  {
                    "text": "Coagulopathies in cancer patients due to thrombocytopenia more common cause of SDH than dural metastasesThrombocytopenia from bone marrow infiltration by tumor or chemotherapy",
                    "sub_points": [
                      "Thrombocytopenia from bone marrow infiltration by tumor or chemotherapy"
                    ]
                  }
                ],
                "Patients With Brain Atrophy": [
                  {
                    "text": "Stretching of bridging cortical veins as they cross subdural space to enter dural venous sinuses"
                  },
                  {
                    "text": "Bleeding into subdural space without associated trauma"
                  }
                ],
                "Coagulopathy": [
                  {
                    "text": "Often associated with hemorrhages elsewhere in central nervous system (CNS) or systemic organs"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Chronic subduralElderly patients ± known neurodegenerative disorderNonlocalizing symptoms",
                    "sub_points": [
                      "Elderly patients ± known neurodegenerative disorder",
                      "Nonlocalizing symptoms"
                    ]
                  },
                  {
                    "text": "Acute subduralAcute posttrauma hemorrhage with mass effectRequires surgical drainage",
                    "sub_points": [
                      "Acute posttrauma hemorrhage with mass effect",
                      "Requires surgical drainage"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Drainage in acute/large examples"
                  },
                  {
                    "text": "Observation only in many chronic subdurals"
                  },
                  {
                    "text": "Excision of chronic neomembranes in some cases to prevent leakage and rebleeding from delicate vessels in granulation tissue"
                  },
                  {
                    "text": "Middle meningeal artery embolization (MMAE) now used as effective minimally invasive treatment for chronic subdural hematomasTraditional surgical evacuation has high recurrence rate of 2-37%, prompting need for other therapies",
                    "sub_points": [
                      "Traditional surgical evacuation has high recurrence rate of 2-37%, prompting need for other therapies"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "ChronicRecurrence possible",
                    "sub_points": [
                      "Recurrence possible"
                    ]
                  },
                  {
                    "text": "AcuteVariable, depending on hematoma size and comorbidities; may be lethal",
                    "sub_points": [
                      "Variable, depending on hematoma size and comorbidities; may be lethal"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "CT Findings": [
                  {
                    "text": "Crescentic extraaxial collection over convexity"
                  },
                  {
                    "text": "Hyperdense crescent in aSDH"
                  },
                  {
                    "text": "Iso- to hypointense signal in crescent in sSDH"
                  },
                  {
                    "text": "Multiseptated collection with enhancing surrounding membranes in cSDH"
                  },
                  {
                    "text": "Other traumatic brain lesions in most patients with aSDH"
                  },
                  {
                    "text": "Rare examples of cSDH calcified/ossified"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Acute clot in aSDH"
                  },
                  {
                    "text": "Neomembranes stripped in sSDH or cSDH (some cases)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Organizing hematoma in subacute phase"
                  },
                  {
                    "text": "Granulation tissueUsually isolated, long, slender myofibroblastsSometimes masses of shorter, cytologically atypical, mitotically active cells with high Ki-67 indexMany macrophagesKi-67 high during active organization of clot",
                    "sub_points": [
                      "Usually isolated, long, slender myofibroblasts",
                      "Sometimes masses of shorter, cytologically atypical, mitotically active cells with high Ki-67 index",
                      "Many macrophages",
                      "Ki-67 high during active organization of clot"
                    ]
                  },
                  {
                    "text": "Extramedullary hematopoiesisErythroblastic cells positive for CD43, CD235a, EPOVery high Ki-67 index",
                    "sub_points": [
                      "Erythroblastic cells positive for CD43, CD235a, EPO",
                      "Very high Ki-67 index"
                    ]
                  },
                  {
                    "text": "Eosinophils, sometimes abundant and with Charcot-Leyden crystals"
                  },
                  {
                    "text": "Blood clot in acute phase only"
                  },
                  {
                    "text": "Potential for occult tumor cells in cancer patients"
                  },
                  {
                    "text": "Purulent exudate when superinfected"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Granulation tissue fibroblasts with plump nuclei, prominent nucleoli, basophilic cytoplasm"
                  },
                  {
                    "text": "Mitoses"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Angiosarcoma": [
                  {
                    "text": "More atypia"
                  },
                  {
                    "text": "Higher cellularity"
                  },
                  {
                    "text": "Neoplastic cells lining vascular channels"
                  }
                ],
                "Gliosarcoma": [
                  {
                    "text": "Intimately admixed areas of neoplastic glial cells and sarcoma"
                  },
                  {
                    "text": "Glial component with hypercellularity and cytologic atypia"
                  },
                  {
                    "text": "Abundant reticulin in sarcoma portion"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Delicate capillaries in granulation tissue can rebleed with little or no additional trauma"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Plump, mitotically active fibroblasts can suggest neoplasm"
                  },
                  {
                    "text": "Extramedullary hematopoiesis can simulate small cell carcinoma or hematopoietic neoplasm"
                  },
                  {
                    "text": "Examine hematoma for occult tumor cells in cancer patients"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cavernous Angioma": {
            "name": "Cavernous Angioma",
            "url": "https://app.pathprimer.com/document/da16ff85-4ea4-4c95-bc6d-1dd0532461f2/lesson/2f9219a5-627d-4578-a1e7-0dbf05dec53d",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Mulberry-like aggregate of hyalinized vascular caverns"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Developmental anomalyInactivating mutations with 2-hit mechanismAutosomal dominant inheritance with variable penetrance in familial form",
                    "sub_points": [
                      "Inactivating mutations with 2-hit mechanism",
                      "Autosomal dominant inheritance with variable penetrance in familial form"
                    ]
                  },
                  {
                    "text": "Environmental exposureRadiation-induced cavernous malformations arise years after receipt of therapeutic radiationRadiation-induced examples may have reorganized vascular channels within extravasated fibrin",
                    "sub_points": [
                      "Radiation-induced cavernous malformations arise years after receipt of therapeutic radiation",
                      "Radiation-induced examples may have reorganized vascular channels within extravasated fibrin"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common mutation in persons of Hispanic American ethnicity isKRIT1(CCM1)"
                  },
                  {
                    "text": "Multiple lesions should prompt consideration of familial form or history of cranial radiation therapy"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Discrete, mulberry-like aggregate of hyalinized blood vessels"
                  },
                  {
                    "text": "Peripheral hemosiderin staining"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Usually have repeated subclinical bleeding episodes leading to varying ages of blood products, dystrophic calcification"
                  },
                  {
                    "text": "Intense gliosis, surrounding hemosiderin"
                  },
                  {
                    "text": "Fibrotic vessel walls (caverns) lack venous or arterial features, such as well-developed muscularis or elastic lamina"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Discrete nature allows for surgical cure"
                  },
                  {
                    "text": "Compact, hyalinized vessels without features of arteries or veins"
                  },
                  {
                    "text": "Hemosiderin-stained and gliotic surrounding parenchyma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Cavernous malformation, cerebral cavernous malformation (CCM), cavernoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Abnormal, compact aggregate of hyalinized vascular channels lined by single layer of endothelium without venous or arterial component"
                  },
                  {
                    "text": "\"Cavernous malformation (CM) is an angiographically occult solitary or rarely multifocal vascular anomaly. Histologically, they comprise multiple tightly packed sinusoidal vessels with fibrotic walls lacking arterial or venous features, contain little or no interposed CNS tissue. Familial and some sporadic CMs are associated with a mutation inCCM1,CCM2, orCCM3.\" (WHO CNS Classification 2021)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Isolated lesion in sporadic form of diseasePrevalence estimated at 0.16-0.9 %",
                    "sub_points": [
                      "Prevalence estimated at 0.16-0.9 %"
                    ]
                  },
                  {
                    "text": "Multiple lesions in familial (inherited/genetic) formNew lesions develop over time at rate of 0.4 lesions per patient per yearConsistent with \"2-hit hypothesis,\" with germline mutation in 1 gene and somatic mutation in 2nd gene within vascular endothelial cells",
                    "sub_points": [
                      "New lesions develop over time at rate of 0.4 lesions per patient per year",
                      "Consistent with \"2-hit hypothesis,\" with germline mutation in 1 gene and somatic mutation in 2nd gene within vascular endothelial cells"
                    ]
                  }
                ],
                "Environmental Exposure": [
                  {
                    "text": "Radiation-induced examplesForm years or decades after receipt of usually therapeutic irradiation, often in childhoodMay be multipleMay be 1 of 2 histologic types",
                    "sub_points": [
                      "Form years or decades after receipt of usually therapeutic irradiation, often in childhood",
                      "May be multiple",
                      "May be 1 of 2 histologic types"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Autosomal dominant inheritance in familial form"
                  },
                  {
                    "text": "3 genes identified to date:KRIT1(CCM1),CCM2(C7orf22, malcavernin),PDCD10(programmed cell death 10, CCM3)Penetrance estimated at 60-88% in patients withKRIT1, 100% inCCM2, 63% inPDCD10",
                    "sub_points": [
                      "Penetrance estimated at 60-88% in patients withKRIT1, 100% inCCM2, 63% inPDCD10"
                    ]
                  },
                  {
                    "text": "EthnicityKRIT1mutation seen in virtually all persons of Hispanic American heritage with cavernomas",
                    "sub_points": [
                      "KRIT1mutation seen in virtually all persons of Hispanic American heritage with cavernomas"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Throughout CNS, including spinal cord"
                  },
                  {
                    "text": "Most (80%) supratentorial"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Seizures are usual presentation but many asymptomatic"
                  },
                  {
                    "text": "Recurrent headache, focal motor/sensory deficits; hemorrhage less common than seizures"
                  },
                  {
                    "text": "Radiation-induced examples usually do not bleed; may be mistaken for recurrent original tumor"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Resection for diagnosis, hemorrhage, enlargement, or seizures"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent following resection"
                  },
                  {
                    "text": "Incidence of symptomatic hemorrhage: 2.5% per year"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Popcorn-ball appearance of mixed hyper- and hypointense blood-containing channels in T1WI"
                  },
                  {
                    "text": "\"Blooming\" artifact due to iron (hemosiderin) in T2 gradient-echo images"
                  },
                  {
                    "text": "Little blood flow"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Mulberry-like cluster of tightly compacted dilated vessels"
                  },
                  {
                    "text": "Heterogeneous discoloration due to admixed acute and subacute blood products, hemosiderin, gliosis, myelin breakdown in surrounding brain"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Closely juxtaposed, dilated vascular channels, little or no intervening brain parenchyma"
                  },
                  {
                    "text": "Variable vascular hyalinization and absence of muscularis or well-developed venous or arterial features"
                  },
                  {
                    "text": "\"Knots\" of hyalinization representing remote thrombosis, as well as ongoing thrombosis"
                  },
                  {
                    "text": "Calcification"
                  },
                  {
                    "text": "Peripheral hemosiderin, gliosis, rarely Gamna-Gandy bodies"
                  },
                  {
                    "text": "Iron-induced axonal spheroids in surrounding parenchyma"
                  },
                  {
                    "text": "Endothelial cells attenuated but cytologically normal despite possible somatic mutation"
                  },
                  {
                    "text": "Radiation-induced examples may show reorganized vascular channels within extravasated fibrin"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Arteriovenous Malformation": [
                  {
                    "text": "Composed of true arteries and veins, high blood flow"
                  },
                  {
                    "text": "Large, wedge-shaped when occurring in cerebral cortex with broad base on leptomeningeal surface"
                  }
                ],
                "Capillary Telangiectasia": [
                  {
                    "text": "Composed of capillaries, devoid of thrombosis, surrounding hemosiderin, or acute/subacute blood products"
                  },
                  {
                    "text": "Almost never seen as surgical specimen"
                  }
                ],
                "Neoplasms Containing Vascular Malformation-Like Aggregates of Blood Vessels": [
                  {
                    "text": "Schwannomas, angiomatous meningiomas, pilocytic astrocytomas most common types"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Discrete nature allows for surgical cure"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Compact, hyalinized vessels without features of arteries or veins"
                  },
                  {
                    "text": "Hemosiderin stained"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "CNS Neoplasms: Glial Tumors": {
        "name": "CNS Neoplasms: Glial Tumors",
        "url": "https://app.pathprimer.com/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
        "topics": {
          "Astrocytoma, IDH-Mutant, WHO Grade 2 or 3": {
            "name": "Astrocytoma, IDH-Mutant, WHO Grade 2 or 3",
            "url": "https://app.pathprimer.com/document/a5672be5-f165-4a99-8dbe-08e06de7f5b4/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infiltrating glioma with astrocytic differentiation, by definition with IDH1 R132H(+) orIDH1/IDH2mutation, withATRXmutation &/orTP53mutation and absence of 1p/19q codeletion"
                  },
                  {
                    "text": "CDKN2A/CDKN2Bhomozygous deletion should be absent for WHO grade 2 or 3; by definition, astrocytoma, IDH-mutant, withCDKN2A/CDKN2Bhomozygous deletion are WHO grade 4"
                  },
                  {
                    "text": "No consensus on exact mitotic threshold for distinguishing WHO grade 2 from WHO grade 3"
                  }
                ],
                "Imaging": [
                  {
                    "text": "T2 hyperintensity paired with relative hypointensity on FLAIR sequences known as T2-FLAIR mismatch sign, specific for astrocytomas, IDH-mutant, WHO grade 2 or 3"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cell distribution more irregular than in oligodendroglioma"
                  },
                  {
                    "text": "Hypercellularity but may be very slight"
                  },
                  {
                    "text": "Nuclear atypia"
                  },
                  {
                    "text": "Cytoplasmic content varies from inconspicuous (naked nuclei) to fibrillary or gemistocytic"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "IDH1 R132H usually (+) in diffuse astrocytomas of adolescents and adults (85%)"
                  },
                  {
                    "text": "IDH1 R132H identifies only mutant protein resulting from most common mutationR132H: Arginine to histidine at position 132",
                    "sub_points": [
                      "R132H: Arginine to histidine at position 132"
                    ]
                  },
                  {
                    "text": "Olig2(+) in most tumors but in variable numbers of nuclei"
                  },
                  {
                    "text": "Ki-67: Low labeling index in WHO grade 2, slightly higher in WHO grade 3"
                  },
                  {
                    "text": "No whole-arm codeletion of chromosomes 1p and 19q"
                  },
                  {
                    "text": "Many withIDH1/IDH2mutation have strong nuclear p53(+) immunohistochemistry &/or loss of nuclear ATRX by immunohistochemistry"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Normal brain"
                  },
                  {
                    "text": "Nonspecific gliosis"
                  },
                  {
                    "text": "Demyelinating disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Infiltrating glioma with astrocytic differentiation, IDH1 R132H(+) orIDH1/IDH2mutated, withATRX&/orTP53mutation and absence of 1p/19q codeletion"
                  },
                  {
                    "text": "Absence of microvascular proliferation, necrosis, orCDKN2A/CDKN2Bhomozygous deletion"
                  },
                  {
                    "text": "No consensus on exact mitotic threshold for distinguishing WHO grade 2 from WHO grade 3"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Most Sporadic, but Occasionally Associated With Tumor Predisposition Syndromes": [
                  {
                    "text": "Patients with Li-Fraumeni syndrome usually have noncanonicalIDH1mutation, i.e., IDH1 p.R132CIDH1 p.R132C mutation uncommon in astrocytomas, IDH-mutant, with sporadic occurrence",
                    "sub_points": [
                      "IDH1 p.R132C mutation uncommon in astrocytomas, IDH-mutant, with sporadic occurrence"
                    ]
                  },
                  {
                    "text": "Patients with Ollier syndrome have postzygotic somatic IDH mutation resulting in mosaicismPatients susceptible to enchondromatosis + IDH-mutant astrocytomasAstrocytomas occur at younger patient age, show possibly more multicentricity, more brainstem locations than sporadic IDH-mutant astrocytomasIDH1 R132H is most common mutation in gliomasIDH1 R132C mutation most common in cartilaginous tumors",
                    "sub_points": [
                      "Patients susceptible to enchondromatosis + IDH-mutant astrocytomas",
                      "Astrocytomas occur at younger patient age, show possibly more multicentricity, more brainstem locations than sporadic IDH-mutant astrocytomas",
                      "IDH1 R132H is most common mutation in gliomas",
                      "IDH1 R132C mutation most common in cartilaginous tumors"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Adults; average age 38 years"
                  },
                  {
                    "text": "Uncommon in patients > 55 years"
                  },
                  {
                    "text": "Pediatric patients; usually adolescents > 14 years"
                  },
                  {
                    "text": "WHO grades 2 and 3 have similar age distribution"
                  }
                ],
                "Sex": [
                  {
                    "text": "Slight male predominance"
                  }
                ],
                "Site": [
                  {
                    "text": "Cerebral hemispheresIDH-mutant gliomas rare in infratentorial sites (cerebellum, brainstem, spinal cord)",
                    "sub_points": [
                      "IDH-mutant gliomas rare in infratentorial sites (cerebellum, brainstem, spinal cord)"
                    ]
                  },
                  {
                    "text": "Diffuse astrocytomas in midline anatomic locations have high prevalence of H3 K27M mutation, lowIDH1/IDH2mutation rateAlways test for H3 K27M IHC or by mutational analysis for tumors in midline sites",
                    "sub_points": [
                      "Always test for H3 K27M IHC or by mutational analysis for tumors in midline sites"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Seizures with cerebral hemispheric lesions"
                  },
                  {
                    "text": "Neurologic deficits uncommon, location dependent"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Observation, in many cases"
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Stereotactic biopsy"
                  },
                  {
                    "text": "ResectionAbility to achieve extensive resection dependent on anatomic locationGross total resection, if safely possibleIn IDH-mutant astrocytoma, even small postoperative volumes have reported negative impact on overall survivalSome advocate 2nd-look operation to remove minor residual tumor",
                    "sub_points": [
                      "Ability to achieve extensive resection dependent on anatomic location",
                      "Gross total resection, if safely possible",
                      "In IDH-mutant astrocytoma, even small postoperative volumes have reported negative impact on overall survivalSome advocate 2nd-look operation to remove minor residual tumor",
                      "Some advocate 2nd-look operation to remove minor residual tumor"
                    ]
                  }
                ],
                "Adjuvant therapy": [
                  {
                    "text": "Some cases; not standard"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Variable depending on site, size, symptomatology, and patient age"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Recurrence, progression to higher grade astrocytoma within 10 years in IDH-mutant gliomas"
                  },
                  {
                    "text": "Significantly different prognosis between IDH-mutant astrocytoma, WHO grade 2 and adult diffuse astrocytoma, IDH-wildtype, with low-grade histologic featuresAdult diffuse astrocytomas, IDH-wildtype, with combined whole chromosome 7 gain and whole chromosome 10 loss (+7/-10) &/orEGFRamplification orTERTpromoter mutation; are defined as glioblastoma, WHO grade 4 per current WHO criteria",
                    "sub_points": [
                      "Adult diffuse astrocytomas, IDH-wildtype, with combined whole chromosome 7 gain and whole chromosome 10 loss (+7/-10) &/orEGFRamplification orTERTpromoter mutation; are defined as glioblastoma, WHO grade 4 per current WHO criteria"
                    ]
                  },
                  {
                    "text": "Prognostic stratification within IDH-mutant astrocytomas based on molecular featuresCDKN2A/CDKN2Bhomozygous deletion in histologically WHO grade 2 or 3 IDH-mutant diffuse astrocytoma is adverse prognostic feature that, by definition, yields diagnosis of WHO grade 4Exact cut-off for mitotic activity to distinguish WHO grade 2 from WHO grade 3 by histologic criteria uncertain, may be superseded by molecular featuresPDGFRA amplification, CDK4 amplification adverse prognostic factors in some studies",
                    "sub_points": [
                      "CDKN2A/CDKN2Bhomozygous deletion in histologically WHO grade 2 or 3 IDH-mutant diffuse astrocytoma is adverse prognostic feature that, by definition, yields diagnosis of WHO grade 4",
                      "Exact cut-off for mitotic activity to distinguish WHO grade 2 from WHO grade 3 by histologic criteria uncertain, may be superseded by molecular featuresPDGFRA amplification, CDK4 amplification adverse prognostic factors in some studies",
                      "PDGFRA amplification, CDK4 amplification adverse prognostic factors in some studies"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Ill-defined or relatively discrete area of T1 hypointensity"
                  },
                  {
                    "text": "T2 hyperintensity paired with relative hypointensity on FLAIR sequences known as T2-FLAIR mismatch signPredictive of WHO grade 2 or 3 astrocytomas with IDH mutation, absence of 1p/19q codeletion",
                    "sub_points": [
                      "Predictive of WHO grade 2 or 3 astrocytomas with IDH mutation, absence of 1p/19q codeletion"
                    ]
                  },
                  {
                    "text": "Usually expansion of affected areas"
                  },
                  {
                    "text": "No rim enhancement with central necrosis, unlike astrocytoma, IDH-mutant, WHO grade 4"
                  },
                  {
                    "text": "Large cyst (some, e.g., gemistocytic types)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Ill-defined; blurring of gray-white junction"
                  },
                  {
                    "text": "Variable mass effect"
                  },
                  {
                    "text": "Large cyst in minority"
                  }
                ],
                "Texture": [
                  {
                    "text": "VariableSoft, gelatinousFirm",
                    "sub_points": [
                      "Soft, gelatinous",
                      "Firm"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Infiltrative, diffuseTrapped axons in white matter best seen on immunostaining for neurofilament proteinGray matter/secondary structures: Minimal perineuronal satellitosis, subpial infiltration, perivascular aggregationAll less common than with oligodendroglioma",
                    "sub_points": [
                      "Trapped axons in white matter best seen on immunostaining for neurofilament protein",
                      "Gray matter/secondary structures: Minimal perineuronal satellitosis, subpial infiltration, perivascular aggregationAll less common than with oligodendroglioma",
                      "All less common than with oligodendroglioma"
                    ]
                  },
                  {
                    "text": "Fibrillary astrocytomaIrregular cell distribution compared to oligodendrogliomaHypercellularity: Slight to moderate in cases with tumoral edemaMicrocysts: None to prominentCytoplasmScant (naked nuclei) in hypocellular areasModerate with processes of fibrillary astrocytesProminent but not gemistocyticFine, fibrillary background (some cases)NucleiAtypia in all cases; nuclear features not grading criterionNuclear enlargement, irregularity, hyperchromasiaPleomorphic giant cells (uncommon)MitosesAbsent or rare in sizable specimensThreshold for WHO grade 3 (anaplastic astrocytoma) not sharply definedCalcifications uncommon",
                    "sub_points": [
                      "Irregular cell distribution compared to oligodendroglioma",
                      "Hypercellularity: Slight to moderate in cases with tumoral edema",
                      "Microcysts: None to prominent",
                      "CytoplasmScant (naked nuclei) in hypocellular areasModerate with processes of fibrillary astrocytesProminent but not gemistocyticFine, fibrillary background (some cases)",
                      "Scant (naked nuclei) in hypocellular areas",
                      "Moderate with processes of fibrillary astrocytes",
                      "Prominent but not gemistocytic",
                      "Fine, fibrillary background (some cases)",
                      "NucleiAtypia in all cases; nuclear features not grading criterion",
                      "Atypia in all cases; nuclear features not grading criterion",
                      "Nuclear enlargement, irregularity, hyperchromasia",
                      "Pleomorphic giant cells (uncommon)",
                      "MitosesAbsent or rare in sizable specimensThreshold for WHO grade 3 (anaplastic astrocytoma) not sharply defined",
                      "Absent or rare in sizable specimens",
                      "Threshold for WHO grade 3 (anaplastic astrocytoma) not sharply defined",
                      "Calcifications uncommon"
                    ]
                  },
                  {
                    "text": "Gemistocytic astrocytoma: Prominent gemistocytesOften, but not invariably, IDH-mutantUsually ≥ 20% of tumor cells; occasionally ≥ 50%Uncommon in pure formRegional variation in number of gemistocytesAngular, polygonal cellsGlassy pink cytoplasmStout processes form coarse, fibrillar backgroundGenerally uniform, peripheral nucleiScattered large, round, dark nuclei with little cytoplasm (small cells)Proliferating componentSmall cell subpopulation with higher Ki-67 index compared to low index in gemistocytic elementFrequent perivascular lymphocytic infiltratesGenerally rare or no mitoses; low Ki-67 labeling indexKi-67 labeled cells usually interspersed nongemistocytic tumor cells",
                    "sub_points": [
                      "Often, but not invariably, IDH-mutant",
                      "Usually ≥ 20% of tumor cells; occasionally ≥ 50%",
                      "Uncommon in pure formRegional variation in number of gemistocytes",
                      "Regional variation in number of gemistocytes",
                      "Angular, polygonal cellsGlassy pink cytoplasmStout processes form coarse, fibrillar background",
                      "Glassy pink cytoplasm",
                      "Stout processes form coarse, fibrillar background",
                      "Generally uniform, peripheral nuclei",
                      "Scattered large, round, dark nuclei with little cytoplasm (small cells)Proliferating componentSmall cell subpopulation with higher Ki-67 index compared to low index in gemistocytic element",
                      "Proliferating component",
                      "Small cell subpopulation with higher Ki-67 index compared to low index in gemistocytic element",
                      "Frequent perivascular lymphocytic infiltrates",
                      "Generally rare or no mitoses; low Ki-67 labeling indexKi-67 labeled cells usually interspersed nongemistocytic tumor cells",
                      "Ki-67 labeled cells usually interspersed nongemistocytic tumor cells"
                    ]
                  }
                ],
                "Grading": [
                  {
                    "text": "Studies mixed on whether mitotic count, Ki-67 proliferation indices can distinguish WHO grades 2 and 3"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Tissue fragments in smear preparations"
                  },
                  {
                    "text": "Mild to moderate nuclear pleomorphism and hyperchromasia"
                  },
                  {
                    "text": "Naked nuclei in hypocellular lesions"
                  },
                  {
                    "text": "Prominent cytoplasm in gemistocytic lesions"
                  },
                  {
                    "text": "Cytoplasmic processes/fibrillar background"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "IDH1 (mutant IDH-1 protein, IDH1 R132H)Most adolescent and adult low- or intermediate-grade diffuse astrocytomas in persons 14-50 years are IDH-mutant, not IDH-wildtypeAntibody only covers common mutation (arginine to histidine); tumors with otherIDH1mutations at same site but with different amino acid substitutions (or withIDH2mutations) still have favorable prognosis but must be identified by mutational analysis",
                    "sub_points": [
                      "Most adolescent and adult low- or intermediate-grade diffuse astrocytomas in persons 14-50 years are IDH-mutant, not IDH-wildtype",
                      "Antibody only covers common mutation (arginine to histidine); tumors with otherIDH1mutations at same site but with different amino acid substitutions (or withIDH2mutations) still have favorable prognosis but must be identified by mutational analysis"
                    ]
                  },
                  {
                    "text": "Olig2(+) but in variable numbers of tumor cell nuclei"
                  },
                  {
                    "text": "GFAPVariable reactivity depending, in part, on amount of cytoplasmCells with naked nuclei (-)GemistocytesPeripheral cytoplasm or all of cytoplasm (+)",
                    "sub_points": [
                      "Variable reactivity depending, in part, on amount of cytoplasm",
                      "Cells with naked nuclei (-)",
                      "GemistocytesPeripheral cytoplasm or all of cytoplasm (+)",
                      "Peripheral cytoplasm or all of cytoplasm (+)"
                    ]
                  },
                  {
                    "text": "p53Diffuse strong nuclear positivity in some IDH-mutant diffuse astrocytomasElevated nuclear p53 labeling less frequent than loss of nuclear ATRX in IDH-mutant astrocytoma, WHO grade 2 or 3",
                    "sub_points": [
                      "Diffuse strong nuclear positivity in some IDH-mutant diffuse astrocytomas",
                      "Elevated nuclear p53 labeling less frequent than loss of nuclear ATRX in IDH-mutant astrocytoma, WHO grade 2 or 3"
                    ]
                  },
                  {
                    "text": "Most adult diffuse astrocytomas withIDH1/IDH2mutation have loss of nuclear ATRXNuclear ATRX almost always should be either completely lost in all tumor nuclei or completely retainedTechnical/tissue fixation issues often hamper ATRX IHC leading to irregular immunostainingSmall subset of inactivatingATRXmutations do not result in protein lossUse neuronal or endothelial cell nuclei as internal control for area of slide being interpretedDo not attempt to interpret area(s) of slide without positive internal control(s)",
                    "sub_points": [
                      "Nuclear ATRX almost always should be either completely lost in all tumor nuclei or completely retainedTechnical/tissue fixation issues often hamper ATRX IHC leading to irregular immunostainingSmall subset of inactivatingATRXmutations do not result in protein loss",
                      "Technical/tissue fixation issues often hamper ATRX IHC leading to irregular immunostaining",
                      "Small subset of inactivatingATRXmutations do not result in protein loss",
                      "Use neuronal or endothelial cell nuclei as internal control for area of slide being interpreted",
                      "Do not attempt to interpret area(s) of slide without positive internal control(s)"
                    ]
                  },
                  {
                    "text": "Ki-67 labeling index lowCut-off for differentiating WHO grade 2 from WHO grade 3 by histologic criteria not established",
                    "sub_points": [
                      "Cut-off for differentiating WHO grade 2 from WHO grade 3 by histologic criteria not established"
                    ]
                  },
                  {
                    "text": "Pediatric diffuse astrocytomas usually not IDH-mutantNo exact age cut-off established for when to test pediatric diffuse astrocytomas forIDH1/IDH2mutations but exceptional in children ages < 14-15 years",
                    "sub_points": [
                      "No exact age cut-off established for when to test pediatric diffuse astrocytomas forIDH1/IDH2mutations but exceptional in children ages < 14-15 years"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Mutations inIDH1/IDH2seen in 85% of diffuse astrocytomas in adolescents and adultsEarly/seminal tumor initiating eventR132H (arginine to histidine, position 132)Other amino acid substitutions occurring at same site uncommon (~ 1/10 to 1/6 of overallIDH1mutations)",
                    "sub_points": [
                      "Early/seminal tumor initiating event",
                      "R132H (arginine to histidine, position 132)",
                      "Other amino acid substitutions occurring at same site uncommon (~ 1/10 to 1/6 of overallIDH1mutations)"
                    ]
                  },
                  {
                    "text": "CDKN2A/CDKN2Bhomozygous deletion should be absent in WHO grade 2 or WHO grade 3 and, when present, is criterion for astrocytoma, IDH-mutant, WHO grade 4Distinction of homozygous vs. hemizygous deletion is difficult on FISH testing due to probe size",
                    "sub_points": [
                      "Distinction of homozygous vs. hemizygous deletion is difficult on FISH testing due to probe size"
                    ]
                  },
                  {
                    "text": "Gain of 12p encompassingCCND2associated with gemistocytic histology in IDH-mutant astrocytomas"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Brain": [
                  {
                    "text": "Low cellularity and even cell density"
                  },
                  {
                    "text": "No microcysts"
                  },
                  {
                    "text": "No atypia"
                  },
                  {
                    "text": "Very low to completely absent Ki-67 labeling"
                  },
                  {
                    "text": "IDH1 R132H(-), p53(-)"
                  }
                ],
                "Nonspecific Gliosis": [
                  {
                    "text": "Evenly spaced, hypertrophic fibrillary or gemistocytic astrocytes"
                  },
                  {
                    "text": "Hemosiderin, in some cases; rare in untreated diffuse astrocytoma"
                  },
                  {
                    "text": "Low Ki-67 index"
                  },
                  {
                    "text": "IDH1 R132H(-)"
                  },
                  {
                    "text": "(-) to weak p53"
                  },
                  {
                    "text": "Intact chromosome 7"
                  }
                ],
                "Demyelinating Disease": [
                  {
                    "text": "Sharp border, usually"
                  },
                  {
                    "text": "Numerous macrophages, CD68(+)"
                  },
                  {
                    "text": "Perivascular lymphocytes"
                  },
                  {
                    "text": "Multinucleated reactive GFAP(+) astrocytes (Creutzfeldt cells)"
                  },
                  {
                    "text": "Loss of myelin (H&E/LFB, LFB/PAS stains, proteolipid protein or myelin basic protein IHC), spared axons"
                  },
                  {
                    "text": "IDH1 R132H(-)"
                  },
                  {
                    "text": "Weak to moderate p53 (scattered cells)"
                  },
                  {
                    "text": "Intact chromosome 7"
                  }
                ],
                "Histologically WHO Grade 2 or 3 Diffuse Astrocytoma": [
                  {
                    "text": "Majority in persons > 55 years that are notIDH1/IDH2mutated are glioblastoma, IDH-wildtype, WHO grade 4 by molecular criteria"
                  },
                  {
                    "text": "All tumors should be tested by IHC for IDH1 R132H, ATRX, p53IDH-wildtype tumors that resolve into glioblastoma, IDH-wildtype, WHO grade 4 by molecular criteria show noIDH1/IDH2mutation, nuclear ATRX retention by IHC; 2/3 are p53(-)",
                    "sub_points": [
                      "IDH-wildtype tumors that resolve into glioblastoma, IDH-wildtype, WHO grade 4 by molecular criteria show noIDH1/IDH2mutation, nuclear ATRX retention by IHC; 2/3 are p53(-)"
                    ]
                  },
                  {
                    "text": "Greater cytologic atypia usually"
                  },
                  {
                    "text": "Mitoses: Rare to numerous"
                  },
                  {
                    "text": "Higher Ki-67 labeling rate usual"
                  }
                ],
                "Oligodendroglioma, IDH-Mutant and 1p/19q Codeleted, WHO Grade 2 or 3": [
                  {
                    "text": "More uniform cell density"
                  },
                  {
                    "text": "Cytologic monomorphismRound nuclei with open chromatin and distinct nucleoli",
                    "sub_points": [
                      "Round nuclei with open chromatin and distinct nucleoli"
                    ]
                  },
                  {
                    "text": "Generally more prominent perineuronal satellitosis and subpial concentration"
                  },
                  {
                    "text": "Perinuclear halo (\"fried egg\" cells)Back-to-back arrays",
                    "sub_points": [
                      "Back-to-back arrays"
                    ]
                  },
                  {
                    "text": "Little fibrillar background"
                  },
                  {
                    "text": "Calcifications"
                  },
                  {
                    "text": "Whole arm loss of both 1p and 19q, i.e., 1p/19q codeletion, by definition"
                  },
                  {
                    "text": "NoATRXmutation &/or protein loss"
                  },
                  {
                    "text": "NoTP53mutation; p53 immunostaining low to absent"
                  },
                  {
                    "text": "No gain of chromosome 7"
                  }
                ],
                "Pilocytic Astrocytoma": [
                  {
                    "text": "Circumscribed and contrast enhancing, usually"
                  },
                  {
                    "text": "Compact architecture but infiltrative periphery, especially in cerebellum and optic nerves"
                  },
                  {
                    "text": "Biphasic patternSpongy, microcystic tissue with eosinophilic granular bodiesCompact piloid tissue with Rosenthal fibers",
                    "sub_points": [
                      "Spongy, microcystic tissue with eosinophilic granular bodies",
                      "Compact piloid tissue with Rosenthal fibers"
                    ]
                  },
                  {
                    "text": "Glomeruloid vasculature, in some cases"
                  },
                  {
                    "text": "Activation of MAPK pathway, incidence site dependent"
                  },
                  {
                    "text": "Often showsBRAF::KIAA1549fusion, occasionallyBRAFV600E mutation,FGFRalterations"
                  },
                  {
                    "text": "IDH1 R132H(-)"
                  }
                ],
                "Diffuse Hemispheric Glioma, H3 G34-Mutant, WHO Grade 4": [
                  {
                    "text": "Usually more hypercellular, with glioblastoma or primitive embryonal appearance, but necrosis or microvascular proliferation may be absent"
                  },
                  {
                    "text": "Positive for H3 G34 mutation by IHC or mutational analysis"
                  },
                  {
                    "text": "Usually shows loss of nuclear ATRX, strong p53(+), similar to astrocytoma, IDH-mutant, WHO grade 2 or 3"
                  },
                  {
                    "text": "Occur in children, young adults"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Infiltrative nature usually precludes complete resection"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Always consider alternative possibility of reactive lesion, e.g., gliosis or demyelinating disease"
                  },
                  {
                    "text": "IDH1 R132H: Specific tumoral marker of IDH-mutant infiltrating gliomas, both astrocytic or oligodendroglial"
                  },
                  {
                    "text": "IDH1 R132H immunostaining directed only against mutant protein resulting from most common mutation; otherIDH1/IDH2mutations must be diagnosed by mutational testing"
                  },
                  {
                    "text": "Loss of nuclear ATRX typical of diffuse astrocytomas, as well as some H3 K27M- or H3 G34V-mutant gliomas, but not oligodendrogliomas or reactive gliosis"
                  },
                  {
                    "text": "Nuclear p53(+) can be seen in 1/3 of glioblastoma, IDH-wildtype, WHO grade 4 as well as some tumors with histone mutations"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Astrocytoma, IDH-Mutant, WHO Grade 4": {
            "name": "Astrocytoma, IDH-Mutant, WHO Grade 4",
            "url": "https://app.pathprimer.com/document/5348f28e-39fe-4243-a702-4557e4abe03e/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Clinical Issues": [
                  {
                    "text": "Much less common than glioblastoma (GBM), IDH-wildtype, WHO grade 4"
                  },
                  {
                    "text": "Patients usually < 55 years"
                  },
                  {
                    "text": "More present de novo than following progression from lower grade astrocytoma, IDH-mutant"
                  },
                  {
                    "text": "Pseudoprogression, apparent posttreatment recurrence due to radiation/chemotherapy effects can be difficult to distinguish clinically and radiologically from active tumor recurrence"
                  },
                  {
                    "text": "Prognosis relatively poor; most patients succumb ≤ 3 years"
                  },
                  {
                    "text": "Rarely develop late CSF dissemination"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Usually less necrotic than GBM, IDH-wildtype; less likely to have enhancement in ring or rim pattern"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "High-grade astrocytic neoplasm with necrosis &/or microvascular proliferation"
                  },
                  {
                    "text": "Multiple tissue patternsTypical: Mixture of small- and medium-sized cells, fibrillary and gemistocytic astrocytesWith oligodendrocyte-like bland tumor cellsFormer GBM with oligodendroglioma component (GBM-O) resolves into other entities, some now astrocytoma, IDH-mutant, WHO grade 4Small percentage with primitive neuronal component",
                    "sub_points": [
                      "Typical: Mixture of small- and medium-sized cells, fibrillary and gemistocytic astrocytes",
                      "With oligodendrocyte-like bland tumor cellsFormer GBM with oligodendroglioma component (GBM-O) resolves into other entities, some now astrocytoma, IDH-mutant, WHO grade 4",
                      "Former GBM with oligodendroglioma component (GBM-O) resolves into other entities, some now astrocytoma, IDH-mutant, WHO grade 4",
                      "Small percentage with primitive neuronal component"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Methylation ofMGMTpromoter suppresses expression of enzyme, optimizing activity of therapeutic alkylating agents (temozolomide)Favorable prognostic and predictive factorCan change to (+) or (-) after treatmentFrequent in IDH-mutant tumors compared to IDH-wildtype",
                    "sub_points": [
                      "Favorable prognostic and predictive factor",
                      "Can change to (+) or (-) after treatment",
                      "Frequent in IDH-mutant tumors compared to IDH-wildtype"
                    ]
                  },
                  {
                    "text": "IDH1 R132H(+) orIDH1/IDH2mutation"
                  },
                  {
                    "text": "Loss of nuclear ATRX positivity"
                  },
                  {
                    "text": "p53(+)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Formerly known as glioblastoma, IDH-mutant, WHO grade 4"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Diffusely infiltrative astrocytic glioma withIDH1orIDH2mutation that exhibits microvascular proliferation or necrosis orCDKN2A/CDKN2Bhomozygous deletion or in any combination; withATRXmutation &/orTP53mutation and absence of 1p/19q codeletionDistinction of homozygous vs. hemizygous deletion is difficult on FISH due to probe size",
                    "sub_points": [
                      "Distinction of homozygous vs. hemizygous deletion is difficult on FISH due to probe size"
                    ]
                  },
                  {
                    "text": "Most arise de novo without documented, antecedent, lower grade IDH-mutant astrocytoma"
                  },
                  {
                    "text": "In one recent study of 97 astrocytomas, IDH-mutant, WHO grade 4, 68 had WHO grade 4 tumor at 1st presentation, 29 arose from prior low-grade lesion"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown": [
                  {
                    "text": "Almost all sporadic"
                  }
                ],
                "Li-Fraumeni Syndrome": [
                  {
                    "text": "IDH-mutant gliomas with IDH1 R132C (CGT → TGT) overrepresentedIDH1 R132H (CGT → CAT) is most common in nonsyndromicIDH1-mutant gliomas (> 85%)",
                    "sub_points": [
                      "IDH1 R132H (CGT → CAT) is most common in nonsyndromicIDH1-mutant gliomas (> 85%)"
                    ]
                  }
                ],
                "Ollier Syndrome": [
                  {
                    "text": "Rare cases of astrocytoma described in patients with mosaicIDH1mutations (Ollier disease or Maffucci syndrome)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Astrocytoma, IDH-mutant, WHO grade 4 less common than glioblastoma (GBM), IDH-wildtype, WHO grade 4"
                  }
                ],
                "Age": [
                  {
                    "text": "Usually < 55 yearsMedian age at diagnosis: 44 years",
                    "sub_points": [
                      "Median age at diagnosis: 44 years"
                    ]
                  },
                  {
                    "text": "Older patients rare (< 1%)Negligible prevalence of noncanonical IDH mutations in WHO grade 4 astrocytoma patients ≥ 55 years argues against universal IDH mutational testing in this population if IDH1 R132H(-)10x higher probability for presence of noncanonicalIDH1mutation in setting of IDH1 R132H(-) immunohistochemistry result in patients < 55 years than those who are > 55 years",
                    "sub_points": [
                      "Negligible prevalence of noncanonical IDH mutations in WHO grade 4 astrocytoma patients ≥ 55 years argues against universal IDH mutational testing in this population if IDH1 R132H(-)",
                      "10x higher probability for presence of noncanonicalIDH1mutation in setting of IDH1 R132H(-) immunohistochemistry result in patients < 55 years than those who are > 55 years"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "More equal M:F ratio than in GBM, IDH-wildtype, wherein males predominate"
                  }
                ],
                "Site": [
                  {
                    "text": "Cerebral hemispheresPreferentially frontal lobesRare in infratentorial sitesAnatomic localization not distinct from oligodendroglioma, IDH-mutant and 1p/19q codeleted, WHO grade 2 or 3",
                    "sub_points": [
                      "Preferentially frontal lobes",
                      "Rare in infratentorial sites",
                      "Anatomic localization not distinct from oligodendroglioma, IDH-mutant and 1p/19q codeleted, WHO grade 2 or 3"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptom duration < 3 months in de novo examples"
                  },
                  {
                    "text": "Longer duration for those that arise from lower grade, IDH-mutant astrocytomas"
                  },
                  {
                    "text": "Specific clinical expressionsSeizures; mass effects, such as headache and herniation; site-dependent, focal, neurologic deficits",
                    "sub_points": [
                      "Seizures; mass effects, such as headache and herniation; site-dependent, focal, neurologic deficits"
                    ]
                  },
                  {
                    "text": "PseudoprogressionApparent posttreatment recurrence may be due to radiation/chemotherapy effectsDifficult to clinically and radiologically distinguish from active tumor recurrenceMore frequent in astrocytomas withMGMTpromoter methylation",
                    "sub_points": [
                      "Apparent posttreatment recurrence may be due to radiation/chemotherapy effectsDifficult to clinically and radiologically distinguish from active tumor recurrenceMore frequent in astrocytomas withMGMTpromoter methylation",
                      "Difficult to clinically and radiologically distinguish from active tumor recurrence",
                      "More frequent in astrocytomas withMGMTpromoter methylation"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "At presentationRadiation and chemotherapy (temozolomide)",
                    "sub_points": [
                      "Radiation and chemotherapy (temozolomide)"
                    ]
                  },
                  {
                    "text": "At suspected recurrenceChemotherapy with active recurrent tumorBevacizumab [vascular endothelial growth factor (VEGF) blocker] some cases with viable tumor progression",
                    "sub_points": [
                      "Chemotherapy with active recurrent tumorBevacizumab [vascular endothelial growth factor (VEGF) blocker] some cases with viable tumor progression",
                      "Bevacizumab [vascular endothelial growth factor (VEGF) blocker] some cases with viable tumor progression"
                    ]
                  },
                  {
                    "text": "Anti-programmed death 1 (PD-1) immune checkpoint inhibitor (pembrolizumab, nivolumab)Most responsive tumors have large number of somatic mutations due to mismatch-repair defects",
                    "sub_points": [
                      "Most responsive tumors have large number of somatic mutations due to mismatch-repair defects"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "PoorMost patients succumb ≤ 3 yearsWith surgery + radiation + chemotherapy, median survival is 31 months (compared to 15 months for GBM, IDH-wildtype)",
                    "sub_points": [
                      "Most patients succumb ≤ 3 years",
                      "With surgery + radiation + chemotherapy, median survival is 31 months (compared to 15 months for GBM, IDH-wildtype)"
                    ]
                  },
                  {
                    "text": "Late dissemination to CSF/drop metastases, bone marrow reported"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Enhancing but large areas of central necrosis usually absent, unlike GBM, IDH-wildtype"
                  },
                  {
                    "text": "Solitary (typical)"
                  },
                  {
                    "text": "Prominent T2/FLAIR hyperintensity (white) signal around enhancing area"
                  },
                  {
                    "text": "Mass effect but generally lesser mass effect than GBM, IDH-wildtype"
                  },
                  {
                    "text": "May develop late CSF dissemination"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Most widely infiltrate brain at initial presentation"
                  }
                ],
                "Cerebral Hemispheres": [
                  {
                    "text": "Generally subcortical"
                  },
                  {
                    "text": "Predilection for frontal lobes"
                  },
                  {
                    "text": "Variably necrotic"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Borders/growth patternGenerally ill defined, infiltrative with secondary structures: Perineuronal satellitosis, perivascular concentration, subpial concentration occasionally seen",
                    "sub_points": [
                      "Generally ill defined, infiltrative with secondary structures: Perineuronal satellitosis, perivascular concentration, subpial concentration occasionally seen"
                    ]
                  },
                  {
                    "text": "Patterns of spreadDirect, local; often along white matter pathways, especially corpus callosum, but also anterior commissure, middle cerebellar peduncleSubependymalIntraspinal leptomeninges (drop metastasis) occurs lateSystemic metastases rarely reportedBone marrow, liver, lymph node",
                    "sub_points": [
                      "Direct, local; often along white matter pathways, especially corpus callosum, but also anterior commissure, middle cerebellar peduncle",
                      "Subependymal",
                      "Intraspinal leptomeninges (drop metastasis) occurs late",
                      "Systemic metastases rarely reportedBone marrow, liver, lymph node",
                      "Bone marrow, liver, lymph node"
                    ]
                  },
                  {
                    "text": "NecrosisIncludes tumor cells and vesselsCoagulative, few macrophages± palisading",
                    "sub_points": [
                      "Includes tumor cells and vessels",
                      "Coagulative, few macrophages",
                      "± palisading"
                    ]
                  },
                  {
                    "text": "Microvascular proliferationGlomeruloid, mass of multiple small vesselsEndothelial proliferation (multilayered, intraluminal)",
                    "sub_points": [
                      "Glomeruloid, mass of multiple small vessels",
                      "Endothelial proliferation (multilayered, intraluminal)"
                    ]
                  },
                  {
                    "text": "Thrombosis of small vessels"
                  },
                  {
                    "text": "MitosesVariableFew in \"quiescent,\" posttreatment tumors",
                    "sub_points": [
                      "VariableFew in \"quiescent,\" posttreatment tumors",
                      "Few in \"quiescent,\" posttreatment tumors"
                    ]
                  },
                  {
                    "text": "Component cell typesFibrillary astrocytesGemistocytesPolymorphic, medium-sized astrocytesOligodendrocyte-like cells with rounded nuclei and nuclear monotonyFormer GBM with oligodendroglioma component (former GBM-O) resolves into other entities, but some are astrocytomas, IDH-mutant, WHO grade 4",
                    "sub_points": [
                      "Fibrillary astrocytes",
                      "Gemistocytes",
                      "Polymorphic, medium-sized astrocytes",
                      "Oligodendrocyte-like cells with rounded nuclei and nuclear monotonyFormer GBM with oligodendroglioma component (former GBM-O) resolves into other entities, but some are astrocytomas, IDH-mutant, WHO grade 4",
                      "Former GBM with oligodendroglioma component (former GBM-O) resolves into other entities, but some are astrocytomas, IDH-mutant, WHO grade 4"
                    ]
                  },
                  {
                    "text": "Perivascular lymphocytes (especially in gemistocytic tumors)"
                  },
                  {
                    "text": "Microglia, CD68(+), may be numerousOne study showed significantly fewer GBM-associated macrophages and microglia in IDH-mutant WHO grade 4 than in IDH-wildtype, but these were more proinflammatory, suggesting possible contribution to better prognosis",
                    "sub_points": [
                      "One study showed significantly fewer GBM-associated macrophages and microglia in IDH-mutant WHO grade 4 than in IDH-wildtype, but these were more proinflammatory, suggesting possible contribution to better prognosis"
                    ]
                  },
                  {
                    "text": "Pattern variationOften mixture of fibrillary and gemistocytic astrocytesGBM with primitive neuronal component, IDH-mutant, uncommonHighly cellular, often circumscribed primitive neuronal (formerly PNET) fociSmall cells in some; larger cells in othersAnaplastic primitive neuronal component (formerly PNET-like) in some cases with large cells, abundant apoptosis, cell-cell wrappingHomer Wright (neuroblastic) rosettes in some cases~ 15% are IDH-mutantGliosarcoma, IDH-mutant, rare (7% of gliosarcomas) compared to gliosarcoma, IDH-wildtype",
                    "sub_points": [
                      "Often mixture of fibrillary and gemistocytic astrocytes",
                      "GBM with primitive neuronal component, IDH-mutant, uncommonHighly cellular, often circumscribed primitive neuronal (formerly PNET) fociSmall cells in some; larger cells in othersAnaplastic primitive neuronal component (formerly PNET-like) in some cases with large cells, abundant apoptosis, cell-cell wrappingHomer Wright (neuroblastic) rosettes in some cases~ 15% are IDH-mutant",
                      "Highly cellular, often circumscribed primitive neuronal (formerly PNET) foci",
                      "Small cells in some; larger cells in others",
                      "Anaplastic primitive neuronal component (formerly PNET-like) in some cases with large cells, abundant apoptosis, cell-cell wrapping",
                      "Homer Wright (neuroblastic) rosettes in some cases",
                      "~ 15% are IDH-mutant",
                      "Gliosarcoma, IDH-mutant, rare (7% of gliosarcomas) compared to gliosarcoma, IDH-wildtype"
                    ]
                  },
                  {
                    "text": "Treatment effects (pseudoprogression)PaucicellularityFibrinoid necrosis of vessels, tumoral, and parenchymal necrosis without peripheral palisadingLittle, if any, microvascular proliferationNuclear pleomorphismHyalinized vesselsCalcificationFew mitosesMany specimens post treatment contain both therapy-induced necrosis and viable tumor with some cell cyclingMay be difficult to assign intermediate cases into pseudoprogression or true tumor progression category",
                    "sub_points": [
                      "Paucicellularity",
                      "Fibrinoid necrosis of vessels, tumoral, and parenchymal necrosis without peripheral palisading",
                      "Little, if any, microvascular proliferation",
                      "Nuclear pleomorphism",
                      "Hyalinized vessels",
                      "Calcification",
                      "Few mitoses",
                      "Many specimens post treatment contain both therapy-induced necrosis and viable tumor with some cell cyclingMay be difficult to assign intermediate cases into pseudoprogression or true tumor progression category",
                      "May be difficult to assign intermediate cases into pseudoprogression or true tumor progression category"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Tissue fragments with fine fibrillar background, individual and clustered cells"
                  },
                  {
                    "text": "Mixture of cell types in accordance with histologic subtypes and tissue patterns"
                  },
                  {
                    "text": "Cellular/nuclear pleomorphism common in irradiated tumors"
                  },
                  {
                    "text": "Mitoses (but may be few)"
                  },
                  {
                    "text": "Microvascular proliferation"
                  },
                  {
                    "text": "Necrosis"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "GFAP(+)Most cases, generally in proportion to abundance of cytoplasmAdipocyte-like cells (+) in lipidized variant",
                    "sub_points": [
                      "Most cases, generally in proportion to abundance of cytoplasm",
                      "Adipocyte-like cells (+) in lipidized variant"
                    ]
                  },
                  {
                    "text": "CytokeratinsAE1/AE3(+) (many cases)CAM5.2(-)",
                    "sub_points": [
                      "AE1/AE3(+) (many cases)",
                      "CAM5.2(-)"
                    ]
                  },
                  {
                    "text": "Olig2(+) but in variable numbers of tumor cells"
                  },
                  {
                    "text": "IDH1 R132H(+) in > 85%"
                  },
                  {
                    "text": "Loss of nuclear ATRX, parallelingATRXmutation"
                  },
                  {
                    "text": "p53(+), but less frequent than loss of nuclear ATRX positivity"
                  },
                  {
                    "text": "Ki-67 labeling indexIntra- and intertumoral variabilityVery high in primitive neuronal (formerly PNET-like) component",
                    "sub_points": [
                      "Intra- and intertumoral variability",
                      "Very high in primitive neuronal (formerly PNET-like) component"
                    ]
                  },
                  {
                    "text": "Macrophage markers (CD68, CD163, HAM56)Many (+) cells (especially in cases with necrosis or post treatment)",
                    "sub_points": [
                      "Many (+) cells (especially in cases with necrosis or post treatment)"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "IDH1/IDH2mutation: 100%"
                  },
                  {
                    "text": "TP53/MDM2/MDM4/p14ARFpathway: 70%"
                  },
                  {
                    "text": "P16INK4a/CDK4/RB1pathway: 50%"
                  },
                  {
                    "text": "EGFRamplification characteristic of GBM, IDH-wildtype, WHO grade 4, almost never seen in astrocytoma, IDH-mutant, WHO grade 4"
                  },
                  {
                    "text": "Methylation ofMGMTpromoter in majority of astrocytomas, IDH-mutantFavorable prognostic and predictive factorCan change to (+) or (-) after treatmentMuch higher percentage ofMGMTmethylation in IDH-mutant astrocytomas than in IDH-wildtype GBMMGMTmethylation contributes to temozolomide sensitivity, better prognosisIDH mutation mediates CpG island methylator (CIMP) phenotypeMutation of single gene,IDH1, establishes G-CIMP by remodeling methylome",
                    "sub_points": [
                      "Favorable prognostic and predictive factor",
                      "Can change to (+) or (-) after treatment",
                      "Much higher percentage ofMGMTmethylation in IDH-mutant astrocytomas than in IDH-wildtype GBMMGMTmethylation contributes to temozolomide sensitivity, better prognosisIDH mutation mediates CpG island methylator (CIMP) phenotypeMutation of single gene,IDH1, establishes G-CIMP by remodeling methylome",
                      "MGMTmethylation contributes to temozolomide sensitivity, better prognosis",
                      "IDH mutation mediates CpG island methylator (CIMP) phenotype",
                      "Mutation of single gene,IDH1, establishes G-CIMP by remodeling methylome"
                    ]
                  },
                  {
                    "text": "AmplificationsMYCamplification in primitive neuronal (formerly PNET-like) component in some IDH-mutant cases",
                    "sub_points": [
                      "MYCamplification in primitive neuronal (formerly PNET-like) component in some IDH-mutant cases"
                    ]
                  },
                  {
                    "text": "Gain of chromosome 7, without loss of whole chromosome 10"
                  },
                  {
                    "text": "Hypermethylation phenotype"
                  },
                  {
                    "text": "Proneural transcription profile"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Oligodendroglioma, IDH-Mutant and 1p/19q Codeleted, WHO Grade 3": [
                  {
                    "text": "Cytologically monomorphous"
                  },
                  {
                    "text": "Round nuclei"
                  },
                  {
                    "text": "Minigemistocytes and gliofibrillary oligodendrocytes"
                  },
                  {
                    "text": "May show areas of WHO grade 2 oligodendroglioma"
                  },
                  {
                    "text": "Whole-arm 1p/19q codeletion in addition toIDH1/IDH2mutation"
                  },
                  {
                    "text": "TERTpromoter mutation, lacksATRXalterations"
                  }
                ],
                "Ependymoma, WHO Grade 3": [
                  {
                    "text": "Discrete but focally infiltrative in some cases"
                  },
                  {
                    "text": "Monomorphous"
                  },
                  {
                    "text": "Perivascular pseudorosettes"
                  },
                  {
                    "text": "True rosettes (uncommon)"
                  },
                  {
                    "text": "EMA(+)Dot-like and microlumina (most cases)Surface staining of rosettes and canals",
                    "sub_points": [
                      "Dot-like and microlumina (most cases)",
                      "Surface staining of rosettes and canals"
                    ]
                  },
                  {
                    "text": "Differing anatomic locations (posterior fossa typical for anaplastic ependymoma, rare for IDH-mutant astrocytoma, WHO grade 4)"
                  },
                  {
                    "text": "Different DNA methylation profiles"
                  },
                  {
                    "text": "Olig2 low-absent"
                  }
                ],
                "Metastatic Neoplasm": [
                  {
                    "text": "Sharp border"
                  },
                  {
                    "text": "Epithelial or melanocytic features"
                  },
                  {
                    "text": "Necrosis sparing vessels; collars of viable tumor"
                  },
                  {
                    "text": "Little microvascular proliferation, except in renal cell"
                  },
                  {
                    "text": "Epithelial or melanocytic markers (+)"
                  },
                  {
                    "text": "Perivascular lymphocytic infiltrates in adjacent brain"
                  }
                ],
                "Primary CNS Lymphoma": [
                  {
                    "text": "Homogeneous contrast enhancement (no dark necrotic center) in immunocompetent patients with lymphoma"
                  },
                  {
                    "text": "Angiocentricity, resulting in patchy lymphoma cell distribution"
                  },
                  {
                    "text": "Typical cytologic features (e.g., round or notched nuclei, prominent nucleoli, scant cytoplasm)"
                  },
                  {
                    "text": "Abundant apoptosis"
                  },
                  {
                    "text": "Ring enhancement, necrosis in immunodeficient patients with lymphoma"
                  },
                  {
                    "text": "No microvascular proliferation"
                  },
                  {
                    "text": "B-cell > > T-cell lymphoma"
                  }
                ],
                "Glioblastoma, IDH-Wildtype, WHO Grade 4": [
                  {
                    "text": "Ring enhancement more common than in astrocytoma, IDH-mutant, WHO grade 4"
                  },
                  {
                    "text": "May have epithelioid, granular cell, giant cell, small cell features"
                  },
                  {
                    "text": "Most gliosarcomas are IDH-wildtype"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Small cell, granular cell, epithelioid, giant cell high-grade astrocytomas are IDH-wildtype, not IDH-mutant"
                  },
                  {
                    "text": "Subset (~ 15%) of high-grade astrocytomas with primitive neuronal component are IDH-mutant"
                  },
                  {
                    "text": "Rare (< 7%) gliosarcoma, IDH-mutant"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gliosarcoma": {
            "name": "Gliosarcoma",
            "url": "https://app.pathprimer.com/document/331c64cb-b309-4a61-93c4-8ebe7c89f48e/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Subtype of glioblastoma, IDH-wildtype"
                  },
                  {
                    "text": "Mesenchymal metaplasia of glial cells, not true mixed glial/mesenchymal neoplasm"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Poor prognosis, akin to that of glioblastoma, ± mesenchymal differentiation"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Usually supratentorial and superficial; well demarcated; enhancing"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Variably discrete, intraoperatively may simulate metastasis or meningioma"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Bulk of lesion can have mesenchymal features"
                  },
                  {
                    "text": "Spread along vessels, mesenchymal component"
                  },
                  {
                    "text": "Tendency of mesenchymal component to mature into low-grade tumor or apparent reactive fibrosis"
                  },
                  {
                    "text": "Specific mesenchymal differentiation, some cases"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Abnormalities, e.g.,TP53mutations, identical in areas both of glial and mesenchymal differentiation (clonal neoplasm)"
                  },
                  {
                    "text": "Olig2(-), unlike typical glioblastoma"
                  },
                  {
                    "text": "CD34 often (+) in mesenchymal component but not in infiltrating component"
                  },
                  {
                    "text": "p53(+), if present in both glial and mesenchymal tissue"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Consider gliosarcoma in any anaplastic fibroblastic process, even if glial component not obvious"
                  },
                  {
                    "text": "Reticulin and GFAP staining useful in distinguishing glial from mesenchymal component"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Subtype of glioblastoma, IDH-wildtype WHO grade 4, not separate tumor type"
                  },
                  {
                    "text": "Phenotypically mixed lesion with glial and mesenchymal differentiationEvident at initial presentation (primary gliosarcoma)Mesenchymal differentiation in preexisting malignant glioma, usually after treatment (secondary gliosarcoma)",
                    "sub_points": [
                      "Evident at initial presentation (primary gliosarcoma)",
                      "Mesenchymal differentiation in preexisting malignant glioma, usually after treatment (secondary gliosarcoma)"
                    ]
                  },
                  {
                    "text": "Occasionally seen in association with oligodendroglial, ependymal, subependymal tumors (rare)"
                  },
                  {
                    "text": "Mesenchymal differentiation of glial cells, not true mixed glial/mesenchymal neoplasm"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Past history of irradiation for CNS tumor in some cases"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Adults: Same age distribution as glioblastomaAny age but usually > 40 years",
                    "sub_points": [
                      "Any age but usually > 40 years"
                    ]
                  },
                  {
                    "text": "Children (rare)"
                  }
                ],
                "Site": [
                  {
                    "text": "Supratentorial in most casesTemporal lobe classic but not only site",
                    "sub_points": [
                      "Temporal lobe classic but not only site"
                    ]
                  },
                  {
                    "text": "Posterior fossa associated with ependymoma (rare)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Similar to glioblastoma"
                  },
                  {
                    "text": "Focal neurologic deficit depending on site"
                  },
                  {
                    "text": "Headaches, seizures, cognitive dysfunction"
                  },
                  {
                    "text": "Macrocephaly, infants (rare)"
                  },
                  {
                    "text": "No prior history of glioma (primary gliosarcoma)"
                  },
                  {
                    "text": "Past history of glioma in some cases (secondary gliosarcoma)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgery, irradiation, and chemotherapy similar to glioblastoma"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Poor, similar to that of ordinary glioblastomaAlso poor for tumors arising in setting of oligodendroglioma (oligosarcoma) or ependymoma (ependymosarcoma)",
                    "sub_points": [
                      "Also poor for tumors arising in setting of oligodendroglioma (oligosarcoma) or ependymoma (ependymosarcoma)"
                    ]
                  },
                  {
                    "text": "Skull penetration with extracranial extension in some cases"
                  },
                  {
                    "text": "Systemic metastases (exceptional)"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Usually supratentorial"
                  },
                  {
                    "text": "Typically superficial and well demarcated"
                  },
                  {
                    "text": "Mass effect and peritumoral edema"
                  },
                  {
                    "text": "Contrast enhancingClassic rim pattern of glioblastoma, some casesCompact superficial mass, some cases",
                    "sub_points": [
                      "Classic rim pattern of glioblastoma, some cases",
                      "Compact superficial mass, some cases"
                    ]
                  },
                  {
                    "text": "Neuroimaging studies reported no significant distinction between glioblastoma and gliosarcoma"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Generally superficial location"
                  },
                  {
                    "text": "Variably discrete; intraoperatively often simulates metastasis or meningioma"
                  },
                  {
                    "text": "Firm"
                  },
                  {
                    "text": "Necrosis (some cases)"
                  },
                  {
                    "text": "Skull penetration (rare)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Conventional astrocytic phenotype (glioblastoma variant)Infiltrating glial component may be scantNests or lobules without reticulin, glial componentSpread along vessels, mesenchymal componentDense, fascicular, sometimes herringbone pattern, reticulin-rich mesenchymal componentTendency of mesenchymal component to mature into low-grade tumor or apparent reactive fibrosisOften considerable atypia in vascular cellsSpecific mesenchymal differentiation, some casesOsteosarcomaChondrosarcomaRhabdomyosarcoma, rareAngiosarcoma, rareLiposarcoma or lipoma, rareLeiomyosarcoma, rareEpithelial differentiation, occasional casesGlandularSquamousFoci of primitive embryonal-like tissue, uncommonLarge round cellsHigh mitotic activityAbundant apoptosisCell-cell wrappingNuclear moldingSmall cells, some cases, occasionally with Homer Wright rosettes",
                    "sub_points": [
                      "Infiltrating glial component may be scant",
                      "Nests or lobules without reticulin, glial component",
                      "Spread along vessels, mesenchymal component",
                      "Dense, fascicular, sometimes herringbone pattern, reticulin-rich mesenchymal component",
                      "Tendency of mesenchymal component to mature into low-grade tumor or apparent reactive fibrosis",
                      "Often considerable atypia in vascular cells",
                      "Specific mesenchymal differentiation, some casesOsteosarcomaChondrosarcomaRhabdomyosarcoma, rareAngiosarcoma, rareLiposarcoma or lipoma, rareLeiomyosarcoma, rare",
                      "Osteosarcoma",
                      "Chondrosarcoma",
                      "Rhabdomyosarcoma, rare",
                      "Angiosarcoma, rare",
                      "Liposarcoma or lipoma, rare",
                      "Leiomyosarcoma, rare",
                      "Epithelial differentiation, occasional casesGlandularSquamous",
                      "Glandular",
                      "Squamous",
                      "Foci of primitive embryonal-like tissue, uncommonLarge round cellsHigh mitotic activityAbundant apoptosisCell-cell wrappingNuclear moldingSmall cells, some cases, occasionally with Homer Wright rosettes",
                      "Large round cells",
                      "High mitotic activity",
                      "Abundant apoptosis",
                      "Cell-cell wrapping",
                      "Nuclear molding",
                      "Small cells, some cases, occasionally with Homer Wright rosettes"
                    ]
                  },
                  {
                    "text": "OligosarcomaArising in setting of oligodendroglioma, WHO grade 2 or 3Dense, fascicular, reticulin-rich mesenchymal component",
                    "sub_points": [
                      "Arising in setting of oligodendroglioma, WHO grade 2 or 3",
                      "Dense, fascicular, reticulin-rich mesenchymal component"
                    ]
                  },
                  {
                    "text": "EpendymosarcomaArising in setting of ependymoma, WHO grade 2 or 3Dense, fascicular, reticulin-rich mesenchymal component",
                    "sub_points": [
                      "Arising in setting of ependymoma, WHO grade 2 or 3",
                      "Dense, fascicular, reticulin-rich mesenchymal component"
                    ]
                  },
                  {
                    "text": "Subependymomasarcoma, reported but exceedingly rare"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Variable features of glioblastoma"
                  },
                  {
                    "text": "Bipolar malignant cells, sarcomatous component, may be scanty"
                  },
                  {
                    "text": "Variable mesenchymal differentiation, e.g., cartilaginous, lipoblasts, rhabdoid cells"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "GFAP(+), often focalNests or fields of glial componentSome spindle cells within mesenchymal component",
                    "sub_points": [
                      "Nests or fields of glial component",
                      "Some spindle cells within mesenchymal component"
                    ]
                  },
                  {
                    "text": "Olig2(-), unlike typical glioblastoma"
                  },
                  {
                    "text": "CD34 often (+) in mesenchymal component but not in infiltrating component"
                  },
                  {
                    "text": "Desmin (+) in lesions with myogenic differentiation"
                  },
                  {
                    "text": "p53(+), if present in both glial and mesenchymal tissue"
                  },
                  {
                    "text": "PNET-like tissueSynaptophysin (+)p53(+), oftenKi-67, very high index",
                    "sub_points": [
                      "Synaptophysin (+)",
                      "p53(+), often",
                      "Ki-67, very high index"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Abnormalities, e.g.,TP53mutations, identical in areas of both glial and mesenchymal differentiation (clonal neoplasm)"
                  },
                  {
                    "text": "Molecular profile similar to primary glioblastomas butEGFRoverexpression or amplification rare"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Glioblastoma in Meninges": [
                  {
                    "text": "Distinction between gliosarcoma and glioblastoma with desmoplastic reaction often problematic"
                  },
                  {
                    "text": "Leptomeningeal tissue or location sometimes recognizable"
                  },
                  {
                    "text": "GFAP(+), Olig2(+) and more pronounced than gliosarcoma"
                  },
                  {
                    "text": "Often mesenchymal markers are (-), e.g., CD34"
                  },
                  {
                    "text": "Radiologic image more typical of diffuse tumor as opposed to well demarcated"
                  },
                  {
                    "text": "Prognostic relevance minimal, if any"
                  }
                ],
                "Meningioma": [
                  {
                    "text": "Rarely as high grade or fascicular"
                  },
                  {
                    "text": "No glial component"
                  },
                  {
                    "text": "Generally whorls &/or psammoma bodies"
                  },
                  {
                    "text": "Less reticulin, not pericellular"
                  },
                  {
                    "text": "EMA(+), SSTR2A(+), PR(+) in some cases"
                  },
                  {
                    "text": "GFAP(-), S100(-) in most cases"
                  }
                ],
                "Metastatic Tumor": [
                  {
                    "text": "No glial component"
                  },
                  {
                    "text": "Epithelial, melanocytic differentiation"
                  },
                  {
                    "text": "More necrosis, usually with perivascular sparing"
                  },
                  {
                    "text": "Little reticulin"
                  },
                  {
                    "text": "Neuroepithelial and glial markers are (-)"
                  }
                ],
                "Pleomorphic Xanthoastrocytoma": [
                  {
                    "text": "No biphasic glial-mesenchymal architecture"
                  },
                  {
                    "text": "Less reticulin, generally not as pericellular"
                  },
                  {
                    "text": "No reticulin-rich, anaplastic spindle cell component"
                  },
                  {
                    "text": "Eosinophilic granular bodies"
                  },
                  {
                    "text": "Xanthomatous (lipidized) cells"
                  },
                  {
                    "text": "Giant cells"
                  },
                  {
                    "text": "Less frequent mitoses, no vascular proliferation or palisading necrosis"
                  }
                ],
                "Solitary Fibrous Tumor": [
                  {
                    "text": "Usually less anaplastic"
                  },
                  {
                    "text": "No glial component"
                  },
                  {
                    "text": "CD34(+) in classic solitary fibrous tumor (SFT), but less staining in hemangiopericytoma (HPC)"
                  },
                  {
                    "text": "Little reticulin in classic SFT but usually abundant in HPC"
                  },
                  {
                    "text": "STAT6(+); BCL2(+) in almost all cases"
                  }
                ],
                "Fibrosarcoma and Undifferentiated Sarcoma": [
                  {
                    "text": "Usually in children"
                  },
                  {
                    "text": "More fascicular"
                  },
                  {
                    "text": "No glial component"
                  },
                  {
                    "text": "Usually monomorphous"
                  },
                  {
                    "text": "Glial or neuroepithelial markers are (-)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Surgeon intraoperative impression often meningioma or metastasis"
                  },
                  {
                    "text": "Macroscopically often well circumscribed but behaves as malignant glioma"
                  },
                  {
                    "text": "Can penetrate skull"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Consider lesion in any anaplastic fibroblastic process, even if glioma not initially apparent"
                  },
                  {
                    "text": "Reticulin staining useful in distinguishing glial from mesenchymal component"
                  },
                  {
                    "text": "GFAP staining often necessary to confirm presence of glial component"
                  },
                  {
                    "text": "Sarcomatous component typically Olig2(-) and often CD34(+)"
                  },
                  {
                    "text": "Sarcomatous component can occur in gliomas other than glioblastoma"
                  },
                  {
                    "text": "Spindle cell appearance occasionally seen in glioblastoma; do not diagnose sarcomatous component without interspersed reticulin"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pilocytic Astrocytoma": {
            "name": "Pilocytic Astrocytoma",
            "url": "https://app.pathprimer.com/document/ca416807-61ef-465b-93e9-2154bb932816/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Low-grade, well-circumscribed tumor with biphasic pattern; WHO grade 1"
                  },
                  {
                    "text": "Criteria for anaplasia not well established"
                  },
                  {
                    "text": "Anaplastic histology,CDKN2Aloss,ATRX, H3 K27M mutations rare but may imply more aggressive behavior"
                  },
                  {
                    "text": "Pilomyxoid astrocytoma (PMA) is considered subtype"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Extent of resection is most important prognostic factor"
                  },
                  {
                    "text": "Overall survival excellent, but residual tumor and neurologic deficits may remain (chronic disease)"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Cystic tumor with enhancing mural nodule"
                  },
                  {
                    "text": "Optic pilocytic astrocytoma (PA) more solid and variable enhancement"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Generally well circumscribed"
                  },
                  {
                    "text": "Infiltrative pattern in some cases, especially cerebellum, optic nerve, chiasm, and tract"
                  },
                  {
                    "text": "Compact fibrillar tissue, sometimes with spongy component (biphasic pattern)"
                  },
                  {
                    "text": "Rosenthal fibers and, less commonly, eosinophilic granular bodies (EGBs)"
                  },
                  {
                    "text": "Vascular proliferation, usually glomeruloid microvascular proliferation common in cystic tumors"
                  },
                  {
                    "text": "Some tumors may have mixed PA and PMA features"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "GFAP(+), Olig2(+), SOX10(+)"
                  },
                  {
                    "text": "Synaptophysin sometimes (+)"
                  },
                  {
                    "text": "Immunohistochemistry can help differentiate diffuse gliomas from PA"
                  },
                  {
                    "text": "Activation of MAPK pathwayMostlyKIAA1549::BRAFfusion withBRAFkinase domain duplication, especially in posterior fossa tumorsFew tumors haveBRAFp.V600E orNF1mutations",
                    "sub_points": [
                      "MostlyKIAA1549::BRAFfusion withBRAFkinase domain duplication, especially in posterior fossa tumors",
                      "Few tumors haveBRAFp.V600E orNF1mutations"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Pilocytic astrocytoma (PA)"
                  },
                  {
                    "text": "Pilomyxoid astrocytoma (PMA); subtype of PA"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Solid glial neoplasm with typical biphasic compact and loose (or myxoid) patterns, piloid histology with low proliferative activity, and Rosenthal fibers"
                  },
                  {
                    "text": "WHO grade 1"
                  },
                  {
                    "text": "Tumors with anaplastic features described, but WHO grade is not assigned to these tumors"
                  },
                  {
                    "text": "PMA is subtype with more aggressive behavior and without WHO grade designation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Neurofibromatosis Type 1 Association": [
                  {
                    "text": "Minority of cases"
                  },
                  {
                    "text": "Usually optic nerve PAs, typically bilateral, but may be seen anywhere in neuraxis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Variable presentation depending on locationOptic nerves: Proptosis, visual lossOptic chiasm/hypothalamus: Visual loss, hypothalamic dysfunction, diencephalic syndrome (rare)Cerebellum: Cerebellar dysfunction (ataxia), especially with vermian lesions, consequences of obstructive hydrocephalusSpinal cord: Motor and sensory deficits depending on level affectedIntra- and paraventricular: Obstructive hydrocephalusPeripheral cerebral hemispheres: Seizures, focal neurologic deficits, mass effects",
                    "sub_points": [
                      "Optic nerves: Proptosis, visual loss",
                      "Optic chiasm/hypothalamus: Visual loss, hypothalamic dysfunction, diencephalic syndrome (rare)",
                      "Cerebellum: Cerebellar dysfunction (ataxia), especially with vermian lesions, consequences of obstructive hydrocephalus",
                      "Spinal cord: Motor and sensory deficits depending on level affected",
                      "Intra- and paraventricular: Obstructive hydrocephalus",
                      "Peripheral cerebral hemispheres: Seizures, focal neurologic deficits, mass effects"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Extent of resection most important prognostic factor"
                  },
                  {
                    "text": "Some tumors may remain dormant or even regress following partial resection"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Usually considered for recurrent, multifocal, or progressive tumors"
                  },
                  {
                    "text": "MAPK pathway inhibitors appear promising"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Usually after recurrence or progression"
                  },
                  {
                    "text": "Suggestion that early radiation may not be advisable"
                  },
                  {
                    "text": "Rare examples of malignant progression years after radiation treatment"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Overall survival good, but residual tumor and neurologic deficits may persist"
                  },
                  {
                    "text": "Most favorable for cerebellar, optic nerve, superficial cerebral, and spinal cord tumors"
                  },
                  {
                    "text": "Less favorable when central or hypothalamic"
                  },
                  {
                    "text": "Solid component often stable or slow growing"
                  },
                  {
                    "text": "Cyst recurrence or reformation is common especially for subtotally resected tumors"
                  },
                  {
                    "text": "Spontaneous regression, especially in optic nerve PAs in setting of neurofibromatosis type 1 (NF1) (rare)"
                  },
                  {
                    "text": "Dissemination in CSF pathways (rare)More common with pilomyxoid variant",
                    "sub_points": [
                      "More common with pilomyxoid variant"
                    ]
                  },
                  {
                    "text": "Transformation to high-grade lesion (rare)Radiation inducedAnaplastic transformation of primary tumorEmergence of malignant infiltrating glioma in radiation fieldSpontaneousSome anaplastic PAs emerge de novo without prior low-grade tumor, and nature of such tumors is controversialSome typical PAs can progress to malignant gliomas in absence of prior radiationTumors withCDKN2Aloss,ATRXmutation, or H3 K27M mutations have been described as more aggressive",
                    "sub_points": [
                      "Radiation inducedAnaplastic transformation of primary tumorEmergence of malignant infiltrating glioma in radiation field",
                      "Anaplastic transformation of primary tumor",
                      "Emergence of malignant infiltrating glioma in radiation field",
                      "SpontaneousSome anaplastic PAs emerge de novo without prior low-grade tumor, and nature of such tumors is controversialSome typical PAs can progress to malignant gliomas in absence of prior radiation",
                      "Some anaplastic PAs emerge de novo without prior low-grade tumor, and nature of such tumors is controversial",
                      "Some typical PAs can progress to malignant gliomas in absence of prior radiation",
                      "Tumors withCDKN2Aloss,ATRXmutation, or H3 K27M mutations have been described as more aggressive"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Discrete, usually with enhancing component"
                  },
                  {
                    "text": "Often macrocystic with enhancing nodule, especially in cerebellum, cerebral hemispheres, and spinal cord"
                  },
                  {
                    "text": "Often dorsally exophytic on brainstem or with cerebellopontine angle extension"
                  },
                  {
                    "text": "Usually little peritumoral edema"
                  },
                  {
                    "text": "More infiltrative in visual pathways"
                  },
                  {
                    "text": "Optic PA often solid without cystic component and variable enhancement"
                  },
                  {
                    "text": "Rare examples demonstrate leptomeningeal spread on contrast-enhanced images"
                  },
                  {
                    "text": "Cyst wall occasionally enhances"
                  },
                  {
                    "text": "Rare examples with peripheral rim enhancement around cystic component"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Well circumscribed"
                  },
                  {
                    "text": "Often cystic with mural nodule in cerebellum, cerebrum, and spinal cord"
                  },
                  {
                    "text": "Occasional examples with hemorrhage"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Borders/growth patternsGenerally well circumscribedInfiltrative pattern in some cases, especially cerebellum and at tumor peripheryLeptomeningeal extension, especially in optic nerve and cerebellum,notsign of aggressive behaviorFilling of perivascular spaces",
                    "sub_points": [
                      "Generally well circumscribed",
                      "Infiltrative pattern in some cases, especially cerebellum and at tumor periphery",
                      "Leptomeningeal extension, especially in optic nerve and cerebellum,notsign of aggressive behavior",
                      "Filling of perivascular spaces"
                    ]
                  },
                  {
                    "text": "Architectural patternsCompact fibrillar tissue with spongy component producing biphasic pattern (common)Fibrillary background (majority)Myxoid background (variable and almost always focal if present)Diffuse infiltrative appearance (rare)Polar-spongioblastoma-like pattern (rare)Focal areas with perivascular or angiocentric arrangementFocal pilomyxoid-like areas are not sufficient to diagnose PMA",
                    "sub_points": [
                      "Compact fibrillar tissue with spongy component producing biphasic pattern (common)",
                      "Fibrillary background (majority)",
                      "Myxoid background (variable and almost always focal if present)",
                      "Diffuse infiltrative appearance (rare)",
                      "Polar-spongioblastoma-like pattern (rare)",
                      "Focal areas with perivascular or angiocentric arrangementFocal pilomyxoid-like areas are not sufficient to diagnose PMA",
                      "Focal pilomyxoid-like areas are not sufficient to diagnose PMA"
                    ]
                  },
                  {
                    "text": "Cellular patternsAstrocytic appearance, fibrillary background (majority)Oligodendroglioma-like, especially in cerebellumDegenerative nuclear atypia, more often in adult tumorsNuclear clustering or multinucleation, imparting pennies on plate appearance",
                    "sub_points": [
                      "Astrocytic appearance, fibrillary background (majority)",
                      "Oligodendroglioma-like, especially in cerebellum",
                      "Degenerative nuclear atypia, more often in adult tumors",
                      "Nuclear clustering or multinucleation, imparting pennies on plate appearance"
                    ]
                  },
                  {
                    "text": "Rosenthal fibers in piloid or compact tissue"
                  },
                  {
                    "text": "Eosinophilic granular bodies, especially in spongy tissue"
                  },
                  {
                    "text": "Calcification in minority of cases, psammoma bodies exceptional"
                  },
                  {
                    "text": "Macrocyst, usually nonneoplastic wall"
                  },
                  {
                    "text": "Degenerative changesNuclear pleomorphism and smudgy chromatinMultiple nuclei in large cells with ample cytoplasmAngioma-like sclerotic vessels, especially cerebellarOften seen in tumors from older patients",
                    "sub_points": [
                      "Nuclear pleomorphism and smudgy chromatin",
                      "Multiple nuclei in large cells with ample cytoplasm",
                      "Angioma-like sclerotic vessels, especially cerebellar",
                      "Often seen in tumors from older patients"
                    ]
                  },
                  {
                    "text": "Necrosis: Coagulative, usually not palisading"
                  },
                  {
                    "text": "Vascular proliferationIntraparenchymal telangiectatic or glomeruloid in many casesCyst wall: Telangiectatic or glomeruloid in linear arrangementMultilayered (true endothelial proliferation) in some anaplastic tumors",
                    "sub_points": [
                      "Intraparenchymal telangiectatic or glomeruloid in many cases",
                      "Cyst wall: Telangiectatic or glomeruloid in linear arrangement",
                      "Multilayered (true endothelial proliferation) in some anaplastic tumors"
                    ]
                  },
                  {
                    "text": "Features of rare anaplastic examplesHistologic criteria for anaplasia in PA not currently well establishedOften adults and exceptionally childrenIncreased cellularity and infiltrative patternIncreased rate of mitoses, more than just focalThreshold for mitotic rate is not established for cases with anaplastic featuresHigh Ki-67 index similar to high-grade gliomas, but cut-off value has not been establishedNuclear pleomorphism and cytologic atypia reminiscent of malignant glioma beyond simple multinucleation or degenerative atypiaPalisading necrosis (rare)Overlaps but is not identical with methylation cluster; \"high-grade glioma with piloid features\"",
                    "sub_points": [
                      "Histologic criteria for anaplasia in PA not currently well established",
                      "Often adults and exceptionally children",
                      "Increased cellularity and infiltrative pattern",
                      "Increased rate of mitoses, more than just focalThreshold for mitotic rate is not established for cases with anaplastic featuresHigh Ki-67 index similar to high-grade gliomas, but cut-off value has not been established",
                      "Threshold for mitotic rate is not established for cases with anaplastic features",
                      "High Ki-67 index similar to high-grade gliomas, but cut-off value has not been established",
                      "Nuclear pleomorphism and cytologic atypia reminiscent of malignant glioma beyond simple multinucleation or degenerative atypia",
                      "Palisading necrosis (rare)",
                      "Overlaps but is not identical with methylation cluster; \"high-grade glioma with piloid features\""
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Bipolar, hair-like cells with long, narrow processes"
                  },
                  {
                    "text": "Round or ovoid, elongate nuclei"
                  },
                  {
                    "text": "Focal myxoid background"
                  },
                  {
                    "text": "Rosenthal fibers and eosinophilic granular bodies"
                  },
                  {
                    "text": "Bland nuclei with vesicular chromatin"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "GFAP(+), SOX10(+)"
                  },
                  {
                    "text": "Olig2(+), especially in oligodendroglioma-like and spongy areas"
                  },
                  {
                    "text": "SynaptophysinSometimes positive, especially in pilomyxoid variantNot sign of neuronal differentiation",
                    "sub_points": [
                      "Sometimes positive, especially in pilomyxoid variant",
                      "Not sign of neuronal differentiation"
                    ]
                  },
                  {
                    "text": "Neurofilament often sparsely positive, highlighting axonal structures at periphery"
                  },
                  {
                    "text": "Vimentin, SOX2, S100 protein, and MAP2 (+); often diffuse and strong"
                  },
                  {
                    "text": "pERK(+), due to MAPK pathway activation"
                  },
                  {
                    "text": "p16(+) often diffuse, strong, nuclearNegative p16 staining associated with worse outcome",
                    "sub_points": [
                      "Negative p16 staining associated with worse outcome"
                    ]
                  },
                  {
                    "text": "Ki-67 labeling is typically low (< 5%)Occasional tumors may have higher Ki-67 indexProliferating vessels have increased labeling",
                    "sub_points": [
                      "Occasional tumors may have higher Ki-67 index",
                      "Proliferating vessels have increased labeling"
                    ]
                  },
                  {
                    "text": "IDH1 R132H (-)"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Activation of MAPK pathwayTandem duplication ofBRAF; fusion withKIAA1549Highest incidence in posterior fossa and optic pathways (≥ 60%); low in cerebral cortexCan be detected by FISH, RNA sequencing or next-generation sequencing panelsOtherBRAFfusions have also been reportedBRAFmutation (often p.V600E) in subsetRAF1alterations, such asSRGAP3::RAF1fusionFGFR1alterations, especially those with oligodendroglioma-like cytologyNTRKfusions (rare)NF1mutation (rare), typically in patients with NF1",
                    "sub_points": [
                      "Tandem duplication ofBRAF; fusion withKIAA1549Highest incidence in posterior fossa and optic pathways (≥ 60%); low in cerebral cortexCan be detected by FISH, RNA sequencing or next-generation sequencing panels",
                      "Highest incidence in posterior fossa and optic pathways (≥ 60%); low in cerebral cortex",
                      "Can be detected by FISH, RNA sequencing or next-generation sequencing panels",
                      "OtherBRAFfusions have also been reported",
                      "BRAFmutation (often p.V600E) in subset",
                      "RAF1alterations, such asSRGAP3::RAF1fusion",
                      "FGFR1alterations, especially those with oligodendroglioma-like cytology",
                      "NTRKfusions (rare)",
                      "NF1mutation (rare), typically in patients with NF1"
                    ]
                  },
                  {
                    "text": "Molecular changes typical of diffuse astrocytomas and oligodendrogliomas are absent"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Piloid Gliosis": [
                  {
                    "text": "No loose, spongy component"
                  },
                  {
                    "text": "Low cellularity, variable amount of inflammatory cells"
                  }
                ],
                "Diffuse Astrocytoma": [
                  {
                    "text": "Diffusely infiltrating"
                  },
                  {
                    "text": "Generally, no Rosenthal fibers or eosinophilic granular bodies"
                  },
                  {
                    "text": "NoBRAFduplication orKIAA1549fusion"
                  },
                  {
                    "text": "IDH1orIDH2-mutant, IDH1 R132H (+) in adult type"
                  }
                ],
                "Oligodendroglioma": [
                  {
                    "text": "Diffusely infiltrating, predilection to cortex"
                  },
                  {
                    "text": "Unusual in cerebellum and spinal cord"
                  },
                  {
                    "text": "Almost always IDH1 R132H (+) in adults"
                  }
                ],
                "Ganglioglioma": [
                  {
                    "text": "Overlap between ganglioglioma with pilocytic features and PA with trapped or neoplastic ganglion cells"
                  },
                  {
                    "text": "Eosinophilic granular bodies usually more prominent"
                  },
                  {
                    "text": "CD34(+) ramified processes in neoplastic cells"
                  }
                ],
                "Pleomorphic Xanthoastrocytoma": [
                  {
                    "text": "Significant component in subarachnoid spaceReticulin rich in leptomeningeal component",
                    "sub_points": [
                      "Reticulin rich in leptomeningeal component"
                    ]
                  },
                  {
                    "text": "Giant cells (larger than \"pennies on plate\")"
                  },
                  {
                    "text": "Lipidized (xanthic) cells"
                  }
                ],
                "Dysembryoplastic Neuroepithelial Tumor": [
                  {
                    "text": "Well-circumscribed, patterned nodules with myxoid background [Alcian blue (+)]"
                  },
                  {
                    "text": "Almost exclusively uniform oligodendroglioma-like cells"
                  },
                  {
                    "text": "Floating neurons, mostly between nodules"
                  },
                  {
                    "text": "No biphasic pattern"
                  },
                  {
                    "text": "As a rule, no Rosenthal fibers or granular bodies"
                  }
                ],
                "Rosette-Forming Glioneuronal Tumor": [
                  {
                    "text": "Glial component may be exactly like PA"
                  },
                  {
                    "text": "Neurocytic rosettes"
                  },
                  {
                    "text": "Synaptophysin (+) perivascular pseudorosettes"
                  }
                ],
                "Ependymoma": [
                  {
                    "text": "Perivascular pseudorosettes different than angiocentric pattern of PA"
                  },
                  {
                    "text": "NoBRAFmutation or duplication"
                  },
                  {
                    "text": "Olig2(-) and SOX10(-)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Stable, exceptional malignant transformation; typically chronic disease"
                  },
                  {
                    "text": "Spontaneous regression (uncommon), especially in NF1"
                  },
                  {
                    "text": "Malignant progression ± prior radiation treatment (rare)"
                  },
                  {
                    "text": "Tumors withCDKN2Aloss orATRXor H3 K27M mutations may behave aggressively"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Do not exclude PA because of focal infiltrative pattern"
                  },
                  {
                    "text": "Do not misinterpret vascular proliferation or necrosis as malignant glioma"
                  },
                  {
                    "text": "All tumors IDH1 R132H immunonegative (no mutation)"
                  },
                  {
                    "text": "RAS/RAF/MAPK pathway activation in majority of tumorsTypically as single genetic alteration",
                    "sub_points": [
                      "Typically as single genetic alteration"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ependymoma": {
            "name": "Ependymoma",
            "url": "https://app.pathprimer.com/document/a2c555a8-7953-422c-9353-220d407aff7d/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Well-circumscribed glial tumor with perivascular pseudorosettes, fibrillar background, epithelial qualities"
                  },
                  {
                    "text": "Classified by molecular groups across anatomic compartmentsSupratentorial (ST) tumors:ZFTAfusion (+) orYAP1fusion (+), or NOS/NECPosterior fossa (PF) tumors: PFA or PFB or NOS/NECSpinal cord tumors:MYCNamplification or NOS/NEC",
                    "sub_points": [
                      "Supratentorial (ST) tumors:ZFTAfusion (+) orYAP1fusion (+), or NOS/NEC",
                      "Posterior fossa (PF) tumors: PFA or PFB or NOS/NEC",
                      "Spinal cord tumors:MYCNamplification or NOS/NEC"
                    ]
                  },
                  {
                    "text": "Can be WHO grade 2 or 3"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common locationSpinal cord in adults and PF in children",
                    "sub_points": [
                      "Spinal cord in adults and PF in children"
                    ]
                  },
                  {
                    "text": "Tumors with similar histology may vary in behavior between adults and children"
                  },
                  {
                    "text": "Extent of resection, key determinant of prognosis"
                  },
                  {
                    "text": "Prognosis varies by location, molecular subtypes, WHO grade"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Typical histologic featuresPerivascular pseudorosettesTrue ependymal rosettes/canal with luminaSheet-like growth pattern, epithelioid cellsHighly fibrillar areas, sometimes with few nuclei",
                    "sub_points": [
                      "Perivascular pseudorosettes",
                      "True ependymal rosettes/canal with lumina",
                      "Sheet-like growth pattern, epithelioid cells",
                      "Highly fibrillar areas, sometimes with few nuclei"
                    ]
                  },
                  {
                    "text": "No specific histologic subtype recognized in CNS WHO 5th ed.Histologic patterns of note: Papillary, tanycytic, clear cell, giant cell, cortical ependymoma",
                    "sub_points": [
                      "Histologic patterns of note: Papillary, tanycytic, clear cell, giant cell, cortical ependymoma"
                    ]
                  },
                  {
                    "text": "Grading criteria not clearly establishedMitotic rates < 5/10 HPF compatible with WHO grade 2",
                    "sub_points": [
                      "Mitotic rates < 5/10 HPF compatible with WHO grade 2"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "GFAP(+), EMA(+), D2-40(+), Olig2(-)"
                  },
                  {
                    "text": "L1CAM(+) in ST ependymoma,ZFTAfusion (+)"
                  },
                  {
                    "text": "H3K27me3 to designate PFA or PFB tumors"
                  },
                  {
                    "text": "MYCNamplification for spinal tumors"
                  },
                  {
                    "text": "Chr 1q gain: Worse prognosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Mostly well-circumscribed tumor with ependymal differentiationPerivascular pseudorosettes or ependymal rosettesComposed of uniform small cells with round nucleiFibrillary matrix",
                    "sub_points": [
                      "Perivascular pseudorosettes or ependymal rosettes",
                      "Composed of uniform small cells with round nuclei",
                      "Fibrillary matrix"
                    ]
                  },
                  {
                    "text": "Recent advances revealed that tumors are best grouped according to age group and tumor location"
                  },
                  {
                    "text": "New WHO classification scheme categorizes ependymomas under following groupsSupratentorial (ST) ependymomas, includingZFTAfusion (+) andYAP1fusion (+) tumorsPosterior fossa (PF) ependymomas, including PFA and PFB groupsSpinal ependymomas, includingMYCN-amplified tumors",
                    "sub_points": [
                      "Supratentorial (ST) ependymomas, includingZFTAfusion (+) andYAP1fusion (+) tumors",
                      "Posterior fossa (PF) ependymomas, including PFA and PFB groups",
                      "Spinal ependymomas, includingMYCN-amplified tumors"
                    ]
                  },
                  {
                    "text": "Can be WHO grade 2 or 3"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown Etiology": [
                  {
                    "text": "Majority of tumors"
                  }
                ],
                "Neurofibromatosis Type 2": [
                  {
                    "text": "Some ependymomas"
                  },
                  {
                    "text": "Often multiple but can be solitary"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "PediatricMost common in PFClassified into group A (PFA; more common) and group B (PFB; rare), based on H3K27me3 staining or DNA methylation profilingST location is less commonZFTAfusion (+) in ~ 80% of ST ependymomasYAP1fusion (+) in ~ 6-7%, young childrenSpinal cord is rare as primary site in childrenSpinal cord may be site for seeding (\"drop metastases\") from supra- and infratentorial tumors",
                    "sub_points": [
                      "Most common in PFClassified into group A (PFA; more common) and group B (PFB; rare), based on H3K27me3 staining or DNA methylation profiling",
                      "Classified into group A (PFA; more common) and group B (PFB; rare), based on H3K27me3 staining or DNA methylation profiling",
                      "ST location is less commonZFTAfusion (+) in ~ 80% of ST ependymomasYAP1fusion (+) in ~ 6-7%, young children",
                      "ZFTAfusion (+) in ~ 80% of ST ependymomas",
                      "YAP1fusion (+) in ~ 6-7%, young children",
                      "Spinal cord is rare as primary site in childrenSpinal cord may be site for seeding (\"drop metastases\") from supra- and infratentorial tumors",
                      "Spinal cord may be site for seeding (\"drop metastases\") from supra- and infratentorial tumors"
                    ]
                  },
                  {
                    "text": "AdultMost common in spinal cordSome spinal ependymomas harborMYCNamplification and have more aggressive behaviorST and PF tumors less commonMost adult PF ependymomas are classified as group PFB tumors",
                    "sub_points": [
                      "Most common in spinal cordSome spinal ependymomas harborMYCNamplification and have more aggressive behavior",
                      "Some spinal ependymomas harborMYCNamplification and have more aggressive behavior",
                      "ST and PF tumors less commonMost adult PF ependymomas are classified as group PFB tumors",
                      "Most adult PF ependymomas are classified as group PFB tumors"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Spinal cordAdult ependymomas most frequent in cervical and thoracic spinal cordSome adult spinal ependymomas harborMYCNamplification (aggressive)Pediatric spinal ependymomas are rareShould prompt consideration of \"drop metastasis\" from intracranial primary site",
                    "sub_points": [
                      "Adult ependymomas most frequent in cervical and thoracic spinal cordSome adult spinal ependymomas harborMYCNamplification (aggressive)",
                      "Some adult spinal ependymomas harborMYCNamplification (aggressive)",
                      "Pediatric spinal ependymomas are rareShould prompt consideration of \"drop metastasis\" from intracranial primary site",
                      "Should prompt consideration of \"drop metastasis\" from intracranial primary site"
                    ]
                  },
                  {
                    "text": "PFPredominantly in infants and young childrenPFA group > 95% of cases; PFB rareOnly 50% of adolescent and < 10% of adult PF ependymomas are PFATypically around 4th ventricle; most common site in childrenMay extend through foramina of Luschka and MagendieBoth grade tumors associated with CSF seeding",
                    "sub_points": [
                      "Predominantly in infants and young childrenPFA group > 95% of cases; PFB rare",
                      "PFA group > 95% of cases; PFB rare",
                      "Only 50% of adolescent and < 10% of adult PF ependymomas are PFA",
                      "Typically around 4th ventricle; most common site in children",
                      "May extend through foramina of Luschka and Magendie",
                      "Both grade tumors associated with CSF seeding"
                    ]
                  },
                  {
                    "text": "STZFTAfusion more common thanYAP1fusionPediatric tumors more often WHO grade 3 &/orZFTAfusion (+)Most often paraventricular with parenchymal extensionPure intraventricular tumor rareMany tumors not directly connected to ventricles",
                    "sub_points": [
                      "ZFTAfusion more common thanYAP1fusion",
                      "Pediatric tumors more often WHO grade 3 &/orZFTAfusion (+)",
                      "Most often paraventricular with parenchymal extension",
                      "Pure intraventricular tumor rare",
                      "Many tumors not directly connected to ventricles"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Spinal cordPain, radiculopathyNeurologic deficit, weakness, or sensory level loss based on tumor locationIncontinence (rare)Signs and symptoms of neurofibromatosis type 2 (rare)",
                    "sub_points": [
                      "Pain, radiculopathy",
                      "Neurologic deficit, weakness, or sensory level loss based on tumor location",
                      "Incontinence (rare)",
                      "Signs and symptoms of neurofibromatosis type 2 (rare)"
                    ]
                  },
                  {
                    "text": "PFSigns and symptoms of obstructive hydrocephalusHeadaches, nausea, and vomiting",
                    "sub_points": [
                      "Signs and symptoms of obstructive hydrocephalus",
                      "Headaches, nausea, and vomiting"
                    ]
                  },
                  {
                    "text": "STFeatures of mass effect, focal neurologic deficit, hydrocephalusSeizures (rare)",
                    "sub_points": [
                      "Features of mass effect, focal neurologic deficit, hydrocephalus",
                      "Seizures (rare)"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Gross total resection is treatment of choice"
                  },
                  {
                    "text": "PF tumors may cause hydrocephalus that requires shunting"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Usually when subtotally resected, recurrent, or anaplastic"
                  },
                  {
                    "text": "Infants and young children who cannot receive radiation"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Local radiation standard for intracranial primary, except for some ST, WHO grade 2, totally resected tumors"
                  },
                  {
                    "text": "Radiation upon recurrence"
                  },
                  {
                    "text": "Craniospinal radiation for select patients, especially with CSF dissemination"
                  },
                  {
                    "text": "May be avoided in most adult spinal cord tumors"
                  },
                  {
                    "text": "Recent studies suggest no benefit of radiation in pediatric PFA tumors"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Spinal cordAdults: Excellent; most ependymomas in this location may be cured by surgeryException:MYCN-amplified spinal ependymomasChildren: Variable, especially if spinal tumor represents \"drop metastasis\" from intracranial primaryPrimary spinal ependymoma is rare in childrenRule out tumor at other CNS sites",
                    "sub_points": [
                      "Adults: Excellent; most ependymomas in this location may be cured by surgeryException:MYCN-amplified spinal ependymomas",
                      "Exception:MYCN-amplified spinal ependymomas",
                      "Children: Variable, especially if spinal tumor represents \"drop metastasis\" from intracranial primaryPrimary spinal ependymoma is rare in childrenRule out tumor at other CNS sites",
                      "Primary spinal ependymoma is rare in children",
                      "Rule out tumor at other CNS sites"
                    ]
                  },
                  {
                    "text": "PFGross total resection most critical prognostic factorPatients < 3 years have poorer prognosisInfantile tumors may be different from pediatric-type ependymomas, but evidence is insufficientWHO grade 3 may have worse prognosisRole of grading within PFA/PFB molecular subtypes is not established yetPFA tumors have worse prognosis than PFB tumorsSome studies in pediatric PF ependymomas failed to find prognostic association based on H3K27me3 stainingFurther molecular heterogeneity amongst PFA ependymomas recently describedPFB group also appear to be heterogeneous",
                    "sub_points": [
                      "Gross total resection most critical prognostic factor",
                      "Patients < 3 years have poorer prognosisInfantile tumors may be different from pediatric-type ependymomas, but evidence is insufficient",
                      "Infantile tumors may be different from pediatric-type ependymomas, but evidence is insufficient",
                      "WHO grade 3 may have worse prognosisRole of grading within PFA/PFB molecular subtypes is not established yet",
                      "Role of grading within PFA/PFB molecular subtypes is not established yet",
                      "PFA tumors have worse prognosis than PFB tumorsSome studies in pediatric PF ependymomas failed to find prognostic association based on H3K27me3 stainingFurther molecular heterogeneity amongst PFA ependymomas recently described",
                      "Some studies in pediatric PF ependymomas failed to find prognostic association based on H3K27me3 staining",
                      "Further molecular heterogeneity amongst PFA ependymomas recently described",
                      "PFB group also appear to be heterogeneous"
                    ]
                  },
                  {
                    "text": "STExtent of resection single most critical prognostic factorSuggestion thatZFTAfusion (+) tumors have worse prognosis is not holding up in some studiesYAP1fusion (+) tumors appear to behave better, but evidence for this is also limitedWHO grade 3 and clear cell subtypes may have worse prognosis",
                    "sub_points": [
                      "Extent of resection single most critical prognostic factor",
                      "Suggestion thatZFTAfusion (+) tumors have worse prognosis is not holding up in some studies",
                      "YAP1fusion (+) tumors appear to behave better, but evidence for this is also limited",
                      "WHO grade 3 and clear cell subtypes may have worse prognosis"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Discrete with variable mass effectPeritumoral edema most prominent in ST tumors",
                    "sub_points": [
                      "Peritumoral edema most prominent in ST tumors"
                    ]
                  },
                  {
                    "text": "Mostly solid, some cystic with enhancing solid componentCystic component more common in spinal intramedullary and ST tumors",
                    "sub_points": [
                      "Cystic component more common in spinal intramedullary and ST tumors"
                    ]
                  },
                  {
                    "text": "Extension into cisterna magna, PF tumors"
                  },
                  {
                    "text": "Hyper- or isointense on T2WI and hypointense on T1WI"
                  },
                  {
                    "text": "Cysts, hemorrhage, or calcifications, low signal on T2WI"
                  },
                  {
                    "text": "Restriction in DWI, hypercellularityEspecially PFA andZFTAfusion (+) ST ependymomas",
                    "sub_points": [
                      "Especially PFA andZFTAfusion (+) ST ependymomas"
                    ]
                  },
                  {
                    "text": "Variable enhancement, usually heterogeneousSpinal tumors typically avidPF tumors, strong and homogeneousST tumors, heterogeneousCortical ependymomas, little or no enhancementRim enhancement, rareEnhancing nodules along spinal cord: CSF dissemination",
                    "sub_points": [
                      "Spinal tumors typically avid",
                      "PF tumors, strong and homogeneous",
                      "ST tumors, heterogeneousCortical ependymomas, little or no enhancement",
                      "Cortical ependymomas, little or no enhancement",
                      "Rim enhancement, rare",
                      "Enhancing nodules along spinal cord: CSF dissemination"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Well circumscribed"
                  },
                  {
                    "text": "May be cystic"
                  },
                  {
                    "text": "Hemorrhagic, cherry red appearance"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Typical histologic features of ependymomaPerivascular pseudorosettesTrue rosettes, lumina, canalsSheet-like growth pattern, epithelioid cellsHighly fibrillar areas, sometimes with few nucleiGemistocyte-like cells in fibrillar areas in some casesNecrosis without palisading common, especially in PFNot in itself indicator of anaplasiaMostly sharp tumor border, occasional infiltrative edgeHypercellular nodulesSome in otherwise low-grade or typical ependymomas with only moderately increased mitotic rateSome with increased atypia, high mitotic activity, and Ki-67 labeling, especially in PFSome suggest that presence of hypercellular nodules has limited effect on prognosisCystic degeneration and associated linear vascular proliferationMost tumors that appear to harbor cysts radiologically show these featuresTelangiectatic vascular proliferation in cyst wall often misleads to high-grade diagnosisCalcifications, mostly in PF and ST tumorsCytoplasmic vacuolization, sometimes lipidized cellsEpithelial surfaces resembling ependymal layer (less common than perivascular pseudorosettes)Peritumoral piloid gliosis, especially spinal tumors",
                    "sub_points": [
                      "Perivascular pseudorosettes",
                      "True rosettes, lumina, canals",
                      "Sheet-like growth pattern, epithelioid cells",
                      "Highly fibrillar areas, sometimes with few nuclei",
                      "Gemistocyte-like cells in fibrillar areas in some cases",
                      "Necrosis without palisading common, especially in PFNot in itself indicator of anaplasia",
                      "Not in itself indicator of anaplasia",
                      "Mostly sharp tumor border, occasional infiltrative edge",
                      "Hypercellular nodulesSome in otherwise low-grade or typical ependymomas with only moderately increased mitotic rateSome with increased atypia, high mitotic activity, and Ki-67 labeling, especially in PFSome suggest that presence of hypercellular nodules has limited effect on prognosis",
                      "Some in otherwise low-grade or typical ependymomas with only moderately increased mitotic rate",
                      "Some with increased atypia, high mitotic activity, and Ki-67 labeling, especially in PF",
                      "Some suggest that presence of hypercellular nodules has limited effect on prognosis",
                      "Cystic degeneration and associated linear vascular proliferationMost tumors that appear to harbor cysts radiologically show these featuresTelangiectatic vascular proliferation in cyst wall often misleads to high-grade diagnosis",
                      "Most tumors that appear to harbor cysts radiologically show these features",
                      "Telangiectatic vascular proliferation in cyst wall often misleads to high-grade diagnosis",
                      "Calcifications, mostly in PF and ST tumors",
                      "Cytoplasmic vacuolization, sometimes lipidized cells",
                      "Epithelial surfaces resembling ependymal layer (less common than perivascular pseudorosettes)",
                      "Peritumoral piloid gliosis, especially spinal tumors"
                    ]
                  },
                  {
                    "text": "Less common featuresHyalinized nodules in some intramedullary tumorsBone &/or cartilaginous metaplasia (rare)Neuronal differentiation, synaptophysin (+), nodules of neuronal differentiation (pale islands) similar to those of nodular/desmoplastic medulloblastoma (rare)Oligodendroglioma-like clear cells and branching vasculature in clear cell ependymomaSome tumor cells may harbor eosinophilic intracytoplasmic granulesGiant cells or cells with bizarre nucleiMelanotic differentiation",
                    "sub_points": [
                      "Hyalinized nodules in some intramedullary tumors",
                      "Bone &/or cartilaginous metaplasia (rare)",
                      "Neuronal differentiation, synaptophysin (+), nodules of neuronal differentiation (pale islands) similar to those of nodular/desmoplastic medulloblastoma (rare)",
                      "Oligodendroglioma-like clear cells and branching vasculature in clear cell ependymoma",
                      "Some tumor cells may harbor eosinophilic intracytoplasmic granules",
                      "Giant cells or cells with bizarre nuclei",
                      "Melanotic differentiation"
                    ]
                  },
                  {
                    "text": "Histologic patterns of interest (no longer listed as subtypes in CNS WHO 5th ed.)Clear cell ependymomaUsually STOligodendroglioma-like with perinuclear clearing and chicken-wire vasculatureRound or polygonal, grooved, and clefted nucleiPerivascular pseudorosettes; true rosettes may not be seenAssociation with aggressive behavior andZFTAfusionTanycytic ependymomaFascicular architectureLong, slender cellsRare perivascular pseudorosettes, no true rosettesCells with prominent cytoplasmic vacuolationPapillary ependymomaPapillary architecture with vascular coreSingle layer of cuboidal cells with smooth surfacesUnlike hobnail surfaces of choroid plexusCortical ependymomaPredominantly spindle cells, tanycytic-likeHistologic features overlap with angiocentric gliomaZFTAfusion (+) in some examplesGiant cell ependymomaDegenerative atypiaAlmost no perivascular pseudorosettes or epithelioid cellsMixed ependymal tumors (hybrid tumors)Subependymoma/ependymomaMyxopapillary ependymoma/classic cellular ependymomaMolecular features may be useful to differentiate",
                    "sub_points": [
                      "Clear cell ependymomaUsually STOligodendroglioma-like with perinuclear clearing and chicken-wire vasculatureRound or polygonal, grooved, and clefted nucleiPerivascular pseudorosettes; true rosettes may not be seenAssociation with aggressive behavior andZFTAfusion",
                      "Usually ST",
                      "Oligodendroglioma-like with perinuclear clearing and chicken-wire vasculature",
                      "Round or polygonal, grooved, and clefted nuclei",
                      "Perivascular pseudorosettes; true rosettes may not be seen",
                      "Association with aggressive behavior andZFTAfusion",
                      "Tanycytic ependymomaFascicular architectureLong, slender cellsRare perivascular pseudorosettes, no true rosettesCells with prominent cytoplasmic vacuolation",
                      "Fascicular architecture",
                      "Long, slender cells",
                      "Rare perivascular pseudorosettes, no true rosettes",
                      "Cells with prominent cytoplasmic vacuolation",
                      "Papillary ependymomaPapillary architecture with vascular coreSingle layer of cuboidal cells with smooth surfacesUnlike hobnail surfaces of choroid plexus",
                      "Papillary architecture with vascular core",
                      "Single layer of cuboidal cells with smooth surfacesUnlike hobnail surfaces of choroid plexus",
                      "Unlike hobnail surfaces of choroid plexus",
                      "Cortical ependymomaPredominantly spindle cells, tanycytic-likeHistologic features overlap with angiocentric gliomaZFTAfusion (+) in some examples",
                      "Predominantly spindle cells, tanycytic-like",
                      "Histologic features overlap with angiocentric glioma",
                      "ZFTAfusion (+) in some examples",
                      "Giant cell ependymomaDegenerative atypiaAlmost no perivascular pseudorosettes or epithelioid cells",
                      "Degenerative atypia",
                      "Almost no perivascular pseudorosettes or epithelioid cells",
                      "Mixed ependymal tumors (hybrid tumors)Subependymoma/ependymomaMyxopapillary ependymoma/classic cellular ependymomaMolecular features may be useful to differentiate",
                      "Subependymoma/ependymoma",
                      "Myxopapillary ependymoma/classic cellular ependymoma",
                      "Molecular features may be useful to differentiate"
                    ]
                  }
                ],
                "Grading": [
                  {
                    "text": "Criteria not clearly establishedArbitrary and subjective use of histologic features may have contributed to skepticism in histologic grading",
                    "sub_points": [
                      "Arbitrary and subjective use of histologic features may have contributed to skepticism in histologic grading"
                    ]
                  },
                  {
                    "text": "Mitotic rates < 5/10 HPF compatible with WHO grade 2Cut-off for WHO grade 3 is unclear in WHO classifications≥ 5/10 HPF or ≥ 10/10 HPF have been used",
                    "sub_points": [
                      "Cut-off for WHO grade 3 is unclear in WHO classifications",
                      "≥ 5/10 HPF or ≥ 10/10 HPF have been used"
                    ]
                  },
                  {
                    "text": "Typically, WHO grade 2 ependymomas do not haveConspicuous pleomorphism or nuclear anaplasiaVascular endothelial proliferation (predictor of recurrence)Palisading necrosis",
                    "sub_points": [
                      "Conspicuous pleomorphism or nuclear anaplasia",
                      "Vascular endothelial proliferation (predictor of recurrence)",
                      "Palisading necrosis"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Tissue fragments of cohesive groups or individual cells"
                  },
                  {
                    "text": "Most cells have well-defined cytoplasm and fibrillary processes"
                  },
                  {
                    "text": "Small, oval nuclei with punctate, salt and pepper-type chromatin"
                  },
                  {
                    "text": "Larger, rounder nuclei with clefts and grooves in clear cell type"
                  },
                  {
                    "text": "Nuclear atypia in proportion to anaplasia"
                  },
                  {
                    "text": "Nuclear pleomorphism (rare), particularly in giant cell ependymoma"
                  },
                  {
                    "text": "Some tumor cells have eosinophilic granules within their cytoplasm"
                  },
                  {
                    "text": "Rare signet ring type cells, especially in cortical ependymomas"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "GFAP(+)Processes more than cytoplasmUsually more GFAP(+) in perivascular pseudorosettes",
                    "sub_points": [
                      "Processes more than cytoplasm",
                      "Usually more GFAP(+) in perivascular pseudorosettes"
                    ]
                  },
                  {
                    "text": "Olig2 mostly (-) or rare (+) nuclei"
                  },
                  {
                    "text": "EMA(+)Surfaces, especially true rosettes, canals, papillaDot-like staining of microlumina",
                    "sub_points": [
                      "Surfaces, especially true rosettes, canals, papilla",
                      "Dot-like staining of microlumina"
                    ]
                  },
                  {
                    "text": "D2-40(+), diffuse or dot-like"
                  },
                  {
                    "text": "S100(+), diffuse and strong, nonspecific"
                  },
                  {
                    "text": "SOX10 is often (-) or only rare (+) nuclei"
                  },
                  {
                    "text": "CD56(+), throughout tumor and microlumina"
                  },
                  {
                    "text": "Keratin (CAM5.2) focal, sometimes diffuse and strong"
                  },
                  {
                    "text": "Synaptophysin focal or weak (+)Classic ependymoma, focal (some cases)Neuronal differentiation, medulloblastoma-like pale islands (rare)",
                    "sub_points": [
                      "Classic ependymoma, focal (some cases)",
                      "Neuronal differentiation, medulloblastoma-like pale islands (rare)"
                    ]
                  },
                  {
                    "text": "IDH1 R132H(-)"
                  },
                  {
                    "text": "Ki-67 variableOften high in pediatric and PF tumors, and low in adult spinal tumors",
                    "sub_points": [
                      "Often high in pediatric and PF tumors, and low in adult spinal tumors"
                    ]
                  },
                  {
                    "text": "L1CAM(+) in some, especially inZFTAfusion (+) tumorsBut not very specific, and molecular verification is needed",
                    "sub_points": [
                      "But not very specific, and molecular verification is needed"
                    ]
                  },
                  {
                    "text": "p65-RELA IHC(+), mostly inZFTAfusion (+) ST ependymoma"
                  },
                  {
                    "text": "Loss of H3K27me3 indicates PFA group and suggests more aggressive biologyRetained H3K27me3 nonspecific but seen in PFB",
                    "sub_points": [
                      "Retained H3K27me3 nonspecific but seen in PFB"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Molecular subtyping using epigenetic features (methylation profiles) of ependymomas accepted by CNS WHO 5th ed.Includes location and somewhat overlaps with existing histologic diagnoses (i.e., subependymoma, ependymoma, myxopapillary ependymoma) and genetic alterations (i.e., gene fusions or amplifications)",
                    "sub_points": [
                      "Includes location and somewhat overlaps with existing histologic diagnoses (i.e., subependymoma, ependymoma, myxopapillary ependymoma) and genetic alterations (i.e., gene fusions or amplifications)"
                    ]
                  },
                  {
                    "text": "Spinal ependymomaSpinal ependymoma,MYCNamplifiedSpinal ependymomaNF2mutations often associated with monosomy 22q",
                    "sub_points": [
                      "Spinal ependymoma,MYCNamplified",
                      "Spinal ependymomaNF2mutations often associated with monosomy 22q",
                      "NF2mutations often associated with monosomy 22q"
                    ]
                  },
                  {
                    "text": "PF ependymomaPFA ependymomaGlobal DNA hypomethylation and CpG island hypermethylation by methylation profilingEZHIP overexpression and H3K27me3 loss on IHCUsually no mutations and balanced genome~ 9%EZHIPand ~ 4% H3 K27M mutation, significance unknownFurther heterogeneity within PFA, significance unknownGain of 1q (25% of cases), may be associated with poor prognosisPFB ependymomaChromosomal instabilityMonosomy 22q and 6 and trisomy 18 most commonGain of 1q (18% of cases), may be associated with poor prognosisFurther subgroups (PFB1-5), significance unknownPF ependymomas, NOS or NEC",
                    "sub_points": [
                      "PFA ependymomaGlobal DNA hypomethylation and CpG island hypermethylation by methylation profilingEZHIP overexpression and H3K27me3 loss on IHCUsually no mutations and balanced genome~ 9%EZHIPand ~ 4% H3 K27M mutation, significance unknownFurther heterogeneity within PFA, significance unknownGain of 1q (25% of cases), may be associated with poor prognosis",
                      "Global DNA hypomethylation and CpG island hypermethylation by methylation profiling",
                      "EZHIP overexpression and H3K27me3 loss on IHC",
                      "Usually no mutations and balanced genome~ 9%EZHIPand ~ 4% H3 K27M mutation, significance unknown",
                      "~ 9%EZHIPand ~ 4% H3 K27M mutation, significance unknown",
                      "Further heterogeneity within PFA, significance unknown",
                      "Gain of 1q (25% of cases), may be associated with poor prognosis",
                      "PFB ependymomaChromosomal instabilityMonosomy 22q and 6 and trisomy 18 most commonGain of 1q (18% of cases), may be associated with poor prognosisFurther subgroups (PFB1-5), significance unknown",
                      "Chromosomal instability",
                      "Monosomy 22q and 6 and trisomy 18 most common",
                      "Gain of 1q (18% of cases), may be associated with poor prognosis",
                      "Further subgroups (PFB1-5), significance unknown",
                      "PF ependymomas, NOS or NEC"
                    ]
                  },
                  {
                    "text": "ST ependymomaST ependymoma,ZTFAfusion (+)ZFTA::RELAfusion causing NF-κB signaling activationZFTA(zinc finger translocation associated) = C11orf95 (chromosome 11 open reading frame 95)CDKN2Ahomozygous deletion, frequentST ependymoma,YAP1fusion (+)YAP1::MAMLD1fusion or other partnersST ependymomas, NOS or NEC",
                    "sub_points": [
                      "ST ependymoma,ZTFAfusion (+)ZFTA::RELAfusion causing NF-κB signaling activationZFTA(zinc finger translocation associated) = C11orf95 (chromosome 11 open reading frame 95)CDKN2Ahomozygous deletion, frequent",
                      "ZFTA::RELAfusion causing NF-κB signaling activation",
                      "ZFTA(zinc finger translocation associated) = C11orf95 (chromosome 11 open reading frame 95)",
                      "CDKN2Ahomozygous deletion, frequent",
                      "ST ependymoma,YAP1fusion (+)YAP1::MAMLD1fusion or other partners",
                      "YAP1::MAMLD1fusion or other partners",
                      "ST ependymomas, NOS or NEC"
                    ]
                  },
                  {
                    "text": "TERTpromoter mutations may identify ependymomas with aggressive behavior, but exact impact is not established yet"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Microlumina with microvilli"
                  },
                  {
                    "text": "Cilia and ciliary apparatus"
                  },
                  {
                    "text": "Runs of intermediate junctions, especially near microlumina"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Spinal Ependymoma": [
                  {
                    "text": "Diffuse astrocytomaNo perivascular pseudorosettesNo EMA(+), dot-like stainingOlig2(+)H3 K27M(+) or IDH1 R132H(+)",
                    "sub_points": [
                      "No perivascular pseudorosettes",
                      "No EMA(+), dot-like staining",
                      "Olig2(+)",
                      "H3 K27M(+) or IDH1 R132H(+)"
                    ]
                  },
                  {
                    "text": "Pilocytic (PA) and pilomyxoid astrocytoma (PMA)Loose, spongy architecture (PA)Piloid cells with Rosenthal fibers within tumor (PA)Piloid gliosis around ependymomaEosinophilic granular bodies (PA)Myxoid background (PMA)Olig2(+), SOX10(+), unlike ependymomaBRAFfusion or mutation",
                    "sub_points": [
                      "Loose, spongy architecture (PA)",
                      "Piloid cells with Rosenthal fibers within tumor (PA)Piloid gliosis around ependymoma",
                      "Piloid gliosis around ependymoma",
                      "Eosinophilic granular bodies (PA)",
                      "Myxoid background (PMA)",
                      "Olig2(+), SOX10(+), unlike ependymoma",
                      "BRAFfusion or mutation"
                    ]
                  },
                  {
                    "text": "SchwannomaAlmost always extraaxialMore intensely and extensively S100(+) (including nuclei) than tanycytic ependymomaLess intensely and diffusely GFAP(+) and EMA(-)Pericellular reticulin or collagen type IVDiffuse nuclear SOX10(+), unlike ependymoma",
                    "sub_points": [
                      "Almost always extraaxial",
                      "More intensely and extensively S100(+) (including nuclei) than tanycytic ependymoma",
                      "Less intensely and diffusely GFAP(+) and EMA(-)",
                      "Pericellular reticulin or collagen type IV",
                      "Diffuse nuclear SOX10(+), unlike ependymoma"
                    ]
                  },
                  {
                    "text": "MeningiomaExtraaxialWhorls and psammoma bodiesSSTR2A(+), EMA membranous (+)S100 patchy (20%), GFAP(-), unlike ependymoma",
                    "sub_points": [
                      "Extraaxial",
                      "Whorls and psammoma bodies",
                      "SSTR2A(+), EMA membranous (+)",
                      "S100 patchy (20%), GFAP(-), unlike ependymoma"
                    ]
                  },
                  {
                    "text": "HemangioblastomaLobular, sometimes vague, architectureNo perivascular pseudorosettesVacuolated (lipidized) tumor cellsInhibin-α (+), EMA(-)",
                    "sub_points": [
                      "Lobular, sometimes vague, architecture",
                      "No perivascular pseudorosettes",
                      "Vacuolated (lipidized) tumor cells",
                      "Inhibin-α (+), EMA(-)"
                    ]
                  }
                ],
                "Posterior Fossa and Supratentorial Ependymoma": [
                  {
                    "text": "AstroblastomaOverlap with ependymoma in some casesPerivascular, thick; unipolar process more epithelioidVascular hyalinizationRecent studies suggest many morphologic \"astroblastomas\" may belong to other entitiesDiagnosis of exclusion; careful work-up needed",
                    "sub_points": [
                      "Overlap with ependymoma in some cases",
                      "Perivascular, thick; unipolar process more epithelioid",
                      "Vascular hyalinization",
                      "Recent studies suggest many morphologic \"astroblastomas\" may belong to other entitiesDiagnosis of exclusion; careful work-up needed",
                      "Diagnosis of exclusion; careful work-up needed"
                    ]
                  },
                  {
                    "text": "Angiocentric gliomaOverlap with cortical ependymoma in some casesInfiltrative growth patternLongitudinal and radial orientation of perivascular cellsSubpial vertical palisading",
                    "sub_points": [
                      "Overlap with cortical ependymoma in some cases",
                      "Infiltrative growth pattern",
                      "Longitudinal and radial orientation of perivascular cells",
                      "Subpial vertical palisading"
                    ]
                  },
                  {
                    "text": "Oligodendroglioma (vs. clear cell ependymoma)Infiltrative; overruns normal brain elementsNo large clefted and grooved nucleiCodeletion of chromosomes 1p and 19q (adult cases)IDH1 R132H(+) and Olig2(+)",
                    "sub_points": [
                      "Infiltrative; overruns normal brain elements",
                      "No large clefted and grooved nuclei",
                      "Codeletion of chromosomes 1p and 19q (adult cases)",
                      "IDH1 R132H(+) and Olig2(+)"
                    ]
                  },
                  {
                    "text": "MedulloblastomaPerivascular pseudorosettes less prominentNeuroblastic (Homer Wright) rosettes (minority)No true rosettes or epithelial surfacesNodules (pale islands) in nodular desmoplastic typeSynaptophysin (+), EMA(-)",
                    "sub_points": [
                      "Perivascular pseudorosettes less prominent",
                      "Neuroblastic (Homer Wright) rosettes (minority)",
                      "No true rosettes or epithelial surfaces",
                      "Nodules (pale islands) in nodular desmoplastic type",
                      "Synaptophysin (+), EMA(-)"
                    ]
                  },
                  {
                    "text": "NeurocytomaCytologically monotonousFinely fibrillar areas of neuropilSynaptophysin (+), EMA(-)",
                    "sub_points": [
                      "Cytologically monotonous",
                      "Finely fibrillar areas of neuropil",
                      "Synaptophysin (+), EMA(-)"
                    ]
                  },
                  {
                    "text": "PA and PMA"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Tumor location, patient age, and radiologic features are often helpful to determine what ancillary tests, including molecular analyses, may be necessary in specific patients"
                  },
                  {
                    "text": "Rare pseudorosettes in otherwise diffuse glioma should not be mistaken for ependymoma"
                  },
                  {
                    "text": "Histologic grading is problematic in ependymomas, especially for uncommon subtypes and tumors with hypercellular nodules"
                  },
                  {
                    "text": "EM is helpful in problematic examples to establish ependymal lineage"
                  },
                  {
                    "text": "IHC studies should be conducted using wide panel that includes glial, neuronal, and epithelial markers for rare variants"
                  },
                  {
                    "text": "Consider L1CAM staining in all ST ependymomas in children with clear cell morphology to rule in/out ST ependymoma,ZFTAfusion (+)"
                  },
                  {
                    "text": "Molecular classification provides important subgroups"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Oligodendroglioma, IDH-Mutant and 1p/19q Codeleted, WHO Grade 2 or 3": {
            "name": "Oligodendroglioma, IDH-Mutant and 1p/19q Codeleted, WHO Grade 2 or 3",
            "url": "https://app.pathprimer.com/document/d091d5a9-ad01-4be9-9814-972df093bd55/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Diffusely infiltrating glioma withIDH1/IDH2mutation&codeletion of chromosomal arms 1p & 19q"
                  },
                  {
                    "text": "WHO grade 2 or 3"
                  },
                  {
                    "text": "WHO grade 3 if tumor hasMitoses ≥ 6/10 HPFormicrovascular proliferationornecrosisorCDKN2A/CDKN2Bhomozygous deletion",
                    "sub_points": [
                      "Mitoses ≥ 6/10 HPFormicrovascular proliferationornecrosisorCDKN2A/CDKN2Bhomozygous deletion"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Seizures, especially common given tumor's affinity for cerebral cortex"
                  },
                  {
                    "text": "Cerebral hemispheres, most often frontal lobe"
                  },
                  {
                    "text": "Prognosis better than IDH-mutant diffuse astrocytoma of equivalent grade"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Almost always supratentorial"
                  },
                  {
                    "text": "Thickened cortex"
                  },
                  {
                    "text": "Calcifications, especially gyriform, occasionally seen"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Infiltrating, with perineuronal satellitosis, perivascular & subpial tumor accumulations"
                  },
                  {
                    "text": "Water clear (fried egg appearance, perinuclear haloes)"
                  },
                  {
                    "text": "Generally round, monomorphous nuclei with delicate chromatin, small nucleoli"
                  },
                  {
                    "text": "Delicate, angulated (chicken-wire) capillaries"
                  },
                  {
                    "text": "Hypercellular nodules, even in WHO grade 2 tumors"
                  },
                  {
                    "text": "May have epithelioid, carcinoma-like appearance"
                  },
                  {
                    "text": "Neuronal differentiation, uncommonGanglion cells rarely tumoral, usually trapped neurons",
                    "sub_points": [
                      "Ganglion cells rarely tumoral, usually trapped neurons"
                    ]
                  },
                  {
                    "text": "Mesenchymal differentiation (oligosarcoma) (rare)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "By definition, all tumors harborIDH1/IDH2mutation & 1p/19q codeletionBalanced translocation, der(1;19)(q10;p10)",
                    "sub_points": [
                      "Balanced translocation, der(1;19)(q10;p10)"
                    ]
                  },
                  {
                    "text": "IDH1 R132H(+); ATRX-retained; p53 often not ↑"
                  },
                  {
                    "text": "GFAP(+) in subset of cellsShould not prompt diagnostic confusion, i.e., astrocytoma",
                    "sub_points": [
                      "Should not prompt diagnostic confusion, i.e., astrocytoma"
                    ]
                  },
                  {
                    "text": "Mutations inTERTpromoter,FUBP1,CIC,NOTCH1"
                  },
                  {
                    "text": "CDKN2A/CDKN2Bhomozygous deletion in WHO grade 3"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Diffusely infiltrating glioma withIDH1orIDH2mutation&codeletion of chromosomal arms 1p & 19q"
                  },
                  {
                    "text": "WHO grade 2 or 3, based on histologic & molecular criteria"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "1-1.5% of all brain tumors in USA"
                  },
                  {
                    "text": "Typically adult patients"
                  },
                  {
                    "text": "Median age at diagnosis41 years for WHO grade 247 years for WHO grade 3",
                    "sub_points": [
                      "41 years for WHO grade 2",
                      "47 years for WHO grade 3"
                    ]
                  },
                  {
                    "text": "Rare in children; usually late teens"
                  }
                ],
                "Site": [
                  {
                    "text": "Cerebral hemispheresMost often frontal lobe",
                    "sub_points": [
                      "Most often frontal lobe"
                    ]
                  },
                  {
                    "text": "Uncommon in deep gray matter, basal ganglia, & thalamus"
                  },
                  {
                    "text": "Posterior fossa or spinal cord (rare)"
                  },
                  {
                    "text": "Gliomatosis cerebri pattern (exceptional)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Seizures; common, given affinity of tumor for cerebral cortex"
                  },
                  {
                    "text": "Neurologic deficit depending on site"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Maximum safe resection"
                  },
                  {
                    "text": "Extent of resection correlates with better overall survival (OS) & progression-free survival (PFS)"
                  }
                ],
                "Adjuvant therapy": [
                  {
                    "text": "Usually reserved for progressive tumors, large residual tumors, & WHO grade 3 tumors"
                  },
                  {
                    "text": "In one trial, adjuvant radiotherapy improved PFS but not OS"
                  },
                  {
                    "text": "Adjuvant chemotherapy + radiation improved OS"
                  },
                  {
                    "text": "Chemotherapy, in some casesTemozolomideProcarbazine, nimustine/CCNU (lomustine), & vincristine (PAV/PCV, respectively)",
                    "sub_points": [
                      "Temozolomide",
                      "Procarbazine, nimustine/CCNU (lomustine), & vincristine (PAV/PCV, respectively)"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Variable, dependent in part on tumor grade, progression to anaplastic oligodendroglioma"
                  },
                  {
                    "text": "Years or decades with little growth in some cases"
                  },
                  {
                    "text": "Better than for IDH-mutant astrocytoma with equivalent grade"
                  },
                  {
                    "text": "Clinical features associated with worse prognosis: Older age, location other than frontal lobe, low Karnofsky score, residual tumor after surgery, enhancement on MR"
                  },
                  {
                    "text": "Histologic features associated with worse prognosisWHO grade, conflicting results but most studies incorporating molecular criteria still suggest differenceHigh mitotic count (≥ 6 mitoses per 10 HPF in one study)Microvascular proliferation &/or necrosis",
                    "sub_points": [
                      "WHO grade, conflicting results but most studies incorporating molecular criteria still suggest differenceHigh mitotic count (≥ 6 mitoses per 10 HPF in one study)Microvascular proliferation &/or necrosis",
                      "High mitotic count (≥ 6 mitoses per 10 HPF in one study)",
                      "Microvascular proliferation &/or necrosis"
                    ]
                  },
                  {
                    "text": "CDKN2A/CDKN2Bhomozygous deletion is associated with worse outcomePresence ofCDKN2A/CDKN2Bhomozygous deletion indicates WHO grade 3 tumorThis is changed from 2016 WHO classification",
                    "sub_points": [
                      "Presence ofCDKN2A/CDKN2Bhomozygous deletion indicates WHO grade 3 tumor",
                      "This is changed from 2016 WHO classification"
                    ]
                  },
                  {
                    "text": "TERTmutation is present in majority of oligodendrogliomas, but those that areTERTwildtype have significantly worse OS"
                  },
                  {
                    "text": "Notch pathway inactivation & PI3K pathway activation are associated with advanced disease"
                  },
                  {
                    "text": "Polysomy of 1p & 19q (leading to relative codeletion) is associated with earlier recurrence & shorter survival"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Indistinct borders"
                  },
                  {
                    "text": "Thickened cortex"
                  },
                  {
                    "text": "T1 hyperintense & T2 hyperintenseAlmost always heterogeneous in signal intensity",
                    "sub_points": [
                      "Almost always heterogeneous in signal intensity"
                    ]
                  },
                  {
                    "text": "Bright on FLAIR; variable mass effect"
                  },
                  {
                    "text": "Elevated 2-hydroxyglutarate levels by MR spectroscopy"
                  },
                  {
                    "text": "Contrast enhancementUsually absent in WHO grade 2 tumorsPresent, at least focally in > 70% of WHO grade 3 tumors",
                    "sub_points": [
                      "Usually absent in WHO grade 2 tumors",
                      "Present, at least focally in > 70% of WHO grade 3 tumors"
                    ]
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Hypo-/isodense mass in cortex & subcortical white matter"
                  },
                  {
                    "text": "Calcifications, especially gyriform"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Thickened cortex"
                  },
                  {
                    "text": "Ill-defined borders, blurring of gray-white junction"
                  },
                  {
                    "text": "Calcification, usually gritty, rarely massive"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Infiltrative of parenchyma"
                  },
                  {
                    "text": "Affinity for cerebral cortex"
                  },
                  {
                    "text": "Secondary structures: Perineuronal satellitosis, perivascular & subpial accumulation of tumor cells"
                  },
                  {
                    "text": "Occasional microcysts"
                  },
                  {
                    "text": "Usually monomorphic"
                  },
                  {
                    "text": "Variable cellularityVery low to high cellularity within same tumorHypercellular tumor nodules with ↑ mitoses even in WHO grade 2 tumorsPredominantly diffuse hypercellularity in WHO grade 3 tumors",
                    "sub_points": [
                      "Very low to high cellularity within same tumor",
                      "Hypercellular tumor nodules with ↑ mitoses even in WHO grade 2 tumors",
                      "Predominantly diffuse hypercellularity in WHO grade 3 tumors"
                    ]
                  },
                  {
                    "text": "CytoplasmWater clear (fried egg appearance)a.k.a. perinuclear haloesArtifact of formalin fixationAbsent in smears & frozen sectionsAlso absent on small biopsies (due to optimal fixation) or frozen section remnantsSharp cell borders when cells back-to-backGliofibrillary oligodendrocytesSmooth-contoured, wedge-shaped cells with apical hyaline or fibrillary inclusionMinigemistocytesSmall, gemistocyte-like cells with glassy, fibrillar cytoplasm & short processes\"Red crunchies\"Brightly eosinophilic, intracytoplasmic granulesSeldom in WHO grade 2, mainly in WHO grade 3Ultrastructural features of Rosenthal fibers &/or lysosomes",
                    "sub_points": [
                      "Water clear (fried egg appearance)a.k.a. perinuclear haloesArtifact of formalin fixationAbsent in smears & frozen sectionsAlso absent on small biopsies (due to optimal fixation) or frozen section remnants",
                      "a.k.a. perinuclear haloes",
                      "Artifact of formalin fixation",
                      "Absent in smears & frozen sections",
                      "Also absent on small biopsies (due to optimal fixation) or frozen section remnants",
                      "Sharp cell borders when cells back-to-back",
                      "Gliofibrillary oligodendrocytesSmooth-contoured, wedge-shaped cells with apical hyaline or fibrillary inclusion",
                      "Smooth-contoured, wedge-shaped cells with apical hyaline or fibrillary inclusion",
                      "MinigemistocytesSmall, gemistocyte-like cells with glassy, fibrillar cytoplasm & short processes",
                      "Small, gemistocyte-like cells with glassy, fibrillar cytoplasm & short processes",
                      "\"Red crunchies\"Brightly eosinophilic, intracytoplasmic granulesSeldom in WHO grade 2, mainly in WHO grade 3Ultrastructural features of Rosenthal fibers &/or lysosomes",
                      "Brightly eosinophilic, intracytoplasmic granules",
                      "Seldom in WHO grade 2, mainly in WHO grade 3",
                      "Ultrastructural features of Rosenthal fibers &/or lysosomes"
                    ]
                  },
                  {
                    "text": "NucleiGenerally round, monomorphousDelicate chromatin, small nucleoliHyperchromatic astrocytoma-like nuclei on frozen sections & on frozen section remnants",
                    "sub_points": [
                      "Generally round, monomorphous",
                      "Delicate chromatin, small nucleoli",
                      "Hyperchromatic astrocytoma-like nuclei on frozen sections & on frozen section remnants"
                    ]
                  },
                  {
                    "text": "CalcificationsUsually corticalDense, undulating gyriform pattern characteristicRarely, large amounts of calcification",
                    "sub_points": [
                      "Usually cortical",
                      "Dense, undulating gyriform pattern characteristic",
                      "Rarely, large amounts of calcification"
                    ]
                  },
                  {
                    "text": "VesselsDelicate, angulated (chicken-wire) capillariesAggregates of larger vessels uncommonMicrovascular proliferation in WHO grade 3",
                    "sub_points": [
                      "Delicate, angulated (chicken-wire) capillaries",
                      "Aggregates of larger vessels uncommon",
                      "Microvascular proliferation in WHO grade 3"
                    ]
                  },
                  {
                    "text": "Mitotic rateLow (< 6/10 HPF) in WHO grade 2High (≥ 6/10 HPF) in WHO grade 3",
                    "sub_points": [
                      "Low (< 6/10 HPF) in WHO grade 2",
                      "High (≥ 6/10 HPF) in WHO grade 3"
                    ]
                  },
                  {
                    "text": "Necrosis (in WHO grade 3)Seen in subset of WHO grade 3 casesOften little or no palisading",
                    "sub_points": [
                      "Seen in subset of WHO grade 3 cases",
                      "Often little or no palisading"
                    ]
                  },
                  {
                    "text": "Neuronal differentiation (uncommon)Neurocytes, sometimes delicate processes forming neuropilGanglion cells rarely tumoral, usually entrapped neuronsSynaptophysin immunopositivity in absence of histologic neuronal differentiation (more common)Primitive neuronal component (rarely in WHO grade 3)",
                    "sub_points": [
                      "Neurocytes, sometimes delicate processes forming neuropil",
                      "Ganglion cells rarely tumoral, usually entrapped neurons",
                      "Synaptophysin immunopositivity in absence of histologic neuronal differentiation (more common)",
                      "Primitive neuronal component (rarely in WHO grade 3)"
                    ]
                  },
                  {
                    "text": "Mesenchymal differentiation (oligosarcoma) (rare)Spindle cell component with reticulin-rich matrix",
                    "sub_points": [
                      "Spindle cell component with reticulin-rich matrix"
                    ]
                  },
                  {
                    "text": "Lobular neuroendocrine-like areas (rare)"
                  },
                  {
                    "text": "Focal spindled areas resembling astrocytomaHistologically mixed \"oligoastrocytomas\" show genetic signature of either astrocytoma or oligodendroglioma, not bothOnly rare, true dual-genotype IDH-mutant \"oligoastrocytoma\" exists with 2 different cell types forming single tumor mass; i.e., collision tumor or 2 different 2nd hits after IDH mutation",
                    "sub_points": [
                      "Histologically mixed \"oligoastrocytomas\" show genetic signature of either astrocytoma or oligodendroglioma, not both",
                      "Only rare, true dual-genotype IDH-mutant \"oligoastrocytoma\" exists with 2 different cell types forming single tumor mass; i.e., collision tumor or 2 different 2nd hits after IDH mutation"
                    ]
                  }
                ],
                "Grading": [
                  {
                    "text": "WHO grade 3 if ≥ 1 of following is present↑ mitotic activity (≥ 6/10 HPF)Microvascular proliferationNecrosisCDKN2A/CDKN2Bhomozygous deletion",
                    "sub_points": [
                      "↑ mitotic activity (≥ 6/10 HPF)",
                      "Microvascular proliferation",
                      "Necrosis",
                      "CDKN2A/CDKN2Bhomozygous deletion"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "NucleiGenerally round, delicate chromatin, small nucleoli, monomorphousOccasional overlap in degree of pleomorphism with astrocytomas of equivalent grade",
                    "sub_points": [
                      "Generally round, delicate chromatin, small nucleoli, monomorphous",
                      "Occasional overlap in degree of pleomorphism with astrocytomas of equivalent grade"
                    ]
                  },
                  {
                    "text": "CytoplasmUsually scant with few processesLittle fibrillar background in tissue aggregatesEosinophilic cytoplasm in minigemistocytes & gliofibrillary oligodendrocytes (more often in WHO grade 3)Intracytoplasmic, brightly eosinophilic, refractile bodies (more often in WHO grade 3)",
                    "sub_points": [
                      "Usually scant with few processes",
                      "Little fibrillar background in tissue aggregates",
                      "Eosinophilic cytoplasm in minigemistocytes & gliofibrillary oligodendrocytes (more often in WHO grade 3)",
                      "Intracytoplasmic, brightly eosinophilic, refractile bodies (more often in WHO grade 3)"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "IDH1 R132H mutation-specific IHC (+) in most casesNoncanonicalIDH1orIDH2mutations are rareHistologically similar pediatric oligodendroglioma cases lack adult molecular features; pediatric-type glioma may be more appropriate terminology&/or presence ofIDH1/IDH2mutation by molecular testing mandatory for diagnosis",
                    "sub_points": [
                      "NoncanonicalIDH1orIDH2mutations are rare",
                      "Histologically similar pediatric oligodendroglioma cases lack adult molecular features; pediatric-type glioma may be more appropriate terminology",
                      "&/or presence ofIDH1/IDH2mutation by molecular testing mandatory for diagnosis"
                    ]
                  },
                  {
                    "text": "ATRX-retained nuclear stainingContrasting with majority of IDH-mutant diffuse astrocytomas",
                    "sub_points": [
                      "Contrasting with majority of IDH-mutant diffuse astrocytomas"
                    ]
                  },
                  {
                    "text": "↑ p53 nuclear labeling, rareMore often in WHO grade 3 tumorsContrasting with strong p53 nuclear labeling in many astrocytomas, IDH-mutant, WHO grade 2 or 3",
                    "sub_points": [
                      "More often in WHO grade 3 tumors",
                      "Contrasting with strong p53 nuclear labeling in many astrocytomas, IDH-mutant, WHO grade 2 or 3"
                    ]
                  },
                  {
                    "text": "Ki-67 labeling indexLow in WHO grade 2, higher in WHO grade 3Exact cutoff not established due to interlaboratory/interobserver variability",
                    "sub_points": [
                      "Low in WHO grade 2, higher in WHO grade 3",
                      "Exact cutoff not established due to interlaboratory/interobserver variability"
                    ]
                  },
                  {
                    "text": "Olig2(+)"
                  },
                  {
                    "text": "GFAP variable, often (+) in subset of cellsCells with eosinophilic cytoplasm often (+)Minigemistocytes & gliofibrillary oligodendrogliaPresence of GFAP(+) cells should not prompt diagnosis of mixed oligoastrocytoma (diagnosis that essentially no longer exists)",
                    "sub_points": [
                      "Cells with eosinophilic cytoplasm often (+)Minigemistocytes & gliofibrillary oligodendroglia",
                      "Minigemistocytes & gliofibrillary oligodendroglia",
                      "Presence of GFAP(+) cells should not prompt diagnosis of mixed oligoastrocytoma (diagnosis that essentially no longer exists)"
                    ]
                  },
                  {
                    "text": "Synaptophysin (+)In areas of neurocytic differentiation, especially neuropilPatchy to diffuse without histologic evidence of neuronal differentiation (occasional)Strong synaptophysin &/or CD56 (+) can lead to diagnostic confusion",
                    "sub_points": [
                      "In areas of neurocytic differentiation, especially neuropil",
                      "Patchy to diffuse without histologic evidence of neuronal differentiation (occasional)",
                      "Strong synaptophysin &/or CD56 (+) can lead to diagnostic confusion"
                    ]
                  },
                  {
                    "text": "H3K27me3 nuclear staining lost in majority of cases; mechanism unknown"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "Codeletion of chromosomes 1p & 19qBeware false-positive codeletion in tumors without complete whole chromosome arm deletion of 1p & 19qFalse positivity seen especially in glioblastoma, IDH-wildtype, with interstitial deletions affecting regions of probe hybridization",
                    "sub_points": [
                      "Beware false-positive codeletion in tumors without complete whole chromosome arm deletion of 1p & 19q",
                      "False positivity seen especially in glioblastoma, IDH-wildtype, with interstitial deletions affecting regions of probe hybridization"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "IDH1orIDH2mutation in all cases"
                  },
                  {
                    "text": "1p/19q codeletionMandatory for diagnosis of oligodendroglioma, IDH-mutant & 1p/19q codeletedMaintained by balanced translocation, der(1;19)(q10;p10)Must involve whole short arm of chromosome 1 & whole long arm of chromosome 19Beware false-positive codeletion in tumors without complete whole chromosome arm deletion of 1p & 19q, especially when tested by FISHFalse positivity seen especially in glioblastoma, IDH-wildtype, with interstitial deletions affecting regions of probe hybridizationRelative codeletion (due to polysomy of 1p & 19q) has been associated with worse outcome",
                    "sub_points": [
                      "Mandatory for diagnosis of oligodendroglioma, IDH-mutant & 1p/19q codeleted",
                      "Maintained by balanced translocation, der(1;19)(q10;p10)",
                      "Must involve whole short arm of chromosome 1 & whole long arm of chromosome 19Beware false-positive codeletion in tumors without complete whole chromosome arm deletion of 1p & 19q, especially when tested by FISHFalse positivity seen especially in glioblastoma, IDH-wildtype, with interstitial deletions affecting regions of probe hybridization",
                      "Beware false-positive codeletion in tumors without complete whole chromosome arm deletion of 1p & 19q, especially when tested by FISH",
                      "False positivity seen especially in glioblastoma, IDH-wildtype, with interstitial deletions affecting regions of probe hybridization",
                      "Relative codeletion (due to polysomy of 1p & 19q) has been associated with worse outcome"
                    ]
                  },
                  {
                    "text": "CIC,FUBP1mutations frequent: Loss of protein expression may have prognostic implicationsFUBP1on chromosome 1p,CICon chromosome 19q",
                    "sub_points": [
                      "FUBP1on chromosome 1p,CICon chromosome 19q"
                    ]
                  },
                  {
                    "text": "TERTpromoter mutations frequent (98%)Associated with ↑ expression of telomerase",
                    "sub_points": [
                      "Associated with ↑ expression of telomerase"
                    ]
                  },
                  {
                    "text": "PIK3CA,PIK3R1,NOTCH1mutationsAssociated with advanced disease in some studies",
                    "sub_points": [
                      "Associated with advanced disease in some studies"
                    ]
                  },
                  {
                    "text": "CDKN2A/CDKN2Bhomozygous deletionPresent only in minority of cases previously called WHO grade 2According to CNS WHO Classification: Assessment of this marker may not be routinely required in tumors that can histologically be unequivocally assigned to either WHO grade 2 or WHO grade 3, testing for homozygous deletion may be helpful in tumors with borderline histologic features, i.e., when present indicates WHO grade 3 tumorDistinction of homozygous vs. hemizygous deletion is difficult on FISH testing due to probe size",
                    "sub_points": [
                      "Present only in minority of cases previously called WHO grade 2",
                      "According to CNS WHO Classification: Assessment of this marker may not be routinely required in tumors that can histologically be unequivocally assigned to either WHO grade 2 or WHO grade 3, testing for homozygous deletion may be helpful in tumors with borderline histologic features, i.e., when present indicates WHO grade 3 tumor",
                      "Distinction of homozygous vs. hemizygous deletion is difficult on FISH testing due to probe size"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Astrocytoma, IDH-Mutant, WHO Grade 2 or 3": [
                  {
                    "text": "Irregular cell distribution; variably variable"
                  },
                  {
                    "text": "Greater nuclear pleomorphism, angulationHyperchromatic nuclei, inconspicuous nucleoli",
                    "sub_points": [
                      "Hyperchromatic nuclei, inconspicuous nucleoli"
                    ]
                  },
                  {
                    "text": "Fibrillar background (some cases)"
                  },
                  {
                    "text": "Loss of nuclear ATRX expression"
                  },
                  {
                    "text": "Presence of ↑ nuclear p53 immunostaining, (less common in oligodendroglioma, IDH-mutant & 1p/19q codeleted)"
                  },
                  {
                    "text": "No 1p/19q whole arm codeletion"
                  }
                ],
                "Glioblastoma, IDH-Wildtype (Small Cell Subtype)": [
                  {
                    "text": "Also show relative nuclear monotony, scant cytoplasm, chicken-wire vasculature, occasional calcifications, cortical involvement"
                  },
                  {
                    "text": "Greater nuclear pleomorphism, angulation"
                  },
                  {
                    "text": "Negative forIDH1/IDH2mutation & no 1p/19 codeletion"
                  },
                  {
                    "text": "Cannot use retention of nuclear ATRX to distinguish since both show this feature"
                  }
                ],
                "Glioblastoma, IDH-Wildtype WithFGFR3::TACC3Fusion": [
                  {
                    "text": "Also show nuclear monotony, arcuate vessels, occasional calcifications"
                  },
                  {
                    "text": "Typically CD34(+)"
                  },
                  {
                    "text": "Negative forIDH1/IDH2mutation & no 1p/19 codeletion"
                  },
                  {
                    "text": "FGFR3::TACC3fusion"
                  }
                ],
                "Dysembryoplastic Neuroepithelial Tumor": [
                  {
                    "text": "May be difficult to distinguish, especially in small, fragmented specimens"
                  },
                  {
                    "text": "Largely cortical with nodular architecture"
                  },
                  {
                    "text": "Floating neurons; little or no perineuronal satellitosis"
                  },
                  {
                    "text": "Internodular specific glioneuronal element"
                  },
                  {
                    "text": "Negative forIDH1/IDH2mutation & no 1p/19 codeletion"
                  },
                  {
                    "text": "FGFR1alterations frequent, rarelyBRAFV600E"
                  }
                ],
                "Polymorphous Low-Grade Neuroepithelial Tumor of the Young": [
                  {
                    "text": "CD34(+), diffuse pericellular"
                  },
                  {
                    "text": "(-) forIDH1/IDH2mutation & no 1p/19 codeletion"
                  },
                  {
                    "text": "FGFR2fusions or other MAPK pathway alterations"
                  }
                ],
                "Neurocytic Tumors (Central or Extraventricular)": [
                  {
                    "text": "Little or no infiltration"
                  },
                  {
                    "text": "Finely fibrillar neuropil & neurocytic rosettes (only occasionally in oligodendrogliomas)"
                  },
                  {
                    "text": "Diffuse immunoreactivity for synaptophysin"
                  },
                  {
                    "text": "Olig2(-) or only very focally (+)"
                  },
                  {
                    "text": "(-) forIDH1/IDH12mutation & no 1p/19 codeletion"
                  }
                ],
                "Ependymoma (Clear Cell Morphology)": [
                  {
                    "text": "Compact architecture, no trapped brain elements except in periphery"
                  },
                  {
                    "text": "Perivascular pseudorosettesMay be small & are GFAP(+)",
                    "sub_points": [
                      "May be small & are GFAP(+)"
                    ]
                  },
                  {
                    "text": "Grooved or clefted nuclei"
                  },
                  {
                    "text": "EMA(+), dot-like, staining microlumina, some cases"
                  },
                  {
                    "text": "Olig2(-) or only very focally (+)"
                  },
                  {
                    "text": "(-) forIDH1/IDH2mutation & no 1p/19 codeletion"
                  },
                  {
                    "text": "Significant percentage haveZFTAfusion"
                  }
                ],
                "Macrophage-Rich Lesions": [
                  {
                    "text": "Demyelinating diseaseImaging, open ring pattern of enhancementSharp borderPerivascular chronic inflammationMacrophagesFoamy or granular, non-water-clear cytoplasmPAS(+), CD68(+), HAM65(+)Olig2(-) & IDH1 R312H(-)Multinucleated astrocytes (Creutzfeldt cells)",
                    "sub_points": [
                      "Imaging, open ring pattern of enhancement",
                      "Sharp border",
                      "Perivascular chronic inflammation",
                      "MacrophagesFoamy or granular, non-water-clear cytoplasmPAS(+), CD68(+), HAM65(+)Olig2(-) & IDH1 R312H(-)",
                      "Foamy or granular, non-water-clear cytoplasm",
                      "PAS(+), CD68(+), HAM65(+)",
                      "Olig2(-) & IDH1 R312H(-)",
                      "Multinucleated astrocytes (Creutzfeldt cells)"
                    ]
                  },
                  {
                    "text": "InfarctLoss of axonsMacrophagesFoamy or granular, not water-clearPAS(+), CD68(+), HAM56(+), IDH1 R132H(-)Ischemic red-dead neurons in acute phaseEndothelial cell hypertrophy & hyperplasia",
                    "sub_points": [
                      "Loss of axons",
                      "MacrophagesFoamy or granular, not water-clearPAS(+), CD68(+), HAM56(+), IDH1 R132H(-)",
                      "Foamy or granular, not water-clear",
                      "PAS(+), CD68(+), HAM56(+), IDH1 R132H(-)",
                      "Ischemic red-dead neurons in acute phase",
                      "Endothelial cell hypertrophy & hyperplasia"
                    ]
                  }
                ],
                "Primary CNS Lymphoma": [
                  {
                    "text": "Vesicular chromatin with nucleoli"
                  },
                  {
                    "text": "Angiocentricity"
                  },
                  {
                    "text": "Lack of chicken-wire vasculature"
                  },
                  {
                    "text": "Lymphoid markers (+), Olig2(-)"
                  }
                ],
                "Metastatic Neoplasms": [
                  {
                    "text": "Epithelial tumors with small uniform nucleii.e., adenocarcinomas of breast & gastric primaryi.e., neuroendocrine tumors",
                    "sub_points": [
                      "i.e., adenocarcinomas of breast & gastric primary",
                      "i.e., neuroendocrine tumors"
                    ]
                  },
                  {
                    "text": "Melanoma"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Seizures especially common given tumor's affinity for cerebral cortex"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "IDH1 R132H IHC(+) (orIDH1/IDH2mutational testing) & codeletion of 1p & 19q required for diagnosisFalse-positives for 1p/19q codeletion can occur, especially in glioblastoma, sometimes due to small interstitial deletions at site of probe hybridization",
                    "sub_points": [
                      "False-positives for 1p/19q codeletion can occur, especially in glioblastoma, sometimes due to small interstitial deletions at site of probe hybridization"
                    ]
                  },
                  {
                    "text": "IHC phenotype of IDH1 R132H IHC(+) with nuclear ATRX retention, minimal nuclear p53(+) strongly suggestive of oligodendroglial lineageOccasional tumors may showTP53mutations",
                    "sub_points": [
                      "Occasional tumors may showTP53mutations"
                    ]
                  },
                  {
                    "text": "Absence of perinuclear haloes or presence of astrocytoma-like areas histologically does not preclude diagnosis"
                  },
                  {
                    "text": "Haloes are especially likely to be absent in frozen sections & small, well-fixed biopsies"
                  },
                  {
                    "text": "Only rare, true dual-genotype IDH-mutant oligoastrocytoma exists with 2 different cell types forming single mass"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Subependymoma": {
            "name": "Subependymoma",
            "url": "https://app.pathprimer.com/document/23a167b8-6392-4e7f-bffc-f14b30381491/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Discrete, lobulated paucicellular glial tumor with rich fibrillar matrix"
                  },
                  {
                    "text": "WHO grade 1"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "More common in lateral and 4th ventricle"
                  },
                  {
                    "text": "Mostly middle-aged adults"
                  },
                  {
                    "text": "Well circumscribed; total excision possible in many cases"
                  },
                  {
                    "text": "Excellent prognosis after gross total resection"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Sharply demarcated T2 hyperintense and minimal or no enhancement"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Nuclear clustering, bland nuclei"
                  },
                  {
                    "text": "Densely fibrillar, paucicellular background"
                  },
                  {
                    "text": "Microcysts, especially when near foramen of Monro"
                  },
                  {
                    "text": "Subtle pseudorosettes, nodular architecture"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Smears often only tissue fragments with fine processes"
                  },
                  {
                    "text": "Dot-like EMA(+) microlumina, some cases, GFAP(+)"
                  },
                  {
                    "text": "Ki-67 typically low but can be variable; significance of higher rate unclear"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Ependymoma"
                  },
                  {
                    "text": "Subependymal giant cell astrocytoma"
                  },
                  {
                    "text": "Diffuse astrocytoma"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "More microcysts in examples near foramen of Monro"
                  },
                  {
                    "text": "More clustering of nuclei in examples away from foramen of Monro"
                  },
                  {
                    "text": "Occasional examples with mixed subependymoma + ependymoma components"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Discrete, paucicellular glial neoplasm with clustered nuclei with abundant fibrillary matrix"
                  },
                  {
                    "text": "WHO grade 1"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Mostly middle-aged adults, rare in children"
                  }
                ],
                "Site": [
                  {
                    "text": "IntraventricularLateral and 4th ventricle more common",
                    "sub_points": [
                      "Lateral and 4th ventricle more common"
                    ]
                  },
                  {
                    "text": "IntraparenchymalSpinal cord; cerebral hemisphere, sometimes superficial and remote from ventriclesSome intraspinal subependymomas may extend along multiple levels and rarely involve entire cord",
                    "sub_points": [
                      "Spinal cord; cerebral hemisphere, sometimes superficial and remote from ventricles",
                      "Some intraspinal subependymomas may extend along multiple levels and rarely involve entire cord"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Obstructive hydrocephalus with lesions at foramen of Monro or 4th ventricle"
                  },
                  {
                    "text": "Pain, motor and sensory deficits with lesions of spinal cord"
                  },
                  {
                    "text": "Other expressions, including seizures with supratentorial intraparenchymal lesions"
                  },
                  {
                    "text": "Acute deficit, some cases, precipitated by intraventricular hemorrhage in large tumor near foramen of Monro"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Well circumscribed; total excision possible in many cases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Good; cure expected with gross total resection"
                  },
                  {
                    "text": "Rare examples of mixed subependymoma/ependymoma may be less favorable, data insufficient for conclusive statement"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Any location but most often on medulla, near foramen of Monro, or in spinal cord"
                  },
                  {
                    "text": "Well circumscribed"
                  },
                  {
                    "text": "Bright in T2W and FLAIR images"
                  },
                  {
                    "text": "Often little, if any, enhancement; exception to rule is discrete CNS tumor enhancement"
                  },
                  {
                    "text": "May be calcified, especially on medulla"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Well circumscribed; color similar to gray matter"
                  },
                  {
                    "text": "Lobulated, especially on medulla"
                  },
                  {
                    "text": "Gritty when densely calcified"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Finely fibrillar, paucicellular background"
                  },
                  {
                    "text": "Small, uniform, cytologically bland nuclei"
                  },
                  {
                    "text": "Nuclear clustering, variableLess prominent at foramen of Monro",
                    "sub_points": [
                      "Less prominent at foramen of Monro"
                    ]
                  },
                  {
                    "text": "Microcysts, variableMore prominent at foramen of MonroSome tumors may have extensive microcystic change",
                    "sub_points": [
                      "More prominent at foramen of Monro",
                      "Some tumors may have extensive microcystic change"
                    ]
                  },
                  {
                    "text": "Calcifications, variableMore common outside of foramen of Monro",
                    "sub_points": [
                      "More common outside of foramen of Monro"
                    ]
                  },
                  {
                    "text": "Subtle or no perivascular pseudorosettes"
                  },
                  {
                    "text": "Rarely mixed subependymoma and ependymoma morphologyUsually 4th ventricle and spinal cordGrade according to ependymoma component, but exact amount of latter in tumor necessary to be designated \"mixed\" is not specified",
                    "sub_points": [
                      "Usually 4th ventricle and spinal cord",
                      "Grade according to ependymoma component, but exact amount of latter in tumor necessary to be designated \"mixed\" is not specified"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Smears poorly, often only tissue fragments, with fine processes"
                  },
                  {
                    "text": "Finely fibrillar background and bland, ependymoma-like nuclei"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Diffusely GFAP(+)"
                  },
                  {
                    "text": "Dot-like EMA(+) microlumina, some cases"
                  },
                  {
                    "text": "Olig2 can be focally (+), somewhat different compared to typical ependymomas"
                  },
                  {
                    "text": "Ki-67, variable; significance of higher rate unclear"
                  },
                  {
                    "text": "Neurofilament protein (-); no evidence of infiltrative pattern"
                  },
                  {
                    "text": "IDH1 R132H(-), BRAF V600E(-)"
                  },
                  {
                    "text": "Rare tumors with nuclear H3 K27M(+)"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Some subependymomas were reported to haveTRPS1mutations on chromosome 8q24.12"
                  },
                  {
                    "text": "Methylation profiling studies found subependymoma profile in all CNS compartments, which may be useful in exceptional cases"
                  },
                  {
                    "text": "Rare examples harbor H3 K27M mutations"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Ependymoma": [
                  {
                    "text": "Uniform medium to high cellularity"
                  },
                  {
                    "text": "Perivascular pseudorosettes"
                  },
                  {
                    "text": "True rosettes, some cases"
                  },
                  {
                    "text": "Few microcysts, if any"
                  },
                  {
                    "text": "No nuclear clustering, except for combined ependymoma-subependymoma (usually 4th ventricular)"
                  },
                  {
                    "text": "Tanycytic type more fascicular than clustered"
                  }
                ],
                "Subependymal Giant Cell Astrocytoma": [
                  {
                    "text": "More cellular, compact, back-to-back large gemistocyte-like cells"
                  },
                  {
                    "text": "Large astrocytes and ganglion-like cells"
                  },
                  {
                    "text": "Immunostaining for GFAP, neurofilament protein, and synaptophysin"
                  },
                  {
                    "text": "Some patients with tuberous sclerosis complex"
                  }
                ],
                "Pilocytic Astrocytoma": [
                  {
                    "text": "Smears readily (pilocytes)"
                  },
                  {
                    "text": "More spongy, less fibrillar tissue"
                  },
                  {
                    "text": "Eosinophilic granular bodies and Rosenthal fibers"
                  }
                ],
                "Central Neurocytoma": [
                  {
                    "text": "Uniform high cellularity"
                  },
                  {
                    "text": "Synaptophysin (+), GFAP(-)"
                  },
                  {
                    "text": "Smears well; many markedly uniform cells with little cytoplasm"
                  },
                  {
                    "text": "Oligodendroglioma-like, neuropil background"
                  }
                ],
                "Infiltrating (Diffuse) Astrocytoma": [
                  {
                    "text": "Infiltrating growth pattern"
                  },
                  {
                    "text": "Little nuclear clustering"
                  },
                  {
                    "text": "No pseudorosettes"
                  },
                  {
                    "text": "EMA(-), IDH1 R132H(+), p53(+), loss of ATRX"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Well-circumscribed glioma, paucicellular, rich fibrillary matrix"
                  },
                  {
                    "text": "Slow growing, WHO Grade 1"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Lack of conspicuous atypia and absent or rare mitoses"
                  },
                  {
                    "text": "More microcysts in examples at foramen of Monro"
                  },
                  {
                    "text": "More clustering of nuclei in examples away from foramen of Monro"
                  },
                  {
                    "text": "Occasional cases with both subependymoma and ependymoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pleomorphic Xanthoastrocytoma": {
            "name": "Pleomorphic Xanthoastrocytoma",
            "url": "https://app.pathprimer.com/document/efcbec84-ee96-4f4d-85ad-9a1cc3672af0/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Pleomorphic, but generally low-grade, reticulin-rich astrocytoma with giant cells, lipidized cells, and spindle cells"
                  },
                  {
                    "text": "Can be WHO grade 2 or 3"
                  },
                  {
                    "text": "Typically showsBRAFmutation andCDKN2A/CDKN2Bdeletion"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Seen in children and young adults, often with seizures"
                  },
                  {
                    "text": "Generally good prognosis when superficial, cystic, and totally excised"
                  },
                  {
                    "text": "Less favorable prognosis with subtotal resection &/or features of anaplasia"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Usually superficial, discrete"
                  },
                  {
                    "text": "Enhancing, sometimes as mural nodule"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Solid component largely in subarachnoid space withPleomorphism and giant cellsEosinophilic granular bodies (EGBs)Large lipidized cellsFascicular architecture",
                    "sub_points": [
                      "Pleomorphism and giant cells",
                      "Eosinophilic granular bodies (EGBs)",
                      "Large lipidized cells",
                      "Fascicular architecture"
                    ]
                  },
                  {
                    "text": "Intracortical infiltrating component"
                  },
                  {
                    "text": "WHO grade 3 criterionIncreased mitotic rate ≥ 5 per 10 HPF",
                    "sub_points": [
                      "Increased mitotic rate ≥ 5 per 10 HPF"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PAS(+) EGBs"
                  },
                  {
                    "text": "Reticulin &/or collagen IV around individual cells or small groups of cells"
                  },
                  {
                    "text": "BRAFV600E mutation andCDKN2A/CDKN2BdeletionSurrogate IHC: BRAF VE1(+) and p16 loss",
                    "sub_points": [
                      "Surrogate IHC: BRAF VE1(+) and p16 loss"
                    ]
                  },
                  {
                    "text": "TERTalterationsMore common in grade 3 tumors",
                    "sub_points": [
                      "More common in grade 3 tumors"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Diagnose with caution in absence of EGBs"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Pleomorphic xanthoastrocytoma (PXA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Astrocytic neoplasm characterized by pleomorphic, multinucleated, and lipidized tumor cells, eosinophilic granular bodies (EGBs), abundant reticulin deposition, and harboringBRAFmutations andCDKN2A/CDKN2Bhomozygous deletion"
                  },
                  {
                    "text": "PXA can be WHO grade 2 or 3"
                  },
                  {
                    "text": "Typically in children and young adults, relatively favorable prognosis compared to diffuse gliomas"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Typically in children and young adults"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Seizures"
                  },
                  {
                    "text": "Motor and sensory disturbance for spinal tumors"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Gross total resection"
                  },
                  {
                    "text": "Recurrent tumors may undergo multiple resections"
                  }
                ],
                "Drugs": [
                  {
                    "text": "BRAFantagonists (e.g., vemurafenib) used successfully"
                  }
                ],
                "Radiation": [
                  {
                    "text": "For cases with anaplastic features (WHO grade 3) and unresectable, disseminated tumors"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "VariableGenerally good for superficial, cystic, gross, totally resected, WHO grade 2 tumorsGross total resection associated with longer recurrence-free survivalLess favorable when subtotally resected &/or multifocalPXA WHO grade 3 is clinically aggressiveNo significant differences in recurrence-free survival and overall survival between children and adults",
                    "sub_points": [
                      "Generally good for superficial, cystic, gross, totally resected, WHO grade 2 tumors",
                      "Gross total resection associated with longer recurrence-free survival",
                      "Less favorable when subtotally resected &/or multifocalPXA WHO grade 3 is clinically aggressive",
                      "PXA WHO grade 3 is clinically aggressive",
                      "No significant differences in recurrence-free survival and overall survival between children and adults"
                    ]
                  },
                  {
                    "text": "BRAFmutation opens possibility of targeted drug therapyMore data are needed to know impact ofBRAFmutation on prognosisBRAFmutation rate not significantly different between pediatric and adult patients",
                    "sub_points": [
                      "More data are needed to know impact ofBRAFmutation on prognosis",
                      "BRAFmutation rate not significantly different between pediatric and adult patients"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Generally in cerebral hemispheresClassically in temporal lobeUsually superficially located",
                    "sub_points": [
                      "Classically in temporal lobe",
                      "Usually superficially located"
                    ]
                  },
                  {
                    "text": "Discrete, enhancing, sometimes as mural nodule"
                  },
                  {
                    "text": "Cystic in ~ 50% of cases"
                  },
                  {
                    "text": "WHO grade 3 tumors may have more aggressive features"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Generally discreteLeptomeningeal component may present",
                    "sub_points": [
                      "Leptomeningeal component may present"
                    ]
                  },
                  {
                    "text": "Cystic in ~ 50% of cases"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Solid componentFascicular architectureNested architecture, some casesPleomorphic and giant cellsLarge lipidized cellsThey may be scanty or absentEGBsPericellular reticulin around individual cells or cell clustersLeptomeningeal tumor spread, may appear solidPerivascular lymphocytesGanglion cell-like component, minority of casesMelanotic tumor cells, rareMay harbor epithelioid cellsRosenthal fibers may be present but distinctly rare within tumor",
                    "sub_points": [
                      "Fascicular architecture",
                      "Nested architecture, some cases",
                      "Pleomorphic and giant cells",
                      "Large lipidized cellsThey may be scanty or absent",
                      "They may be scanty or absent",
                      "EGBs",
                      "Pericellular reticulin around individual cells or cell clusters",
                      "Leptomeningeal tumor spread, may appear solid",
                      "Perivascular lymphocytes",
                      "Ganglion cell-like component, minority of cases",
                      "Melanotic tumor cells, rare",
                      "May harbor epithelioid cells",
                      "Rosenthal fibers may be present but distinctly rare within tumor"
                    ]
                  },
                  {
                    "text": "Intracortical componentInfiltrative growthMay mimic diffuse astrocytomaCalcifications, some cases",
                    "sub_points": [
                      "Infiltrative growthMay mimic diffuse astrocytoma",
                      "May mimic diffuse astrocytoma",
                      "Calcifications, some cases"
                    ]
                  }
                ],
                "Grading": [
                  {
                    "text": "Tumors with increased mitoses are considered WHO grade 3≥ 5 per 10 HPF (~ 2 mm²)",
                    "sub_points": [
                      "≥ 5 per 10 HPF (~ 2 mm²)"
                    ]
                  },
                  {
                    "text": "Anaplastic features may be de novo or seen at recurrence"
                  },
                  {
                    "text": "Independent prognostic role of other features are not yet well established, but high-grade tumors often showHigher cellularity and less pleomorphismMore epithelioid and less elongated cells than classic grade 2Rhabdoid cell componentVascular proliferationNecrosis, including palisading necrosis",
                    "sub_points": [
                      "Higher cellularity and less pleomorphism",
                      "More epithelioid and less elongated cells than classic grade 2",
                      "Rhabdoid cell component",
                      "Vascular proliferation",
                      "Necrosis, including palisading necrosis"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Tissue fragments and individual cells"
                  },
                  {
                    "text": "Eosinophilic glassy cytoplasm and large processes"
                  },
                  {
                    "text": "Nuclear pleomorphism"
                  },
                  {
                    "text": "EGBs"
                  },
                  {
                    "text": "Fibrillary, glial background"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "Reticulin around individual or small groups of cells"
                  },
                  {
                    "text": "PAS(+) EGBs"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "GFAP(+), usually some cells, but not all"
                  },
                  {
                    "text": "S100(+), usually diffuse"
                  },
                  {
                    "text": "Olig2(+) in small glial cells"
                  },
                  {
                    "text": "Synaptophysin (+/-)Neuronal component, if anySome cells (+) with both GFAP and synaptophysin",
                    "sub_points": [
                      "Neuronal component, if any",
                      "Some cells (+) with both GFAP and synaptophysin"
                    ]
                  },
                  {
                    "text": "Neurofilament typically (-)Individual cells and rare clusters may be (+)",
                    "sub_points": [
                      "Individual cells and rare clusters may be (+)"
                    ]
                  },
                  {
                    "text": "CD34(+/-), variable"
                  },
                  {
                    "text": "Collagen IV around individual or small groups of cells"
                  },
                  {
                    "text": "Ki-67, variable depending on degree of anaplasiaTypically < 1% in grade 2 casesMean Ki-67 index of 15% in grade 3 cases",
                    "sub_points": [
                      "Typically < 1% in grade 2 cases",
                      "Mean Ki-67 index of 15% in grade 3 cases"
                    ]
                  },
                  {
                    "text": "BRAF VE1 IHC (+) in ~ 60% of cases"
                  },
                  {
                    "text": "Loss of p16 staining may be useful (as surrogate forCDNK2A/CDNK2Bdeletion)"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "BRAFV600E mutation in 60-80% of tumors~ 50% of WHO grade 3 PXA",
                    "sub_points": [
                      "~ 50% of WHO grade 3 PXA"
                    ]
                  },
                  {
                    "text": "CDKN2A/CDNK2Bdeletion~ 95% of cases, usually homozygous deletionFrequent loss of chromosome 9",
                    "sub_points": [
                      "~ 95% of cases, usually homozygous deletion",
                      "Frequent loss of chromosome 9"
                    ]
                  },
                  {
                    "text": "TERTpromoter mutation orTERTamplificationMore common in grade 3 tumors",
                    "sub_points": [
                      "More common in grade 3 tumors"
                    ]
                  },
                  {
                    "text": "Low incidence ofTP53mutations"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Glioblastoma, Epithelioid Subtype": [
                  {
                    "text": "More infiltrative, usually not compact"
                  },
                  {
                    "text": "Usually not with fascicular architecture"
                  },
                  {
                    "text": "Uniform, smaller, rounded &/or rhabdoid cells"
                  },
                  {
                    "text": "Less pleomorphismGiant cells and lipidized cells are exceptional",
                    "sub_points": [
                      "Giant cells and lipidized cells are exceptional"
                    ]
                  },
                  {
                    "text": "Molecular features significantly overlap with grade 3 PXAMay be indistinguishable in some cases",
                    "sub_points": [
                      "May be indistinguishable in some cases"
                    ]
                  }
                ],
                "Glioblastoma, Giant Cell Subtype": [
                  {
                    "text": "Also compact and rich in reticulin"
                  },
                  {
                    "text": "Usually not with fascicular architecture"
                  },
                  {
                    "text": "More pleomorphic, bizarre giant cells"
                  },
                  {
                    "text": "Few, if any, EGBs"
                  },
                  {
                    "text": "Different genetic profilesEGFRamplification, monosomy 10 and polysomy 7FrequentTP53mutationsIDH1/IDH2mutations, less common",
                    "sub_points": [
                      "EGFRamplification, monosomy 10 and polysomy 7",
                      "FrequentTP53mutations",
                      "IDH1/IDH2mutations, less common"
                    ]
                  },
                  {
                    "text": "May be associated with germline or acquired mutations inPOLEor DNA mismatch repair genes"
                  }
                ],
                "Ganglion Cell Tumor": [
                  {
                    "text": "Dysmorphic ganglion cells"
                  },
                  {
                    "text": "Nonpleomorphic glial component (ganglioglioma)"
                  },
                  {
                    "text": "Microcysts, some cases"
                  },
                  {
                    "text": "Lipidized, xanthomatous cells absent"
                  },
                  {
                    "text": "CDKN2A/CDKN2Bloss is rare"
                  }
                ],
                "Pilocytic Astrocytoma With Degenerative Atypia": [
                  {
                    "text": "Microcystic component with myxoid matrix"
                  },
                  {
                    "text": "Compact component with bipolar cells"
                  },
                  {
                    "text": "Less pleomorphism"
                  },
                  {
                    "text": "Multinucleation (pennies on plate)"
                  },
                  {
                    "text": "More fibrillarity"
                  },
                  {
                    "text": "Rosenthal fibers"
                  },
                  {
                    "text": "Often diffuse strong staining with p16"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Discreteness facilitates complete resection, some cases"
                  },
                  {
                    "text": "Superficial, solid cystic with occasional mass effect"
                  },
                  {
                    "text": "Anaplastic change associated with poor prognosis"
                  },
                  {
                    "text": "Successful treatment using MAPK inhibitors"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Minimal diagnostic featuresPleomorphism, giant cells ± lipidized cellsEGBsSpindle cells and extensive reticulin network",
                    "sub_points": [
                      "Pleomorphism, giant cells ± lipidized cells",
                      "EGBs",
                      "Spindle cells and extensive reticulin network"
                    ]
                  },
                  {
                    "text": "Critical molecular featuresBRAFmutations, most commonlyBRAFV600ECDKN2A/CDKN2Bdeletion, often homozygous",
                    "sub_points": [
                      "BRAFmutations, most commonlyBRAFV600E",
                      "CDKN2A/CDKN2Bdeletion, often homozygous"
                    ]
                  },
                  {
                    "text": "Diagnosis should be made with caution in absence of EGBs"
                  },
                  {
                    "text": "Much of tumor can be in subarachnoid space with abundant reticulin"
                  },
                  {
                    "text": "Leptomeningeal component of tumor may look different"
                  },
                  {
                    "text": "Anaplastic featuresThreshold of 5 or more mitoses per 10 HPF accepted by most experts and used as criterion for WHO grade 3Difficult to distinguish from giant cell glioblastomaEGBs and molecular features are helpfulDifficult to distinguish from epithelioid glioblastomaMore uniform, epithelioid and rhabdoid cells1 of 3 molecular subtypes may not be distinguishable",
                    "sub_points": [
                      "Threshold of 5 or more mitoses per 10 HPF accepted by most experts and used as criterion for WHO grade 3",
                      "Difficult to distinguish from giant cell glioblastomaEGBs and molecular features are helpful",
                      "EGBs and molecular features are helpful",
                      "Difficult to distinguish from epithelioid glioblastomaMore uniform, epithelioid and rhabdoid cells1 of 3 molecular subtypes may not be distinguishable",
                      "More uniform, epithelioid and rhabdoid cells",
                      "1 of 3 molecular subtypes may not be distinguishable"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Myxopapillary Ependymoma": {
            "name": "Myxopapillary Ependymoma",
            "url": "https://app.pathprimer.com/document/fd4e0d77-f1f4-46ab-8539-37fdfbf50175/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Low-grade, mucin-rich ependymal neoplasm most commonly located in filum terminale/conus medullaris"
                  },
                  {
                    "text": "WHO grade 2"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Distal spinal cord (filum terminale/conus medullaris)"
                  },
                  {
                    "text": "Extradural, pre- or postsacral or intraosseous (rare)"
                  },
                  {
                    "text": "Exceptionally above foramen magnum"
                  },
                  {
                    "text": "Prognosis generally good but may seed neuraxis"
                  },
                  {
                    "text": "Recurrence related to extent of resection and intactness of capsule during removal"
                  },
                  {
                    "text": "Dissemination more likely in children"
                  },
                  {
                    "text": "Prognosis poor for rare pre- or postsacral lesions; potential for metastases"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Soft, sometimes myxoid \"bag-like mass\""
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Large, dark, pleomorphic without increased mitotic or Ki-67 rate (giant cell ependymoma) in rare cases"
                  },
                  {
                    "text": "Perivascular arrangement of epithelial cells around mucin"
                  },
                  {
                    "text": "Fibrillar tumor similar to tanycytic ependymoma but often with perivascular myxoid substance"
                  },
                  {
                    "text": "Dense sclerosis or infarction in some cases"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Alcian blue"
                  },
                  {
                    "text": "GFAP(+), S100(+) focal D2-40(+)"
                  },
                  {
                    "text": "EMA, dot-like pattern or focal surface staining"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Well-circumscribed filum terminale lesion amenable to complete resection in some cases"
                  },
                  {
                    "text": "Do not interpret nuclear pleomorphism in giant cell ependymoma as evidence of anaplasia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Myxopapillary ependymoma (MPE)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Low-grade, mucin-rich ependymal neoplasm most commonly located in filum terminale/conus medullaris"
                  },
                  {
                    "text": "WHO grade 2 ( CNS WHO 5th ed.)Designated as WHO grade 1 neoplasm in 2016 WHO",
                    "sub_points": [
                      "Designated as WHO grade 1 neoplasm in 2016 WHO"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "More common in adults, rare in children"
                  }
                ],
                "Site": [
                  {
                    "text": "Distal spinal cord (filum terminale/conus medullaris) most common"
                  },
                  {
                    "text": "Extradural, pre- or postsacral or intraosseous (rare)"
                  },
                  {
                    "text": "Exceptionally above foramen magnum"
                  },
                  {
                    "text": "Multifocal in ~ 10% of all cases"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Motor or sensory disturbance depending on location within spinal cord"
                  }
                ],
                "Treatment": [
                  {
                    "text": "SurgeryTotal resection is treatment of choice and may be achieved in 3/4 of cases in large series",
                    "sub_points": [
                      "Total resection is treatment of choice and may be achieved in 3/4 of cases in large series"
                    ]
                  },
                  {
                    "text": "RadiationReserved for subtotal resection, recurrence, or disseminated disease",
                    "sub_points": [
                      "Reserved for subtotal resection, recurrence, or disseminated disease"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Generally good but may seed neuraxis"
                  },
                  {
                    "text": "Recurrence related to extent of resection and intactness of capsule during removal"
                  },
                  {
                    "text": "CSF dissemination more likely in children and may portend worse outcome"
                  },
                  {
                    "text": "Poor for rare pre- or postsacral lesions; potential for metastasesSo-called sacral ependymomas may be different tumor type/subtype",
                    "sub_points": [
                      "So-called sacral ependymomas may be different tumor type/subtype"
                    ]
                  },
                  {
                    "text": "Anaplastic histologic features associated with aggressive behavior"
                  },
                  {
                    "text": "Change in WHO grading may need further studiesRetrospective studies for last decade suggested that MPEs in adults may be more aggressive compared to typical ependymomasSome studies reported 10-year recurrence rate ~ 40% and overall survival rate > 95%It is not clear whether MPEs behave differently in pediatric population when compared with adult series",
                    "sub_points": [
                      "Retrospective studies for last decade suggested that MPEs in adults may be more aggressive compared to typical ependymomas",
                      "Some studies reported 10-year recurrence rate ~ 40% and overall survival rate > 95%",
                      "It is not clear whether MPEs behave differently in pediatric population when compared with adult series"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Discrete, contrast enhancing"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Well circumscribed, encapsulated in some cases"
                  },
                  {
                    "text": "Spontaneous rupture with involvement of nerve roots or CSF dissemination possible"
                  },
                  {
                    "text": "Soft, sometimes mucinous \"bag\""
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Perivascular arrangement of epithelial cells around mucin"
                  },
                  {
                    "text": "Pseudopapillae, ribbons or strands of epithelial cells"
                  },
                  {
                    "text": "Epithelial surfaces in some cases"
                  },
                  {
                    "text": "Fibrillar tumor similar to tanycytic ependymoma but often with perivascular myxoid substance"
                  },
                  {
                    "text": "Microcysts"
                  },
                  {
                    "text": "Dense sclerosis or infarction in some cases, absence of interspersed reticulin fibers, unlike schwannoma"
                  },
                  {
                    "text": "Eosinophilic, PAS(+) spherules with spiculated reticulin staining in occasional cases"
                  },
                  {
                    "text": "Large, hyperchromatic pleomorphic nuclei without increased mitotic or Ki-67 rate in occasional cases"
                  },
                  {
                    "text": "Some tumors may have densely cellular and hypocellular areas, imparting biphasic appearance to tumor"
                  },
                  {
                    "text": "Some examples have cellular fibrillary areas with diminished myxoid background, resembling tanycytic ependymoma"
                  },
                  {
                    "text": "Hybrid tumorsSome tumors have areas that resemble classic ependymomas with perivascular rosettesIn hybrid tumors, there is often distinct areas of typical MPE with cellular areas containing typical perivascular pseudorosettesPrognostic significance of these hybrid tumors remain to be determined",
                    "sub_points": [
                      "Some tumors have areas that resemble classic ependymomas with perivascular rosettes",
                      "In hybrid tumors, there is often distinct areas of typical MPE with cellular areas containing typical perivascular pseudorosettes",
                      "Prognostic significance of these hybrid tumors remain to be determined"
                    ]
                  },
                  {
                    "text": "Aggressive histologic featuresExceptional, often tumors have high cellularity and reduced mucinIncreased mitoses often > 6 per 10 HPF or 6 per 2 mm²Microvascular proliferation, necrosis ± palisadingIncreased Ki-67 labeling index, often > 15%No WHO grade designated",
                    "sub_points": [
                      "Exceptional, often tumors have high cellularity and reduced mucin",
                      "Increased mitoses often > 6 per 10 HPF or 6 per 2 mm²",
                      "Microvascular proliferation, necrosis ± palisading",
                      "Increased Ki-67 labeling index, often > 15%",
                      "No WHO grade designated"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Smears show fibrillar, mucinous background"
                  },
                  {
                    "text": "Epithelial cells with ependymal characteristics"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "Alcian bluePerivascular, may be only focal",
                    "sub_points": [
                      "Perivascular, may be only focal"
                    ]
                  },
                  {
                    "text": "TrichromeMarked perivascular staining, less pronounced than Alcian blue",
                    "sub_points": [
                      "Marked perivascular staining, less pronounced than Alcian blue"
                    ]
                  },
                  {
                    "text": "PASEosinophilic spherules strongly positive",
                    "sub_points": [
                      "Eosinophilic spherules strongly positive"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "GFAP(+), S100(+) focal"
                  },
                  {
                    "text": "EMA(+), D2-40(+)Dot-like pattern or focal surface staining",
                    "sub_points": [
                      "Dot-like pattern or focal surface staining"
                    ]
                  },
                  {
                    "text": "Ki-67 low, usually < 2%Anaplastic examples may have > 10% labeling",
                    "sub_points": [
                      "Anaplastic examples may have > 10% labeling"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "No mutations or fusions"
                  },
                  {
                    "text": "Recurrent gains of chromosome16 and losses of chromosome 10"
                  },
                  {
                    "text": "Aneuploidy was found to be associated with anaplastic histologic features"
                  },
                  {
                    "text": "MPEs are characterized by increased cellular metabolism, associated with upregulation of HIF1α"
                  },
                  {
                    "text": "Forms distinct cluster on DNA methylation profilingMay aid diagnosis and potentially prognostication",
                    "sub_points": [
                      "May aid diagnosis and potentially prognostication"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Schwannoma": [
                  {
                    "text": "Nerve root origin, rather than filum terminale"
                  },
                  {
                    "text": "Antoni A and Antoni B tissue, Verocay bodies, interspersed reticulin fibers, especially in Antoni A"
                  },
                  {
                    "text": "Diffuse rather than perivascular mucinous material in myxoid variants"
                  },
                  {
                    "text": "S100(+), SOX10(+) and GFAP(-) or focal"
                  }
                ],
                "Paraganglioma": [
                  {
                    "text": "Acinar architecture (zellballen)"
                  },
                  {
                    "text": "No (or only scant) myxoid background"
                  },
                  {
                    "text": "Chromogranin (+), S100(+) sustentacular cells &/or chief cells, cytokeratins (+) in some cases"
                  }
                ],
                "Tanycytic Ependymoma": [
                  {
                    "text": "Currently not recognized subtype of ependymoma"
                  },
                  {
                    "text": "Lack of myxoid background, cysts, and papillary structures"
                  },
                  {
                    "text": "Resembles pilocytic astrocytoma, except for occasional perivascular pseudorosettes"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Well-circumscribed filum terminale lesion amenable to complete resection in some cases"
                  },
                  {
                    "text": "Disseminated or multifocal, rare"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Histologic features of most MPEs are distinctive and easy to recognize"
                  },
                  {
                    "text": "May be only focally mucinous, typically around vessels"
                  },
                  {
                    "text": "Papillary architecture may be obscured with significant fibrosis in some cases"
                  },
                  {
                    "text": "Nuclear pleomorphism in giant cell ependymoma not to be interpreted necessarily as evidence of anaplasia"
                  },
                  {
                    "text": "Some tumors may have classic ependymoma component; prognosis of these hybrid tumors is uncertain"
                  },
                  {
                    "text": "Some anaplastic features may actually portend more aggressive outcome, but further evidence for this assertion is needed"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ganglioglioma": {
            "name": "Ganglioglioma",
            "url": "https://app.pathprimer.com/document/242c501a-4b90-472f-a988-b0ca614f71f9/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Well-differentiated tumors with dysplastic ganglion cells with neoplastic glial component"
                  },
                  {
                    "text": "Frequent MAPK pathway alterations"
                  },
                  {
                    "text": "Ganglioglioma (GG), WHO grade 1"
                  },
                  {
                    "text": "Anaplastic GG, WHO grade 3Grading criteria poorly defined",
                    "sub_points": [
                      "Grading criteria poorly defined"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Slow growing, indolent"
                  },
                  {
                    "text": "Frequent history of seizures"
                  },
                  {
                    "text": "Cyst with enhancing mural nodule, many cases"
                  },
                  {
                    "text": "Resectable; excellent prognosis, rarely fatal"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Compact (not infiltrative) with dysmorphic neuronsLarge, pleomorphic, vesicular, hyperchromatic nucleiIrregular apical dendrites, coarse peripheral Nissl substance",
                    "sub_points": [
                      "Large, pleomorphic, vesicular, hyperchromatic nuclei",
                      "Irregular apical dendrites, coarse peripheral Nissl substance"
                    ]
                  },
                  {
                    "text": "Neoplastic glial componentOften pilocytic-likeFibrillary astrocytoma-like or oligodendroctye-like",
                    "sub_points": [
                      "Often pilocytic-like",
                      "Fibrillary astrocytoma-like or oligodendroctye-like"
                    ]
                  },
                  {
                    "text": "Eosinophilic granular bodies, lymphocytes"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Neoplastic neurons: Granular/surface synaptophysin, neurofilament protein, NeuN (+)"
                  },
                  {
                    "text": "Glial component and intermediate cells: S100, GFAP (+)"
                  },
                  {
                    "text": "CD34(+) ramified cells"
                  },
                  {
                    "text": "Ki-67 labeling low (< 3%) in glial component"
                  },
                  {
                    "text": "BRAFp.V600E (and other MAPK pathway alterations)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Diffuse glioma with entrapped neurons"
                  },
                  {
                    "text": "Pilocytic astrocytoma"
                  },
                  {
                    "text": "Pleomorphic xanthoastrocytoma"
                  },
                  {
                    "text": "Dysembryoplastic neuroepithelial tumor"
                  },
                  {
                    "text": "Multinodular and vacuolating neuronal tumor"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Ganglioglioma (GG)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Well-differentiated glioneuronal tumor composed of mixed ganglion cell and glial neoplastic elements"
                  },
                  {
                    "text": "Frequent MAPK pathway alterations"
                  },
                  {
                    "text": "GG and anaplastic GG, WHO grade 1 and 3, respectively"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Histogenesis": [
                  {
                    "text": "Presumed origin from pluripotential progenitor cells showing divergent differentiation to glial and neuronal cells"
                  },
                  {
                    "text": "Presence of less mature neurons (ganglioid cells) suggests stepwise transformation to larger neurons"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare, < 2% of all brain tumors"
                  }
                ],
                "Age": [
                  {
                    "text": "All ages but usually children or young adults"
                  }
                ],
                "Site": [
                  {
                    "text": "Frequently supratentorial; predilection for temporal lobe"
                  },
                  {
                    "text": "Also cerebellum, optic nerve, brainstem, pineal region, spinal cord, neurohypophysis (rare)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptoms may precede diagnosis by several yearsSeizuresOne of long-term epilepsy-associated tumors (LEATs)Obstructive hydrocephalus, increased intracranial pressure, headachesSite-dependent neurologic deficits",
                    "sub_points": [
                      "SeizuresOne of long-term epilepsy-associated tumors (LEATs)",
                      "One of long-term epilepsy-associated tumors (LEATs)",
                      "Obstructive hydrocephalus, increased intracranial pressure, headaches",
                      "Site-dependent neurologic deficits"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Slowly growing or stable"
                  },
                  {
                    "text": "Involvement of subarachnoid space not indicative of malignancy"
                  },
                  {
                    "text": "Only rare anaplastic transformation"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Simple, even partial, resection may suffice"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent long-term prognosis"
                  },
                  {
                    "text": "Infrequent recurrence7.5-year recurrence-free survival of 97%",
                    "sub_points": [
                      "7.5-year recurrence-free survival of 97%"
                    ]
                  },
                  {
                    "text": "Poor with rare anaplastic transformationUsually of glial component5-year recurrence rate of 100%",
                    "sub_points": [
                      "Usually of glial component",
                      "5-year recurrence rate of 100%"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Hypointense on T1WI, hyperintense on T2WI"
                  },
                  {
                    "text": "Cyst with contrast-enhancing mural nodule in classic GG"
                  },
                  {
                    "text": "Solid, nodular, or rim-like enhancement, occasional GG"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Iso- or hypodense, heterogeneous"
                  },
                  {
                    "text": "Frequent calcification"
                  },
                  {
                    "text": "Scalloped calvaria in superficial examples"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Superficial, corticocentric, &/or subarachnoid location"
                  },
                  {
                    "text": "Solid or cystic with little mass effect"
                  },
                  {
                    "text": "Well-circumscribed mural nodule"
                  },
                  {
                    "text": "Sometimes calcified (gritty)"
                  }
                ],
                "Sections to Be Submitted": [
                  {
                    "text": "Entire mural nodule (if small), portion of cyst wall"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Compact growth pattern overall"
                  },
                  {
                    "text": "Extension into nearby subarachnoid space common"
                  },
                  {
                    "text": "Neuronal componentVesicular, often multiple nuclei; prominent nucleoliVariable Nissl substance, perimembranous aggregationNeuronal component sometimes inconspicuous, requiring immunohistochemistry for neuronal markers2 patterns: Compact nodules or dispersed individual neoplastic ganglion cells",
                    "sub_points": [
                      "Vesicular, often multiple nuclei; prominent nucleoli",
                      "Variable Nissl substance, perimembranous aggregation",
                      "Neuronal component sometimes inconspicuous, requiring immunohistochemistry for neuronal markers",
                      "2 patterns: Compact nodules or dispersed individual neoplastic ganglion cells"
                    ]
                  },
                  {
                    "text": "Glial component, mixed or geographically separateOften astrocytic; pilocytic or fibrillary-likeOligodendrocyte-like morphology, someOften lobular architectureNests of neoplastic cells, trapped or encircledReticulin-, collagen-rich interlobular stroma ± lymphocytes",
                    "sub_points": [
                      "Often astrocytic; pilocytic or fibrillary-like",
                      "Oligodendrocyte-like morphology, some",
                      "Often lobular architectureNests of neoplastic cells, trapped or encircledReticulin-, collagen-rich interlobular stroma ± lymphocytes",
                      "Nests of neoplastic cells, trapped or encircled",
                      "Reticulin-, collagen-rich interlobular stroma ± lymphocytes"
                    ]
                  },
                  {
                    "text": "Microcyst-rich patternSmaller ganglion cells and piloid glia",
                    "sub_points": [
                      "Smaller ganglion cells and piloid glia"
                    ]
                  },
                  {
                    "text": "Myxoid degeneration and white matter rarefaction, some"
                  },
                  {
                    "text": "Eosinophilic granular bodies (EGBs)"
                  },
                  {
                    "text": "Rosenthal fibers, less common"
                  },
                  {
                    "text": "Dystrophic calcifications"
                  },
                  {
                    "text": "Perivascular or parenchymal lymphoid infiltrate"
                  },
                  {
                    "text": "DesmoplasiaEspecially with tumors involving subarachnoid spaceTrichrome (+), reticulin rich",
                    "sub_points": [
                      "Especially with tumors involving subarachnoid spaceTrichrome (+), reticulin rich",
                      "Trichrome (+), reticulin rich"
                    ]
                  }
                ],
                "Histologic Grading": [
                  {
                    "text": "Anaplastic GG, WHO grade 3No consensus on grading criteriaAnaplastic component usually glial, GFAP(+)May resemble conventional anaplastic astrocytoma or glioblastomaDiagnose only when clear neuronal component present; infiltrating gliomas with entrapped normal neurons far more frequentFrequent mitosesNecrosis in some casesMicrovascular proliferation in some casesAggressive, like malignant gliomas; tend to recurAnaplastic neuronal componentRare, criteria unclearOverlaps practically and conceptually with embryonal tumorsSarcomatous change in anaplastic GG, rare",
                    "sub_points": [
                      "No consensus on grading criteria",
                      "Anaplastic component usually glial, GFAP(+)May resemble conventional anaplastic astrocytoma or glioblastomaDiagnose only when clear neuronal component present; infiltrating gliomas with entrapped normal neurons far more frequentFrequent mitosesNecrosis in some casesMicrovascular proliferation in some casesAggressive, like malignant gliomas; tend to recur",
                      "May resemble conventional anaplastic astrocytoma or glioblastomaDiagnose only when clear neuronal component present; infiltrating gliomas with entrapped normal neurons far more frequent",
                      "Diagnose only when clear neuronal component present; infiltrating gliomas with entrapped normal neurons far more frequent",
                      "Frequent mitoses",
                      "Necrosis in some cases",
                      "Microvascular proliferation in some cases",
                      "Aggressive, like malignant gliomas; tend to recur",
                      "Anaplastic neuronal componentRare, criteria unclearOverlaps practically and conceptually with embryonal tumors",
                      "Rare, criteria unclear",
                      "Overlaps practically and conceptually with embryonal tumors",
                      "Sarcomatous change in anaplastic GG, rare"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Ganglion cells better preserved than in frozen sectionsLarger, rounder than normal ganglion cellsOpen chromatin, prominent nucleiCoarse peripheral Nissl substance",
                    "sub_points": [
                      "Larger, rounder than normal ganglion cells",
                      "Open chromatin, prominent nuclei",
                      "Coarse peripheral Nissl substance"
                    ]
                  },
                  {
                    "text": "Fibrillar background of glial cell processes"
                  },
                  {
                    "text": "EGBs, lymphocytes"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "SynaptophysinFine, granular surface staining of ganglion cells but not specific for neoplastic neurons",
                    "sub_points": [
                      "Fine, granular surface staining of ganglion cells but not specific for neoplastic neurons"
                    ]
                  },
                  {
                    "text": "ChromograninPunctate cytoplasmic staining in ganglion cells",
                    "sub_points": [
                      "Punctate cytoplasmic staining in ganglion cells"
                    ]
                  },
                  {
                    "text": "NeuNRange from negative to weak positive in dysplastic ganglion cellsStrong positive in nonneoplastic entrapped neurons",
                    "sub_points": [
                      "Range from negative to weak positive in dysplastic ganglion cells",
                      "Strong positive in nonneoplastic entrapped neurons"
                    ]
                  },
                  {
                    "text": "Neurofilament (+) in dysplastic ganglion cellsAlso seen in focal cortical dysplasia but rare in entrapped cortical neurons",
                    "sub_points": [
                      "Also seen in focal cortical dysplasia but rare in entrapped cortical neurons"
                    ]
                  },
                  {
                    "text": "MAP2(+) in neuronal cellsNegative or only weak in glial cells, unlike diffuse glioma",
                    "sub_points": [
                      "Negative or only weak in glial cells, unlike diffuse glioma"
                    ]
                  },
                  {
                    "text": "GFAP(+) glial component and reactive astrocytes"
                  },
                  {
                    "text": "S100(+) in glial and variable in neuronal cells"
                  },
                  {
                    "text": "Some tumor cells (+) for both neuronal and glial markers"
                  },
                  {
                    "text": "CD34 (+)Cells with ramified processes within tumor and in surrounding cortex",
                    "sub_points": [
                      "Cells with ramified processes within tumor and in surrounding cortex"
                    ]
                  },
                  {
                    "text": "Collagen IV and laminin (+) in desmoplastic tumors"
                  },
                  {
                    "text": "Ki-67: Low labeling index in glial component and (-) in neuronal component"
                  },
                  {
                    "text": "BRAF V600E IHC (+) in mutant casesStronger in neuronal component",
                    "sub_points": [
                      "Stronger in neuronal component"
                    ]
                  },
                  {
                    "text": "Cyclin-D1 (+)Correlates with MAPK pathway activation",
                    "sub_points": [
                      "Correlates with MAPK pathway activation"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "MAPK pathway activation with genetic alterations predicting activation of pathway in up to 90%BRAFgene alterations in ~ 70% of casesBRAFp.V600E point mutation in 10-60% of casesNon-p.V600E mutations, rareKIAA1549::BRAFfusion rare (unlike pilocytic astrocytoma)Rare presentation in neurofibromatosis type 1 patients with homozygousNF1gene inactivationRarely alterations inFGFR1,FGFR2,RAF1, orKRAS",
                    "sub_points": [
                      "BRAFgene alterations in ~ 70% of casesBRAFp.V600E point mutation in 10-60% of casesNon-p.V600E mutations, rareKIAA1549::BRAFfusion rare (unlike pilocytic astrocytoma)",
                      "BRAFp.V600E point mutation in 10-60% of cases",
                      "Non-p.V600E mutations, rare",
                      "KIAA1549::BRAFfusion rare (unlike pilocytic astrocytoma)",
                      "Rare presentation in neurofibromatosis type 1 patients with homozygousNF1gene inactivation",
                      "Rarely alterations inFGFR1,FGFR2,RAF1, orKRAS"
                    ]
                  },
                  {
                    "text": "Abnormalities of tuberous sclerosis genes (TSC1/TSC2), rare"
                  },
                  {
                    "text": "Concurrent H3 K27M mutations (both WHO grades 1 and 3)Presence of H3 K27M alone does not warrant WHO grade 4 designation",
                    "sub_points": [
                      "Presence of H3 K27M alone does not warrant WHO grade 4 designation"
                    ]
                  },
                  {
                    "text": "CDKN2Ahomozygous deletion, rareMay be associated with anaplastic histology and aggressive behavior",
                    "sub_points": [
                      "May be associated with anaplastic histology and aggressive behavior"
                    ]
                  },
                  {
                    "text": "Additional alterations reported in anaplastic GGTERTpromoter mutations,TP53mutations, ATRX loss",
                    "sub_points": [
                      "TERTpromoter mutations,TP53mutations, ATRX loss"
                    ]
                  },
                  {
                    "text": "Proposed clinicopathologic/molecular subgroups for pediatric posterior fossa and spinal cord GGsGroup I (classic GGs):BRAFp.V600E mutation in subset, lack ofKIAA1549::BRAFGroup II (pilocytic astrocytoma with foci of gangliocytic differentiation): FrequentKIAA1549::BRAF",
                    "sub_points": [
                      "Group I (classic GGs):BRAFp.V600E mutation in subset, lack ofKIAA1549::BRAF",
                      "Group II (pilocytic astrocytoma with foci of gangliocytic differentiation): FrequentKIAA1549::BRAF"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Dense core granules in ganglion cellsInconspicuous in normal CNS neurons",
                    "sub_points": [
                      "Inconspicuous in normal CNS neurons"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Brain": [
                  {
                    "text": "Ordered, organized complexity"
                  },
                  {
                    "text": "Layered cerebral cortical architecture with apical dendrites directed to cortical surface"
                  },
                  {
                    "text": "Cytologically normal neurons; only rarely binucleate"
                  },
                  {
                    "text": "Perineuronal (\"satellite\") oligodendroglia"
                  },
                  {
                    "text": "No calcifications"
                  }
                ],
                "Infiltrating Glioma With Trapped Normal Neurons": [
                  {
                    "text": "Consider in cases of suspected anaplastic GG"
                  },
                  {
                    "text": "Much more common than GG"
                  },
                  {
                    "text": "Normal cortical neuronsPolar cytoplasm, apical dendrites oriented toward piaSize variation not present to extent seen in GGCytologically atypical (neoplastic) perineuronal \"satellite\" glial cellsTrapped native neurons within tumors may acquire cytologic abnormalities but no abnormal clustering or binucleation",
                    "sub_points": [
                      "Polar cytoplasm, apical dendrites oriented toward pia",
                      "Size variation not present to extent seen in GG",
                      "Cytologically atypical (neoplastic) perineuronal \"satellite\" glial cells",
                      "Trapped native neurons within tumors may acquire cytologic abnormalities but no abnormal clustering or binucleation"
                    ]
                  },
                  {
                    "text": "IDH1/IDH2mutations exclude diagnosis of GG"
                  }
                ],
                "Meningioangiomatosis With Trapped Cortical Ganglion Cells": [
                  {
                    "text": "Plaque-like intracortical lesion"
                  },
                  {
                    "text": "Perivascular fibroblastic or meningothelial cells deep into cortexEMA(+) in some cases",
                    "sub_points": [
                      "EMA(+) in some cases"
                    ]
                  },
                  {
                    "text": "Laminated psammoma bodies, not nondescript calcospherites"
                  },
                  {
                    "text": "Associated meningioma, some cases"
                  }
                ],
                "Cortical Dysplasia and Tubers": [
                  {
                    "text": "No cyst or compact architectureAbnormal neurons in cortex, subcortical white matterLarge, glassy cells (balloon cells); PAS, S100 (+)",
                    "sub_points": [
                      "Abnormal neurons in cortex, subcortical white matter",
                      "Large, glassy cells (balloon cells); PAS, S100 (+)"
                    ]
                  },
                  {
                    "text": "No perivascular lymphocytes"
                  },
                  {
                    "text": "Hyperintensity on T2 and FLAIR MR in underlying white matter"
                  }
                ],
                "Desmoplastic Infantile Ganglioglioma": [
                  {
                    "text": "Solid, dura-attached, superficial mass with surrounding cyst"
                  },
                  {
                    "text": "Markedly desmoplastic"
                  },
                  {
                    "text": "Ganglioid cells smaller than conventional ganglion cellsOverlap in size and shape with neoplastic astrocytes",
                    "sub_points": [
                      "Overlap in size and shape with neoplastic astrocytes"
                    ]
                  },
                  {
                    "text": "Cellular, mitotically active embryonal-like areas, some cases"
                  }
                ],
                "Neurocytic Tumors With Ganglion Cell Component": [
                  {
                    "text": "Predominant population of small neurocytesMonotonous, oligodendroglioma-like",
                    "sub_points": [
                      "Monotonous, oligodendroglioma-like"
                    ]
                  },
                  {
                    "text": "Ganglion cell and glial component, some cases (\"ganglioglioneurocytoma\")"
                  }
                ],
                "Dysembryoplastic Neuroepithelial Tumor": [
                  {
                    "text": "Usually solid, not cystic"
                  },
                  {
                    "text": "Patterned, nodular architecture"
                  },
                  {
                    "text": "Prominent component of oligodendrocyte-like cells"
                  },
                  {
                    "text": "Large neurons \"floating\" in micropools of mucinLittle neuronal dysmorphism, clustering, or atypia",
                    "sub_points": [
                      "Little neuronal dysmorphism, clustering, or atypia"
                    ]
                  },
                  {
                    "text": "Axons ensheathed by oligodendrocyte-like cells in \"specific glioneuronal element\"May be difficult to find",
                    "sub_points": [
                      "May be difficult to find"
                    ]
                  },
                  {
                    "text": "Mucoid background, Alcian blue (+)Nodules especially (+)",
                    "sub_points": [
                      "Nodules especially (+)"
                    ]
                  },
                  {
                    "text": "No desmoplasia"
                  },
                  {
                    "text": "Few, if any, EGBs in nodules"
                  },
                  {
                    "text": "No chronic inflammation"
                  },
                  {
                    "text": "FGFR1alterations common,BRAFalterations rare"
                  }
                ],
                "Pleomorphic Xanthoastrocytoma": [
                  {
                    "text": "Large, pleomorphic, spindle to epithelioid astrocytes, some lipidized"
                  },
                  {
                    "text": "Coarse and delicate granular bodies in nearly all cases"
                  },
                  {
                    "text": "Minor infiltration of cortex with entrapped neurons"
                  },
                  {
                    "text": "Anaplastic features in pleomorphic xanthoastrocytoma (PXA) component (~ 15% of cases)"
                  },
                  {
                    "text": "Composite PXA-GG far less commonDifficult practical distinction between GG and PXA with ganglion cell component",
                    "sub_points": [
                      "Difficult practical distinction between GG and PXA with ganglion cell component"
                    ]
                  },
                  {
                    "text": "Typically harborsCDKN2Ahomozygous deletionAssociated with decreased p16 IHC",
                    "sub_points": [
                      "Associated with decreased p16 IHC"
                    ]
                  }
                ],
                "Pilocytic Astrocytoma": [
                  {
                    "text": "Classic lesion without neoplastic ganglion cellsMay contain some synaptophysin (+) cells",
                    "sub_points": [
                      "May contain some synaptophysin (+) cells"
                    ]
                  },
                  {
                    "text": "Pilocytic astrocytoma with neuronal (neurocytic) componentDifficult practical and conceptual distinction from GG",
                    "sub_points": [
                      "Difficult practical and conceptual distinction from GG"
                    ]
                  }
                ],
                "Subependymal Giant Cell Astrocytoma (Tuberous Sclerosis)": [
                  {
                    "text": "Tuberous sclerosis complex association in most cases"
                  },
                  {
                    "text": "Site specific; near foramen of Monro"
                  },
                  {
                    "text": "Mixed glioneuronal immunophenotype"
                  },
                  {
                    "text": "Large cells, some with ganglion cell features, but usually not full ganglion cell phenotype"
                  },
                  {
                    "text": "No chronic inflammation but mast cells frequent"
                  }
                ],
                "Medulloblastoma": [
                  {
                    "text": "Predominant small round blue cell component except in highly differentiated nodular/desmoplastic examples"
                  },
                  {
                    "text": "Posttreatment maturation and small cell depletion in some cases"
                  }
                ],
                "CNS Neuroblastoma With Ganglion Cell Differentiation": [
                  {
                    "text": "Concomitant ganglion cell and small round blue cell components"
                  },
                  {
                    "text": "Tumors with more equal differentiated:undifferentiated cell ratios"
                  },
                  {
                    "text": "Practical and conceptual overlap with ganglion cell tumors with only focal immature neurons or neuroblasts"
                  }
                ],
                "Ganglion Cell Metaplasia": [
                  {
                    "text": "Pituitary adenomaSite specific: Sella turcicaVarying population of adenoma cells, often hormone producing",
                    "sub_points": [
                      "Site specific: Sella turcica",
                      "Varying population of adenoma cells, often hormone producing"
                    ]
                  },
                  {
                    "text": "Gliomas, especially oligodendrogliomaFocal phenomenon in otherwise typical infiltrating oligodendrogliomaSynaptophysin (+) in 20%1p/19q codeletion, including ganglion cells of oligodendrogliomas",
                    "sub_points": [
                      "Focal phenomenon in otherwise typical infiltrating oligodendroglioma",
                      "Synaptophysin (+) in 20%",
                      "1p/19q codeletion, including ganglion cells of oligodendrogliomas"
                    ]
                  },
                  {
                    "text": "ParagangliomaSite specific: Filum terminaleDominant population of chief cells",
                    "sub_points": [
                      "Site specific: Filum terminale",
                      "Dominant population of chief cells"
                    ]
                  },
                  {
                    "text": "Atypical teratoid/rhabdoid tumor (AT/RT)Extremely rare",
                    "sub_points": [
                      "Extremely rare"
                    ]
                  }
                ],
                "Polymorphous Low-Grade Neuroepithelial Tumor of the Young": [
                  {
                    "text": "Infiltrative growth, invariable presence of oligodendrocyte-like cellular components"
                  },
                  {
                    "text": "Lack ganglion cell forms"
                  },
                  {
                    "text": "Intensely CD34(+) in neoplastic cells and ramified neural processes"
                  },
                  {
                    "text": "Genetic abnormalities involvingBRAF,FGFR2,orFGFR3"
                  }
                ],
                "Multinodular and Vacuolating Neuronal Tumor": [
                  {
                    "text": "Nodular architecture, prominent vacuolation"
                  },
                  {
                    "text": "Lack of dysmorphic neuronal features or multinucleation"
                  },
                  {
                    "text": "Cell component varies from overtly neuronal to cytologically ambiguous"
                  },
                  {
                    "text": "Synaptophysin, chromogranin, neurofilament protein (-)"
                  },
                  {
                    "text": "Absence of calcifications, perivascular lymphocytes"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Rule out infiltrating glioma with entrapped neurons"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gangliocytoma": {
            "name": "Gangliocytoma",
            "url": "https://app.pathprimer.com/document/70bbd752-337a-483b-87f4-2db5bf14755e/lesson/a94cd451-5caa-45c0-891c-86497557ef33",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Well-differentiated tumors composed mainly of large, mature ganglion cells, often with dysplastic features"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Slow growing, indolent"
                  },
                  {
                    "text": "One of long-term epilepsy-associated tumors (LEATs)"
                  },
                  {
                    "text": "Most commonly supratentorial, cortical, and subcortical"
                  },
                  {
                    "text": "Slowly growing or stable"
                  },
                  {
                    "text": "Excellent long-term prognosis"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Solid, noncystic appearance"
                  },
                  {
                    "text": "No enhancement"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Compact, noninfiltrative growth pattern"
                  },
                  {
                    "text": "Cellularity similar to or less than normal gray matterArchitecturally disorganizedNo small neurons, perineuronal oligodendroglia, reactive astrocytes, or microglia",
                    "sub_points": [
                      "Architecturally disorganized",
                      "No small neurons, perineuronal oligodendroglia, reactive astrocytes, or microglia"
                    ]
                  },
                  {
                    "text": "Neuropil-rich background (neuritic processes)"
                  },
                  {
                    "text": "Cytologically dysmorphic, multipolar, binucleated neuronsLarge, pleomorphic vesicular or hyperchromatic nucleiNissl substance absent or coarse and peripherally misplaced",
                    "sub_points": [
                      "Large, pleomorphic vesicular or hyperchromatic nuclei",
                      "Nissl substance absent or coarse and peripherally misplaced"
                    ]
                  },
                  {
                    "text": "No mitotically active neuroblasts"
                  },
                  {
                    "text": "Neurodegenerative pathology"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Synaptophysin, chromogranin, neurofilament, MAP2 (+)"
                  },
                  {
                    "text": "NeuN(-) or only weak (+)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Normal brain"
                  },
                  {
                    "text": "Cortical dysplasia and tubers"
                  },
                  {
                    "text": "Hypothalamic hamartoma"
                  },
                  {
                    "text": "Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)"
                  },
                  {
                    "text": "Neurocytic tumors with ganglion cell component"
                  },
                  {
                    "text": "Subependymal giant cell astrocytoma (tuberous sclerosis)"
                  },
                  {
                    "text": "Embryonal tumors with ganglion cell differentiation"
                  },
                  {
                    "text": "Sellar gangliocytoma/mixed gangliocytoma-adenoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Well-differentiated tumors composed mainly of large, mature ganglion cells, often with dysplastic features"
                  },
                  {
                    "text": "WHO grade 1"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare"
                  }
                ],
                "Age": [
                  {
                    "text": "Predominantly children and young adults"
                  }
                ],
                "Site": [
                  {
                    "text": "Most commonly supratentorial, cortical, and subcortical"
                  },
                  {
                    "text": "Rarely spinal cord, thalamus, and basal ganglia"
                  }
                ],
                "Presentation": [
                  {
                    "text": "SeizuresOne of long-term epilepsy-associated tumors (LEATs)",
                    "sub_points": [
                      "One of long-term epilepsy-associated tumors (LEATs)"
                    ]
                  },
                  {
                    "text": "Focal neurologic deficits, rare"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Slowly growing or stable"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Simple, even partial, resection"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent long-term prognosis"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Hypointense on T1WI, hyperintense on T2WI"
                  },
                  {
                    "text": "Solid, noncystic appearance"
                  },
                  {
                    "text": "No enhancement"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Compact, noninfiltrative growth patternCellularity similar to or less than normal gray matterArchitecturally disorganizedNo small neurons, perineuronal oligodendroglia, reactive astrocytes, or microglia",
                    "sub_points": [
                      "Cellularity similar to or less than normal gray matter",
                      "Architecturally disorganized",
                      "No small neurons, perineuronal oligodendroglia, reactive astrocytes, or microglia"
                    ]
                  },
                  {
                    "text": "Neuropil-rich background (neuritic processes)"
                  },
                  {
                    "text": "Cytologically dysmorphic, multipolar neuronsPoorly formed, irregularly arranged apical dendritesDisorganized, not oriented toward pial surfaceLarge, pleomorphic vesicular or hyperchromatic nucleiBi- or multinucleated with prominent nucleoliIntranuclear cytoplasmic inclusionsNissl substanceCoarse, irregular, peripherally misplacedAbsent in many cases",
                    "sub_points": [
                      "Poorly formed, irregularly arranged apical dendritesDisorganized, not oriented toward pial surface",
                      "Disorganized, not oriented toward pial surface",
                      "Large, pleomorphic vesicular or hyperchromatic nucleiBi- or multinucleated with prominent nucleoliIntranuclear cytoplasmic inclusions",
                      "Bi- or multinucleated with prominent nucleoli",
                      "Intranuclear cytoplasmic inclusions",
                      "Nissl substanceCoarse, irregular, peripherally misplacedAbsent in many cases",
                      "Coarse, irregular, peripherally misplaced",
                      "Absent in many cases"
                    ]
                  },
                  {
                    "text": "Ganglioid cells: Less mature, intermediate-sized neurons"
                  },
                  {
                    "text": "No mitotically active neuroblastsIf present, consider CNS ganglioneuroblastoma",
                    "sub_points": [
                      "If present, consider CNS ganglioneuroblastoma"
                    ]
                  },
                  {
                    "text": "Neurodegenerative pathologyTypically seen in patients > 30 years of ageGranulovacuolar degeneration (cytoplasmic vacuoles with basophilic granules)Tau-related changesNeurofibrillary tangles: Argyrophilic, tau protein, and ubiquitin (+)Neuropil threadsα-synuclein pathology, minority of cases",
                    "sub_points": [
                      "Typically seen in patients > 30 years of age",
                      "Granulovacuolar degeneration (cytoplasmic vacuoles with basophilic granules)",
                      "Tau-related changesNeurofibrillary tangles: Argyrophilic, tau protein, and ubiquitin (+)",
                      "Neurofibrillary tangles: Argyrophilic, tau protein, and ubiquitin (+)",
                      "Neuropil threads",
                      "α-synuclein pathology, minority of cases"
                    ]
                  },
                  {
                    "text": "Reticulin fibers, often perivascular"
                  },
                  {
                    "text": "CalcificationsScattered small calcospherites, commonDense, confluent (\"brain stone\")",
                    "sub_points": [
                      "Scattered small calcospherites, common",
                      "Dense, confluent (\"brain stone\")"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Dysmorphic ganglion cellsLarger, rounder than normal ganglion cellsOpen chromatin, prominent nucleoliNissl substance coarse and peripheral",
                    "sub_points": [
                      "Larger, rounder than normal ganglion cells",
                      "Open chromatin, prominent nucleoli",
                      "Nissl substance coarse and peripheral"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Synaptophysin (+), membranous accentuation"
                  },
                  {
                    "text": "Chromogranin (+), punctate cytoplasmic"
                  },
                  {
                    "text": "MAP2(+)"
                  },
                  {
                    "text": "NeuN(-) or only weak (+)"
                  },
                  {
                    "text": "Neurofilament (+/-) in cell bodies"
                  },
                  {
                    "text": "BRAF V600E (-)"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "No recurrent alterations described"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Dense core granules in ganglion cells"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Brain": [
                  {
                    "text": "Ordered, organized complexity"
                  },
                  {
                    "text": "Layered cortex, apical dendrites directed to cortical surface"
                  },
                  {
                    "text": "Cytologically normal neurons; binucleate neurons exceptional"
                  },
                  {
                    "text": "Perineuronal (\"satellite\") oligodendroglia"
                  },
                  {
                    "text": "No calcifications"
                  }
                ],
                "Cortical Dysplasia and Tubers": [
                  {
                    "text": "Abnormal neurons in cortex, subcortical white matter"
                  },
                  {
                    "text": "No mass effect"
                  },
                  {
                    "text": "May not be possible to differentiate in some cases"
                  }
                ],
                "Hypothalamic Hamartoma": [
                  {
                    "text": "Solid, little or no mass effect"
                  },
                  {
                    "text": "Essentially identical to nonneoplastic gray matter; little if any dysmorphism"
                  }
                ],
                "Multinodular and Vacuolating Neuronal Tumor": [
                  {
                    "text": "Nodular architecture, prominent vacuolation"
                  },
                  {
                    "text": "Lack of dysmorphic neuronal features or multinucleation"
                  },
                  {
                    "text": "Cell component varies from overtly neuronal to cytologically ambiguous"
                  },
                  {
                    "text": "Typically synaptophysin, chromogranin, neurofilament (-)"
                  }
                ],
                "Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)": [
                  {
                    "text": "Site specific to cerebellum"
                  },
                  {
                    "text": "Association with Cowden syndrome"
                  },
                  {
                    "text": "Pathognomonic radiologic appearance"
                  },
                  {
                    "text": "Differentiation of internal granule cells to large ganglion cells"
                  }
                ],
                "Neurocytic Tumors With Ganglion Cell Component": [
                  {
                    "text": "Predominant population of small neurocytesMonotonous, oligodendroglioma-like",
                    "sub_points": [
                      "Monotonous, oligodendroglioma-like"
                    ]
                  },
                  {
                    "text": "Ganglion cell and glial component, some cases (\"ganglioglioneurocytoma\")"
                  }
                ],
                "Subependymal Giant Cell Astrocytoma (Tuberous Sclerosis)": [
                  {
                    "text": "Tuberous sclerosis complex association in most cases"
                  },
                  {
                    "text": "Site specific; near foramen of Monro"
                  },
                  {
                    "text": "Mixed glioneuronal immunophenotype"
                  },
                  {
                    "text": "Large cells, some with ganglion cell features, but usually not full ganglion cell phenotype"
                  }
                ],
                "CNS Neuroblastoma With Ganglion Cell Differentiation": [
                  {
                    "text": "Concomitant, ganglion cell, and small round blue cell component"
                  },
                  {
                    "text": "Tumors with more equal differentiated:undifferentiated cell ratios"
                  }
                ],
                "Medulloblastoma": [
                  {
                    "text": "Predominant small round blue cell component except in highly differentiated nodular/desmoplastic examples"
                  },
                  {
                    "text": "Posttreatment maturation and small cell depletion, some cases"
                  }
                ],
                "Sellar Gangliocytoma/Mixed Gangliocytoma-Adenoma": [
                  {
                    "text": "Site specific; sella turcica"
                  },
                  {
                    "text": "Varying population of adenoma cells, often hormone producingMost common somatotroph adenoma",
                    "sub_points": [
                      "Most common somatotroph adenoma"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "CNS Neoplasms: Nonglial Tumors": {
        "name": "CNS Neoplasms: Nonglial Tumors",
        "url": "https://app.pathprimer.com/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
        "topics": {
          "Meningioma": {
            "name": "Meningioma",
            "url": "https://app.pathprimer.com/document/af734990-b722-48e2-9fca-6156be9c8923/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most sporadic, few after irradiation, rare tumors associated with neurofibromatosis type 2 (NF2), schwannomatosis"
                  },
                  {
                    "text": "Clear cell meningiomas can be associated with germlineSMARCE1mutations"
                  },
                  {
                    "text": "Rhabdoid meningiomas can be associated with germlineBAP1mutations"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Peak: 65-75 years"
                  },
                  {
                    "text": "Located throughout CNS"
                  },
                  {
                    "text": "Recurrence risk increases with grade and incomplete resection"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Intensely enhancing with extension along dura (dural tail)"
                  },
                  {
                    "text": "Peritumoral edema may be seen with WHO grade 2 or 3 meningiomas or WHO grade 1 secretory, microcystic, angiomatous subtypes"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Multiple subtypes and histologic patterns"
                  },
                  {
                    "text": "Grading based on histologic subtype, brain invasion, mitotic rate, or algorithm using 5 histologic features"
                  },
                  {
                    "text": "Atypical meningioma (WHO grade 2) = 4 mitoses/10 HPForat least 3 of following 5 variables: Sheeting, small cells, macronucleoli, hypercellularity, necrosis;orbrain invasion;orclear cellorchordoid subtype"
                  },
                  {
                    "text": "Anaplastic meningioma (WHO grade 3) = ≥ 20 mitoses per 10 HPForovert malignant features resembling carcinoma, melanoma, sarcoma,orrhabdoidorpapillary subtype&/orhomozygousCDKN2A/Bdeletion&/orTERTpromoter mutation"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "SSTR2A(+), EMA(+) (may be weak or focal), dual E-cadherin/D2-40(+), vimentin (+), cytokeratin (+/-), S100(+/-)SSTR2A is more sensitive diagnostic marker than EMASSTR2A(+) in most meningiomas, even atypical, anaplastic",
                    "sub_points": [
                      "SSTR2A is more sensitive diagnostic marker than EMA",
                      "SSTR2A(+) in most meningiomas, even atypical, anaplastic"
                    ]
                  },
                  {
                    "text": "Unlike SFT, (-) for STAT6 nuclear (+)"
                  },
                  {
                    "text": "Loss of H3K27me3 is observed in ~ 10-20% of anaplastic meningioma and is associated with shorter overall survival"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Cytology (smears) often more specific than frozen sections"
                  },
                  {
                    "text": "Anaplastic meningiomas, often cytokeratin (+), can be confused with metastatic carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Neoplasm arising from meningothelial (arachnoid) cells, usually dural based"
                  },
                  {
                    "text": "WHO grade 1 (benign), 2 (atypical), or 3 (anaplastic)"
                  },
                  {
                    "text": "Presence of homozygousCDKN2A/Bdeletion &/orTERTpromoter mutation are evidence for meningioma, WHO grade 3"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "RadiationSurvivors of childhood leukemia and brain tumors; often interval of decade or more",
                    "sub_points": [
                      "Survivors of childhood leukemia and brain tumors; often interval of decade or more"
                    ]
                  }
                ],
                "Other Risk Factors/Syndromes": [
                  {
                    "text": "Neurofibromatosis type 2 (NF2)Multiple, potentially innumerableEarly onset, childhood",
                    "sub_points": [
                      "Multiple, potentially innumerable",
                      "Early onset, childhood"
                    ]
                  },
                  {
                    "text": "SchwannomatosisSMARCB1germline mutation5% of individuals with schwannomatosis develop meningiomas through mutation of SWI/SNF chromatin remodeling complex subunit,SMARCB1",
                    "sub_points": [
                      "SMARCB1germline mutation",
                      "5% of individuals with schwannomatosis develop meningiomas through mutation of SWI/SNF chromatin remodeling complex subunit,SMARCB1"
                    ]
                  },
                  {
                    "text": "Germline mutations inSMARCE1associated with multiple clear cell meningiomas"
                  },
                  {
                    "text": "Germline mutation inBAP1associated with subset of rhabdoid meningiomasPresence ofBAP1mutation correlates with prognosisTumor suppressor geneBAP1, ubiquitin carboxy-terminal hydrolase, inactivated in subset of high-grade rhabdoid meningiomas; patients with BAP1(-) rhabdoid meningiomas had reduced time to recurrence compared with patients with BAP1-retained rhabdoid meningiomas",
                    "sub_points": [
                      "Presence ofBAP1mutation correlates with prognosisTumor suppressor geneBAP1, ubiquitin carboxy-terminal hydrolase, inactivated in subset of high-grade rhabdoid meningiomas; patients with BAP1(-) rhabdoid meningiomas had reduced time to recurrence compared with patients with BAP1-retained rhabdoid meningiomas",
                      "Tumor suppressor geneBAP1, ubiquitin carboxy-terminal hydrolase, inactivated in subset of high-grade rhabdoid meningiomas; patients with BAP1(-) rhabdoid meningiomas had reduced time to recurrence compared with patients with BAP1-retained rhabdoid meningiomas"
                    ]
                  },
                  {
                    "text": "Other uncommon syndromes associated with increased meningioma riskNevoid basal cell carcinoma syndrome, multiple endocrine neoplasia type 1 (MEN1), Cowden syndrome, Werner syndrome, Rubinstein-Taybi syndrome",
                    "sub_points": [
                      "Nevoid basal cell carcinoma syndrome, multiple endocrine neoplasia type 1 (MEN1), Cowden syndrome, Werner syndrome, Rubinstein-Taybi syndrome"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Common; ~ 30% of primary intracranial tumors in some series"
                  }
                ],
                "Age": [
                  {
                    "text": "Peak: 65-75 yearsUncommon in childrenNF2 and other familial tumor predisposition syndromes should be sought in children with meningiomas",
                    "sub_points": [
                      "Uncommon in childrenNF2 and other familial tumor predisposition syndromes should be sought in children with meningiomas",
                      "NF2 and other familial tumor predisposition syndromes should be sought in children with meningiomas"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "F:M = 2:1Spinal, F:M ~ 10:1",
                    "sub_points": [
                      "Spinal, F:M ~ 10:1"
                    ]
                  },
                  {
                    "text": "In atypical and anaplastic tumors, M > F"
                  },
                  {
                    "text": "Equal sex distribution in hereditary syndromes; equal sex distribution or slight M > F for pediatric meningiomas"
                  }
                ],
                "Site": [
                  {
                    "text": "Parasagittal, convexities, sphenoid ridgeFalcine tumors sometimes bilateral",
                    "sub_points": [
                      "Falcine tumors sometimes bilateral"
                    ]
                  },
                  {
                    "text": "Posterior fossa (10%)"
                  },
                  {
                    "text": "Optic nerve sheath (uncommon)"
                  },
                  {
                    "text": "Intraventricular (uncommon)"
                  },
                  {
                    "text": "Spinal (10%)Rare below thoracic level, then often clear cell type",
                    "sub_points": [
                      "Rare below thoracic level, then often clear cell type"
                    ]
                  },
                  {
                    "text": "Ectopic: Intraosseous, scalp, sinuses, parotid, parapharyngeal space, mediastinum, lung, adrenal"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Location dependentParasagittal: Headache, seizures, monoparesis of contralateral legAnterior falx: Headache, optic atrophy, personality changesFrontal skull base: Impaired vision, headache, anosmia, mental changesLateral sphenoid wing: Painless unilateral exophthalmos, unilateral loss of vision and hearingOptic nerve: Exophthalmos, monocular loss of visionSpinal cord: Pain, Brown-Séquard syndrome",
                    "sub_points": [
                      "Parasagittal: Headache, seizures, monoparesis of contralateral leg",
                      "Anterior falx: Headache, optic atrophy, personality changes",
                      "Frontal skull base: Impaired vision, headache, anosmia, mental changes",
                      "Lateral sphenoid wing: Painless unilateral exophthalmos, unilateral loss of vision and hearing",
                      "Optic nerve: Exophthalmos, monocular loss of vision",
                      "Spinal cord: Pain, Brown-Séquard syndrome"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Who grade 1: Grows slowly and compresses adjacent structures"
                  },
                  {
                    "text": "Who grade 2: Variable, some recur or invade brain"
                  },
                  {
                    "text": "Who grade 3 Sarcoma-like; recur, invade, and may metastasize to lung, liver, bone, lymph nodes, etc."
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Observation when stable, especially if densely calcified"
                  },
                  {
                    "text": "Gross total resection is treatment of choice"
                  },
                  {
                    "text": "Preoperative embolizationMore often required in higher grade meningiomas",
                    "sub_points": [
                      "More often required in higher grade meningiomas"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Limited efficacy in recurrent tumors"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Most incompletely excised WHO grade 2 tumors, all WHO grade 3 tumors; stereotactic radiosurgery (gamma knife) for critically located and skull base tumors"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent for completely excised WHO grade 1 and 2 tumors"
                  },
                  {
                    "text": "Poor for WHO grade 3 anaplastic tumors"
                  },
                  {
                    "text": "Recurrence risk increases with grade and presence of residual tumor"
                  },
                  {
                    "text": "Skull base meningiomas often recur"
                  },
                  {
                    "text": "Brain invasion occurs most often in meningiomas with additional high-grade features, adverse prognosis in such casesBrain invasion in gross totally resected, otherwise benign-appearing meningiomas remain controversial: Recurrence rates similar to other WHO grade 2 meningiomas in some, but not all, studies",
                    "sub_points": [
                      "Brain invasion in gross totally resected, otherwise benign-appearing meningiomas remain controversial: Recurrence rates similar to other WHO grade 2 meningiomas in some, but not all, studies"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Isointense to gray matter on T1WI"
                  },
                  {
                    "text": "Isointense to cortex on T2WI (most cases)Most CNS tumors hyperintense (i.e., bright)",
                    "sub_points": [
                      "Most CNS tumors hyperintense (i.e., bright)"
                    ]
                  },
                  {
                    "text": "Hypointense, dark, fibrous type, due to collagen and calcium"
                  },
                  {
                    "text": "Intensely enhancingExtension along dura (dural tail)Most meningiomas but not specific",
                    "sub_points": [
                      "Extension along dura (dural tail)Most meningiomas but not specific",
                      "Most meningiomas but not specific"
                    ]
                  },
                  {
                    "text": "Peritumoral edemaCommon inWHO grades 2 and 3Microcystic, angiomatous, secretory types often associated with edema but almost always WHO grade 1",
                    "sub_points": [
                      "Common inWHO grades 2 and 3Microcystic, angiomatous, secretory types often associated with edema but almost always WHO grade 1",
                      "WHO grades 2 and 3",
                      "Microcystic, angiomatous, secretory types often associated with edema but almost always WHO grade 1"
                    ]
                  },
                  {
                    "text": "Macrocyst, in some cases, especially microcystic subtype"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Calcifications, highest incidence in spinal tumors"
                  },
                  {
                    "text": "Hyperostosis of adjacent skull but not spine"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Broad based with dural attachment in most casesGritty, especially psammomatous spinal tumorsSometimes gelatinous or cystic",
                    "sub_points": [
                      "Gritty, especially psammomatous spinal tumors",
                      "Sometimes gelatinous or cystic"
                    ]
                  },
                  {
                    "text": "Solid, globular, circumscribedFlat, plate-like (en plaque) variant",
                    "sub_points": [
                      "Flat, plate-like (en plaque) variant"
                    ]
                  },
                  {
                    "text": "Bilobed, dumbbell-shaped (falcine or tentorial)"
                  },
                  {
                    "text": "Atypical and anaplastic types often attached to brainInfrequent in WHO grade 1 except for microcystic subtype",
                    "sub_points": [
                      "Infrequent in WHO grade 1 except for microcystic subtype"
                    ]
                  },
                  {
                    "text": "Fibrous types especially smooth surfaced"
                  },
                  {
                    "text": "Microcystic typesMacrocystic in minority of casesOften attached to edematous brainSometimes embedded in brain",
                    "sub_points": [
                      "Macrocystic in minority of cases",
                      "Often attached to edematous brain",
                      "Sometimes embedded in brain"
                    ]
                  },
                  {
                    "text": "Adjacent skull often thickened± tumor invasion",
                    "sub_points": [
                      "± tumor invasion"
                    ]
                  },
                  {
                    "text": "Invasion of superior sagittal sinus with parasagittal tumors"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "BordersWith brainGenerally sharp, pushingPerivascular extension (Virchow-Robin space) difficult to distinguish from true invasion in random sectionsCortical invasion, WHO grade 2 (and 3)With bone, soft tissuesEven WHO grade 1 meningiomas often infiltrate skull but rarely spineAssociated hyperostosis, not osteolysis",
                    "sub_points": [
                      "With brainGenerally sharp, pushingPerivascular extension (Virchow-Robin space) difficult to distinguish from true invasion in random sectionsCortical invasion, WHO grade 2 (and 3)",
                      "Generally sharp, pushing",
                      "Perivascular extension (Virchow-Robin space) difficult to distinguish from true invasion in random sections",
                      "Cortical invasion, WHO grade 2 (and 3)",
                      "With bone, soft tissuesEven WHO grade 1 meningiomas often infiltrate skull but rarely spineAssociated hyperostosis, not osteolysis",
                      "Even WHO grade 1 meningiomas often infiltrate skull but rarely spine",
                      "Associated hyperostosis, not osteolysis"
                    ]
                  },
                  {
                    "text": "MeningothelialLobules of cells with ample cytoplasm and indistinct borders (syncytia)Nuclear pseudoinclusions (cytoplasmic invaginations)Homogeneous, light gray nuclei",
                    "sub_points": [
                      "Lobules of cells with ample cytoplasm and indistinct borders (syncytia)",
                      "Nuclear pseudoinclusions (cytoplasmic invaginations)",
                      "Homogeneous, light gray nuclei"
                    ]
                  },
                  {
                    "text": "Fibrous (fibroblastic)Spindle-shaped cells in fasciclesVariable collagen and reticulin contentLinear stromal calcifications",
                    "sub_points": [
                      "Spindle-shaped cells in fascicles",
                      "Variable collagen and reticulin content",
                      "Linear stromal calcifications"
                    ]
                  },
                  {
                    "text": "TransitionalMixed meningothelial and fibrous featuresWhorls and psammoma bodies common",
                    "sub_points": [
                      "Mixed meningothelial and fibrous features",
                      "Whorls and psammoma bodies common"
                    ]
                  },
                  {
                    "text": "PsammomatousAbundant psammoma bodiesFew meningothelial cells in some cases",
                    "sub_points": [
                      "Abundant psammoma bodiesFew meningothelial cells in some cases",
                      "Few meningothelial cells in some cases"
                    ]
                  },
                  {
                    "text": "AngiomatousInnumerable blood vesselsLarge, thick blood vessels mimic vascular malformation; small vessels mimic hemangioblastoma",
                    "sub_points": [
                      "Innumerable blood vesselsLarge, thick blood vessels mimic vascular malformation; small vessels mimic hemangioblastoma",
                      "Large, thick blood vessels mimic vascular malformation; small vessels mimic hemangioblastoma"
                    ]
                  },
                  {
                    "text": "MicrocysticLoose texture, intercellular spacesFoci of classic meningioma patterns present or notFoamy cellsNuclear pleomorphism, scattered cells, mimic hemangioblastomaThickened, hyalinized vesselsOften histologic overlaps with angiomatous subtype (distinction unimportant clinically)",
                    "sub_points": [
                      "Loose texture, intercellular spaces",
                      "Foci of classic meningioma patterns present or not",
                      "Foamy cells",
                      "Nuclear pleomorphism, scattered cells, mimic hemangioblastoma",
                      "Thickened, hyalinized vesselsOften histologic overlaps with angiomatous subtype (distinction unimportant clinically)",
                      "Often histologic overlaps with angiomatous subtype (distinction unimportant clinically)"
                    ]
                  },
                  {
                    "text": "SecretoryPseudopsammoma bodies in meningothelial cellsSmall, eosinophilic spheresProteinaceous material, not calcified",
                    "sub_points": [
                      "Pseudopsammoma bodies in meningothelial cellsSmall, eosinophilic spheresProteinaceous material, not calcified",
                      "Small, eosinophilic spheres",
                      "Proteinaceous material, not calcified"
                    ]
                  },
                  {
                    "text": "Lymphoplasmacyte richClassic meningioma with abundant chronic inflammationLymphocytes, plasma cells, sometime abundant histiocytesMore appropriate name may be inflammation-rich meningioma",
                    "sub_points": [
                      "Classic meningioma with abundant chronic inflammation",
                      "Lymphocytes, plasma cells, sometime abundant histiocytes",
                      "More appropriate name may be inflammation-rich meningioma"
                    ]
                  },
                  {
                    "text": "MetaplasticNot single histologic typeLipomatous, xanthomatous, cartilaginous, myxoid, osseousLipomatous closely resembles normal adipose tissueMyxoid meningioma composed of elongate cells embedded in mucinNot epithelial chordoma-like cells, as in chordoid meningiomaSclerosing meningioma rare subtype not specifically designatedFibrosis may completely overshadow scant interspersed meningioma cellsSome show differing neuroimaging features than conventional meningioma",
                    "sub_points": [
                      "Not single histologic type",
                      "Lipomatous, xanthomatous, cartilaginous, myxoid, osseousLipomatous closely resembles normal adipose tissueMyxoid meningioma composed of elongate cells embedded in mucinNot epithelial chordoma-like cells, as in chordoid meningioma",
                      "Lipomatous closely resembles normal adipose tissue",
                      "Myxoid meningioma composed of elongate cells embedded in mucinNot epithelial chordoma-like cells, as in chordoid meningioma",
                      "Not epithelial chordoma-like cells, as in chordoid meningioma",
                      "Sclerosing meningioma rare subtype not specifically designatedFibrosis may completely overshadow scant interspersed meningioma cellsSome show differing neuroimaging features than conventional meningioma",
                      "Fibrosis may completely overshadow scant interspersed meningioma cells",
                      "Some show differing neuroimaging features than conventional meningioma"
                    ]
                  },
                  {
                    "text": "Chordoid, WHO grade 2Epithelial, chordoma-like formationsUsually have other features fulfilling criteria for WHO grade 2Percentage of chordoid component required unclear but more than just focalMay increase in percentage with multiple recurrencesPrognosis parallels WHO grade 2 when > 50% of tumor shows these featuresRarely pure, usually associated with conventional meningioma",
                    "sub_points": [
                      "Epithelial, chordoma-like formations",
                      "Usually have other features fulfilling criteria for WHO grade 2",
                      "Percentage of chordoid component required unclear but more than just focalMay increase in percentage with multiple recurrencesPrognosis parallels WHO grade 2 when > 50% of tumor shows these features",
                      "May increase in percentage with multiple recurrences",
                      "Prognosis parallels WHO grade 2 when > 50% of tumor shows these features",
                      "Rarely pure, usually associated with conventional meningioma"
                    ]
                  },
                  {
                    "text": "Clear cell, WHO grade 2MonomorphousClear, glycogen-rich, PAS(+) cytoplasmProminent perivascular and interstitial hyalinizationCollagen blocks obliterate pattern with timeOften exists in pure formFew, if any, whorls, no psammoma bodies or nuclear inclusions",
                    "sub_points": [
                      "Monomorphous",
                      "Clear, glycogen-rich, PAS(+) cytoplasm",
                      "Prominent perivascular and interstitial hyalinization",
                      "Collagen blocks obliterate pattern with time",
                      "Often exists in pure form",
                      "Few, if any, whorls, no psammoma bodies or nuclear inclusions"
                    ]
                  },
                  {
                    "text": "Rhabdoid, WHO grade 3Rhabdoid cellsEccentric nuclei, prominent nucleoliEosinophilic cytoplasmic paranuclear whorlIncreased mitoses and Ki-67 index should be present in true rhabdoid casesRarely pure, usually associated with conventional meningioma, sometimes with papillary featuresSignificance of rhabdoid features in absence of concomitant atypia and mitoses unclearRhabdoid cell percentage was not associated with recurrence in one large studyOne large study suggests rhabdoid meningiomas should be graded analogously to nonrhabdoid tumors with caution that some may still behave aggressively, and close follow-up is recommendedCases in which inclusions consist of accumulations of complex interdigitating cell processes rather than intermediate filaments not true prognostically adverse rhabdoid meningiomaAdverse prognosis in cases withBAP1association",
                    "sub_points": [
                      "Rhabdoid cellsEccentric nuclei, prominent nucleoliEosinophilic cytoplasmic paranuclear whorl",
                      "Eccentric nuclei, prominent nucleoli",
                      "Eosinophilic cytoplasmic paranuclear whorl",
                      "Increased mitoses and Ki-67 index should be present in true rhabdoid cases",
                      "Rarely pure, usually associated with conventional meningioma, sometimes with papillary features",
                      "Significance of rhabdoid features in absence of concomitant atypia and mitoses unclearRhabdoid cell percentage was not associated with recurrence in one large studyOne large study suggests rhabdoid meningiomas should be graded analogously to nonrhabdoid tumors with caution that some may still behave aggressively, and close follow-up is recommendedCases in which inclusions consist of accumulations of complex interdigitating cell processes rather than intermediate filaments not true prognostically adverse rhabdoid meningioma",
                      "Rhabdoid cell percentage was not associated with recurrence in one large study",
                      "One large study suggests rhabdoid meningiomas should be graded analogously to nonrhabdoid tumors with caution that some may still behave aggressively, and close follow-up is recommended",
                      "Cases in which inclusions consist of accumulations of complex interdigitating cell processes rather than intermediate filaments not true prognostically adverse rhabdoid meningioma",
                      "Adverse prognosis in cases withBAP1association"
                    ]
                  },
                  {
                    "text": "Papillary, WHO grade 3Perivascular pseudorosettesRarely pure, usually associated with atypical meningioma elementSometimes associated with rhabdoid features",
                    "sub_points": [
                      "Perivascular pseudorosettes",
                      "Rarely pure, usually associated with atypical meningioma element",
                      "Sometimes associated with rhabdoid features"
                    ]
                  },
                  {
                    "text": "Rare tissue patternsOncocytic (mitochondrion rich)Granular cytoplasmMeningioma with meningioangiomatosisUsually children or young adultsPerivascular proliferation of elongated, fibroblast-like cells and meningothelial cellsMay mimic brain invasion and thus meningioma WHO grade 2Trapped islands of cortex with preserved ganglion cells; neurofibrillary tangles in some; psammoma bodiesEpithelioidCords or small lobules resembling glandular differentiation (rare)Secretory subtypeMetastasis to meningiomaBreast carcinoma most common",
                    "sub_points": [
                      "Oncocytic (mitochondrion rich)Granular cytoplasm",
                      "Granular cytoplasm",
                      "Meningioma with meningioangiomatosisUsually children or young adultsPerivascular proliferation of elongated, fibroblast-like cells and meningothelial cellsMay mimic brain invasion and thus meningioma WHO grade 2Trapped islands of cortex with preserved ganglion cells; neurofibrillary tangles in some; psammoma bodies",
                      "Usually children or young adults",
                      "Perivascular proliferation of elongated, fibroblast-like cells and meningothelial cells",
                      "May mimic brain invasion and thus meningioma WHO grade 2",
                      "Trapped islands of cortex with preserved ganglion cells; neurofibrillary tangles in some; psammoma bodies",
                      "EpithelioidCords or small lobules resembling glandular differentiation (rare)Secretory subtype",
                      "Cords or small lobules resembling glandular differentiation (rare)",
                      "Secretory subtype",
                      "Metastasis to meningiomaBreast carcinoma most common",
                      "Breast carcinoma most common"
                    ]
                  },
                  {
                    "text": "Miscellaneous featuresDural venous sinus invasion, including of superior sagittal sinus, of no prognostic significanceInvasion of dura itself does not affect gradingInvasion of soft tissue, even sinuses or orbit, does not affect gradingSystemic metastasesUsually WHO grade 3, but \"benign metastasizing meningioma\" reportedLung most common siteOther sites: Liver, lymph nodes, bonePostembolization, intravascular embolic materialIncreased perinecrotic, mitoses, and Ki-67Dural tail on imagingClustered vessels or tumorPetaloid, tyrosine-rich crystals (rare)Nuclear hyperchromatism, enlargement, atypia not grading criterionOften occurs in microcystic meningiomas",
                    "sub_points": [
                      "Dural venous sinus invasion, including of superior sagittal sinus, of no prognostic significanceInvasion of dura itself does not affect gradingInvasion of soft tissue, even sinuses or orbit, does not affect grading",
                      "Invasion of dura itself does not affect grading",
                      "Invasion of soft tissue, even sinuses or orbit, does not affect grading",
                      "Systemic metastasesUsually WHO grade 3, but \"benign metastasizing meningioma\" reportedLung most common siteOther sites: Liver, lymph nodes, bone",
                      "Usually WHO grade 3, but \"benign metastasizing meningioma\" reported",
                      "Lung most common site",
                      "Other sites: Liver, lymph nodes, bone",
                      "Postembolization, intravascular embolic materialIncreased perinecrotic, mitoses, and Ki-67",
                      "Increased perinecrotic, mitoses, and Ki-67",
                      "Dural tail on imagingClustered vessels or tumor",
                      "Clustered vessels or tumor",
                      "Petaloid, tyrosine-rich crystals (rare)",
                      "Nuclear hyperchromatism, enlargement, atypia not grading criterionOften occurs in microcystic meningiomas",
                      "Often occurs in microcystic meningiomas"
                    ]
                  },
                  {
                    "text": "Grading criteriaMitoses≤ 3 mitoses per 10 HPF: WHO grade 1; ≥ 4 mitoses per 10 HPF: WHO grade 2; ≥ 20 mitoses per 10 HPF: WHO grade 3Mitoses increased around foci of embolic necrosisBrain invasion: WHO grade 2Presence of ≥ 3 of 5 cytoarchitectural features listed: WHO grade 2Spontaneous necrosis1 of 5 cytoarchitectural grading criteria for atypical meningiomaNecrosis as single factor in otherwise WHO grade 1 meningiomas suggested to predict recurrenceNecrosis to be used as grading criterion should be spontaneous, small stellate areas of necrosisLarge areas of ischemic necrosis, either spontaneous or postembolization, not predictive of prognosisEmbolization for meningioma more likely required for those of higher gradeIn large study, embolized meningiomas showed higher frequencies of necrosis (89%), nuclear atypia (72%), macronucleoli (58%), sheeting (31%), high mitotic index (30%), brain invasion (14%) compared with nonembolized counterpartsHistologic features likely reflect patient selection biases rather than artifacts induced by embolization procedureGrading parameters can still be utilized effectively after embolizationProminent nucleoli1 of 5 cytoarchitectural grading criteria for atypical meningiomaShould be detectable at 10x magnificationHypercellularity1 of 5 cytoarchitectural grading criteria for atypical meningiomaDefined as > 52 cells across single HPF (40x)Small cell formation1 of 5 cytoarchitectural grading criteria for atypical meningiomaCells with high nuclear:cytoplasmic ratiosSheeting architecture1 of 5 cytoarchitectural grading criteria for atypical meningiomaStreaming of cells, loss of whorls or fibroblastic patternPresence of homozygousCDKN2A/Bdeletion &/orTERTpromoter mutation are evidence for meningioma, WHO grade 3",
                    "sub_points": [
                      "Mitoses≤ 3 mitoses per 10 HPF: WHO grade 1; ≥ 4 mitoses per 10 HPF: WHO grade 2; ≥ 20 mitoses per 10 HPF: WHO grade 3Mitoses increased around foci of embolic necrosis",
                      "≤ 3 mitoses per 10 HPF: WHO grade 1; ≥ 4 mitoses per 10 HPF: WHO grade 2; ≥ 20 mitoses per 10 HPF: WHO grade 3",
                      "Mitoses increased around foci of embolic necrosis",
                      "Brain invasion: WHO grade 2",
                      "Presence of ≥ 3 of 5 cytoarchitectural features listed: WHO grade 2",
                      "Spontaneous necrosis1 of 5 cytoarchitectural grading criteria for atypical meningiomaNecrosis as single factor in otherwise WHO grade 1 meningiomas suggested to predict recurrenceNecrosis to be used as grading criterion should be spontaneous, small stellate areas of necrosisLarge areas of ischemic necrosis, either spontaneous or postembolization, not predictive of prognosisEmbolization for meningioma more likely required for those of higher gradeIn large study, embolized meningiomas showed higher frequencies of necrosis (89%), nuclear atypia (72%), macronucleoli (58%), sheeting (31%), high mitotic index (30%), brain invasion (14%) compared with nonembolized counterpartsHistologic features likely reflect patient selection biases rather than artifacts induced by embolization procedureGrading parameters can still be utilized effectively after embolization",
                      "1 of 5 cytoarchitectural grading criteria for atypical meningioma",
                      "Necrosis as single factor in otherwise WHO grade 1 meningiomas suggested to predict recurrence",
                      "Necrosis to be used as grading criterion should be spontaneous, small stellate areas of necrosis",
                      "Large areas of ischemic necrosis, either spontaneous or postembolization, not predictive of prognosis",
                      "Embolization for meningioma more likely required for those of higher gradeIn large study, embolized meningiomas showed higher frequencies of necrosis (89%), nuclear atypia (72%), macronucleoli (58%), sheeting (31%), high mitotic index (30%), brain invasion (14%) compared with nonembolized counterpartsHistologic features likely reflect patient selection biases rather than artifacts induced by embolization procedureGrading parameters can still be utilized effectively after embolization",
                      "In large study, embolized meningiomas showed higher frequencies of necrosis (89%), nuclear atypia (72%), macronucleoli (58%), sheeting (31%), high mitotic index (30%), brain invasion (14%) compared with nonembolized counterparts",
                      "Histologic features likely reflect patient selection biases rather than artifacts induced by embolization procedure",
                      "Grading parameters can still be utilized effectively after embolization",
                      "Prominent nucleoli1 of 5 cytoarchitectural grading criteria for atypical meningiomaShould be detectable at 10x magnification",
                      "1 of 5 cytoarchitectural grading criteria for atypical meningioma",
                      "Should be detectable at 10x magnification",
                      "Hypercellularity1 of 5 cytoarchitectural grading criteria for atypical meningiomaDefined as > 52 cells across single HPF (40x)",
                      "1 of 5 cytoarchitectural grading criteria for atypical meningioma",
                      "Defined as > 52 cells across single HPF (40x)",
                      "Small cell formation1 of 5 cytoarchitectural grading criteria for atypical meningiomaCells with high nuclear:cytoplasmic ratios",
                      "1 of 5 cytoarchitectural grading criteria for atypical meningioma",
                      "Cells with high nuclear:cytoplasmic ratios",
                      "Sheeting architecture1 of 5 cytoarchitectural grading criteria for atypical meningiomaStreaming of cells, loss of whorls or fibroblastic pattern",
                      "1 of 5 cytoarchitectural grading criteria for atypical meningioma",
                      "Streaming of cells, loss of whorls or fibroblastic pattern",
                      "Presence of homozygousCDKN2A/Bdeletion &/orTERTpromoter mutation are evidence for meningioma, WHO grade 3"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Often more specific than frozen sectionsSmears well: Tissue fragments and some individual cellsWhorls, psammoma bodiesNuclear pseudoinclusionsClear (washed out) chromatinLinear cytoplasmic streakingDegenerative atypia (in some cases)NucleoliSmall: WHO grade 1Larger: WHO grades 2 and 3 (some)",
                    "sub_points": [
                      "Smears well: Tissue fragments and some individual cells",
                      "Whorls, psammoma bodies",
                      "Nuclear pseudoinclusions",
                      "Clear (washed out) chromatin",
                      "Linear cytoplasmic streaking",
                      "Degenerative atypia (in some cases)",
                      "NucleoliSmall: WHO grade 1Larger: WHO grades 2 and 3 (some)",
                      "Small: WHO grade 1",
                      "Larger: WHO grades 2 and 3 (some)"
                    ]
                  },
                  {
                    "text": "Cellular elongation, fibrous type"
                  },
                  {
                    "text": "Nuclear pleomorphism and vacuolated tumor cells, microcystic variant"
                  },
                  {
                    "text": "Small cell change, some WHO grade 2 types"
                  },
                  {
                    "text": "Pseudopsammoma bodies, secretory variant"
                  },
                  {
                    "text": "Short cords of cells in myxoid matrix, chordoid subtype"
                  },
                  {
                    "text": "Perivascular pseudorosettes, papillary subtype"
                  },
                  {
                    "text": "Rhabdoid cells, rhabdoid variant"
                  },
                  {
                    "text": "Mitoses in WHO grades 2 and 3"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "EMA(+)Almost all, but may be focal/weak especially in fibrous subtype and higher grade meningiomasMembrane pattern",
                    "sub_points": [
                      "Almost all, but may be focal/weak especially in fibrous subtype and higher grade meningiomas",
                      "Membrane pattern"
                    ]
                  },
                  {
                    "text": "CytokeratinsCK18(+), in ~ 2/3 of cases; CK20(-); other CKs variably and focally (+); secretory type, routinely (+) in pseudopsammoma bodies, CK7, CK8, CK18, CK19, and AE1/AE3",
                    "sub_points": [
                      "CK18(+), in ~ 2/3 of cases; CK20(-); other CKs variably and focally (+); secretory type, routinely (+) in pseudopsammoma bodies, CK7, CK8, CK18, CK19, and AE1/AE3"
                    ]
                  },
                  {
                    "text": "CEASecretory subtype (+) in and around pseudopsammoma bodies",
                    "sub_points": [
                      "Secretory subtype (+) in and around pseudopsammoma bodies"
                    ]
                  },
                  {
                    "text": "Steroid receptorsProgesterone receptorsVariable percentage of (+) cells, from none to almost all(-) staining does not rule out meningiomaLess likely (+) in anaplastic typesEstrogen receptorsUsually (-)",
                    "sub_points": [
                      "Progesterone receptorsVariable percentage of (+) cells, from none to almost all(-) staining does not rule out meningiomaLess likely (+) in anaplastic types",
                      "Variable percentage of (+) cells, from none to almost all",
                      "(-) staining does not rule out meningioma",
                      "Less likely (+) in anaplastic types",
                      "Estrogen receptorsUsually (-)",
                      "Usually (-)"
                    ]
                  },
                  {
                    "text": "S100 variably (+)Usually not strongly and diffusely, including nuclei, like schwannoma",
                    "sub_points": [
                      "Usually not strongly and diffusely, including nuclei, like schwannoma"
                    ]
                  },
                  {
                    "text": "Vimentin (+) in almost all cases; little diagnostic valueHighlights intracytoplasmic inclusion in rhabdoid meningiomas",
                    "sub_points": [
                      "Highlights intracytoplasmic inclusion in rhabdoid meningiomas"
                    ]
                  },
                  {
                    "text": "Ki-67Considerable intra- and intertumoral variationWHO grade 1 lesions usually ≤ 5%No defined threshold for WHO grade 1 vs. WHO grade 2 or WHO grade 2 vs. WHO grade 3One metaanalysis suggests > 4% is associated with worse prognosisHigh in WHO grade 3",
                    "sub_points": [
                      "Considerable intra- and intertumoral variation",
                      "WHO grade 1 lesions usually ≤ 5%",
                      "No defined threshold for WHO grade 1 vs. WHO grade 2 or WHO grade 2 vs. WHO grade 3One metaanalysis suggests > 4% is associated with worse prognosis",
                      "One metaanalysis suggests > 4% is associated with worse prognosis",
                      "High in WHO grade 3"
                    ]
                  },
                  {
                    "text": "Meningiomas have dual immunoreactivity for D2-40 (podoplanin) and E-cadherinMany tumor types are immunoreactive for one or the other but not bothPaired IHC(+) can be superior to EMA, even in unusual meningioma subtypes",
                    "sub_points": [
                      "Many tumor types are immunoreactive for one or the other but not both",
                      "Paired IHC(+) can be superior to EMA, even in unusual meningioma subtypes"
                    ]
                  },
                  {
                    "text": "SSTR2ADiffuse strong membranous, cytoplasmic immunoreactivitySuperior to EMA, even in unusual meningioma subtypesOverall best IHC for meningioma identification in most laboratories",
                    "sub_points": [
                      "Diffuse strong membranous, cytoplasmic immunoreactivity",
                      "Superior to EMA, even in unusual meningioma subtypes",
                      "Overall best IHC for meningioma identification in most laboratories"
                    ]
                  },
                  {
                    "text": "Loss of H3K27me3 observed in ~ 10-20% of anaplastic meningioma and is associated with shorter overall survival"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "LOH 22q12.2 (monosomy 22) and mutation of retainedNF2allele most frequent abnormality: Seen in fibrous, transitional, psammomatous subtypesOther classic drivers of conventional meningioma:TRAF7,AKT1,KLF4,SMO,PIK3CAChromosome 5 gain seen in large number of angiomatous, microcystic, and metaplastic meningiomasCombinedTRAF7andKLF4mutations characterize secretory subtypeGermline mutations inSMARCE1identified as cause of multiple clear cell meningiomas;SMARCE1somatic mutations also common in clear cell meningiomasBAP1in rhabdoid meningiomas",
                    "sub_points": [
                      "Other classic drivers of conventional meningioma:TRAF7,AKT1,KLF4,SMO,PIK3CA",
                      "Chromosome 5 gain seen in large number of angiomatous, microcystic, and metaplastic meningiomas",
                      "CombinedTRAF7andKLF4mutations characterize secretory subtype",
                      "Germline mutations inSMARCE1identified as cause of multiple clear cell meningiomas;SMARCE1somatic mutations also common in clear cell meningiomas",
                      "BAP1in rhabdoid meningiomas"
                    ]
                  },
                  {
                    "text": "Losses of 1p, 6q, 10, 14q, and 18q: Atypical or anaplastic typesLosses of 6q and 14q (e.g.,MEG3,NDRG2) especially important",
                    "sub_points": [
                      "Losses of 6q and 14q (e.g.,MEG3,NDRG2) especially important"
                    ]
                  },
                  {
                    "text": "Gains or amplifications of 1q, 9q, 12q, 15q, 17q, and 20q: Atypical or anaplastic types"
                  },
                  {
                    "text": "Overall higher proportion of copy number alterations in meningiomas with unfavorable prognosisOne study showed recurrent losses of 1p, 6q, 14q and 18q, and gain of 1q (all previously identified as indicators of poor outcome)",
                    "sub_points": [
                      "One study showed recurrent losses of 1p, 6q, 14q and 18q, and gain of 1q (all previously identified as indicators of poor outcome)"
                    ]
                  },
                  {
                    "text": "Loss of 1p and 7p in radiation-induced tumors"
                  },
                  {
                    "text": "TERTpromoter mutation &/or homozygousCDKN2A/CDKN2Bdeletion now definitional of anaplastic, WHO grade 3 meningiomasDistinction of homozygous vs. hemizygous deletion is difficult on FISH testing due to probe sizeGenetic features may or may not be in combination with histology resembling carcinoma, sarcoma, or melanoma &/or markedly elevated mitotic rate",
                    "sub_points": [
                      "Distinction of homozygous vs. hemizygous deletion is difficult on FISH testing due to probe size",
                      "Genetic features may or may not be in combination with histology resembling carcinoma, sarcoma, or melanoma &/or markedly elevated mitotic rate"
                    ]
                  },
                  {
                    "text": "Methylation ofMGMTpromoter uncommonNo rationale to test meningiomas forMGMTmethylation status in clinical setting",
                    "sub_points": [
                      "No rationale to test meningiomas forMGMTmethylation status in clinical setting"
                    ]
                  },
                  {
                    "text": "5% of individuals with schwannomatosis develop meningiomas through mutation of SWI/SNF chromatin remodeling complex subunit,SMARCB1"
                  },
                  {
                    "text": "DNA methylationStudies suggest that compared with WHO grading, classification by individual and combined methylation classes more accurately identifies patients at high risk of disease progression in tumors with WHO grade 1 histology, and patients at lower risk of recurrence among WHO grade 2 tumors",
                    "sub_points": [
                      "Studies suggest that compared with WHO grading, classification by individual and combined methylation classes more accurately identifies patients at high risk of disease progression in tumors with WHO grade 1 histology, and patients at lower risk of recurrence among WHO grade 2 tumors"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Interdigitating cell membranes"
                  },
                  {
                    "text": "Cytoplasmic intermediate filaments, vimentin"
                  },
                  {
                    "text": "Desmosomes"
                  },
                  {
                    "text": "Microlumina with microvilli (secretory subtype)"
                  },
                  {
                    "text": "Intracytoplasmic mass of intermediate filaments (rhabdoid subtype)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Meningothelial Hyperplasia": [
                  {
                    "text": "Adjacent lesion prompting proliferationAdjacent hemorrhageInflammationDifficult distinction from lymphoplasmacytic meningioma (in some cases)",
                    "sub_points": [
                      "Adjacent hemorrhage",
                      "InflammationDifficult distinction from lymphoplasmacytic meningioma (in some cases)",
                      "Difficult distinction from lymphoplasmacytic meningioma (in some cases)"
                    ]
                  },
                  {
                    "text": "Small, not large, compact mass of meningothelial cells"
                  }
                ],
                "Schwannoma": [
                  {
                    "text": "Smears poorlyTissue fragments onlyFascicular architectureClub-shaped nuclei",
                    "sub_points": [
                      "Tissue fragments onlyFascicular architectureClub-shaped nuclei",
                      "Fascicular architecture",
                      "Club-shaped nuclei"
                    ]
                  },
                  {
                    "text": "S100(+), SOX10(+), EMA(-), SSTR2A(-)"
                  },
                  {
                    "text": "Collagen IV (+) and reticulin (+), pericellular"
                  }
                ],
                "Chordoma": [
                  {
                    "text": "Midline; bone destruction; physaliphorous cells; brachyury (+), keratin (+), EMA(+); S100(+/-)"
                  }
                ],
                "Hemangioblastoma": [
                  {
                    "text": "Rare supratentorially; no whorls or psammoma bodies; extensive reticulin in reticular variant; inhibin-α (+) stromal cells"
                  },
                  {
                    "text": "Few, if any, EMA(+) cells"
                  }
                ],
                "Melanocytoma": [
                  {
                    "text": "Nested architecture; melanin variable"
                  },
                  {
                    "text": "HMB-45, Melan-A, S100, SOX10 (+); EMA, SSTR2A (-)"
                  }
                ],
                "Meningioangiomatosis": [
                  {
                    "text": "Intracortical, plaque-like"
                  },
                  {
                    "text": "Abundant trapped brain with ganglion cells"
                  },
                  {
                    "text": "Perivascular meningothelial and spindle cells"
                  },
                  {
                    "text": "Associated with meningioma in some cases"
                  }
                ],
                "Solitary Fibrous Tumor": [
                  {
                    "text": "Collagen strips between spindle cells, solitary fibrous tumor morphology"
                  },
                  {
                    "text": "Reticulin-rich, hemangiopericytoma-morphology"
                  },
                  {
                    "text": "No calcifications or psammoma bodies"
                  },
                  {
                    "text": "CD34(+)Solitary fibrous tumor (SFT): DiffuseHemangiopericytoma (HPC): Variable, may be (-)",
                    "sub_points": [
                      "Solitary fibrous tumor (SFT): Diffuse",
                      "Hemangiopericytoma (HPC): Variable, may be (-)"
                    ]
                  },
                  {
                    "text": "EMA(-), except focally in loose textured areas"
                  },
                  {
                    "text": "STAT6 nuclear IHC(+) due toSTAT6::NAB2fusion and STAT6 nuclear translocation (not seen in meningiomas)"
                  }
                ],
                "Metastatic Carcinoma": [
                  {
                    "text": "Strong cytokeratin (+) vs. mostly (-) meningiomas"
                  }
                ],
                "Primary Hematopoietic Diseases": [
                  {
                    "text": "Rosai-Dorfman disease: Large, S100(+) histiocytes; emperipolesis"
                  }
                ],
                "Meningeal Fibrosarcoma": [
                  {
                    "text": "Monomorphous, often spindle cells; herringbone pattern (some); abundant pericellular reticulin, EMA(-)"
                  }
                ],
                "Gemistocytic Astrocytoma": [
                  {
                    "text": "Enters diagnostic consideration more in frozen than permanent sections"
                  },
                  {
                    "text": "Intraparenchymal, infiltrating"
                  },
                  {
                    "text": "Fibrillar background"
                  },
                  {
                    "text": "Perivascular chronic inflammation"
                  },
                  {
                    "text": "GFAP(+)"
                  }
                ],
                "Astroblastoma": [
                  {
                    "text": "Intraparenchymal"
                  },
                  {
                    "text": "Often cystic"
                  },
                  {
                    "text": "Vessel hyalinization"
                  },
                  {
                    "text": "GFAP usually (+), but not always"
                  },
                  {
                    "text": "Some focally EMA(+), surface staining, microlumina"
                  }
                ],
                "Vascular Malformation (Angiomatous and Microcystic Meningiomas)": [
                  {
                    "text": "No neoplastic meningothelial cells"
                  }
                ],
                "Superficial Glioblastoma/Gliosarcoma": [
                  {
                    "text": "GFAP(+) component"
                  },
                  {
                    "text": "Abundant pericellular reticulin in sarcoma component"
                  },
                  {
                    "text": "EMA(-), except for rare example with epithelial differentiation"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Highly variable histologic patterns"
                  },
                  {
                    "text": "Cytology (smears) often more specific than frozen sections"
                  },
                  {
                    "text": "Anaplastic meningiomas often cytokeratin (+), can be confused with metastatic carcinoma"
                  }
                ]
              },
              "GRADING": {
                "WHO Grade 1": [
                  {
                    "text": "Meningothelial, fibrous, transitional, angiomatous, microcystic, secretory, metaplastic, lymphoplasmacyte rich, psammomatous≤ 3 mitoses per 10 HPFNo brain invasion",
                    "sub_points": [
                      "≤ 3 mitoses per 10 HPF",
                      "No brain invasion"
                    ]
                  }
                ],
                "WHO Grade 2": [
                  {
                    "text": "≥ 4 mitoses/10 HPFor"
                  },
                  {
                    "text": "3 of followingHypercellularitySmall cells with high nuclear:cytoplasmic ratio, clusteredProminent nucleoliUninterrupted growth pattern (sheeting)Spontaneous necrosis ± palisading",
                    "sub_points": [
                      "Hypercellularity",
                      "Small cells with high nuclear:cytoplasmic ratio, clustered",
                      "Prominent nucleoli",
                      "Uninterrupted growth pattern (sheeting)",
                      "Spontaneous necrosis ± palisading"
                    ]
                  },
                  {
                    "text": "Brain invasionorchordoidorclear cell subtype"
                  }
                ],
                "WHO Grade 3": [
                  {
                    "text": "≥ 20 mitoses per 10 HPFor"
                  },
                  {
                    "text": "Overt malignant features resembling carcinoma, melanoma, sarcoma,or"
                  },
                  {
                    "text": "Rhabdoidorpapillary subtype &/or"
                  },
                  {
                    "text": "TERTpromoter mutation &/or"
                  },
                  {
                    "text": "CDKN2A/Bhomozygous deletion"
                  },
                  {
                    "text": "Spontaneous necrosis frequent but not required"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Germinoma": {
            "name": "Germinoma",
            "url": "https://app.pathprimer.com/document/9f3b6782-ffea-44d5-998b-409fffb264fe/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Clinical Issues": [
                  {
                    "text": "Most common: Midline structures (pineal, sellar, suprasellar)Pineal: Paralysis of upward gaze and convergence (Parinaud syndrome)Sellar: Diabetes insipidus",
                    "sub_points": [
                      "Pineal: Paralysis of upward gaze and convergence (Parinaud syndrome)",
                      "Sellar: Diabetes insipidus"
                    ]
                  },
                  {
                    "text": "Highly radiosensitive: Pure germinomas have > 90% 5-year survival rate"
                  },
                  {
                    "text": "Several-year history of symptoms, e.g., pituitary insufficiency, not inconsistent with germinoma"
                  },
                  {
                    "text": "Peak age of incidence: 15-20 years"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Strong, homogeneous enhancementPituitary or pineal location, occasionally both",
                    "sub_points": [
                      "Pituitary or pineal location, occasionally both"
                    ]
                  },
                  {
                    "text": "Occasionally enhancement along ventricular lining"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "OCT4, SALL4, LIN28A (+)"
                  },
                  {
                    "text": "CD117 (C-Kit) (+)"
                  },
                  {
                    "text": "PLAP(+) but less reliable than other markers"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Teratomas or nongerminomatous germ cell tumor"
                  },
                  {
                    "text": "Granulomatous diseases (e.g., sarcoidosis)"
                  },
                  {
                    "text": "Langerhans cell histiocytosis"
                  },
                  {
                    "text": "Pineal parenchymal tumors"
                  },
                  {
                    "text": "Malignant lymphoma"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Crush artifact, sometimes severe, can distort tumor cells and obscure diagnosis"
                  },
                  {
                    "text": "Immunohistochemistry may be necessary for tumor detection"
                  },
                  {
                    "text": "Exclude other nongerminomatous components, e.g., yolk sac tumor, choriocarcinoma, especially in presence of positive serum or CSF markers"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Malignant germ cell tumor with large primordial cells and substantial population of lymphoid cells"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Majority of all intracranial germ cell tumors"
                  },
                  {
                    "text": "Incidence varies geographicallyHigher incidence in Japan",
                    "sub_points": [
                      "Higher incidence in Japan"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Most occur in first 3 decades"
                  },
                  {
                    "text": "Peak incidence: 15-20 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Pineal tumor more common in males"
                  },
                  {
                    "text": "Sellar/suprasellar tumors slightly more common in females"
                  }
                ],
                "Site": [
                  {
                    "text": "Majority in midline, mostly solitaryPineal, most commonSellar/suprasellar",
                    "sub_points": [
                      "Pineal, most common",
                      "Sellar/suprasellar"
                    ]
                  },
                  {
                    "text": "Rare sitesSynchronous pineal/suprasellarBasal ganglia, uni- or bilateralDiffuse subependymal seeding, mostly along lateral ventricles",
                    "sub_points": [
                      "Synchronous pineal/suprasellar",
                      "Basal ganglia, uni- or bilateral",
                      "Diffuse subependymal seeding, mostly along lateral ventricles"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "PinealParalysis of upward gaze and convergence (Parinaud syndrome)Hydrocephalus",
                    "sub_points": [
                      "Paralysis of upward gaze and convergence (Parinaud syndrome)",
                      "Hydrocephalus"
                    ]
                  },
                  {
                    "text": "Suprasellar/sellarVisual disturbance, field defectsHypopituitarismDiabetes insipidus",
                    "sub_points": [
                      "Visual disturbance, field defects",
                      "Hypopituitarism",
                      "Diabetes insipidus"
                    ]
                  },
                  {
                    "text": "Basal ganglia and thalamusHemiparesis",
                    "sub_points": [
                      "Hemiparesis"
                    ]
                  },
                  {
                    "text": "Some tumors associated with precocious puberty, regardless of site"
                  },
                  {
                    "text": "1/3 of patients have long (> 6 months) interval between symptoms and diagnosis"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Highly radiosensitive"
                  },
                  {
                    "text": "Combined radiation and chemotherapy associated with better survival"
                  },
                  {
                    "text": "Surgical resection beyond biopsy provides no advantage in survival"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "> 90% 5-year survival rate with combination treatmentSomewhat less favorable prognosis for tumors with syncytiotrophoblastic componentEarly diagnosis associated with better overall survival",
                    "sub_points": [
                      "Somewhat less favorable prognosis for tumors with syncytiotrophoblastic component",
                      "Early diagnosis associated with better overall survival"
                    ]
                  },
                  {
                    "text": "Risk of secondary tumor following radiation necessitates long-term follow-up"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Solid pineal tumor with occasional cystic component"
                  },
                  {
                    "text": "Isointense or hyperintense to gray matter on T1WI"
                  },
                  {
                    "text": "Hyperintense on FLAIR and T2WI"
                  },
                  {
                    "text": "Strong, homogeneous enhancement"
                  },
                  {
                    "text": "Occasionally enhancing tumor along ventricular walls"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Specimen often small without specific characteristics"
                  },
                  {
                    "text": "Tough consistency due to fibrous tissue in some cases"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Homogeneous sheets, lobules, or individual cells"
                  },
                  {
                    "text": "Large, round, dyscohesive cells"
                  },
                  {
                    "text": "Prominent, irregular, bar-shaped nucleoli and pale cytoplasm"
                  },
                  {
                    "text": "Mitoses and apoptotic cells common"
                  },
                  {
                    "text": "Isolated multinucleated syncytiotrophoblasts uncommon"
                  },
                  {
                    "text": "Inflammatory cell componentAlways lymphocytic, sometimes dense, can obscure tumorGerminal centers in some casesNoncaseating granulomas (variable)",
                    "sub_points": [
                      "Always lymphocytic, sometimes dense, can obscure tumor",
                      "Germinal centers in some cases",
                      "Noncaseating granulomas (variable)"
                    ]
                  },
                  {
                    "text": "Necrosis uncommon"
                  },
                  {
                    "text": "Calcifications, usually overrun normal pineal corpora arenacea (\"brain sand\")"
                  },
                  {
                    "text": "Brain parenchymal infiltration mimic other tumors, such as malignant glioma"
                  },
                  {
                    "text": "Specimens often show crush artifact"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "SmearTumor cellsLarge nuclei with central macronucleoliDiscrete cell membranesClear or vacuolated cytoplasmSmall lymphocytesVariable number, mature T cellsOften significant nuclear streaking and crush artifact on smears",
                    "sub_points": [
                      "Tumor cellsLarge nuclei with central macronucleoliDiscrete cell membranesClear or vacuolated cytoplasm",
                      "Large nuclei with central macronucleoli",
                      "Discrete cell membranes",
                      "Clear or vacuolated cytoplasm",
                      "Small lymphocytesVariable number, mature T cells",
                      "Variable number, mature T cells",
                      "Often significant nuclear streaking and crush artifact on smears"
                    ]
                  },
                  {
                    "text": "CSF cytology: Rarely positive"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "PAS-DReactivity: Positive, diastase labileStaining pattern: Highlights cytoplasmic glycogen in tumor cells",
                    "sub_points": [
                      "Reactivity: Positive, diastase labile",
                      "Staining pattern: Highlights cytoplasmic glycogen in tumor cells"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "PLAP(+)Less reliable than other antibodiesProne to background staining false-positives and false-negatives",
                    "sub_points": [
                      "Less reliable than other antibodies",
                      "Prone to background staining false-positives and false-negatives"
                    ]
                  },
                  {
                    "text": "OCT4, SALL4, LIN28A (+)"
                  },
                  {
                    "text": "CD117 (C-Kit)(+)"
                  },
                  {
                    "text": "D2-40(+)"
                  },
                  {
                    "text": "Cytokeratin (+), occasionally"
                  },
                  {
                    "text": "Isolated syncytiotrophoblasts hCG-β(+)"
                  },
                  {
                    "text": "Ki-67, high labeling index"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Frequent MAPK pathway mutations"
                  },
                  {
                    "text": "PI3K/mTOR pathway mutations"
                  },
                  {
                    "text": "Frequent copy number variations"
                  },
                  {
                    "text": "Gain-of-functionKITalterations"
                  },
                  {
                    "text": "Isochromosome 12p"
                  },
                  {
                    "text": "Globally low DNA methylation"
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "PLAP is often increased in CSF"
                  },
                  {
                    "text": "hCG-β(+) in CSF and serum in cases with syncytiotrophoblasts"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pineal Parenchymal Tumors": [
                  {
                    "text": "Cohesive tumor architecture"
                  },
                  {
                    "text": "Absent or scant lymphocytic infiltrate"
                  },
                  {
                    "text": "Synaptophysin (+)"
                  },
                  {
                    "text": "OCT4 and CD117 (-)"
                  }
                ],
                "Granulomatous Lesions": [
                  {
                    "text": "SarcoidosisPotentially confused with germinomas with abundant granulomatous reactionNo malignant cellsOCT4 and PLAP (-)Common at base of brain, rare in pineal region",
                    "sub_points": [
                      "Potentially confused with germinomas with abundant granulomatous reaction",
                      "No malignant cells",
                      "OCT4 and PLAP (-)",
                      "Common at base of brain, rare in pineal region"
                    ]
                  },
                  {
                    "text": "Granulomatous hypophysitis/giant cell granulomaLimited to pituitaryNo atypical cellsGiant cells, mixed inflammatory infiltrates in some casesOCT4 and PLAP (-)",
                    "sub_points": [
                      "Limited to pituitary",
                      "No atypical cells",
                      "Giant cells, mixed inflammatory infiltrates in some cases",
                      "OCT4 and PLAP (-)"
                    ]
                  },
                  {
                    "text": "TuberculosisNecrosisAcid-fast bacilliNo tumor cells",
                    "sub_points": [
                      "Necrosis",
                      "Acid-fast bacilli",
                      "No tumor cells"
                    ]
                  }
                ],
                "Langerhans Cell Histiocytosis": [
                  {
                    "text": "Langerhans cellsFolded, clefted nucleiMay appear as dyscohesive as germinoma but may have focal clusters",
                    "sub_points": [
                      "Folded, clefted nuclei",
                      "May appear as dyscohesive as germinoma but may have focal clusters"
                    ]
                  },
                  {
                    "text": "Eosinophils and mixed inflammatory cells"
                  },
                  {
                    "text": "CD1a(+)"
                  },
                  {
                    "text": "OCT4 and PLAP (-)"
                  },
                  {
                    "text": "Many BRAF VE1 immunohistochemistry (+) (mutated forBRAFV600E)"
                  }
                ],
                "Malignant Lymphoma": [
                  {
                    "text": "Most common in older adults or immunocompromised individuals"
                  },
                  {
                    "text": "Periventricular dissemination rare"
                  },
                  {
                    "text": "Typically CD20, CD79a, and MUM1 (+)"
                  },
                  {
                    "text": "SALL4, LIN28A, OCT4, and CD117 (-)"
                  }
                ],
                "Teratomas and Other Germ Cell Tumors": [
                  {
                    "text": "Limited biopsies of mixed germ cell tumors may miss nongerminomatous component(s)Increased serum or CSF α-fetoprotein levelsα-fetoprotein (+) on biopsy suggests yolk sac componentCarcinoma-like histologic features or Schiller-Duval bodiesCD30 positivity in biopsy suggests embryonal carcinoma component",
                    "sub_points": [
                      "Increased serum or CSF α-fetoprotein levels",
                      "α-fetoprotein (+) on biopsy suggests yolk sac componentCarcinoma-like histologic features or Schiller-Duval bodies",
                      "Carcinoma-like histologic features or Schiller-Duval bodies",
                      "CD30 positivity in biopsy suggests embryonal carcinoma component"
                    ]
                  },
                  {
                    "text": "Midline tumor with cyst and MR signal characteristics of fat &/or calcification suggests teratomatous component"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "More likely to produce diabetes insipidus than other tumors"
                  },
                  {
                    "text": "Compatible with year-long preoperative history in spite of brisk mitotic activity"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Crush artifact, sometimes severe, can obscure tumor cells"
                  },
                  {
                    "text": "Immunohistochemistry (CD117 and OCT4) may be necessary for detection of rare tumor cells"
                  },
                  {
                    "text": "Exclude other nongerminomatous components, (e.g., yolk sac tumor and choriocarcinoma) in presence of positive serum/CSF markers"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Medulloblastoma": {
            "name": "Medulloblastoma",
            "url": "https://app.pathprimer.com/document/24b696ba-af4d-4d89-bbe4-d62f54d54536/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Embryonal tumor of cerebellum and dorsal midbrain"
                  },
                  {
                    "text": "WHO grade 4"
                  },
                  {
                    "text": "Either genetically or histologically defined"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Gorlin: SHH-activated, desmoplastic/nodular"
                  },
                  {
                    "text": "Li-Fraumeni: SHH-activated andTP53-mutant, often desmoplastic/nodular"
                  },
                  {
                    "text": "Turcot type 2, familial adenomatous polyposis (APC): WNT activated, classic"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Prognosis overall favorable but dependent on stage and subtype"
                  },
                  {
                    "text": "Overall, most favorable type is WNT-activated subtype, which is recognized by nuclear β-catenin and monosomy 6"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Medulloblastoma (MB), histologically definedClassicDesmoplastic/nodularMB with extensive nodularityLarge cell/anaplastic",
                    "sub_points": [
                      "Classic",
                      "Desmoplastic/nodular",
                      "MB with extensive nodularity",
                      "Large cell/anaplastic"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "MB, genetically definedWNT-activatedSHH-activated andTP53-mutantSHH-activated andTP53-wildtypeNon-WNT/non-SHH (groups 3 and 4)",
                    "sub_points": [
                      "WNT-activated",
                      "SHH-activated andTP53-mutant",
                      "SHH-activated andTP53-wildtype",
                      "Non-WNT/non-SHH (groups 3 and 4)"
                    ]
                  },
                  {
                    "text": "YAP1 and GAB1 (+) in SHH-activated"
                  },
                  {
                    "text": "YAP1, LEF1, ALK1, nuclear β-catenin (+) in WNT-activated"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Identification of molecular pathways via surrogate IHC"
                  },
                  {
                    "text": "Separating groups 3 and 4 is not as important for practical purposes; currently difficult to do with IHC"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Embryonal tumor of cerebellum and dorsal brainstem"
                  },
                  {
                    "text": "Unrelated to other embryonal tumors"
                  },
                  {
                    "text": "Unrelated to Ewing sarcoma"
                  },
                  {
                    "text": "WHO grade 4"
                  },
                  {
                    "text": "Medulloblastoma (MB) may be either genetically or histologically defined"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "2 Principal Pathways, Proposed": [
                  {
                    "text": "External granule neuron precursor cellsActivation of Sonic hedgehog (SHH) pathwayDesmoplastic/nodular MB (DNMB) and MB with extensive nodularity (MBEN)",
                    "sub_points": [
                      "Activation of Sonic hedgehog (SHH) pathway",
                      "Desmoplastic/nodular MB (DNMB) and MB with extensive nodularity (MBEN)"
                    ]
                  },
                  {
                    "text": "Derivatives of ventricular matrix zoneActivation of wingless (WNT) pathwayClassic histologic type",
                    "sub_points": [
                      "Activation of wingless (WNT) pathway",
                      "Classic histologic type"
                    ]
                  }
                ],
                "Predisposing Cancer Syndromes": [
                  {
                    "text": "Gorlin (PTCH1,PTCH2,SUFU): SHH-activated, DNMB and MBEN"
                  },
                  {
                    "text": "Li-Fraumeni (TP53): SHH-activated andTP53-mutant, often DNMB/MBEN"
                  },
                  {
                    "text": "Turcot type 2, familial adenomatous polyposis (APC): WNT-activated, classic"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Infancy (< 3 years of age)DNMB (47-57%) and MBEN (20%)SHH-activated,TP53-wildtype and group 3",
                    "sub_points": [
                      "DNMB (47-57%) and MBEN (20%)",
                      "SHH-activated,TP53-wildtype and group 3"
                    ]
                  },
                  {
                    "text": "ChildrenClassic histologic type most commonWNT-activated and SHH-activated,TP53-mutant",
                    "sub_points": [
                      "Classic histologic type most common",
                      "WNT-activated and SHH-activated,TP53-mutant"
                    ]
                  },
                  {
                    "text": "AdultsClassic type (76%), DNMB (21%)Non-WNT/non-SHH group 3 exceedingly rare",
                    "sub_points": [
                      "Classic type (76%), DNMB (21%)",
                      "Non-WNT/non-SHH group 3 exceedingly rare"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "CerebellumVermis: Typically classic typeHemisphere: Typically desmoplastic/nodular type",
                    "sub_points": [
                      "Vermis: Typically classic type",
                      "Hemisphere: Typically desmoplastic/nodular type"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Manifestations of obstructive hydrocephalus"
                  },
                  {
                    "text": "Cerebellar dysfunction"
                  },
                  {
                    "text": "Cranial nerve signs"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Prone to CSF dissemination, especially as spinal drop metastases"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection: Gross total aimed"
                  },
                  {
                    "text": "Chemotherapy (systemic ± intraventricular)Chemotherapy alone in DNMB/MBEN, < 3 years of age",
                    "sub_points": [
                      "Chemotherapy alone in DNMB/MBEN, < 3 years of age"
                    ]
                  },
                  {
                    "text": "RadiationTumor + neuraxis, standard except for very young patientsAvoided in favorable subtypes, especially in young patients",
                    "sub_points": [
                      "Tumor + neuraxis, standard except for very young patients",
                      "Avoided in favorable subtypes, especially in young patients"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Overall favorable with therapy but dependent on stage and subtypeExcellent: > 90% 5-year overall survival (OS) for WNT-activated classic MBMost WNT-activated MBs are classic type, but not all classic MBs are WNT-activatedFavorable: > 80% 5-year OS for SHH-activated,TP53-wildtype, DNMB/MBEN in infants, with total resectionLess favorable with subtotal resection, metastatic disease, older age, large cell/anaplastic type, non-WNT/non-SHHLess favorable for SHH-activated MB withSUFUmutationUnfavorable for SHH-activated MB withTP53mutationNo prognostic impact ofTP53mutation in WNT-activated MBEspecially unfavorable when associated withMYCamplification",
                    "sub_points": [
                      "Excellent: > 90% 5-year overall survival (OS) for WNT-activated classic MBMost WNT-activated MBs are classic type, but not all classic MBs are WNT-activated",
                      "Most WNT-activated MBs are classic type, but not all classic MBs are WNT-activated",
                      "Favorable: > 80% 5-year OS for SHH-activated,TP53-wildtype, DNMB/MBEN in infants, with total resection",
                      "Less favorable with subtotal resection, metastatic disease, older age, large cell/anaplastic type, non-WNT/non-SHH",
                      "Less favorable for SHH-activated MB withSUFUmutation",
                      "Unfavorable for SHH-activated MB withTP53mutationNo prognostic impact ofTP53mutation in WNT-activated MB",
                      "No prognostic impact ofTP53mutation in WNT-activated MB",
                      "Especially unfavorable when associated withMYCamplification"
                    ]
                  },
                  {
                    "text": "Late metastasis to bones, lymph nodes, lungs (uncommon)"
                  },
                  {
                    "text": "Peritoneal implants through shunt (uncommon)"
                  },
                  {
                    "text": "Radiation-induced secondary tumors (6% of MB patients), ~ 60% malignantOccur 5-10 years post irradiationMost common malignant 2nd tumor: High-grade gliomaPosterior cerebral hemispheresCerebellum; differential includes glial differentiation in original MBMost common benign 2nd tumor: Meningioma",
                    "sub_points": [
                      "Occur 5-10 years post irradiation",
                      "Most common malignant 2nd tumor: High-grade gliomaPosterior cerebral hemispheresCerebellum; differential includes glial differentiation in original MB",
                      "Posterior cerebral hemispheres",
                      "Cerebellum; differential includes glial differentiation in original MB",
                      "Most common benign 2nd tumor: Meningioma"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "T1 hypointense to gray matter, T2 isointense to gray matter, restricted diffusion"
                  },
                  {
                    "text": "Variable contrast enhancement, often only slight"
                  },
                  {
                    "text": "Striking nodularity (\"bunch of grapes\") in MBEN"
                  },
                  {
                    "text": "Metastatic disease at presentation; leptomeningeal, intracranial, or intraspinal (rare)Any type but especially large cell/anaplastic",
                    "sub_points": [
                      "Any type but especially large cell/anaplastic"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Generally large, fleshy"
                  },
                  {
                    "text": "Involvement of subarachnoid space"
                  },
                  {
                    "text": "Firm, nodular in nodular/desmoplastic type"
                  },
                  {
                    "text": "Necrosis, especially when large cell/anaplastic"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "MBs, histologically definedClassic MB (~ 70%)Highly cellular sheets and lobulesNeuroblastic (Homer Wright) rosettes with fibrillar neuropil coreStacked linear arraysPerivascular pseudorosettes and stellate zones of finely fibrillar neuropilWNT-activated MBs are classic type, but WNT is rarest molecular typeMajority of classic MBs are non-WNT/non-SHHDNMB (15-20%)Circumscribed, nodular pale areas (\"pale islands\")Vary in size from small and identifiable only with reticulin staining to large and dominantNeurocytic differentiation: Round, bland cells; finely fibrillar neuropil; cell streaming; few mitoses; often apoptotic cellsInternodular tissue more cellular, cytologically atypical, mitotically active; higher Ki-67 indexMust be both nodular and desmoplastic, only 1 is not sufficientAlmost always SHH-activatedMBENMultiple nodules with neurocytic differentiation lacking significant reticulin depositionOccurs in infants, favorable prognosisRelated to DNMB, SHH-activatedLarge cell/anaplastic MBRequired degree of anaplasia and percent of tumor cross-sectional area unclear, but generally severe anaplasia &/or large cells > 50% of tumor areaLarge cells, ≥ 2x as large over small cells in classic MBNuclear molding, pleomorphism, cell overlappingCell-cell wrapping, around apoptotic or viable cellNuclear pleomorphismHigh mitotic activityAbundant apoptosisLarge cell phenotype characterized by round, dyscohesive cells with prominent nucleiResembles lymphomaParticularly associated with SHH-activated,TP53-mutant subtype withGLI2andMYCNamplification",
                    "sub_points": [
                      "Classic MB (~ 70%)Highly cellular sheets and lobulesNeuroblastic (Homer Wright) rosettes with fibrillar neuropil coreStacked linear arraysPerivascular pseudorosettes and stellate zones of finely fibrillar neuropilWNT-activated MBs are classic type, but WNT is rarest molecular typeMajority of classic MBs are non-WNT/non-SHH",
                      "Highly cellular sheets and lobules",
                      "Neuroblastic (Homer Wright) rosettes with fibrillar neuropil core",
                      "Stacked linear arrays",
                      "Perivascular pseudorosettes and stellate zones of finely fibrillar neuropil",
                      "WNT-activated MBs are classic type, but WNT is rarest molecular typeMajority of classic MBs are non-WNT/non-SHH",
                      "Majority of classic MBs are non-WNT/non-SHH",
                      "DNMB (15-20%)Circumscribed, nodular pale areas (\"pale islands\")Vary in size from small and identifiable only with reticulin staining to large and dominantNeurocytic differentiation: Round, bland cells; finely fibrillar neuropil; cell streaming; few mitoses; often apoptotic cellsInternodular tissue more cellular, cytologically atypical, mitotically active; higher Ki-67 indexMust be both nodular and desmoplastic, only 1 is not sufficientAlmost always SHH-activated",
                      "Circumscribed, nodular pale areas (\"pale islands\")Vary in size from small and identifiable only with reticulin staining to large and dominantNeurocytic differentiation: Round, bland cells; finely fibrillar neuropil; cell streaming; few mitoses; often apoptotic cells",
                      "Vary in size from small and identifiable only with reticulin staining to large and dominant",
                      "Neurocytic differentiation: Round, bland cells; finely fibrillar neuropil; cell streaming; few mitoses; often apoptotic cells",
                      "Internodular tissue more cellular, cytologically atypical, mitotically active; higher Ki-67 index",
                      "Must be both nodular and desmoplastic, only 1 is not sufficient",
                      "Almost always SHH-activated",
                      "MBENMultiple nodules with neurocytic differentiation lacking significant reticulin depositionOccurs in infants, favorable prognosisRelated to DNMB, SHH-activated",
                      "Multiple nodules with neurocytic differentiation lacking significant reticulin deposition",
                      "Occurs in infants, favorable prognosis",
                      "Related to DNMB, SHH-activated",
                      "Large cell/anaplastic MBRequired degree of anaplasia and percent of tumor cross-sectional area unclear, but generally severe anaplasia &/or large cells > 50% of tumor areaLarge cells, ≥ 2x as large over small cells in classic MBNuclear molding, pleomorphism, cell overlappingCell-cell wrapping, around apoptotic or viable cellNuclear pleomorphismHigh mitotic activityAbundant apoptosisLarge cell phenotype characterized by round, dyscohesive cells with prominent nucleiResembles lymphomaParticularly associated with SHH-activated,TP53-mutant subtype withGLI2andMYCNamplification",
                      "Required degree of anaplasia and percent of tumor cross-sectional area unclear, but generally severe anaplasia &/or large cells > 50% of tumor area",
                      "Large cells, ≥ 2x as large over small cells in classic MB",
                      "Nuclear molding, pleomorphism, cell overlapping",
                      "Cell-cell wrapping, around apoptotic or viable cell",
                      "Nuclear pleomorphism",
                      "High mitotic activity",
                      "Abundant apoptosis",
                      "Large cell phenotype characterized by round, dyscohesive cells with prominent nucleiResembles lymphoma",
                      "Resembles lymphoma",
                      "Particularly associated with SHH-activated,TP53-mutant subtype withGLI2andMYCNamplification"
                    ]
                  },
                  {
                    "text": "Patterns of spreadInfiltrates cerebellum and choroid plexusExtension into subarachnoid space (common)Reentry into brain as columns of cells in molecular layerCSF dissemination, usually spinal drop metastases, especially in large cell/anaplastic types; subfrontal metastases also commonPotential for peritoneal implants with ventriculoperitoneal shuntCirculating tumor cells (leptomeningeal spread or systemic metastases)",
                    "sub_points": [
                      "Infiltrates cerebellum and choroid plexus",
                      "Extension into subarachnoid space (common)",
                      "Reentry into brain as columns of cells in molecular layer",
                      "CSF dissemination, usually spinal drop metastases, especially in large cell/anaplastic types; subfrontal metastases also common",
                      "Potential for peritoneal implants with ventriculoperitoneal shunt",
                      "Circulating tumor cells (leptomeningeal spread or systemic metastases)"
                    ]
                  },
                  {
                    "text": "Biphasic patternNodules similar to but often less well defined than DNMBNo perinodular reticulin, no GFAP(+) intranodular astrocytes",
                    "sub_points": [
                      "Nodules similar to but often less well defined than DNMB",
                      "No perinodular reticulin, no GFAP(+) intranodular astrocytes"
                    ]
                  },
                  {
                    "text": "DesmoplasiaCommon in all types with leptomeningeal extensionWithout nodules, not diagnostic of DNMB",
                    "sub_points": [
                      "Common in all types with leptomeningeal extension",
                      "Without nodules, not diagnostic of DNMB"
                    ]
                  },
                  {
                    "text": "Mitoses; variable from rare to many"
                  },
                  {
                    "text": "Apoptosis; prominent overallEspecially prominent, as large \"apoptotic lakes,\" in large cell/anaplastic type",
                    "sub_points": [
                      "Especially prominent, as large \"apoptotic lakes,\" in large cell/anaplastic type"
                    ]
                  },
                  {
                    "text": "Necrosis; less common than apoptosisUsually without pseudopalisading",
                    "sub_points": [
                      "Usually without pseudopalisading"
                    ]
                  },
                  {
                    "text": "Calcification; uncommonDystrophic in necrotic or apoptotic areas",
                    "sub_points": [
                      "Dystrophic in necrotic or apoptotic areas"
                    ]
                  },
                  {
                    "text": "Ganglion cell differentiation, especially in DNMB (uncommon)"
                  },
                  {
                    "text": "Myogenic (striated) differentiation (medullomyoblastoma); rare"
                  },
                  {
                    "text": "Melanocytic differentiation (melanotic MB)Pigmented epithelium, usually tubules; rareSurrogate IHC may be unreliable for molecular subtyping",
                    "sub_points": [
                      "Pigmented epithelium, usually tubules; rare",
                      "Surrogate IHC may be unreliable for molecular subtyping"
                    ]
                  },
                  {
                    "text": "Combined myogenic and melanocytic differentiation; rare"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Classic type: Small uniform cells with varying degrees of atypia, sometimes very slight"
                  },
                  {
                    "text": "Anaplastic type: Large angulated cells"
                  },
                  {
                    "text": "Large cell type: Large round cells with prominent nucleoli"
                  },
                  {
                    "text": "Few cell processes and little fibrillar background as opposed to ependymoma"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "SynaptophysinOverall (+) but weak or patchy in some casesEspecially (+) inNodules in DNMB histologic typeNeuropil within rosettes or perivascular pseudorosettesIndividual cells in large cell type",
                    "sub_points": [
                      "Overall (+) but weak or patchy in some cases",
                      "Especially (+) inNodules in DNMB histologic typeNeuropil within rosettes or perivascular pseudorosettesIndividual cells in large cell type",
                      "Nodules in DNMB histologic type",
                      "Neuropil within rosettes or perivascular pseudorosettes",
                      "Individual cells in large cell type"
                    ]
                  },
                  {
                    "text": "GFAPOccasional astrocytes in intranodular areas of DNMB (in some cases)Bipolar or stellate cells in nodules, often concentrated at periphery",
                    "sub_points": [
                      "Occasional astrocytes in intranodular areas of DNMB (in some cases)",
                      "Bipolar or stellate cells in nodules, often concentrated at periphery"
                    ]
                  },
                  {
                    "text": "Neurofilament protein, variable depending on antibody(+) in neuropil and pale islands of DNMB",
                    "sub_points": [
                      "(+) in neuropil and pale islands of DNMB"
                    ]
                  },
                  {
                    "text": "Muscle markers in medullomyoblastoma"
                  },
                  {
                    "text": "Melanocytic markers in melanotic MB"
                  },
                  {
                    "text": "YAP1(+) in both SHH- and WNT-activated subtypes"
                  },
                  {
                    "text": "GAB1 and filamin A (+) in SHH-activated type"
                  },
                  {
                    "text": "LEF1 and ALK (+) in WNT-activated subtype"
                  },
                  {
                    "text": "β-catenin nuclear (+) in WNT-activated subtype, often focal"
                  },
                  {
                    "text": "Ki-67 elevatedAs in other small blue cell tumors, mitoses may be difficult to identify due to rapidity of cells going through cycleKi-67 allows better appreciation of numbers of cells in cell cycleKi-67 low to nearly absent in areas with advanced neurocytic differentiation or in pale islands in DNMBKi-67 levels do not contribute to prognosis beyond histologic/molecular typing",
                    "sub_points": [
                      "As in other small blue cell tumors, mitoses may be difficult to identify due to rapidity of cells going through cycle",
                      "Ki-67 allows better appreciation of numbers of cells in cell cycle",
                      "Ki-67 low to nearly absent in areas with advanced neurocytic differentiation or in pale islands in DNMB",
                      "Ki-67 levels do not contribute to prognosis beyond histologic/molecular typing"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "MBs, genetically definedMB, WNT-activatedMutation inCTNNB1(β-catenin),APC,AXIN1/AXIN2Monosomy chromosome 6MB, SHH-activated andTP53-mutantGLI2,MYCN, orSHHamplificationAssociated with chromothripsisMB, SHH-activated andTP53-wildtypeInactivatingPTCH1orSUFUmutationsActivatingSMOmutations orGLI2amplificationChromosome arm 10q lossTERTpromoter mutations, especially in adults with good outcome2 methylation subtypes with variable outcomes in infantsMB, non-WNT/non-SHHMethylation groups 3 and 4, difficult to separate by IHCGroup 3 almost exclusively in childrenMost non-WNT/non-SHH MB have classic histologyLarge cell/anaplastic types are usually group 3Activation ofGFI1andGFI1Bvia enhancer hijacking in group 3MYCoverexpression in group 3MYCamplification (25%), especially in infantsMYCNamplification in group 4",
                    "sub_points": [
                      "MB, WNT-activatedMutation inCTNNB1(β-catenin),APC,AXIN1/AXIN2Monosomy chromosome 6",
                      "Mutation inCTNNB1(β-catenin),APC,AXIN1/AXIN2",
                      "Monosomy chromosome 6",
                      "MB, SHH-activated andTP53-mutantGLI2,MYCN, orSHHamplificationAssociated with chromothripsis",
                      "GLI2,MYCN, orSHHamplification",
                      "Associated with chromothripsis",
                      "MB, SHH-activated andTP53-wildtypeInactivatingPTCH1orSUFUmutationsActivatingSMOmutations orGLI2amplificationChromosome arm 10q lossTERTpromoter mutations, especially in adults with good outcome2 methylation subtypes with variable outcomes in infants",
                      "InactivatingPTCH1orSUFUmutations",
                      "ActivatingSMOmutations orGLI2amplification",
                      "Chromosome arm 10q loss",
                      "TERTpromoter mutations, especially in adults with good outcome",
                      "2 methylation subtypes with variable outcomes in infants",
                      "MB, non-WNT/non-SHHMethylation groups 3 and 4, difficult to separate by IHCGroup 3 almost exclusively in childrenMost non-WNT/non-SHH MB have classic histologyLarge cell/anaplastic types are usually group 3Activation ofGFI1andGFI1Bvia enhancer hijacking in group 3MYCoverexpression in group 3MYCamplification (25%), especially in infantsMYCNamplification in group 4",
                      "Methylation groups 3 and 4, difficult to separate by IHC",
                      "Group 3 almost exclusively in children",
                      "Most non-WNT/non-SHH MB have classic histology",
                      "Large cell/anaplastic types are usually group 3",
                      "Activation ofGFI1andGFI1Bvia enhancer hijacking in group 3",
                      "MYCoverexpression in group 3MYCamplification (25%), especially in infants",
                      "MYCamplification (25%), especially in infants",
                      "MYCNamplification in group 4"
                    ]
                  },
                  {
                    "text": "Isodicentric 17q: i(17)qCombination of gain of 17q and loss of 17pUsually with classic typePrincipally in non-SHH/non-WNT tumors, especially group 4Prognostic significance debated; isolated 17p loss may be unfavorable",
                    "sub_points": [
                      "Combination of gain of 17q and loss of 17p",
                      "Usually with classic type",
                      "Principally in non-SHH/non-WNT tumors, especially group 4",
                      "Prognostic significance debated; isolated 17p loss may be unfavorable"
                    ]
                  },
                  {
                    "text": "Methylation &/or gene expression profilingFurther subtyping of each genetically defined groupNo specific gene alterations or copy number aberrationsPossible age-related subtypes of WNT-activated2-4 subtypes of SHH-activated MB4-8 subtypes of non-WNT/non-SHH MBs",
                    "sub_points": [
                      "Further subtyping of each genetically defined group",
                      "No specific gene alterations or copy number aberrationsPossible age-related subtypes of WNT-activated2-4 subtypes of SHH-activated MB4-8 subtypes of non-WNT/non-SHH MBs",
                      "Possible age-related subtypes of WNT-activated",
                      "2-4 subtypes of SHH-activated MB",
                      "4-8 subtypes of non-WNT/non-SHH MBs"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Atypical Teratoid/Rhabdoid Tumor": [
                  {
                    "text": "Common in posterior fossa; mimics MB"
                  },
                  {
                    "text": "Generally more nuclear pleomorphism and more cytoplasm, but occasional MB-like small cell architecture"
                  },
                  {
                    "text": "PolyimmunophenotypicEMA, GFAP, cytokeratins, actin",
                    "sub_points": [
                      "EMA, GFAP, cytokeratins, actin"
                    ]
                  },
                  {
                    "text": "Loss of nuclear immunostaining for INI1 (BAF47)Defining feature in majority of cases (SMARCB1mutation); small minority have BRG1 loss (SMARCA4mutation)",
                    "sub_points": [
                      "Defining feature in majority of cases (SMARCB1mutation); small minority have BRG1 loss (SMARCA4mutation)"
                    ]
                  }
                ],
                "Embryonal Tumor With Multilayered Rosettes": [
                  {
                    "text": "Any CNS embryonal tumor with C19MC alteration"
                  },
                  {
                    "text": "Prominent neuropilNot in discrete islands as in DNMB",
                    "sub_points": [
                      "Not in discrete islands as in DNMB"
                    ]
                  },
                  {
                    "text": "True (lumen-containing) rosettesSometimes arising in neuropil areasDistinctive, granular subapical band",
                    "sub_points": [
                      "Sometimes arising in neuropil areas",
                      "Distinctive, granular subapical band"
                    ]
                  }
                ],
                "Anaplastic Glioma and Glioblastoma": [
                  {
                    "text": "May be radiation-induced 2nd primary"
                  },
                  {
                    "text": "Microvascular proliferation and necrosis with pseudopalisading (more common)"
                  },
                  {
                    "text": "Synaptophysin (-), except for trapped brain"
                  },
                  {
                    "text": "GFAP(+) (in some cases)"
                  }
                ],
                "Ependymoma": [
                  {
                    "text": "Generally sharper tumor-cerebellum interface"
                  },
                  {
                    "text": "Less involvement of subarachnoid space"
                  },
                  {
                    "text": "More prominent perivascular pseudorosettes"
                  },
                  {
                    "text": "Nodules of higher cellularity in less cellular background tumor (common)"
                  },
                  {
                    "text": "True (lumen-containing) rosettes (in some cases)"
                  },
                  {
                    "text": "Microvascular proliferation, rare in MB"
                  },
                  {
                    "text": "GFAP(+), especially perivascular pseudorosettes"
                  },
                  {
                    "text": "Synaptophysin usually (-) but can be focally (+)"
                  },
                  {
                    "text": "EMA(+) microlumina (common but not required)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Propensity for CSF dissemination generally dictates neuraxis irradiation in most cases"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Consider possibility of atypical teratoid/rhabdoid tumor, especially in patients < 2 years old: Stain for INI1 (BAF47)"
                  },
                  {
                    "text": "Identification of molecular pathways used in classification, surrogate IHC stains"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Metastatic Neoplasms, Intraparenchymal, Brain and Spinal Cord": {
            "name": "Metastatic Neoplasms, Intraparenchymal, Brain and Spinal Cord",
            "url": "https://app.pathprimer.com/document/26695005-c0a8-47cc-a7cb-0408b8325f12/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Clinical Issues": [
                  {
                    "text": "Throughout CNS"
                  },
                  {
                    "text": "Cerebral hemispheres and cerebellum most common"
                  },
                  {
                    "text": "Generally, gray matter, especially cortex near gray-white junction"
                  },
                  {
                    "text": "Enhancing edema-producing mass in cerebellum in middle-aged patient is especially suspicious for metastasis"
                  },
                  {
                    "text": "CNS metastases usually late in disease, especially renal cell carcinoma and uveal melanoma"
                  },
                  {
                    "text": "CNS metastasis may be initial presentation of cutaneous melanoma, lung carcinoma"
                  },
                  {
                    "text": "CNS metastases to unusual sitesDura, often simulating meningiomaInfundibular stalk, resulting in diabetes insipidusPure leptomeningeal, simulating infectious meningitisIntraparenchymal brainstem or spinal cord, pituitaryTumor-to-tumor metastases, especially to pituitary adenoma, meningioma",
                    "sub_points": [
                      "Dura, often simulating meningioma",
                      "Infundibular stalk, resulting in diabetes insipidus",
                      "Pure leptomeningeal, simulating infectious meningitis",
                      "Intraparenchymal brainstem or spinal cord, pituitary",
                      "Tumor-to-tumor metastases, especially to pituitary adenoma, meningioma"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "Almost all enhancing"
                  },
                  {
                    "text": "Peritumoral edema, usually prominent, steroid responsive"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Carcinoma (majority): Most from lung, breast, colon"
                  },
                  {
                    "text": "Melanoma (common, often hemorrhagic)"
                  },
                  {
                    "text": "Sometimes without known primary"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Cytology on intraoperative smear/touch preparation: Cohesive tissue fragments (in most cases)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Glioma with epithelioid or epithelial differentiation"
                  },
                  {
                    "text": "Primary CNS lymphoma"
                  },
                  {
                    "text": "Medulloblastoma"
                  },
                  {
                    "text": "Hemangioblastoma (vs. renal cell carcinoma)"
                  },
                  {
                    "text": "Choroid plexus papilloma and carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Malignant neoplasm metastatic from systemic siteTumors in cranial vault also may occur secondary to direct extension from adjacent sites",
                    "sub_points": [
                      "Tumors in cranial vault also may occur secondary to direct extension from adjacent sites"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Site": [
                  {
                    "text": "Throughout CNSCerebral hemispheres and cerebellum most commonRare sitesPinealBrainstemChoroid plexusSpinal cord",
                    "sub_points": [
                      "Cerebral hemispheres and cerebellum most common",
                      "Rare sitesPinealBrainstemChoroid plexusSpinal cord",
                      "Pineal",
                      "Brainstem",
                      "Choroid plexus",
                      "Spinal cord"
                    ]
                  },
                  {
                    "text": "Generally, gray matter, especially cortex near gray-white junction"
                  },
                  {
                    "text": "Often multiple, occasionally miliary"
                  },
                  {
                    "text": "Enhancing, edema-producing mass in cerebellum in middle-aged patient is especially suspicious for metastasis"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Often late in disease, especially renal cell carcinoma and uveal melanoma, but sometimes as initial clinical event, such as lung carcinoma, melanoma"
                  },
                  {
                    "text": "Expressions of mass effectAcutely with hemorrhage (especially with melanoma)From peritumoral edema typically pronounced in metastasesSite-dependent neurologic deficits",
                    "sub_points": [
                      "Acutely with hemorrhage (especially with melanoma)",
                      "From peritumoral edema typically pronounced in metastases",
                      "Site-dependent neurologic deficits"
                    ]
                  },
                  {
                    "text": "Seizures"
                  },
                  {
                    "text": "Global, nonlocalizing signs with advanced multifocal intraparenchymal disease &/or leptomeningeal dissemination"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Excision"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Various chemotherapy protocols, depending on tumor type"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Focal or whole brain"
                  },
                  {
                    "text": "Stereotactic radiosurgery"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Poor"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Discrete for most, although some ill defined"
                  },
                  {
                    "text": "Spherical"
                  },
                  {
                    "text": "Almost all enhancingSometimes with dark, necrotic center (rim enhancement)",
                    "sub_points": [
                      "Sometimes with dark, necrotic center (rim enhancement)"
                    ]
                  },
                  {
                    "text": "Peritumoral edema, usually prominent, steroid responsive"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Discrete mass(es)"
                  },
                  {
                    "text": "Often focally or extensively necrotic"
                  },
                  {
                    "text": "Hemorrhagic (especially melanoma)"
                  },
                  {
                    "text": "Gray or black (some melanomas)"
                  },
                  {
                    "text": "Gelatinous (some mucin-producing adenocarcinomas)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "BordersTypically sharp, discreteFew, if any, entrapped neurons or gliaMinority infiltrative, usually along perivascular spacesExtension of tumor from leptomeningeal diseaseSarcomasExtension along cranial nerves (especially CNV) with adenoid cystic carcinoma",
                    "sub_points": [
                      "Typically sharp, discreteFew, if any, entrapped neurons or glia",
                      "Few, if any, entrapped neurons or glia",
                      "Minority infiltrative, usually along perivascular spacesExtension of tumor from leptomeningeal diseaseSarcomas",
                      "Extension of tumor from leptomeningeal disease",
                      "Sarcomas",
                      "Extension along cranial nerves (especially CNV) with adenoid cystic carcinoma"
                    ]
                  },
                  {
                    "text": "Peritumoral brainChronic inflammationGliosisEdema",
                    "sub_points": [
                      "Chronic inflammation",
                      "Gliosis",
                      "Edema"
                    ]
                  },
                  {
                    "text": "NecrosisFrequent, often extensiveTypically spares vessels and perivascular cuff of tumorUsually little, if any, pseudopalisading",
                    "sub_points": [
                      "Frequent, often extensive",
                      "Typically spares vessels and perivascular cuff of tumor",
                      "Usually little, if any, pseudopalisading"
                    ]
                  },
                  {
                    "text": "Microvascular proliferationUsually absentSometimes around and within renal cell carcinoma",
                    "sub_points": [
                      "Usually absent",
                      "Sometimes around and within renal cell carcinoma"
                    ]
                  },
                  {
                    "text": "HemorrhageIn some cases, especially melanoma",
                    "sub_points": [
                      "In some cases, especially melanoma"
                    ]
                  },
                  {
                    "text": "Lymphocytic infiltratesEspecially immediately surrounding brain but also intratumoral; not thought to affect prognosis",
                    "sub_points": [
                      "Especially immediately surrounding brain but also intratumoral; not thought to affect prognosis"
                    ]
                  },
                  {
                    "text": "Architectural patternsSheet-likeLobularFascicularPapillaryGlandularEpithelioid",
                    "sub_points": [
                      "Sheet-like",
                      "Lobular",
                      "Fascicular",
                      "Papillary",
                      "Glandular",
                      "Epithelioid"
                    ]
                  },
                  {
                    "text": "Glioma-like glassy cytoplasm (uncommon)"
                  },
                  {
                    "text": "Tumor typesCarcinoma (majority)Most from lung, breast, colonMelanoma (common, often hemorrhagic)Sometimes without known primaryGerm cell tumors (rare); most are primary in CNSSarcoma (rare), i.e., leiomyosarcoma, liposarcoma, rhabdomyosarcoma, synovial sarcoma",
                    "sub_points": [
                      "Carcinoma (majority)Most from lung, breast, colon",
                      "Most from lung, breast, colon",
                      "Melanoma (common, often hemorrhagic)Sometimes without known primary",
                      "Sometimes without known primary",
                      "Germ cell tumors (rare); most are primary in CNS",
                      "Sarcoma (rare), i.e., leiomyosarcoma, liposarcoma, rhabdomyosarcoma, synovial sarcoma"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Cohesive tissue fragments, in most cases"
                  },
                  {
                    "text": "Sharp cell borders"
                  },
                  {
                    "text": "Secretory product, in adenocarcinoma"
                  },
                  {
                    "text": "Prominent nucleoliEspecially in melanoma and adenocarcinoma",
                    "sub_points": [
                      "Especially in melanoma and adenocarcinoma"
                    ]
                  },
                  {
                    "text": "Intranuclear pseudoinclusionsIn melanoma, papillary thyroid carcinoma",
                    "sub_points": [
                      "In melanoma, papillary thyroid carcinoma"
                    ]
                  },
                  {
                    "text": "Necrotic debris"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "MucicarmineIntracytoplasmic, globular in adenocarcinoma",
                    "sub_points": [
                      "Intracytoplasmic, globular in adenocarcinoma"
                    ]
                  },
                  {
                    "text": "TrichromePositive in intratumoral septa",
                    "sub_points": [
                      "Positive in intratumoral septa"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "CarcinomaSquamous cell (any site)CK5/6, p63, p40 (may be superior to p63)LungAdenocarcinoma: CAM5.2, CK7, napsin-A, TTF-1Small cell: CAM5.2, TTF-1, CD56BreastCK7, GATA3, GCDFP, BER-EP4, mammaglobin, ER/PRColorectalCAM5.2, CK20, CDX2, BER-EP4GastroesophagealCK7, CK20, CDX2, BER-EP4PancreaticobiliaryCK7, CK20, CK19, CDX2, BER-EP4, DPC4/SMAD4 (loss)ProstateNKX3.1, P501s, P504s (AMACR), PSA, PSAPRenal cellPAX8, PAX2, RCC, CD10, CAIXUrothelialGATA3, p63, uroplakinThyroidPAX8, TTF-1, thyroglobulinAdrenalInhibin-α, Melan-AHepatocellularHepPar1, glypican-3, arginase, polyclonal CEA (canalicular)OvaryPAX8, CK7, WT-1, BER-EP4, ER/PR",
                    "sub_points": [
                      "Squamous cell (any site)CK5/6, p63, p40 (may be superior to p63)",
                      "CK5/6, p63, p40 (may be superior to p63)",
                      "LungAdenocarcinoma: CAM5.2, CK7, napsin-A, TTF-1Small cell: CAM5.2, TTF-1, CD56",
                      "Adenocarcinoma: CAM5.2, CK7, napsin-A, TTF-1",
                      "Small cell: CAM5.2, TTF-1, CD56",
                      "BreastCK7, GATA3, GCDFP, BER-EP4, mammaglobin, ER/PR",
                      "CK7, GATA3, GCDFP, BER-EP4, mammaglobin, ER/PR",
                      "ColorectalCAM5.2, CK20, CDX2, BER-EP4",
                      "CAM5.2, CK20, CDX2, BER-EP4",
                      "GastroesophagealCK7, CK20, CDX2, BER-EP4",
                      "CK7, CK20, CDX2, BER-EP4",
                      "PancreaticobiliaryCK7, CK20, CK19, CDX2, BER-EP4, DPC4/SMAD4 (loss)",
                      "CK7, CK20, CK19, CDX2, BER-EP4, DPC4/SMAD4 (loss)",
                      "ProstateNKX3.1, P501s, P504s (AMACR), PSA, PSAP",
                      "NKX3.1, P501s, P504s (AMACR), PSA, PSAP",
                      "Renal cellPAX8, PAX2, RCC, CD10, CAIX",
                      "PAX8, PAX2, RCC, CD10, CAIX",
                      "UrothelialGATA3, p63, uroplakin",
                      "GATA3, p63, uroplakin",
                      "ThyroidPAX8, TTF-1, thyroglobulin",
                      "PAX8, TTF-1, thyroglobulin",
                      "AdrenalInhibin-α, Melan-A",
                      "Inhibin-α, Melan-A",
                      "HepatocellularHepPar1, glypican-3, arginase, polyclonal CEA (canalicular)",
                      "HepPar1, glypican-3, arginase, polyclonal CEA (canalicular)",
                      "OvaryPAX8, CK7, WT-1, BER-EP4, ER/PR",
                      "PAX8, CK7, WT-1, BER-EP4, ER/PR"
                    ]
                  },
                  {
                    "text": "MelanomaS100, Melan-A, HMB-45, SOX10",
                    "sub_points": [
                      "S100, Melan-A, HMB-45, SOX10"
                    ]
                  },
                  {
                    "text": "SarcomaDesmin, myogenin",
                    "sub_points": [
                      "Desmin, myogenin"
                    ]
                  },
                  {
                    "text": "Germ cellOCT4, SALL4, PLAP, CD117 (c-Kit), α-fetoprotein, β-hCG",
                    "sub_points": [
                      "OCT4, SALL4, PLAP, CD117 (c-Kit), α-fetoprotein, β-hCG"
                    ]
                  },
                  {
                    "text": "Lymphoma and leukemiaHematopoietic markers, especially CD45, CD20, CD79a, and CD43",
                    "sub_points": [
                      "Hematopoietic markers, especially CD45, CD20, CD79a, and CD43"
                    ]
                  }
                ],
                "Gene Expression Profiling": [
                  {
                    "text": "May be useful in identifying tissue of origin"
                  }
                ],
                "Mutational Testing (Often Next Generation Sequencing Panels)": [
                  {
                    "text": "EGFR,ALK,KRAStesting often requested on metastatic adenocarcinoma of lung"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Glioblastoma": [
                  {
                    "text": "Conventional typeInfiltrating with trapped glia and neuronsSmall, somewhat elongate cells (in most cases)GFAP(+)Microvascular proliferationUncommon in metastases, except for renal cellNecrosis with pseudopalisading and including vesselsNecrosis in metastases usually spares vessels and cuff of perivascular tumor",
                    "sub_points": [
                      "Infiltrating with trapped glia and neurons",
                      "Small, somewhat elongate cells (in most cases)",
                      "GFAP(+)",
                      "Microvascular proliferationUncommon in metastases, except for renal cell",
                      "Uncommon in metastases, except for renal cell",
                      "Necrosis with pseudopalisading and including vesselsNecrosis in metastases usually spares vessels and cuff of perivascular tumor",
                      "Necrosis in metastases usually spares vessels and cuff of perivascular tumor"
                    ]
                  },
                  {
                    "text": "Epithelioid variantConventional, infiltrating tumor elsewhere in specimen (in some cases)GFAP(+)May be EMA(+), cytokeratins (+)",
                    "sub_points": [
                      "Conventional, infiltrating tumor elsewhere in specimen (in some cases)",
                      "GFAP(+)",
                      "May be EMA(+), cytokeratins (+)"
                    ]
                  },
                  {
                    "text": "With epithelial metaplasiaConventional, infiltrating tumor elsewhere in specimenGFAP(+)May be EMA(+), cytokeratins (+)Often with mesenchymal differentiation (gliosarcoma)Reticulin rich",
                    "sub_points": [
                      "Conventional, infiltrating tumor elsewhere in specimen",
                      "GFAP(+)",
                      "May be EMA(+), cytokeratins (+)",
                      "Often with mesenchymal differentiation (gliosarcoma)Reticulin rich",
                      "Reticulin rich"
                    ]
                  }
                ],
                "Anaplastic Oligodendroglioma With Epithelioid Features": [
                  {
                    "text": "Infiltrating with trapped glia and neurons"
                  },
                  {
                    "text": "Features of typical oligodendroglioma elsewhere in specimen"
                  },
                  {
                    "text": "Often GFAP(+), Olig2(+)"
                  },
                  {
                    "text": "Epithelial markers (-)"
                  },
                  {
                    "text": "IDH mutation and 1p/19q codeletion"
                  }
                ],
                "Primary CNS Lymphoma": [
                  {
                    "text": "Infiltrating"
                  },
                  {
                    "text": "Angiocentric"
                  },
                  {
                    "text": "Necrosis rare in sporadic lesions"
                  },
                  {
                    "text": "Lymphoid markers (+)"
                  },
                  {
                    "text": "No fibrosis"
                  }
                ],
                "Medulloblastoma": [
                  {
                    "text": "Poorly differentiated cells or nodular/desmoplastic (in some cases)"
                  },
                  {
                    "text": "Cytokeratins, EMA, TTF-1 (-); melanocytic markers (-)"
                  },
                  {
                    "text": "Synaptophysin (+), YAP1, GAB1, β-catenin should not be used to make diagnosis of medulloblastomaNuclear staining for β-catenin (WNT pathway activation)Staining for GAB1 (SHH pathway activation)",
                    "sub_points": [
                      "Nuclear staining for β-catenin (WNT pathway activation)",
                      "Staining for GAB1 (SHH pathway activation)"
                    ]
                  }
                ],
                "Hemangioblastoma": [
                  {
                    "text": "Main differential diagnosis when considering metastatic CNS renal cell carcinoma"
                  },
                  {
                    "text": "Inhibin-α (+), S100(+)"
                  },
                  {
                    "text": "PAX2, PAX8, CD10 (-)"
                  },
                  {
                    "text": "EMA(-) but sometimes focally (+)"
                  },
                  {
                    "text": "Low Ki-67 index but overlap"
                  }
                ],
                "Choroid Plexus Papilloma and Carcinoma": [
                  {
                    "text": "Intraventricular or at cerebellopontine angle"
                  },
                  {
                    "text": "Almost all occur in children"
                  },
                  {
                    "text": "Usually EMA(-), BER-EP4(-)"
                  },
                  {
                    "text": "Papillomas usually CK7(+), CK20(-)"
                  },
                  {
                    "text": "Synaptophysin (+), in some cases"
                  }
                ],
                "Meningioma": [
                  {
                    "text": "Main differential diagnosis when considering dural metastasis"
                  },
                  {
                    "text": "Usually dural based; noninfiltrative of brain"
                  },
                  {
                    "text": "Atypical and anaplastic variants may show tongues of tumor extending into brain"
                  },
                  {
                    "text": "Vimentin (+), SSTR2A(+)"
                  },
                  {
                    "text": "EMA variably (+), weak, focal, membranousS100(+) focal in fibroblastic types",
                    "sub_points": [
                      "S100(+) focal in fibroblastic types"
                    ]
                  },
                  {
                    "text": "Keratin usually (-) except high-grade examples and secretory types"
                  },
                  {
                    "text": "Claudin-6 (+)"
                  },
                  {
                    "text": "Dual D2-40(+)/E-cadherin (+)"
                  },
                  {
                    "text": "Dural metastases most commonly from breast, lung but can be prostate, other unusual sources"
                  },
                  {
                    "text": "Dural metastases often unassociated with parenchymal metastases"
                  }
                ],
                "Papillary Tumor of Pineal Region": [
                  {
                    "text": "Keratin (AE1/AE3, CAM5.2, CK18) (+)"
                  },
                  {
                    "text": "May have focal GFAP(+), dot-like EMA(+)"
                  },
                  {
                    "text": "May have focal synaptophysin and MAP2 (+)"
                  },
                  {
                    "text": "Ki-67 usually low"
                  }
                ],
                "Tumor-to-Tumor Metastasis": [
                  {
                    "text": "Most common CNS \"recipient\" tumor types: Pituitary adenoma, meningioma"
                  },
                  {
                    "text": "Most common \"donor\" systemic tumor types to cause tumor-to-tumor metastasis: Breast, lung"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Search for metastatic tumor (especially melanoma in intracranial hemorrhages)"
                  },
                  {
                    "text": "Use immunomarkers in panels rather than in isolation"
                  },
                  {
                    "text": "Antibodies often demonstrate immunostaining in tumor types outside of originally described specificity (e.g., TTF-1 in nonlung, nonthyroid cancers)"
                  },
                  {
                    "text": "AE1/AE3 seen in reactive astrocytes"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Primary Central Nervous System Lymphomas": {
            "name": "Primary Central Nervous System Lymphomas",
            "url": "https://app.pathprimer.com/document/3e336208-2757-41d0-aa09-c7a6bc1337dd/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Clinical Issues": [
                  {
                    "text": "Median age at presentation60-65 years in immunocompetent patients with diffuse large B-cell lymphoma (DLBCL)30-35 years in immunocompromised patients",
                    "sub_points": [
                      "60-65 years in immunocompetent patients with diffuse large B-cell lymphoma (DLBCL)",
                      "30-35 years in immunocompromised patients"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "Homogeneous enhancement in immunocompetent patients"
                  },
                  {
                    "text": "Ring pattern in immunocompromised patients"
                  },
                  {
                    "text": "Can be multifocal"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Characteristic perivascular cuffing pattern of tumor cells"
                  },
                  {
                    "text": "Infiltrating component mimics infiltrating glioma"
                  },
                  {
                    "text": "Microvascular proliferation rare"
                  },
                  {
                    "text": "Corticosteroids cause extensive apoptosis and macrophage infiltrate-simulating demyelination"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "DLBCLCD45(+), CD20(+), PAX5(+), CD79a(+)",
                    "sub_points": [
                      "CD45(+), CD20(+), PAX5(+), CD79a(+)"
                    ]
                  },
                  {
                    "text": "Germinal center typeCD10(+) (defined as > 30% of tumor cells)CD10(-), BCL6(+), MUM1(-)",
                    "sub_points": [
                      "CD10(+) (defined as > 30% of tumor cells)",
                      "CD10(-), BCL6(+), MUM1(-)"
                    ]
                  },
                  {
                    "text": "Nongerminal center typeCD10(-) and BCL6(-)CD10(-), BCL6(+), MUM1(+)",
                    "sub_points": [
                      "CD10(-) and BCL6(-)",
                      "CD10(-), BCL6(+), MUM1(+)"
                    ]
                  },
                  {
                    "text": "Double-hit/triple-hit lymphoma (rare)MYC(+) and BCL2(+) or BCL6(+)MYC(+), BCL2(+), and BCL6(+)",
                    "sub_points": [
                      "MYC(+) and BCL2(+) or BCL6(+)",
                      "MYC(+), BCL2(+), and BCL6(+)"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Corticosteroid treatment can melt primary CNS lymphomas"
                  },
                  {
                    "text": "May closely mimic infiltrating glioma in neuropil"
                  },
                  {
                    "text": "Microvascular proliferation typically absent"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Primary central nervous system lymphoma (PCNSL)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Rare variant of extranodal, non-Hodgkin lymphoma restricted to brain, spinal cord, eye, and meninges"
                  },
                  {
                    "text": "> 95% PCNSL is diffuse large B-cell lymphoma (DLBCL)"
                  },
                  {
                    "text": "Note that posttransplant lymphoproliferative disorder (PTLD) is not considered PCNSL"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Immunodeficiency States": [
                  {
                    "text": "Increased risk for Epstein-Barr virus (EBV)-driven CNS lymphomaInfectionsHIV/AIDSEBVIatrogenic immunosuppression, e.g., organ transplant, drugs (methotrexate, mycophenolate mofetil)Congenital immunodeficiency syndromesWiskott-Aldrich syndromeSevere combined immunodeficiencyIgA deficiencyAutoimmune diseasesRheumatoid arthritisSjögren syndromeSystemic lupus erythematosusImmune senescence [e.g., EBV(+) DLBCL not otherwise specified (NOS)]",
                    "sub_points": [
                      "InfectionsHIV/AIDSEBV",
                      "HIV/AIDS",
                      "EBV",
                      "Iatrogenic immunosuppression, e.g., organ transplant, drugs (methotrexate, mycophenolate mofetil)",
                      "Congenital immunodeficiency syndromesWiskott-Aldrich syndromeSevere combined immunodeficiencyIgA deficiency",
                      "Wiskott-Aldrich syndrome",
                      "Severe combined immunodeficiency",
                      "IgA deficiency",
                      "Autoimmune diseasesRheumatoid arthritisSjögren syndromeSystemic lupus erythematosus",
                      "Rheumatoid arthritis",
                      "Sjögren syndrome",
                      "Systemic lupus erythematosus",
                      "Immune senescence [e.g., EBV(+) DLBCL not otherwise specified (NOS)]"
                    ]
                  }
                ],
                "Unknown Etiology in Most Immunocompetent Patients": [
                  {
                    "text": "Viruses, such as EBV or HIV, are absent in immunocompetent patients with PCNSL"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare, ~ 3% of all primary CNS tumors"
                  }
                ],
                "Age": [
                  {
                    "text": "Median age at presentation varies based on immune status60-70 years in immunocompetent patients30-40 years in immunocompromised patients",
                    "sub_points": [
                      "60-70 years in immunocompetent patients",
                      "30-40 years in immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Rare in children"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Focal neurologic deficits"
                  },
                  {
                    "text": "Mass effects"
                  },
                  {
                    "text": "Neuropsychologic signs"
                  },
                  {
                    "text": "Ocular symptoms"
                  },
                  {
                    "text": "Rarely, seizures, fever, or night sweats"
                  },
                  {
                    "text": "May simulate encephalitis or leukoencephalopathy, especially in lymphomatosis cerebri type"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Autologous stem cell transplantation, especially in young patients with relapse"
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Biopsy for diagnosis is only procedure of choice"
                  },
                  {
                    "text": "Debulking to relieve mass effect (uncommon)"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Chemotherapy containing high-dose methotrexate"
                  },
                  {
                    "text": "Rituximab (monoclonal antibody against CD20) in most combination regimens"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Avoided in some centers as frontline treatment"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "More aggressive than systemic DLBCL"
                  },
                  {
                    "text": "Poor survivalMedian survival ~ 20-45 months for immunocompetent patientsMedian survival ~ 12-18 months for immunocompromised patients",
                    "sub_points": [
                      "Median survival ~ 20-45 months for immunocompetent patients",
                      "Median survival ~ 12-18 months for immunocompromised patients"
                    ]
                  },
                  {
                    "text": "CSF dissemination in minority of cases but can involve eye"
                  },
                  {
                    "text": "Cell of origin may not be associated with prognosis"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Majority affect cerebral hemispheres (deep brain, periventricular region, corpus callosum, cerebellum)"
                  },
                  {
                    "text": "~ 1/3 multifocal"
                  },
                  {
                    "text": "Iso- or hypointense on T1WI"
                  },
                  {
                    "text": "Hyperintense on T2W1 and FLAIR images"
                  },
                  {
                    "text": "Variable but pronounced contrast enhancement, different between immunocompetent and immunodeficient patientsNo dark, necrotic center in sporadic casesCentral necrosis (rim pattern) similar to glioblastoma in immunocompromised patients",
                    "sub_points": [
                      "No dark, necrotic center in sporadic cases",
                      "Central necrosis (rim pattern) similar to glioblastoma in immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Leakage of contrast in perfusion-weighted images"
                  },
                  {
                    "text": "Decreased signal in diffusion-weighted images"
                  },
                  {
                    "text": "Difficult to distinguish from CNS involvement by systemic lymphomaMultifocal lesions and uncommon locations as well as extradural masses should prompt evaluation",
                    "sub_points": [
                      "Multifocal lesions and uncommon locations as well as extradural masses should prompt evaluation"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solitary or multiple, large, irregular, and pale"
                  },
                  {
                    "text": "Soft, fish flesh appearance, slightly darker than gray matter"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Angiocentricity with tumor cells forming layers around vessels"
                  },
                  {
                    "text": "Angioinvasion, focal, sometimes with vascular necrosis"
                  },
                  {
                    "text": "Diffuse, single-cell invasion, without perineuronal satellitosis"
                  },
                  {
                    "text": "Large, round to irregular nuclei with prominent nucleoli"
                  },
                  {
                    "text": "Small reactive T lymphocytes, usually sparse to moderate but sometimes prominent"
                  },
                  {
                    "text": "Apoptosis and necrosis (especially after steroid treatment)"
                  },
                  {
                    "text": "Necrosis (without pseudopalisading) in immunocompromised or steroid-treated patients"
                  },
                  {
                    "text": "No microvascular proliferation"
                  },
                  {
                    "text": "Corticosteroid effectsIncreased apoptosisFew, if any, viable tumor cellsMacrophage-rich infiltrate with variable number of lymphocytes and plasma cellsFoci of necrosis",
                    "sub_points": [
                      "Increased apoptosis",
                      "Few, if any, viable tumor cells",
                      "Macrophage-rich infiltrate with variable number of lymphocytes and plasma cells",
                      "Foci of necrosis"
                    ]
                  }
                ],
                "Other Subtypes of CNS Lymphoma (< 5%)": [
                  {
                    "text": "PCNSLSmall, angulated cellsOlder patientsT-cell-associated antigens CD2, CD3, and CD5 (+)May express cytotoxic markers",
                    "sub_points": [
                      "Small, angulated cells",
                      "Older patients",
                      "T-cell-associated antigens CD2, CD3, and CD5 (+)",
                      "May express cytotoxic markers"
                    ]
                  },
                  {
                    "text": "Anaplastic large cell lymphoma (form of T-cell lymphoma)Not associated with immunodeficiencyExtensive leptomeningeal spreadLarge, round, pleomorphic cells with marked cytologic atypiaALK(+) and t(2:5) translocationTypically CD30, CD45, and EMA (+)Occasionally CD3, CD43, and CD45RO (+)ALK(-) cases are worse than ALK(+) casesUsually in children or young adultsVery rare (< 1% of PCNSLs)",
                    "sub_points": [
                      "Not associated with immunodeficiency",
                      "Extensive leptomeningeal spread",
                      "Large, round, pleomorphic cells with marked cytologic atypia",
                      "ALK(+) and t(2:5) translocation",
                      "Typically CD30, CD45, and EMA (+)",
                      "Occasionally CD3, CD43, and CD45RO (+)",
                      "ALK(-) cases are worse than ALK(+) cases",
                      "Usually in children or young adults",
                      "Very rare (< 1% of PCNSLs)"
                    ]
                  },
                  {
                    "text": "Primary intraocular lymphomaOptic nerve, retina, or vitreousUsually bilateralMost are DLBCLVitreous cytology often helpful",
                    "sub_points": [
                      "Optic nerve, retina, or vitreous",
                      "Usually bilateral",
                      "Most are DLBCL",
                      "Vitreous cytology often helpful"
                    ]
                  },
                  {
                    "text": "Extranodal marginal zone B-cell lymphoma/mucosa-associated lymphoid tissue (MALT) lymphomaDural-based, meningioma-like massRarely arising in brainFemale predominanceMonocytoid cells (small to medium-sized with pale cytoplasm) &/or plasma cells/plasmacytoid cellsLess cytologic atypia than DLBCLSlightly irregular tumor nuclei with inconspicuous nucleoliCD20, PAX5, CD79a (+)Trisomy 3 most common genetic abnormality",
                    "sub_points": [
                      "Dural-based, meningioma-like massRarely arising in brain",
                      "Rarely arising in brain",
                      "Female predominance",
                      "Monocytoid cells (small to medium-sized with pale cytoplasm) &/or plasma cells/plasmacytoid cells",
                      "Less cytologic atypia than DLBCLSlightly irregular tumor nuclei with inconspicuous nucleoli",
                      "Slightly irregular tumor nuclei with inconspicuous nucleoli",
                      "CD20, PAX5, CD79a (+)",
                      "Trisomy 3 most common genetic abnormality"
                    ]
                  },
                  {
                    "text": "Lymphomatoid granulomatosisEBV-driven B-cell lymphoproliferative processAngiocentric, angiodestructivePolymorphous backgroundCoagulation necrosisOften involves lung &/or skin in addition to CNS",
                    "sub_points": [
                      "EBV-driven B-cell lymphoproliferative process",
                      "Angiocentric, angiodestructive",
                      "Polymorphous background",
                      "Coagulation necrosis",
                      "Often involves lung &/or skin in addition to CNS"
                    ]
                  },
                  {
                    "text": "Classic Hodgkin lymphomaDural based, often at skull baseSecondary involvement more common than primary classic Hodgkin lymphoma (rare)Reed-Sternberg cells essential to diagnosisBackground with eosinophils and small lymphocytes",
                    "sub_points": [
                      "Dural based, often at skull base",
                      "Secondary involvement more common than primary classic Hodgkin lymphoma (rare)",
                      "Reed-Sternberg cells essential to diagnosis",
                      "Background with eosinophils and small lymphocytes"
                    ]
                  },
                  {
                    "text": "Intravascular lymphomatosisHighly aggressive form involving multiple organs without mass lesionsPoor prognosis, most patients diagnosed post mortemExclusively intraluminal localization of malignant lymphocytes (large B-cell lymphoma most common type)",
                    "sub_points": [
                      "Highly aggressive form involving multiple organs without mass lesions",
                      "Poor prognosis, most patients diagnosed post mortem",
                      "Exclusively intraluminal localization of malignant lymphocytes (large B-cell lymphoma most common type)"
                    ]
                  },
                  {
                    "text": "Lymphomatosis cerebri (rare clinicoradiographic variant)MR appearance suggests diffuse leukoencephalopathyAbsent or mild contrast enhancementBroad differentials: Toxic encephalopathy, infections/inflammation, vascular disorders, leukodystrophy, gliomatosis cerebri, progressive multifocal leukoencephalopathy (PML)No discrete mass lesionsInfarcts, necrosis, hemorrhageDiffuse infiltration of neuropils by malignant B lymphocytes",
                    "sub_points": [
                      "MR appearance suggests diffuse leukoencephalopathyAbsent or mild contrast enhancementBroad differentials: Toxic encephalopathy, infections/inflammation, vascular disorders, leukodystrophy, gliomatosis cerebri, progressive multifocal leukoencephalopathy (PML)",
                      "Absent or mild contrast enhancement",
                      "Broad differentials: Toxic encephalopathy, infections/inflammation, vascular disorders, leukodystrophy, gliomatosis cerebri, progressive multifocal leukoencephalopathy (PML)",
                      "No discrete mass lesions",
                      "Infarcts, necrosis, hemorrhage",
                      "Diffuse infiltration of neuropils by malignant B lymphocytes"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Dispersed individual cells"
                  },
                  {
                    "text": "Large, hyperchromatic nuclei with large nucleoli"
                  },
                  {
                    "text": "Scant amphophilic cytoplasm"
                  },
                  {
                    "text": "Apoptotic cells and mitotic figures"
                  },
                  {
                    "text": "Macrophages, some tingible body type, especially after corticosteroid treatment"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "Tree ring pattern of reticulin staining in affected vessels"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Common markers for B-cell lymphomaCD45(+)CD20(+)PAX5(+)CD79a(+)",
                    "sub_points": [
                      "CD45(+)",
                      "CD20(+)",
                      "PAX5(+)",
                      "CD79a(+)"
                    ]
                  },
                  {
                    "text": "Germinal center phenotype (less common in PCNSL)CD10(+) (defined as protein expression in > 30% of tumor cells)CD10(-), BCL6(+), and MUM1(-)",
                    "sub_points": [
                      "CD10(+) (defined as protein expression in > 30% of tumor cells)",
                      "CD10(-), BCL6(+), and MUM1(-)"
                    ]
                  },
                  {
                    "text": "Nongerminal phenotypeCD10(-) and BCL6(-)CD10(-), BCL6(+), and MUM1(+)",
                    "sub_points": [
                      "CD10(-) and BCL6(-)",
                      "CD10(-), BCL6(+), and MUM1(+)"
                    ]
                  },
                  {
                    "text": "Double protein expressorc-Myc(+) in > 40% of tumor cellsBCL2(+) in > 50% of tumor cells",
                    "sub_points": [
                      "c-Myc(+) in > 40% of tumor cells",
                      "BCL2(+) in > 50% of tumor cells"
                    ]
                  },
                  {
                    "text": "High Ki-67 labeling index"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "EBV(+) in most CNS lymphomas in immunosuppressed patients"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Fluorescence in situ hybridization (FISH)High-grade B-cell lymphoma withMYCandBCL2&/orBCL6rearrangements (double-hit/triple-hit lymphoma)",
                    "sub_points": [
                      "High-grade B-cell lymphoma withMYCandBCL2&/orBCL6rearrangements (double-hit/triple-hit lymphoma)"
                    ]
                  },
                  {
                    "text": "Unique molecular signatureAlterations in B-cell receptor/Toll-like receptor/NF-κB pathways in > 90% of casesFrequently mutated genes:MYD88,CD79a,CARD11,TBL1XR1,PRDM1,CREBBP,CDKN2A,PIM1",
                    "sub_points": [
                      "Alterations in B-cell receptor/Toll-like receptor/NF-κB pathways in > 90% of cases",
                      "Frequently mutated genes:MYD88,CD79a,CARD11,TBL1XR1,PRDM1,CREBBP,CDKN2A,PIM1"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Systemic Malignant Lymphoma Involving CNS": [
                  {
                    "text": "May be difficult to distinguish from PCNSL"
                  },
                  {
                    "text": "Prior history of systemic lymphoma or immunosuppression"
                  },
                  {
                    "text": "Some cases initially considered PCNSL may prove to be systemic tumors on follow-up"
                  },
                  {
                    "text": "DLBCL with germinal center phenotype [e.g., CD10(+)] is more likely systemic lymphoma than PCNSL"
                  }
                ],
                "Glioblastoma": [
                  {
                    "text": "Tissue fragments with fibrillar background on smears"
                  },
                  {
                    "text": "Variable cell size, processes"
                  },
                  {
                    "text": "Little angiocentricity"
                  },
                  {
                    "text": "Vascular endothelial proliferation and palisading necrosis"
                  },
                  {
                    "text": "GFAP(+), most cases"
                  },
                  {
                    "text": "Somewhat smaller cells in glioblastoma with embryonal component; synaptophysin (+)"
                  }
                ],
                "Anaplastic Oligodendroglioma": [
                  {
                    "text": "Cellular monotony"
                  },
                  {
                    "text": "Perineuronal satellitosis"
                  },
                  {
                    "text": "Few lymphocytes"
                  },
                  {
                    "text": "CD45(-)"
                  },
                  {
                    "text": "S100(+)"
                  },
                  {
                    "text": "GFAP(+)"
                  },
                  {
                    "text": "IDH1(+)"
                  },
                  {
                    "text": "Vascular endothelial proliferation in most cases"
                  }
                ],
                "Metastatic Carcinoma": [
                  {
                    "text": "Tissue fragments and cells with sharply defined cytoplasm in smear preparations"
                  },
                  {
                    "text": "Well circumscribed, corticocentric"
                  },
                  {
                    "text": "Organoid patterns, cohesive architecture"
                  },
                  {
                    "text": "Stromal desmoplasia"
                  },
                  {
                    "text": "Immunostaining profileKeratin (+)CD45(-)",
                    "sub_points": [
                      "Keratin (+)",
                      "CD45(-)"
                    ]
                  },
                  {
                    "text": "Tissue necrosis may simulate false angiocentric pattern"
                  }
                ],
                "Cerebral Infarction": [
                  {
                    "text": "Slight, if any, lymphoid infiltrate, no atypia"
                  },
                  {
                    "text": "Ischemic, red-dead neurons in acute examples"
                  },
                  {
                    "text": "Abundant macrophages in subacute examples"
                  }
                ],
                "Cerebral Abscess": [
                  {
                    "text": "Uniform thickness; occasional multiloculate ring enhancement"
                  },
                  {
                    "text": "Suppuration"
                  },
                  {
                    "text": "Mixed lymphoplasmacytic infiltrate with neutrophils"
                  },
                  {
                    "text": "Capsule in well-developed, organizing lesions"
                  },
                  {
                    "text": "Rare CD20(+) cells"
                  }
                ],
                "Encephalitis": [
                  {
                    "text": "Minimal or no cytologic atypia"
                  },
                  {
                    "text": "Principally T cells, almost no CD20(+) cells"
                  },
                  {
                    "text": "Microglial clusters"
                  }
                ],
                "Demyelinating Disease": [
                  {
                    "text": "Restricted to white matterDemarcatedPeriventricular lesions may not enhance",
                    "sub_points": [
                      "Demarcated",
                      "Periventricular lesions may not enhance"
                    ]
                  },
                  {
                    "text": "Predominantly macrophages"
                  },
                  {
                    "text": "Perivascular small lymphocytes (T cells)"
                  },
                  {
                    "text": "Occasional astrocytes with multiple micronuclei (Creutzfeldt cells)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Corticosteroid treatment can melt PCNSLs and make lymphoma diagnosis very challenging"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Paucicellular areas may closely mimic infiltrating glioma"
                  },
                  {
                    "text": "Widely scattered tumor cells may be inconspicuous among small reactive lymphocytes"
                  },
                  {
                    "text": "Microvascular proliferation rare or often nonexistent"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Adamantinomatous Craniopharyngioma": {
            "name": "Adamantinomatous Craniopharyngioma",
            "url": "https://app.pathprimer.com/document/65df1e81-b8b6-4ad4-bf52-6727e5291b6d/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "(Supra)sellar epithelial neoplasm resembling ameloblastoma or keratinizing and calcifying odontogenic cyst"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Bimodal with peaks at 5-10 years and 50-60 years"
                  },
                  {
                    "text": "More common, even in adults, than papillary craniopharyngioma"
                  },
                  {
                    "text": "Recur after incomplete excision"
                  }
                ],
                "Imaging": [
                  {
                    "text": "CT: Partially Ca⁺⁺, partially cystic and solid, cystic suprasellar mass"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Distinctive palisading epithelium, loose stellate reticulum, and \"wet\" keratin in most cases"
                  },
                  {
                    "text": "Peritumoral piloid gliosis, Rosenthal fibers common"
                  },
                  {
                    "text": "\"Wet\" keratin diagnostic even in absence of viable epithelium"
                  },
                  {
                    "text": "Xanthomatous cells only suggest diagnosis"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Immunopositive for β-catenin but IHC(+) focal and maximal in whorls; β-catenin intranuclear (nuclear translocation) and cytoplasmic"
                  },
                  {
                    "text": "Immunonegative for mutant BRAF VE1 (BRAFV600E)"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Adamantinomatous or papillary typeNuclear palisades and \"wet\" keratin in adamantinomatousβ-catenin nuclear immunoreactivity in adamantinomatousPapillary type lacks \"wet\" keratin, calcificationsPapillary type BRAF VE1 IHC(+), no nuclear β-catenin immunoreactivity",
                    "sub_points": [
                      "Nuclear palisades and \"wet\" keratin in adamantinomatous",
                      "β-catenin nuclear immunoreactivity in adamantinomatous",
                      "Papillary type lacks \"wet\" keratin, calcifications",
                      "Papillary type BRAF VE1 IHC(+), no nuclear β-catenin immunoreactivity"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Suprasellar or sellar epithelial neoplasm resembling ameloblastoma and calcifying odontogenic cyst"
                  },
                  {
                    "text": "WHO grade I"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Possible origin in remnants of Rathke pouch epithelium or misplaced odontogenic rests along pituitary stalk"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Estimated around 1.1-1.7 per million population (data available from Italy, Sweden, Hong Kong)Higher incidence rates reported in Asia and Africa",
                    "sub_points": [
                      "Higher incidence rates reported in Asia and Africa"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Bimodal with peaks at 5-10 years and 50-60 years"
                  },
                  {
                    "text": "Rarely, congenital or in senescence"
                  },
                  {
                    "text": "More common, even in adults, than papillary craniopharyngioma"
                  }
                ],
                "Site": [
                  {
                    "text": "SuprasellarInfrequent intrasellar componentExtension into neighboring structuresPosterior extension to prepontine and interpeduncular cisterns, cerebellopontine angle, even foramen magnum",
                    "sub_points": [
                      "Infrequent intrasellar component",
                      "Extension into neighboring structures",
                      "Posterior extension to prepontine and interpeduncular cisterns, cerebellopontine angle, even foramen magnum"
                    ]
                  },
                  {
                    "text": "Intranasal, sphenoid sinus, cerebellopontine angle, and pineal region are rare primary sites"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Visual disturbances"
                  },
                  {
                    "text": "Endocrine deficienciesGrowth failure and delayed puberty in childrenDeficiencies of GH > LH/FSH > ACTH > TSHDiabetes insipidus (adults > children)",
                    "sub_points": [
                      "Growth failure and delayed puberty in children",
                      "Deficiencies of GH > LH/FSH > ACTH > TSH",
                      "Diabetes insipidus (adults > children)"
                    ]
                  },
                  {
                    "text": "Headache"
                  },
                  {
                    "text": "Cognitive impairment and personality changes"
                  },
                  {
                    "text": "Rare chemical meningitis with cyst spillage"
                  }
                ],
                "Treatment": [],
                "Options, risks, complications": [
                  {
                    "text": "Treatment controversial"
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Complete resection, but technically challenging, and with risk of operative damage to hypothalamus and neighboring structures with need for lifelong pituitary hormone replacement"
                  },
                  {
                    "text": "Subtotal resection with observation"
                  },
                  {
                    "text": "Cyst aspiration, repeated, for recurrent lesions"
                  }
                ],
                "Adjuvant therapy": [
                  {
                    "text": "Intracystic bleomycin to control recurrence"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Radiation (conventional or stereotactic) for subtotally resected tumors"
                  },
                  {
                    "text": "Intralesional, to control cysts in some cases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Cystic recurrences common after incomplete excisionDebatable relationship between Ki-67 index and likelihood of recurrence",
                    "sub_points": [
                      "Debatable relationship between Ki-67 index and likelihood of recurrence"
                    ]
                  },
                  {
                    "text": "Studies report 5-year recurrence-free survival ~ 60%; overall survival > 90%Variable incidence of endocrinologic deficiencies",
                    "sub_points": [
                      "Variable incidence of endocrinologic deficiencies"
                    ]
                  },
                  {
                    "text": "Rarely undergoes malignant transformationMultiple recurrences and radiation increase riskPrior radiotherapy in almost all cases",
                    "sub_points": [
                      "Multiple recurrences and radiation increase riskPrior radiotherapy in almost all cases",
                      "Prior radiotherapy in almost all cases"
                    ]
                  },
                  {
                    "text": "Severe visual problems and vision loss reported in 30% of patients over long termRisk factors for severe visual loss: Optic nerve edema, early age at presentation, recurrences",
                    "sub_points": [
                      "Risk factors for severe visual loss: Optic nerve edema, early age at presentation, recurrences"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [],
                "Location": [
                  {
                    "text": "Extraaxial, suprasellar at interface with pituitary stalk and pituitary glandSupra- and infra-, rarely intrasellar",
                    "sub_points": [
                      "Supra- and infra-, rarely intrasellar"
                    ]
                  }
                ],
                "Size": [
                  {
                    "text": "Variable, often > 5 cm"
                  },
                  {
                    "text": "May be massive in recurrence"
                  }
                ],
                "Radiographic Findings": [
                  {
                    "text": "CT: Calcified, solid-cystic with enhancement of solid component"
                  },
                  {
                    "text": "MR: Best imaging toolCystic component hyperintense on T1WI and shows broad lipid spectrum on MRSSolid component variable in T1W1 and T2W1, calcifications are hypointense on T2WISolid component enhances variably, cyst wall enhances strongly",
                    "sub_points": [
                      "Cystic component hyperintense on T1WI and shows broad lipid spectrum on MRS",
                      "Solid component variable in T1W1 and T2W1, calcifications are hypointense on T2WI",
                      "Solid component enhances variably, cyst wall enhances strongly"
                    ]
                  }
                ],
                "MR Findings": [
                  {
                    "text": "T1W1 images: Hyperintense with fluid levels consistent with cystic natureHeterogeneous with 3 components: Large hyperintense cyst superiorly, isointense solid mass inferiorly, and calcified nodule with solid areaOccasionally, hypointense",
                    "sub_points": [
                      "Heterogeneous with 3 components: Large hyperintense cyst superiorly, isointense solid mass inferiorly, and calcified nodule with solid area",
                      "Occasionally, hypointense"
                    ]
                  },
                  {
                    "text": "Most hyperintense on T2WI"
                  },
                  {
                    "text": "Heterogeneous enhancement"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Mixed low-density and isointense signalsSolid portion enhances or forms peripheral ring enhancement surrounding cyst",
                    "sub_points": [
                      "Solid portion enhances or forms peripheral ring enhancement surrounding cyst"
                    ]
                  },
                  {
                    "text": "CT superior to MR for detection of calcification"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Irregular interface with surrounding brainDensely adherent to adjacent structures",
                    "sub_points": [
                      "Densely adherent to adjacent structures"
                    ]
                  },
                  {
                    "text": "Lobular, partly cystic, often calcifiedCysts with dark \"motor oil\" fluid, rich in glistening cholesterol crystalsPotential for chemical meningitis with spillage",
                    "sub_points": [
                      "Cysts with dark \"motor oil\" fluid, rich in glistening cholesterol crystalsPotential for chemical meningitis with spillage",
                      "Potential for chemical meningitis with spillage"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "BordersGenerally circumscribed but often microscopic brain invasionSmall tongues of tissue extend into hypothalamic parenchyma",
                    "sub_points": [
                      "Generally circumscribed but often microscopic brain invasionSmall tongues of tissue extend into hypothalamic parenchyma",
                      "Small tongues of tissue extend into hypothalamic parenchyma"
                    ]
                  },
                  {
                    "text": "Patterns of spreadUsually expansion and local infiltrationDissemination in cerebrospinal fluid (CSF) or surgical tract, rare",
                    "sub_points": [
                      "Usually expansion and local infiltration",
                      "Dissemination in cerebrospinal fluid (CSF) or surgical tract, rare"
                    ]
                  },
                  {
                    "text": "Compact sheets, nodules, anastomosing trabeculae, and \"clover leafs\" of squamous epithelium"
                  },
                  {
                    "text": "Peripheral layer of palisaded epithelium surrounds loose stellate reticulum"
                  },
                  {
                    "text": "Nodules of plump anucleate squames \"ghost\" cells, \"wet\" keratin"
                  },
                  {
                    "text": "Intralobular whorl-like formations"
                  },
                  {
                    "text": "Degenerative changes, often in recurrencesCysts with flat epithelium, squamous debrisFibrosis, chronic inflammation, cholesterol cleftsExtensive calcification or, rarely, ossificationOften scant epithelium post irradiation",
                    "sub_points": [
                      "Cysts with flat epithelium, squamous debris",
                      "Fibrosis, chronic inflammation, cholesterol clefts",
                      "Extensive calcification or, rarely, ossification",
                      "Often scant epithelium post irradiation"
                    ]
                  },
                  {
                    "text": "Piloid gliosis in surrounding brain"
                  },
                  {
                    "text": "Rarely, melanin pigment"
                  },
                  {
                    "text": "Rarely, collision tumor with pituitary adenoma"
                  },
                  {
                    "text": "Malignant transformation rareHistologic features/type of malignant tumor variable",
                    "sub_points": [
                      "Histologic features/type of malignant tumor variable"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Cohesive clumps or sheets of epithelium"
                  },
                  {
                    "text": "Nodules of \"wet\" keratin"
                  },
                  {
                    "text": "Macrophages, amorphous debris, calcifications, reactive piloid astrocytes"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "CK7, CK8, CK14 (+)"
                  },
                  {
                    "text": "β-catenin (+) in whorls; intranuclear (nuclear translocation) and cytoplasmic"
                  },
                  {
                    "text": "Ki-67 low; labeling indices not definitively shown to predict recurrence"
                  },
                  {
                    "text": "Immunonegative for cytoplasmic mutant BRAF VE1 (BRAFV600E)"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "β-catenin mutations"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Papillary Craniopharyngioma": [
                  {
                    "text": "Lacks prominent palisading, \"wet\" keratin, stellate reticulum, calcifications, fibrosis"
                  },
                  {
                    "text": "No machinery oil-like fluidNo cholesterol in cyst fluid",
                    "sub_points": [
                      "No cholesterol in cyst fluid"
                    ]
                  },
                  {
                    "text": "No xanthogranulomatous reaction"
                  },
                  {
                    "text": "Nuclear β-catenin (-), CK8(-) and CK20(-)"
                  },
                  {
                    "text": "Immunopositive for cytoplasmic mutant BRAF VE1 (BRAFV600E)"
                  }
                ],
                "Rathke Cleft Cyst With Squamous Metaplasia": [
                  {
                    "text": "More intra- than suprasellar"
                  },
                  {
                    "text": "Squamous tissue often focally overlain by ciliated &/or mucus-containing cells"
                  },
                  {
                    "text": "No \"wet\" keratin or calcification"
                  },
                  {
                    "text": "β-catenin (-) nuclei"
                  },
                  {
                    "text": "CK8(+) and CK20(+)"
                  }
                ],
                "Epidermoid Cyst": [
                  {
                    "text": "Uniloculated, thin layer of keratinizing squamous epithelium"
                  },
                  {
                    "text": "Flaky or \"dry\" keratin principal component"
                  },
                  {
                    "text": "Keratohyaline granules"
                  },
                  {
                    "text": "No nuclear palisades"
                  },
                  {
                    "text": "No \"wet\" keratin"
                  },
                  {
                    "text": "Almost no fibrous tissue"
                  }
                ],
                "Pilocytic Astrocytoma": [
                  {
                    "text": "Greater cellularity than piloid gliosis"
                  },
                  {
                    "text": "Often biphasic or with loose, spongy, microcystic tissue"
                  },
                  {
                    "text": "Eosinophilic granular bodies in some cases"
                  }
                ],
                "Xanthogranuloma of Sellar Region": [
                  {
                    "text": "Cholesterol clefts, macrophages, giant cells, inflammation, hemosiderin, necrosis, and cysts"
                  },
                  {
                    "text": "No epithelium identified in some cases"
                  },
                  {
                    "text": "Reactive process; not single entity"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Adherence to local structures minimizes chance of total excision without postoperative neurological/neuroendocrine deficits"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Complex epithelial tumor with ribbons of palisaded cells, calcification"
                  },
                  {
                    "text": "\"Wet\" keratin alone diagnostic"
                  },
                  {
                    "text": "Piloid gliosis with Rosenthal fibers may surround craniopharyngioma and mimic glioma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pituitary Adenoma/PitNET": {
            "name": "Pituitary Adenoma/PitNET",
            "url": "https://app.pathprimer.com/document/6def3544-bb8b-4e8a-9f3a-39cf7ed41969/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Pituitary neuroendocrine tumor (PitNET)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Occur mainly in 4th-7th decade"
                  },
                  {
                    "text": "Often present with clinical features of hormone excess"
                  },
                  {
                    "text": "Larger adenomas often present with mass effects"
                  },
                  {
                    "text": "Typical approach via transsphenoidal route"
                  },
                  {
                    "text": "Drugs: Dopamine agonists, somatostatin analogs, growth hormone (GH) receptor antagonists, temozolomide"
                  },
                  {
                    "text": "Conventional radiotherapy for incompletely resected or recurrent tumors"
                  },
                  {
                    "text": "5 subtypes acknowledged as more aggressive adenomasSparsely granulated somatotroph adenomaSilent corticotroph adenomaCrooke cell corticotroph adenomaPoorly differentiated PIT1-lineage adenomaLactotroph adenoma in men",
                    "sub_points": [
                      "Sparsely granulated somatotroph adenoma",
                      "Silent corticotroph adenoma",
                      "Crooke cell corticotroph adenoma",
                      "Poorly differentiated PIT1-lineage adenoma",
                      "Lactotroph adenoma in men"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "With rare exception (e.g., suprasellar or sphenoid sinus), arise in sella"
                  },
                  {
                    "text": "Extensions: Suprasellar, lateral (cavernous sinus), inferior (sphenoid sinus), posterior fossa"
                  },
                  {
                    "text": "Enhance but delayed from and less than normal gland"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PAS to highlight ACTH cells, effacement of acinar architecture"
                  },
                  {
                    "text": "Reticulin stain reveals loss of acinar pattern"
                  },
                  {
                    "text": "IHC has key role in clinical and biochemical correlationHormone subunits [GH, prolactin (PRL), ACTH, LH, FSH, TSH, and α-subunit]Transcription factors (SF1, PIT-1, TPIT)",
                    "sub_points": [
                      "Hormone subunits [GH, prolactin (PRL), ACTH, LH, FSH, TSH, and α-subunit]",
                      "Transcription factors (SF1, PIT-1, TPIT)"
                    ]
                  },
                  {
                    "text": "Elevated Ki-67 index in some casesTerm \"atypical adenoma\" no longer utilizedMention elevated Ki-67 in report, as closer follow-up may be beneficial",
                    "sub_points": [
                      "Term \"atypical adenoma\" no longer utilized",
                      "Mention elevated Ki-67 in report, as closer follow-up may be beneficial"
                    ]
                  },
                  {
                    "text": "Ultrastructural study necessary for classification in minority of cases"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Pituitary neuroendocrine tumor (PitNET)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Monoclonal adenohypophysial tumors composed of secretory cells typically demonstrating pituitary hormone production or transcription factors"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Pathophysiology": [
                  {
                    "text": "Majority sporadicClonal expansion of anterior pituitary hormone-producing cells; risk factors for sporadic cases not identifiedSomatic mutationsGNASgene in 40% of sporadic somatotroph adenomas (rarely identified in other pituitary adenoma subtypes)USP8gene in 30-60% of sporadic corticotroph adenomas (mutation rarely identified in other pituitary adenoma subtypes)PIK3CAgene in nonfunctioning pituitary adenomasMcCune-Albright syndrome with involvement of 20q13.2Growth hormone (GH)-secreting pituitary adenomas, café au lait macules, fibrous dysplasia of skullPostzygotic mutations inGNASSyndrome arises sporadically, and no confirmed cases of vertical transmission",
                    "sub_points": [
                      "Clonal expansion of anterior pituitary hormone-producing cells; risk factors for sporadic cases not identified",
                      "Somatic mutationsGNASgene in 40% of sporadic somatotroph adenomas (rarely identified in other pituitary adenoma subtypes)USP8gene in 30-60% of sporadic corticotroph adenomas (mutation rarely identified in other pituitary adenoma subtypes)PIK3CAgene in nonfunctioning pituitary adenomas",
                      "GNASgene in 40% of sporadic somatotroph adenomas (rarely identified in other pituitary adenoma subtypes)",
                      "USP8gene in 30-60% of sporadic corticotroph adenomas (mutation rarely identified in other pituitary adenoma subtypes)",
                      "PIK3CAgene in nonfunctioning pituitary adenomas",
                      "McCune-Albright syndrome with involvement of 20q13.2Growth hormone (GH)-secreting pituitary adenomas, café au lait macules, fibrous dysplasia of skullPostzygotic mutations inGNASSyndrome arises sporadically, and no confirmed cases of vertical transmission",
                      "Growth hormone (GH)-secreting pituitary adenomas, café au lait macules, fibrous dysplasia of skull",
                      "Postzygotic mutations inGNAS",
                      "Syndrome arises sporadically, and no confirmed cases of vertical transmission"
                    ]
                  },
                  {
                    "text": "Minority due to heritable (germline) mutationsMultiple endocrine neoplasia 1 (MEN1)Germline heterozygous mutations inMEN1gene (11q13) associated with pituitary adenomas, parathyroid hyperplasia/adenomas, neuroendocrine tumors of gastroenteropancreatic tractCarney complex with involvement of 2p16 and 17qMay have multiple pituitary adenomas; adenomas with both GH, prolactin (PRL) immunostaining, some with surrounding mammosomatotroph hyperplasiaFamilial isolated pituitary adenomaAryl hydrocarbon receptor-interacting protein (AIP) gene, 11q13Often produce GH &/or PRLRare in sporadic acromegaly cases but found more frequently in pituitary gigantism cases, patients with macroadenomas diagnosed at age ≤ 30 yearsMEN4 with germline mutations inCDKN1BgeneRare but most common phenotype primary hyperparathyroidism, pituitary adenomasX-linked acrogigantism (XLAG) associated withGPR101microduplicationHereditary pheochromocytoma and paraganglioma syndrome related to succinate dehydrogenase (SDH) genes",
                    "sub_points": [
                      "Multiple endocrine neoplasia 1 (MEN1)Germline heterozygous mutations inMEN1gene (11q13) associated with pituitary adenomas, parathyroid hyperplasia/adenomas, neuroendocrine tumors of gastroenteropancreatic tract",
                      "Germline heterozygous mutations inMEN1gene (11q13) associated with pituitary adenomas, parathyroid hyperplasia/adenomas, neuroendocrine tumors of gastroenteropancreatic tract",
                      "Carney complex with involvement of 2p16 and 17qMay have multiple pituitary adenomas; adenomas with both GH, prolactin (PRL) immunostaining, some with surrounding mammosomatotroph hyperplasia",
                      "May have multiple pituitary adenomas; adenomas with both GH, prolactin (PRL) immunostaining, some with surrounding mammosomatotroph hyperplasia",
                      "Familial isolated pituitary adenomaAryl hydrocarbon receptor-interacting protein (AIP) gene, 11q13Often produce GH &/or PRLRare in sporadic acromegaly cases but found more frequently in pituitary gigantism cases, patients with macroadenomas diagnosed at age ≤ 30 years",
                      "Aryl hydrocarbon receptor-interacting protein (AIP) gene, 11q13",
                      "Often produce GH &/or PRL",
                      "Rare in sporadic acromegaly cases but found more frequently in pituitary gigantism cases, patients with macroadenomas diagnosed at age ≤ 30 years",
                      "MEN4 with germline mutations inCDKN1BgeneRare but most common phenotype primary hyperparathyroidism, pituitary adenomas",
                      "Rare but most common phenotype primary hyperparathyroidism, pituitary adenomas",
                      "X-linked acrogigantism (XLAG) associated withGPR101microduplication",
                      "Hereditary pheochromocytoma and paraganglioma syndrome related to succinate dehydrogenase (SDH) genes"
                    ]
                  },
                  {
                    "text": "Epigenetic changesTumor suppressor protein p16, cyclin-dependent kinase inhibitor encoded byCDKN2Agene, frequently downregulated in pituitary tumors, especially in nonfunctioning pituitary adenomasExpression of DNA damage inducible gene 45 g (GADD45G), p53-regulated gene that negatively regulates pituitary growth, downregulated in nonfunctioning pituitary adenomas due to promoter methylationDifferential down/upregulation of miRNAs, signaling pathways",
                    "sub_points": [
                      "Tumor suppressor protein p16, cyclin-dependent kinase inhibitor encoded byCDKN2Agene, frequently downregulated in pituitary tumors, especially in nonfunctioning pituitary adenomas",
                      "Expression of DNA damage inducible gene 45 g (GADD45G), p53-regulated gene that negatively regulates pituitary growth, downregulated in nonfunctioning pituitary adenomas due to promoter methylation",
                      "Differential down/upregulation of miRNAs, signaling pathways"
                    ]
                  },
                  {
                    "text": "Does not appear to be increased risk for pituitary adenomas in transgender persons receiving hormone therapies"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "10-25% of intracranial neoplasms, depending on practice"
                  },
                  {
                    "text": "Prevalence of pituitary tumors ~ 1/1,000 population"
                  },
                  {
                    "text": "Mainly 4th-7th decade; average age 51 yearsFemales slightly more frequent overallFemale predominance in corticotroph and somatotroph adenomasMale predominance in gonadotroph adenomasClinically nonfunctioning adenomas (gonadotroph adenomas) rare in young patients, increase with ageGonadotroph adenomas with mean age 58 yearsLactotroph adenomas common in youth, decrease with ageSomatotroph adenomas mostly in patients ages 20-50 years",
                    "sub_points": [
                      "Females slightly more frequent overallFemale predominance in corticotroph and somatotroph adenomasMale predominance in gonadotroph adenomas",
                      "Female predominance in corticotroph and somatotroph adenomas",
                      "Male predominance in gonadotroph adenomas",
                      "Clinically nonfunctioning adenomas (gonadotroph adenomas) rare in young patients, increase with age",
                      "Gonadotroph adenomas with mean age 58 years",
                      "Lactotroph adenomas common in youth, decrease with age",
                      "Somatotroph adenomas mostly in patients ages 20-50 years"
                    ]
                  },
                  {
                    "text": "Adenomas uncommon in children2% of all adenomasMost PRL- or ACTH-producing",
                    "sub_points": [
                      "2% of all adenomas",
                      "Most PRL- or ACTH-producing"
                    ]
                  },
                  {
                    "text": "Incidental adenomas seen in 10-22% of autopsies, depending on extent of step sectioningMost common adenoma type sparsely granulated lactotroph adenomaSeries by Buurman and Saeger showed 9.6% of 3,048 autopsies contained subclinical pituitary adenoma (none yielding reported clinical symptoms)Series by Costello in 1936 showed 22.5% of 1,000 autopsy cases contained adenomas, identified upon serial sectioning of gland and examination of 3-10 sections per gland",
                    "sub_points": [
                      "Most common adenoma type sparsely granulated lactotroph adenoma",
                      "Series by Buurman and Saeger showed 9.6% of 3,048 autopsies contained subclinical pituitary adenoma (none yielding reported clinical symptoms)",
                      "Series by Costello in 1936 showed 22.5% of 1,000 autopsy cases contained adenomas, identified upon serial sectioning of gland and examination of 3-10 sections per gland"
                    ]
                  },
                  {
                    "text": "Clinical classification based on endocrinologic features (clinically functioning vs. nonfunctioning) and neuroimaging (size, involvement of adjacent structures)"
                  },
                  {
                    "text": "Recent study of 1,169 surgically resected adenomas using transcription factor classification showed42.5% SF1-lineage gonadotroph adenomas29.9% PIT-1-lineage adenomas53% GH predominant (somatotroph, mammosomatotroph/mixed)28% PRL predominant (lactotroph, acidophil stem cell)2% thyrotroph adenoma14% plurihormonal PIT-1-positive adenoma3% not otherwise specified17.1% TPIT-lineage corticotroph adenomas4.5% null cell tumors0.5% unusual plurihormonal tumors5% not classified (technical reasons)",
                    "sub_points": [
                      "42.5% SF1-lineage gonadotroph adenomas",
                      "29.9% PIT-1-lineage adenomas53% GH predominant (somatotroph, mammosomatotroph/mixed)28% PRL predominant (lactotroph, acidophil stem cell)2% thyrotroph adenoma14% plurihormonal PIT-1-positive adenoma3% not otherwise specified",
                      "53% GH predominant (somatotroph, mammosomatotroph/mixed)",
                      "28% PRL predominant (lactotroph, acidophil stem cell)",
                      "2% thyrotroph adenoma",
                      "14% plurihormonal PIT-1-positive adenoma",
                      "3% not otherwise specified",
                      "17.1% TPIT-lineage corticotroph adenomas",
                      "4.5% null cell tumors",
                      "0.5% unusual plurihormonal tumors",
                      "5% not classified (technical reasons)"
                    ]
                  },
                  {
                    "text": "Biologically most common adenoma type is lactotroph adenomasMany PRL-producing adenomas managed medically, never come to surgery",
                    "sub_points": [
                      "Many PRL-producing adenomas managed medically, never come to surgery"
                    ]
                  },
                  {
                    "text": "Double (or multiple) adenomas uncommon (< 2%) but well recognized and likely underestimatedCited incidences of 1% in autopsy and 0.4-1.3% in surgical series likely underestimates2.6% in surgical series by MagriSeries by Costello in 1936 of 1,000 autopsies showed 265 adenomas in 224 glands (2 cases with 3 adenomas, 1 with > 3 adenomas)Series by Buurman and Saeger of 3,048 autopsies; 5.4% of autopsy-identified adenomas were found to be multiple (334 adenomas found in 316 pituitaries, 17 with 2 or more); almost all microadenomas, most < 3 mmLiterature review noted most commonly found with GH- or ACTH-producing tumors, but assorted combinations reportedAdenomas may be separated vs. contiguous",
                    "sub_points": [
                      "Cited incidences of 1% in autopsy and 0.4-1.3% in surgical series likely underestimates2.6% in surgical series by MagriSeries by Costello in 1936 of 1,000 autopsies showed 265 adenomas in 224 glands (2 cases with 3 adenomas, 1 with > 3 adenomas)Series by Buurman and Saeger of 3,048 autopsies; 5.4% of autopsy-identified adenomas were found to be multiple (334 adenomas found in 316 pituitaries, 17 with 2 or more); almost all microadenomas, most < 3 mm",
                      "2.6% in surgical series by Magri",
                      "Series by Costello in 1936 of 1,000 autopsies showed 265 adenomas in 224 glands (2 cases with 3 adenomas, 1 with > 3 adenomas)",
                      "Series by Buurman and Saeger of 3,048 autopsies; 5.4% of autopsy-identified adenomas were found to be multiple (334 adenomas found in 316 pituitaries, 17 with 2 or more); almost all microadenomas, most < 3 mm",
                      "Literature review noted most commonly found with GH- or ACTH-producing tumors, but assorted combinations reported",
                      "Adenomas may be separated vs. contiguous"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Vast majority in sella turcicaRare, extrasellar examples on pituitary stalkEctopic adenomas uncommon, thought to arise from pharyngeal pituitary remnantsIn clivus, sphenoid sinus, suprasellar, 3rd ventricleRare prolactinoma in ovarian teratoma",
                    "sub_points": [
                      "Rare, extrasellar examples on pituitary stalk",
                      "Ectopic adenomas uncommon, thought to arise from pharyngeal pituitary remnantsIn clivus, sphenoid sinus, suprasellar, 3rd ventricle",
                      "In clivus, sphenoid sinus, suprasellar, 3rd ventricle",
                      "Rare prolactinoma in ovarian teratoma"
                    ]
                  },
                  {
                    "text": "Dural invasion/surgical invasiveness (based on surgeon's assessment of involvement of bone, dura, or cavernous sinus by tumor)Surgical invasiveness (40% of cases) less frequent than microscopic evidence of dural invasion (85%)Dural invasion increases with tumor size: 69%, 88%, and 94% of microadenomas, macroadenomas, and tumors with suprasellar extension, respectively",
                    "sub_points": [
                      "Surgical invasiveness (40% of cases) less frequent than microscopic evidence of dural invasion (85%)",
                      "Dural invasion increases with tumor size: 69%, 88%, and 94% of microadenomas, macroadenomas, and tumors with suprasellar extension, respectively"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Clinically functioning microadenomas manifest with hypersecretory features (i.e., hyperprolactinemia, hypercortisolism)"
                  },
                  {
                    "text": "Clinically functioning and nonfunctioning macroadenomas (defined as > 1 cm) manifest with mass effectsHeadache and visual disturbanceHypopituitarism due to decreased function of LH-FSH, TSH, &/or GH cells by compression of pituitary stalk and glandCauses low-level hyperprolactinemia (usually < 150 ng/mL) (stalk section effect)",
                    "sub_points": [
                      "Headache and visual disturbance",
                      "Hypopituitarism due to decreased function of LH-FSH, TSH, &/or GH cells by compression of pituitary stalk and gland",
                      "Causes low-level hyperprolactinemia (usually < 150 ng/mL) (stalk section effect)"
                    ]
                  },
                  {
                    "text": "Patterns of growth and extension varyLateral extension into cavernous sinuses with resultant cranial neuropathyUpward extension with resultant hypothalamic dysfunction, obstructive hydrocephalus, and brain displacement (but not invasion)Downward extension into paranasal sinuses",
                    "sub_points": [
                      "Lateral extension into cavernous sinuses with resultant cranial neuropathy",
                      "Upward extension with resultant hypothalamic dysfunction, obstructive hydrocephalus, and brain displacement (but not invasion)",
                      "Downward extension into paranasal sinuses"
                    ]
                  },
                  {
                    "text": "Pituitary apoplexy, with acute/subacute worsening of symptoms (usually headache, worsening vision)Apoplexy may be due to necrosis, hemorrhage, or both into adenoma, causing swelling, mass effect in excess of mass of adenoma itselfMay require emergent/semiemergent surgical decompression",
                    "sub_points": [
                      "Apoplexy may be due to necrosis, hemorrhage, or both into adenoma, causing swelling, mass effect in excess of mass of adenoma itself",
                      "May require emergent/semiemergent surgical decompression"
                    ]
                  },
                  {
                    "text": "Diabetes insipidus rarely associated with pituitary adenoma; suggests alternate diagnosis"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Principal treatmentVia transsphenoidal route, since minimally invasiveTransfrontal approach for macroadenomas with large suprasellar componentResection of 2/3 of gland for unidentified minute corticotroph adenomas advocated by someFailure to find discrete adenoma at time of surgery occurs in 10-15% of corticotroph adenoma cases, even in experienced centers (usually densely granulated corticotroph adenomas)2/3 of pituitary gland resections reported to have high initial remission rate, low operative morbidity",
                    "sub_points": [
                      "Via transsphenoidal route, since minimally invasive",
                      "Transfrontal approach for macroadenomas with large suprasellar component",
                      "Resection of 2/3 of gland for unidentified minute corticotroph adenomas advocated by someFailure to find discrete adenoma at time of surgery occurs in 10-15% of corticotroph adenoma cases, even in experienced centers (usually densely granulated corticotroph adenomas)2/3 of pituitary gland resections reported to have high initial remission rate, low operative morbidity",
                      "Failure to find discrete adenoma at time of surgery occurs in 10-15% of corticotroph adenoma cases, even in experienced centers (usually densely granulated corticotroph adenomas)",
                      "2/3 of pituitary gland resections reported to have high initial remission rate, low operative morbidity"
                    ]
                  },
                  {
                    "text": "Repeat surgery indicated inRapid progressionVisual lossPersistent hyperfunction, especially of ACTH adenomas (Cushing disease)Failure of medical therapy",
                    "sub_points": [
                      "Rapid progression",
                      "Visual loss",
                      "Persistent hyperfunction, especially of ACTH adenomas (Cushing disease)",
                      "Failure of medical therapy"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Dopamine agonists reduce PRL level and size of PRL adenomas"
                  },
                  {
                    "text": "Somatostatin analogsInteract with somatostatin receptors on GH and TSH adenoma cells, reduce hormone secretionPartly inhibit IGF-1 production by liver, kidney, heart, and lungsCause little reduction in tumor volume",
                    "sub_points": [
                      "Interact with somatostatin receptors on GH and TSH adenoma cells, reduce hormone secretion",
                      "Partly inhibit IGF-1 production by liver, kidney, heart, and lungs",
                      "Cause little reduction in tumor volume"
                    ]
                  },
                  {
                    "text": "GH receptor antagonists result in normalization of IGF-1 levels"
                  },
                  {
                    "text": "Cyproheptadine generally fails to reduce ACTH levels in Cushing diseaseMedical agents reducing adrenal steroid hormone production more successful",
                    "sub_points": [
                      "Medical agents reducing adrenal steroid hormone production more successful"
                    ]
                  },
                  {
                    "text": "Clinically, nonfunctioning tumors show variable or unsatisfactory response to medical therapy"
                  },
                  {
                    "text": "ChemotherapyTemozolomide for aggressive tumors occasionally utilizedOther conventional chemotherapies unsuccessful",
                    "sub_points": [
                      "Temozolomide for aggressive tumors occasionally utilized",
                      "Other conventional chemotherapies unsuccessful"
                    ]
                  }
                ],
                "Radiation": [
                  {
                    "text": "Conventional radiotherapy for incompletely resected or recurrent tumors used sparinglyIn patients medically unable to undergo surgical interventionIn patients with hormone-secreting tumors uncontrolled by other therapiesComplications include hypopituitarism and postradiation glioma/sarcoma",
                    "sub_points": [
                      "In patients medically unable to undergo surgical intervention",
                      "In patients with hormone-secreting tumors uncontrolled by other therapies",
                      "Complications include hypopituitarism and postradiation glioma/sarcoma"
                    ]
                  },
                  {
                    "text": "Stereotactic radiosurgery, some casesOptic apparatus spared",
                    "sub_points": [
                      "Optic apparatus spared"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Adenomas with elevated proliferative activity are considered aggressive/more likely to recur"
                  },
                  {
                    "text": "5 subtypes acknowledged as more aggressive adenomasSparsely granulated somatotroph adenomaSilent corticotroph adenomaCrooke cell corticotroph adenomaPoorly differentiated PIT1 lineage adenoma (formerly plurihormonal PIT-1-positive adenoma)Lactotroph adenoma in men",
                    "sub_points": [
                      "Sparsely granulated somatotroph adenoma",
                      "Silent corticotroph adenoma",
                      "Crooke cell corticotroph adenoma",
                      "Poorly differentiated PIT1 lineage adenoma (formerly plurihormonal PIT-1-positive adenoma)",
                      "Lactotroph adenoma in men"
                    ]
                  },
                  {
                    "text": "Clinically silent corticotroph adenomas comprise up to 20% of nonfunctioning adenomas and exhibit higher rate of recurrence"
                  },
                  {
                    "text": "Recurrences not rareRecent study of 162 first recurrences and 37 second recurrences compared histology, labeling indices with 1st adenomaKi-67 index: Unchanged in 43 cases (26%), increased in 69 cases (43%), decreased in 50 cases (31%)Change of tumor type without change of common transcription factor in 82 cases2nd independent de novo adenoma present in 10 cases, probably due to changes of transcription factorsp53: Unchanged in recurrences in 44% of cases, increased in 33%, decreased in 22%",
                    "sub_points": [
                      "Recent study of 162 first recurrences and 37 second recurrences compared histology, labeling indices with 1st adenomaKi-67 index: Unchanged in 43 cases (26%), increased in 69 cases (43%), decreased in 50 cases (31%)Change of tumor type without change of common transcription factor in 82 cases2nd independent de novo adenoma present in 10 cases, probably due to changes of transcription factorsp53: Unchanged in recurrences in 44% of cases, increased in 33%, decreased in 22%",
                      "Ki-67 index: Unchanged in 43 cases (26%), increased in 69 cases (43%), decreased in 50 cases (31%)",
                      "Change of tumor type without change of common transcription factor in 82 cases",
                      "2nd independent de novo adenoma present in 10 cases, probably due to changes of transcription factors",
                      "p53: Unchanged in recurrences in 44% of cases, increased in 33%, decreased in 22%"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Extensions: Suprasellar, lateral (cavernous sinus), inferior (sphenoid sinus), posterior fossa"
                  }
                ],
                "Location": [
                  {
                    "text": "With rare exception (suprasellar location, sphenoid sinus), arise in sella"
                  }
                ],
                "Size": [
                  {
                    "text": "Tumors < 1 cm: Microadenomas"
                  },
                  {
                    "text": "Larger lesions: Macroadenomas"
                  },
                  {
                    "text": "Rare tumors > 5 cm: Giant adenomas (some authors use > 4 cm)"
                  }
                ],
                "Radiographic Findings": [
                  {
                    "text": "Radiographic grading based on adenoma effects upon sellaGrade 0: Microadenomas not associated with enlargementGrade 1: Intrasellar adenomas with only slight enlargementGrades 2-4: Macroadenomas showing diffuse sellar enlargement without bone erosion, focal bone erosion, and extensive invasion/destruction, respectively",
                    "sub_points": [
                      "Grade 0: Microadenomas not associated with enlargement",
                      "Grade 1: Intrasellar adenomas with only slight enlargement",
                      "Grades 2-4: Macroadenomas showing diffuse sellar enlargement without bone erosion, focal bone erosion, and extensive invasion/destruction, respectively"
                    ]
                  },
                  {
                    "text": "Simple finding of dural invasion common when sought microscopically (85%), but present in only 40% of adenomas radiographically or operatively"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Assessment of adenoma size best achieved by MR"
                  },
                  {
                    "text": "Typical MR study consists of coronal, 3-mm sections studied on T1-weighted images before and after gadolinium administrationAdenomas enhance, but delayed from and less than normal glandMidline infundibulum; slight convexity of superior pituitary surface",
                    "sub_points": [
                      "Adenomas enhance, but delayed from and less than normal gland",
                      "Midline infundibulum; slight convexity of superior pituitary surface"
                    ]
                  },
                  {
                    "text": "Sagittal imaging occasionally utilized"
                  },
                  {
                    "text": "CT less sensitive and specific than MR, given artifacts related to surrounding bone and, to some extent, soft tissue contrast"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "H&E to show tinctorial characteristics of cells (acidophilic, basophilic, chromophobic)Terms not closely correlated with specific hormone productionDesignations not intended as diagnostic terms (e.g., chromophobic adenoma)",
                    "sub_points": [
                      "Terms not closely correlated with specific hormone production",
                      "Designations not intended as diagnostic terms (e.g., chromophobic adenoma)"
                    ]
                  },
                  {
                    "text": "Most adenomas uniform in cell makeupMost have round, polygonal, or, occasionally, elongate cells with round to ovoid nuclei, delicately stippled chromatin, inconspicuous nucleoli, and moderately abundant cytoplasmAtypia uncommon and mitoses rare",
                    "sub_points": [
                      "Most have round, polygonal, or, occasionally, elongate cells with round to ovoid nuclei, delicately stippled chromatin, inconspicuous nucleoli, and moderately abundant cytoplasm",
                      "Atypia uncommon and mitoses rare"
                    ]
                  },
                  {
                    "text": "Unique histologic features in some (i.e., Crooke hyaline change in Crooke cell adenoma, fibrous bodies in sparsely granulated somatotroph adenoma)"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "PAS to highlight ACTH cells and effacement of acinar architecture"
                  },
                  {
                    "text": "Reticulin stain reveals loss of acinar pattern"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Key role in clinical and biochemical correlation"
                  },
                  {
                    "text": "Adenoma classification now largely based on transcription factor and specific anterior pituitary hormonal immunotype"
                  },
                  {
                    "text": "Transcription factorsPIT-1, SF1, TPIT",
                    "sub_points": [
                      "PIT-1, SF1, TPIT"
                    ]
                  },
                  {
                    "text": "Hormones routinely sought usually includeACTH, GH, PRL, TSH-β, FSH-β, LH-β",
                    "sub_points": [
                      "ACTH, GH, PRL, TSH-β, FSH-β, LH-β"
                    ]
                  },
                  {
                    "text": "Synaptophysin (+) in 100% of pituitary adenomas"
                  },
                  {
                    "text": "Chromogranin A (+) in 70% of pituitary adenomasMostly FSH-LH, null cell, TSH typesFocal to negative in lactotroph adenomas",
                    "sub_points": [
                      "Mostly FSH-LH, null cell, TSH types",
                      "Focal to negative in lactotroph adenomas"
                    ]
                  },
                  {
                    "text": "Low-molecular-weight keratin (+) in 85%CAM5.2(+) in 98% of somatotroph adenomasThroughout cytoplasm in densely granulated somatotroph adenomasAs rounded cytoplasmic fibrous bodies in > 70% of adenoma cells in sparsely granulated somatotroph adenomasCAM5.2(+) in 87.5% of lactotroph adenomasScattered keratin (+) fibrous bodies in 2/3 of acidophil stem cell adenomasCAM5.2(+) in 88.6% of poorly differentiated PIT-1 lineage adenomasWith scattered fibrous bodies in 29.5%CAM5.2(+) in 100% of corticotroph adenomasWith thick ring-like pattern in Crooke cell adenomasCAM5.2(+) in 61.9% of gonadotroph adenomasCAM5.2(+) in 71.8% of null cell adenomas",
                    "sub_points": [
                      "CAM5.2(+) in 98% of somatotroph adenomasThroughout cytoplasm in densely granulated somatotroph adenomasAs rounded cytoplasmic fibrous bodies in > 70% of adenoma cells in sparsely granulated somatotroph adenomas",
                      "Throughout cytoplasm in densely granulated somatotroph adenomas",
                      "As rounded cytoplasmic fibrous bodies in > 70% of adenoma cells in sparsely granulated somatotroph adenomas",
                      "CAM5.2(+) in 87.5% of lactotroph adenomasScattered keratin (+) fibrous bodies in 2/3 of acidophil stem cell adenomas",
                      "Scattered keratin (+) fibrous bodies in 2/3 of acidophil stem cell adenomas",
                      "CAM5.2(+) in 88.6% of poorly differentiated PIT-1 lineage adenomasWith scattered fibrous bodies in 29.5%",
                      "With scattered fibrous bodies in 29.5%",
                      "CAM5.2(+) in 100% of corticotroph adenomasWith thick ring-like pattern in Crooke cell adenomas",
                      "With thick ring-like pattern in Crooke cell adenomas",
                      "CAM5.2(+) in 61.9% of gonadotroph adenomas",
                      "CAM5.2(+) in 71.8% of null cell adenomas"
                    ]
                  },
                  {
                    "text": "Other keratinsCK7 either negative or reactive in only few scattered cells in 90% of all pituitary adenomasCorticotroph and sparsely granulated somatotroph adenomas consistently CK20(+) [and CK7(-)]All other adenoma subtypes were almost always CK20(-)",
                    "sub_points": [
                      "CK7 either negative or reactive in only few scattered cells in 90% of all pituitary adenomas",
                      "Corticotroph and sparsely granulated somatotroph adenomas consistently CK20(+) [and CK7(-)]",
                      "All other adenoma subtypes were almost always CK20(-)"
                    ]
                  },
                  {
                    "text": "Ki-67 elevation in subsetTerm \"atypical adenoma\" no longer utilizedMost pathologists specify identified elevated cell cycle labeling rates in report, noting need for closer follow-up to monitor for earlier recurrence",
                    "sub_points": [
                      "Term \"atypical adenoma\" no longer utilized",
                      "Most pathologists specify identified elevated cell cycle labeling rates in report, noting need for closer follow-up to monitor for earlier recurrence"
                    ]
                  },
                  {
                    "text": "Others utilized: α-subunit, ER, GATA3, p27, FGFR4, MGMT"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Specific morphologic features are original basis of classification"
                  },
                  {
                    "text": "Ultrastructural study still necessary for classification of some adenoma variants"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Adenohypophysis": [
                  {
                    "text": "Normal acini by reticulin staining"
                  }
                ],
                "Pituitary Nodular Hyperplasia": [
                  {
                    "text": "Enlarged acini by reticulin staining"
                  }
                ],
                "Metastatic Carcinoma": [
                  {
                    "text": "Degree of cytologic atypia incompatible with pituitary adenoma"
                  },
                  {
                    "text": "Cannot be diagnosed based on sellar biopsyRare carcinomas may produce hormone (GH, ACTH)",
                    "sub_points": [
                      "Rare carcinomas may produce hormone (GH, ACTH)"
                    ]
                  },
                  {
                    "text": "Clinical work-up essential"
                  }
                ],
                "Ependymoma": [
                  {
                    "text": "Immunoreactive for GFAP rather than synaptophysin"
                  }
                ],
                "Pituitary Blastoma": [
                  {
                    "text": "Early childhood"
                  },
                  {
                    "text": "Small blastema-like cells, true rosettes, large glandular structuresDICER1mutation",
                    "sub_points": [
                      "DICER1mutation"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Choroid Plexus Papilloma and Atypical Papilloma": {
            "name": "Choroid Plexus Papilloma and Atypical Papilloma",
            "url": "https://app.pathprimer.com/document/9364d751-aa22-4616-908c-19fe7a5e4f71/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Papillary neoplasms arising from choroid plexus epithelium"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "ChildrenLateral or 3rd ventricle",
                    "sub_points": [
                      "Lateral or 3rd ventricle"
                    ]
                  },
                  {
                    "text": "Adults4th ventricle or cerebellopontine angle",
                    "sub_points": [
                      "4th ventricle or cerebellopontine angle"
                    ]
                  },
                  {
                    "text": "Total excision most important prognostic factor"
                  },
                  {
                    "text": "Prognosis excellentMalignant progression rareCerebrospinal fluid dissemination uncommonChance of recurrence greater with atypical papilloma",
                    "sub_points": [
                      "Malignant progression rare",
                      "Cerebrospinal fluid dissemination uncommon",
                      "Chance of recurrence greater with atypical papilloma"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "More complex papillary architecture than normal plexus"
                  },
                  {
                    "text": "Surface of epithelium flat rather than normal cobblestone"
                  },
                  {
                    "text": "Atypical papilloma: ≥ 2 mitoses per 10 HPF"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Cytokeratins, usually CK7(+) and CK20(-)"
                  },
                  {
                    "text": "GFAP(+) in some cases, especially cells with long bipolar processes (glial differentiation)"
                  },
                  {
                    "text": "EMA(+), membranous in some cases, S100(+), Kir7.1(+)"
                  },
                  {
                    "text": "Synaptophysin (+) diffuse in many cases, neuropil islands (rare)"
                  },
                  {
                    "text": "Transthyretin (+) in most cases"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Papilloma vs.Normal choroid plexusAtypical papilloma",
                    "sub_points": [
                      "Normal choroid plexus",
                      "Atypical papilloma"
                    ]
                  },
                  {
                    "text": "Atypical papilloma vs.Carcinoma",
                    "sub_points": [
                      "Carcinoma"
                    ]
                  },
                  {
                    "text": "Papillary ependymoma"
                  },
                  {
                    "text": "Papillary endolymphatic sac tumorAt cerebellopontine angle",
                    "sub_points": [
                      "At cerebellopontine angle"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Papillary neoplasms arising from choroid plexus epithelium"
                  },
                  {
                    "text": "Papilloma: WHO grade 1; atypical papilloma: WHO grade 2"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Inherited Tumor Syndromes": [
                  {
                    "text": "GermlineTP53mutation, e.g., Li-Fraumeni (uncommon)"
                  },
                  {
                    "text": "Aicardi (rare)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Site": [
                  {
                    "text": "Lateral or 3rd ventricle (children), 4th ventricle or cerebellopontine angle (adults)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptoms of increased intracranial pressure, craniosynostosis resulting in premature suture (before 2 years of age)"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Excision"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Papilloma, excellent"
                  },
                  {
                    "text": "Atypical papilloma: Good but higher rate of recurrence and cerebrospinal fluid spread"
                  },
                  {
                    "text": "Total excision most important prognostic factor"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Intraventricular or cerebellopontine angle, intensely enhancing"
                  },
                  {
                    "text": "Irregular, lobulated, if not overtly papillary"
                  },
                  {
                    "text": "Diffuse ventriculomegaly in some cases"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Discrete, often papillary, intraoperative bleeding (occasionally)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "PapillomaTransition to normal choroid plexus commonVariably complex papillary architecture, surface epithelium flat, not cobblestoneLimited (usually no) extension into brainVariably pseudostratified, unlike simple epithelium of normal plexusFoci with elongate, bipolar tumor cells (glial differentiation)Acinar rather than papillary architecture (rare)Prominent vascular hyalinization in some casesVariable intratumoral cytological atypia, pleomorphic nuclei (unusual)Mitoses, necrosis (uncommon)Calcifications in some cases, bone or cartilage (rare)Focal lipofuscin pigmentation epithelium (uncommon)Oncocytic change, focal (occasional)Neuropil islands, synaptophysin (+) (rare)",
                    "sub_points": [
                      "Transition to normal choroid plexus common",
                      "Variably complex papillary architecture, surface epithelium flat, not cobblestone",
                      "Limited (usually no) extension into brain",
                      "Variably pseudostratified, unlike simple epithelium of normal plexus",
                      "Foci with elongate, bipolar tumor cells (glial differentiation)",
                      "Acinar rather than papillary architecture (rare)",
                      "Prominent vascular hyalinization in some cases",
                      "Variable intratumoral cytological atypia, pleomorphic nuclei (unusual)",
                      "Mitoses, necrosis (uncommon)",
                      "Calcifications in some cases, bone or cartilage (rare)",
                      "Focal lipofuscin pigmentation epithelium (uncommon)",
                      "Oncocytic change, focal (occasional)",
                      "Neuropil islands, synaptophysin (+) (rare)"
                    ]
                  },
                  {
                    "text": "Atypical papillomaSame features as papilloma but alsoMore crowding, cytological atypia, pseudostratification (usually)Solid, nonpapillary areas, necrosis in some cases≥ 2 mitoses per 10 HPF is suggested threshold",
                    "sub_points": [
                      "Same features as papilloma but alsoMore crowding, cytological atypia, pseudostratification (usually)Solid, nonpapillary areas, necrosis in some cases",
                      "More crowding, cytological atypia, pseudostratification (usually)",
                      "Solid, nonpapillary areas, necrosis in some cases",
                      "≥ 2 mitoses per 10 HPF is suggested threshold"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Tissue fragments with smooth epithelial surfaces; individual, nonciliated columnar cells"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Immunophenotype of normal choroid plexusGFAP(+) in some cases, especially cells with long bipolar cells (glial differentiation)EMA(+), membranous in some cases, S100(+), Kir7.1(+)Synaptophysin (+) diffuse in many cases, neuropil islands (rare)Transthyretin (+) in most casesCytokeratins, usually CK7(+) and CK20(-)NHERF1 and NF2 (+) in choroid plexus and ependymal neoplasms",
                    "sub_points": [
                      "GFAP(+) in some cases, especially cells with long bipolar cells (glial differentiation)",
                      "EMA(+), membranous in some cases, S100(+), Kir7.1(+)",
                      "Synaptophysin (+) diffuse in many cases, neuropil islands (rare)",
                      "Transthyretin (+) in most cases",
                      "Cytokeratins, usually CK7(+) and CK20(-)",
                      "NHERF1 and NF2 (+) in choroid plexus and ependymal neoplasms"
                    ]
                  },
                  {
                    "text": "Ki-67 labeling index ~ 1-2%"
                  },
                  {
                    "text": "p53(+), papilloma rare; atypical papilloma ~ 10%"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "No specific molecular features separating papilloma from atypical papilloma"
                  },
                  {
                    "text": "Frequent chromosome-wide gains in papilloma and atypical papilloma but few losses"
                  },
                  {
                    "text": "Methylation profiling may be of help in risk stratification of choroid plexus tumors"
                  },
                  {
                    "text": "TERTpromoter mutations and rare fusions (e.g.CCDC47-PRKCA) reported to be associated with more aggressive behavior in adults"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Choroid Plexus": [
                  {
                    "text": "Simple papillary architecture without pseudostratification or cytologic atypia"
                  },
                  {
                    "text": "Cobblestone cell surfaces"
                  },
                  {
                    "text": "Calcifications deeply situated in stroma, not peripherally in papillae"
                  },
                  {
                    "text": "No mitoses"
                  },
                  {
                    "text": "Thicker vessels"
                  }
                ],
                "Choroid Plexus Carcinoma": [
                  {
                    "text": "More mitoses; number distinguishing atypical papilloma from carcinoma generally ≥ 5-10 per 10 HPF but no consensus number; often ≥ 5 in presence of solid architecture, necrosis, etc."
                  },
                  {
                    "text": "Greater atypia but overlap with atypical papilloma"
                  },
                  {
                    "text": "Solid, nonpapillary architecture in some cases"
                  },
                  {
                    "text": "Overt anaplasia in some cases"
                  },
                  {
                    "text": "Necrosis is frequently present but can also be in some atypical papillomas and rare papillomas"
                  }
                ],
                "Papillary Ependymoma": [
                  {
                    "text": "Less papillary, fibrillated, glial cytologic features"
                  },
                  {
                    "text": "EMA(+) microlumina in some cases"
                  }
                ],
                "Papillary Endolymphatic Sac Tumor (at Cerebellopontine Angle)": [
                  {
                    "text": "Bone destruction (petrous portion of temporal bone)"
                  },
                  {
                    "text": "Simpler, lower papillary epithelium"
                  },
                  {
                    "text": "von Hippel-Lindau syndrome in some cases"
                  },
                  {
                    "text": "PAX8 and CA-9 expression, similar to renal cell carcinoma in addition to cytokeratins"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Choroid Plexus Carcinoma": {
            "name": "Choroid Plexus Carcinoma",
            "url": "https://app.pathprimer.com/document/d9e71dc3-9b89-4928-8350-1f471a01b593/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Anaplastic epithelial neoplasm of choroid plexus"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Rare cases syndromicGermlineTP53mutation, e.g., Li-FraumeniAicardi",
                    "sub_points": [
                      "GermlineTP53mutation, e.g., Li-Fraumeni",
                      "Aicardi"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Lateral ventricle (most cases)"
                  },
                  {
                    "text": "4th ventricle (rare)"
                  },
                  {
                    "text": "Usual < 3 years of age"
                  },
                  {
                    "text": "PrognosisExcellent for well-differentiated examples after gross total resectionPoor in highly anaplastic types",
                    "sub_points": [
                      "Excellent for well-differentiated examples after gross total resection",
                      "Poor in highly anaplastic types"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "More cellular than papilloma"
                  },
                  {
                    "text": "Considerable inter- and intratumoral variation in degree of anaplasia"
                  },
                  {
                    "text": "Mitotically, no precise cutoff from atypical papilloma but carcinoma generally ≥ 5-10 per 10 HPF; often ≥ 5 per 10 HPF in presence of solid areas, hypercellularity, and necrosis"
                  },
                  {
                    "text": "Solid, nonpapillary areas (most cases)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "TP53mutations in ~ 50% of cases"
                  },
                  {
                    "text": "Chromosomal instability frequent in choroid plexus carcinoma"
                  },
                  {
                    "text": "Cytokeratins, generally CK7(+) and CK20(-)"
                  },
                  {
                    "text": "BER-EP4(-) and S100(+) in most cases"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Atypical papilloma"
                  },
                  {
                    "text": "Atypical teratoid/rhabdoid tumorDistinction problematic in some cases",
                    "sub_points": [
                      "Distinction problematic in some cases"
                    ]
                  },
                  {
                    "text": "Metastatic carcinoma"
                  },
                  {
                    "text": "Glioblastoma"
                  },
                  {
                    "text": "Anaplastic ependymoma and astroblastoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Choroid plexus carcinoma (CPC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Anaplastic neoplasm originating in choroid plexus epithelium (WHO grade 3)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Inherited Tumor Syndromes": [
                  {
                    "text": "GermlineTP53mutation, e.g., Li-Fraumeni in ~ 44%"
                  },
                  {
                    "text": "Aicardi (rare)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Site": [
                  {
                    "text": "Lateral (most cases)"
                  },
                  {
                    "text": "4th ventricle (rare)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Pediatric tumor"
                  },
                  {
                    "text": "Usually in patients < 3 years of age"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Evolution from papilloma, rarely evident"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Irradiation and chemotherapy, depending on age"
                  },
                  {
                    "text": "Observation alone in some centers if totally resected and well differentiated"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent for well-differentiated examples after gross total resection"
                  },
                  {
                    "text": "Poor for anaplastic types and with p53 diffuse staining/mutation"
                  },
                  {
                    "text": "Risk of cerebrospinal fluid dissemination, especially anaplastic types"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Generally largeLobular; papillary (in some cases)",
                    "sub_points": [
                      "Lobular; papillary (in some cases)"
                    ]
                  },
                  {
                    "text": "Enhancing"
                  },
                  {
                    "text": "Diffuse dilation of ventricular system (in some cases)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Fleshy"
                  },
                  {
                    "text": "Hemorrhage and necrosis mainly in anaplastic types"
                  },
                  {
                    "text": "Invasive in some cases"
                  },
                  {
                    "text": "Intraoperative bleeding in some cases"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "More cellular and cytologically more atypical than papilloma"
                  },
                  {
                    "text": "Separate areas of &/or transitional areas to regions of lower-grade tumor (frequent)"
                  },
                  {
                    "text": "Invasion of adjacent brain in some cases but may be seen in papillomas"
                  },
                  {
                    "text": "Variable differentiationOvertly papillaryPapillary and focal solid growth patternsPredominantly solid with sometimes conspicuous nuclear pleomorphismSolid, undifferentiated",
                    "sub_points": [
                      "Overtly papillary",
                      "Papillary and focal solid growth patterns",
                      "Predominantly solid with sometimes conspicuous nuclear pleomorphism",
                      "Solid, undifferentiated"
                    ]
                  },
                  {
                    "text": "Calcifications (occasional)"
                  },
                  {
                    "text": "Eosinophilic globulesUsually in areas with marked nuclear pleomorphism and prominent cytoplasm",
                    "sub_points": [
                      "Usually in areas with marked nuclear pleomorphism and prominent cytoplasm"
                    ]
                  },
                  {
                    "text": "Necrosis (frequent)"
                  },
                  {
                    "text": "Oncocytic change (uncommon)"
                  },
                  {
                    "text": "MitosesGenerally ≥ 5-10 per 10 HPFNo precise cutoff from atypical papilloma butOften ≥ 5 mitoses per 10 HPF in presence of solid areas, hypercellularity, and necrosis",
                    "sub_points": [
                      "Generally ≥ 5-10 per 10 HPF",
                      "No precise cutoff from atypical papilloma butOften ≥ 5 mitoses per 10 HPF in presence of solid areas, hypercellularity, and necrosis",
                      "Often ≥ 5 mitoses per 10 HPF in presence of solid areas, hypercellularity, and necrosis"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Tissue fragments"
                  },
                  {
                    "text": "Individual columnar cells"
                  },
                  {
                    "text": "Nuclear atypia, mitoses"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Cytokeratins, generally CK7(+) and CK20(-)"
                  },
                  {
                    "text": "BER-EP4(-) and S100(+) in most cases"
                  },
                  {
                    "text": "Kir7.1(+)"
                  },
                  {
                    "text": "Ki-67Inter- and intratumoral variabilityUsually > 10% in large areas",
                    "sub_points": [
                      "Inter- and intratumoral variability",
                      "Usually > 10% in large areas"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "TP53mutations in ~ 50% of cases"
                  },
                  {
                    "text": "TP53alterations associated with poorer prognosis in choroid plexus tumors in some studies"
                  },
                  {
                    "text": "Notch pathway activation induces choroid plexus tumors in mice and is present in subset of human choroid plexus tumors"
                  },
                  {
                    "text": "MYCactivation cooperates withTP53to form CPCs in murine models"
                  },
                  {
                    "text": "Chromosomal instability frequent in CPC"
                  },
                  {
                    "text": "Increased number ofTP53mutant copies associated with worse survival in CPC"
                  },
                  {
                    "text": "TAF12, NFYC,andRAD54Lputative oncogenes concurrently gained"
                  },
                  {
                    "text": "Methylation profiling identifies may be helpful in identifying subgroups of choroid plexus tumors with more aggressive behavior"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Atypical Choroid Plexus Papilloma, Grade 2": [
                  {
                    "text": "Fewer mitosesNo consensus on distinction by mitotic countAtypical papilloma ≥ 2 and generally ≤ 5-10 per 10 HPFIn carcinoma, often ≥ 2 and < 5 per 10 HPF in presence of solid areas, increased cellularity, pleomorphism, necrosis",
                    "sub_points": [
                      "No consensus on distinction by mitotic count",
                      "Atypical papilloma ≥ 2 and generally ≤ 5-10 per 10 HPF",
                      "In carcinoma, often ≥ 2 and < 5 per 10 HPF in presence of solid areas, increased cellularity, pleomorphism, necrosis"
                    ]
                  },
                  {
                    "text": "Usually less cellular, more papillary; little, if any, solid tissue and necrosis"
                  }
                ],
                "Atypical Teratoid/Rhabdoid Tumor": [
                  {
                    "text": "Jumbled, nonpapillary architecture"
                  },
                  {
                    "text": "Rhabdoid cells in most cases"
                  },
                  {
                    "text": "Polyimmunophenotypic"
                  },
                  {
                    "text": "Nuclear INI1 or BRG1 loss in neoplastic cells"
                  },
                  {
                    "text": "Difficult to distinguish in some cases"
                  }
                ],
                "Metastatic Carcinoma": [
                  {
                    "text": "Usually intraparenchymal and extraventricular"
                  },
                  {
                    "text": "Near cerebral cortical gray-white junction or cerebellum"
                  },
                  {
                    "text": "More epithelial markers (+), e.g., EMA, BER-EP4, TTF-1"
                  },
                  {
                    "text": "Almost always limited to adults, while CPC usually limited to young children"
                  }
                ],
                "Glioblastoma": [
                  {
                    "text": "Epicenter in brain parenchyma"
                  },
                  {
                    "text": "Diffusely infiltrative, nonpapillary"
                  },
                  {
                    "text": "Generally smaller cells"
                  },
                  {
                    "text": "Necrosis with pseudopalisading &/or microvascular proliferation"
                  },
                  {
                    "text": "Usually GFAP(+) and OLIG2(+)"
                  },
                  {
                    "text": "Epithelial markers (-), except for those with epithelial metaplasia"
                  }
                ],
                "Anaplastic Ependymoma and Astroblastoma": [
                  {
                    "text": "Usually paraventricular location"
                  },
                  {
                    "text": "Perivascular pseudorosettes; no true papillae"
                  },
                  {
                    "text": "Prominent hyalinization in astroblastoma"
                  },
                  {
                    "text": "GFAP(+) in most cases"
                  },
                  {
                    "text": "EMA(+), especially of microlumina"
                  }
                ],
                "Embryonal Neoplasms": [
                  {
                    "text": "Small cell nonpapillary neoplasms"
                  },
                  {
                    "text": "No epithelial differentiation"
                  },
                  {
                    "text": "Synaptophysin (+)"
                  }
                ],
                "Cribriform Neuroepithelial Tumor": [
                  {
                    "text": "Very rare, low-grade intraventricular neoplasm"
                  },
                  {
                    "text": "Cribriform/trabecular architecture"
                  },
                  {
                    "text": "Surface EMA staining, INI1 loss"
                  }
                ],
                "Papillary Tumor of Pineal Region": [
                  {
                    "text": "Similar morphologic and immunophenotypic features"
                  },
                  {
                    "text": "Pineal gland location not feature of choroid plexus tumors"
                  },
                  {
                    "text": "Cell pleomorphism and mitotic activity less pronounced"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "CPC extremely rare in adultsConsider metastatic adenocarcinoma 1st in adults rather than CPC",
                    "sub_points": [
                      "Consider metastatic adenocarcinoma 1st in adults rather than CPC"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Central Neurocytoma": {
            "name": "Central Neurocytoma",
            "url": "https://app.pathprimer.com/document/30da896b-3bea-4304-aa81-f3565d2086db/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Well-differentiated intraventricular neoplasm with neurocytic differentiation near foramen of Monro"
                  },
                  {
                    "text": "WHO grade 2"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Signs of increased intracranial pressure"
                  },
                  {
                    "text": "Favorable prognosis"
                  },
                  {
                    "text": "Extent of resection most important prognostic factor"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cytologic monomorphism"
                  },
                  {
                    "text": "Resembles oligodendroglioma"
                  },
                  {
                    "text": "Perivascular, ependymoma-like neuropil rosettes in most cases"
                  },
                  {
                    "text": "Microcalcifications frequent"
                  },
                  {
                    "text": "Atypical neurocytoma defined by Ki-67 labeling indices> 2% in one study and > 3% in another",
                    "sub_points": [
                      "> 2% in one study and > 3% in another"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Synaptophysin (+) in neurocytes and neuropil"
                  },
                  {
                    "text": "NeuN, INSM1 (+)"
                  },
                  {
                    "text": "Loss of heterozygosity in 1p and 19q frequent"
                  },
                  {
                    "text": "Whole chromosomal arm 1p/19q codeletion typical of oligodendroglial tumors usually absent"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Oligodendroglioma"
                  },
                  {
                    "text": "Ependymoma"
                  },
                  {
                    "text": "Myxoid glioneuronal tumor"
                  },
                  {
                    "text": "Pineocytoma"
                  },
                  {
                    "text": "Primitive neuroectodermal tumor"
                  },
                  {
                    "text": "Subependymal giant cell astrocytoma (tuberous sclerosis)"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Consider central neurocytoma in presence of discrete intraventricular oligodendroglioma-like tumor near foramen of Monro"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Well-differentiated intraventricular neoplasm with neurocytic differentiation near foramen of Monro"
                  },
                  {
                    "text": "WHO grade 2"
                  },
                  {
                    "text": "Numerical grading for \"atypical\" category not developed"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Peak incidence at 20-34 years but may rarely develop in children and older adults"
                  },
                  {
                    "text": "Incidence rate slightly lower in males compared to females"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Signs of increased intracranial pressure"
                  },
                  {
                    "text": "Intraventricular hemorrhage, minority of cases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Favorable"
                  },
                  {
                    "text": "Extent of resection most important factor"
                  },
                  {
                    "text": "Recurrence rate greater for \"atypical\" examples"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Heterogeneous contrast enhancement, often patchy"
                  },
                  {
                    "text": "Attached to ependymal surface and septum pellucidum near foramen of Monro"
                  },
                  {
                    "text": "Obstructive hydrocephalus, occasional hemorrhage"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Calcifications, frequent"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cells in sheets or large lobules, remarkable cytologic uniformity"
                  },
                  {
                    "text": "Perinuclear halos (oligodendroglioma-like)"
                  },
                  {
                    "text": "Ependymoma-like perivascular pseudorosette-like, nucleus-free zones &/or larger patches of neuropil"
                  },
                  {
                    "text": "Microcalcifications, frequent"
                  },
                  {
                    "text": "Delicate vessels with little surrounding stroma"
                  },
                  {
                    "text": "Differentiation to ganglion cells, uncommon"
                  },
                  {
                    "text": "Lipidization (\"central liponeurocytoma\"), rarely"
                  },
                  {
                    "text": "Atypical neurocytomaDefined by Ki-67 labeling indices > 2-3%Increased mitoses (usually ≥ 3 per 10 HPF)Microvascular proliferation &/or necrosis in some casesKi-67 proliferative index not uniform prognostic factor in all studies",
                    "sub_points": [
                      "Defined by Ki-67 labeling indices > 2-3%",
                      "Increased mitoses (usually ≥ 3 per 10 HPF)",
                      "Microvascular proliferation &/or necrosis in some cases",
                      "Ki-67 proliferative index not uniform prognostic factor in all studies"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Round, uniform nuclei with delicate chromatin and small nucleoli, scant cytoplasm"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Synaptophysin (+) neurocytes, perivascular pseudorosette-like and larger neuropil zones"
                  },
                  {
                    "text": "NeuN, INSM1 (+)"
                  },
                  {
                    "text": "Chromogranin-A (-), except in neoplastic or entrapped normal ganglion cells"
                  },
                  {
                    "text": "L1CAM(+) because it is neuronal cell adhesion molecule"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Loss of heterozygosity in 1p and 19q frequent"
                  },
                  {
                    "text": "Whole chromosomal arm 1p/19q codeletion typical of oligodendroglial tumors usually absent"
                  },
                  {
                    "text": "Frequent gains (2p, 10q, 11q, and 18q) and losses (1p, 6q, 12q, 17p, 17q, and 20p)"
                  },
                  {
                    "text": "Whole gains of chromosome 7 but withoutEGFRamplification"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Oligodendroglioma, IDH-Mutant and 1p/19q Codeleted": [
                  {
                    "text": "Not midline intraventricular mass"
                  },
                  {
                    "text": "Diffuse infiltration with \"secondary structures\""
                  },
                  {
                    "text": "1p/19q codeletion,IDH1/IDH2mutation"
                  }
                ],
                "Myxoid Glioneuronal Tumor": [
                  {
                    "text": "Previously known as dysembryoplastic neuroepithelial tumor-like neoplasm of septum pellucidum"
                  },
                  {
                    "text": "Low cellularity, myxoid background, floating neurons (rare)"
                  },
                  {
                    "text": "Largely synaptophysin/NeuN (-)"
                  },
                  {
                    "text": "FrequentPDGFRAp.K385 mutation"
                  }
                ],
                "Subependymal Giant Cell Astrocytoma": [
                  {
                    "text": "In setting of tuberous sclerosis"
                  },
                  {
                    "text": "Exclusively large, spindle to epithelioid cells"
                  }
                ],
                "Ependymoma (Especially Clear Cell Type)": [
                  {
                    "text": "Para- not intraventricular when supratentorial"
                  },
                  {
                    "text": "Clefted, lobulated nuclei in clear cell type"
                  },
                  {
                    "text": "Not as cytologically monomorphous"
                  },
                  {
                    "text": "Coarser (glial) processes in perivascular pseudorosettes"
                  },
                  {
                    "text": "GFAP(+) perivascular pseudorosettes, EMA(+) microlumina"
                  }
                ],
                "Pineocytoma": [
                  {
                    "text": "Site-specific, large pineocytomatous rosettes"
                  }
                ],
                "Embryonal Tumors": [
                  {
                    "text": "High cellularity, brisk mitotic index activity; high Ki-67 proliferative index"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Consider central neurocytoma in presence of discrete intraventricular oligodendroglioma-like tumor near foramen of Monro"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pineal Parenchymal Neoplasms": {
            "name": "Pineal Parenchymal Neoplasms",
            "url": "https://app.pathprimer.com/document/35a826c8-f360-4af8-bf6e-2c615ed06cb3/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Nongerm cell, nonteratomatous tumor of pineal region derived from pineal parenchymal cells"
                  },
                  {
                    "text": "3 types: Pineocytoma, WHO grade 1; pineal parenchymal tumor (PPT) of intermediate differentiation (PPTID), WHO grades 2-3, pineoblastoma (PB), WHO grade 4"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Clinical presentation nearly identical for different types of PPTs, germinomas, teratomas"
                  },
                  {
                    "text": "All potentially aggressive, capable of leptomeningeal dissemination, except pineocytoma"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Pineocytomas noninvasive"
                  },
                  {
                    "text": "Homogeneous enhancement with contrast"
                  },
                  {
                    "text": "Tumor size for pineocytomas and PPTIDs usually 2-5 cm"
                  },
                  {
                    "text": "PBs more likely poorly demarcated"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Isomorphic cells with scant cytoplasm"
                  },
                  {
                    "text": "Pineocytoma rosettes devoid of central blood vessel, often broad zones of anuclear, fibrillary, eosinophilic neuritic processes"
                  },
                  {
                    "text": "Homer Wright, Flexner-Wintersteiner rosettes, anaplasia possible in PB"
                  },
                  {
                    "text": "Grading based on mitotic activity/Ki-67 labeling rate; absent in pineocytoma, high in PB, intermediate in PPTID"
                  },
                  {
                    "text": "Pineocytomas, some PPTID may contain ganglion cells, pleomorphic cells that do not further affect prognosis"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "IHC (+) for synaptophysin, NSE"
                  },
                  {
                    "text": "Neurofilament (+) in pineocytomas and PPTIDNeurofilament (+) cells in PPTID prognostically favorable",
                    "sub_points": [
                      "Neurofilament (+) cells in PPTID prognostically favorable"
                    ]
                  },
                  {
                    "text": "Ki-67 helpful in distinguishing types of PPTs"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Papillary tumor of pineal region"
                  },
                  {
                    "text": "Germinoma"
                  },
                  {
                    "text": "Metastatic carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Pineal parenchymal tumor (PPT)"
                  },
                  {
                    "text": "PPT of intermediate differentiation (PPTID)"
                  },
                  {
                    "text": "Pineoblastoma (PB)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Nongerm cell, nonteratomatous tumors of pineal gland originating from pineal parenchymal cells"
                  },
                  {
                    "text": "3 typesPineocytoma, WHO grade 1PPTID, WHO grades 2-3PB, WHO grade 4",
                    "sub_points": [
                      "Pineocytoma, WHO grade 1",
                      "PPTID, WHO grades 2-3",
                      "PB, WHO grade 4"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown for Most PPTs": [
                  {
                    "text": "PBs may be associated with germlineRB1(chromosome 13q) alterationsOccasionally occur as part of \"trilateral retinoblastoma\"",
                    "sub_points": [
                      "Occasionally occur as part of \"trilateral retinoblastoma\""
                    ]
                  },
                  {
                    "text": "PBs may occur in pleuropulmonary blastoma familial tumor predisposition syndrome withDICER1mutation"
                  },
                  {
                    "text": "Occurrence with familial adenomatosis polyposis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare, account for < 1% of all brain tumors"
                  },
                  {
                    "text": "PPTs account for only 30% of all pineal region tumorsGerminomas, teratomas, cysts more prevalent",
                    "sub_points": [
                      "Germinomas, teratomas, cysts more prevalent"
                    ]
                  },
                  {
                    "text": "PPTIDs more common than pineocytomas or PBs"
                  }
                ],
                "Age": [
                  {
                    "text": "Pineocytoma, WHO grade 1; PPTIDs, grades 2-3Mean age: 38 years but occur throughout adulthood",
                    "sub_points": [
                      "Mean age: 38 years but occur throughout adulthood"
                    ]
                  },
                  {
                    "text": "PB, WHO grade 4Mean age: 18 yearsRecent study of 72 cases, age range broad (6 months-60 years) but 87% ≤ 18 years, 28% ≤ 3 years",
                    "sub_points": [
                      "Mean age: 18 years",
                      "Recent study of 72 cases, age range broad (6 months-60 years) but 87% ≤ 18 years, 28% ≤ 3 years"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Clinical symptoms may be indistinguishable from other pineal region massesSymptoms referable to hydrocephalusCompression of tectal plate and paralysis of upward gaze",
                    "sub_points": [
                      "Symptoms referable to hydrocephalus",
                      "Compression of tectal plate and paralysis of upward gaze"
                    ]
                  },
                  {
                    "text": "Recent study of 72 PBs, 39% were metastatic at presentation"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Resection for pineocytomas"
                  },
                  {
                    "text": "Adjuvant chemotherapy, radiotherapy for PPTIDs and PBs"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent, with resection only, for pineocytoma"
                  },
                  {
                    "text": "With exception of pineocytomas, all PPTs potentially aggressive, capable of leptomeningeal dissemination"
                  },
                  {
                    "text": "In PPTID, higher tumor grade, subtotal resection and neuraxis spread are negative prognostic factors"
                  },
                  {
                    "text": "In PB, age < 3 years at diagnosis, metastatic disease, omission of upfront radiation, chromosome 16q loss are negative prognostic factors"
                  },
                  {
                    "text": "Recent DNA methylation profiling of PBs identified 5 groups with prognostic implications, groups 1, 2, 3, RB, MYCTumors group 1 and 2 almost exclusively exhibited deleterious homozygous loss-of-function alterations in miRNA biogenesis genes (DICER1 > > DROSHA,DGCR8) in 62% and 100% of group 1 and 2 tumors, respectivelyGroups 1-3 arose in older children (median ages 5.2-14.0 years), had intermediate to excellent survival (5-year overall survival of 68%, 100%, 80%, groups 1, 2, 3, respectively)Group 3 primarily in adolescents, adults with few genetic alterationsRecurrent alterations of oncogenic miR-17/92-RB1 and MYC pathway were observed in RB and MYC subgroup, respectively, characterized byRB1loss with gain of miR-17/92, and recurrent gain or amplification ofMYCGroupRBandMYCPB patients were much younger (median age: 1.3-1.4 years) with dismal survival (5-year overall survival 37.5% and 28.6%, respectively)Of 72 tumors with DNA methylation classification, significant numbers of PBs in each group21 were group 1, 11 were group 2, 13 were group 3, 9 were RB, 18 were MYC",
                    "sub_points": [
                      "Tumors group 1 and 2 almost exclusively exhibited deleterious homozygous loss-of-function alterations in miRNA biogenesis genes (DICER1 > > DROSHA,DGCR8) in 62% and 100% of group 1 and 2 tumors, respectivelyGroups 1-3 arose in older children (median ages 5.2-14.0 years), had intermediate to excellent survival (5-year overall survival of 68%, 100%, 80%, groups 1, 2, 3, respectively)Group 3 primarily in adolescents, adults with few genetic alterations",
                      "Groups 1-3 arose in older children (median ages 5.2-14.0 years), had intermediate to excellent survival (5-year overall survival of 68%, 100%, 80%, groups 1, 2, 3, respectively)",
                      "Group 3 primarily in adolescents, adults with few genetic alterations",
                      "Recurrent alterations of oncogenic miR-17/92-RB1 and MYC pathway were observed in RB and MYC subgroup, respectively, characterized byRB1loss with gain of miR-17/92, and recurrent gain or amplification ofMYCGroupRBandMYCPB patients were much younger (median age: 1.3-1.4 years) with dismal survival (5-year overall survival 37.5% and 28.6%, respectively)",
                      "GroupRBandMYCPB patients were much younger (median age: 1.3-1.4 years) with dismal survival (5-year overall survival 37.5% and 28.6%, respectively)",
                      "Of 72 tumors with DNA methylation classification, significant numbers of PBs in each group21 were group 1, 11 were group 2, 13 were group 3, 9 were RB, 18 were MYC",
                      "21 were group 1, 11 were group 2, 13 were group 3, 9 were RB, 18 were MYC"
                    ]
                  },
                  {
                    "text": "Prognosis for PBs recently linked to subgroup type as assessed by DNA methylation"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Some clues, but neuroimaging features cannot reliably distinguish grade"
                  },
                  {
                    "text": "Pineocytomas, PPTIDsOften well circumscribedTumor size usually 2-5 cmUsually homogeneous, may show peripheral calcification or occasional cystic change",
                    "sub_points": [
                      "Often well circumscribed",
                      "Tumor size usually 2-5 cm",
                      "Usually homogeneous, may show peripheral calcification or occasional cystic change"
                    ]
                  },
                  {
                    "text": "PBs more likely poorly demarcated, noncalcified"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Pineocytoma, WHO Grade 1": [
                  {
                    "text": "Lobular or diffuse patterns"
                  },
                  {
                    "text": "Varying size and numbers of pineocytomatous rosettesAnucleated center of rosettes contain delicate cell processes resembling neuropilSmaller, circular ones resemble Homer Wright rosettes",
                    "sub_points": [
                      "Anucleated center of rosettes contain delicate cell processes resembling neuropil",
                      "Smaller, circular ones resemble Homer Wright rosettes"
                    ]
                  },
                  {
                    "text": "Isomorphic cells with round nuclei, stippled chromatin, scant cytoplasm"
                  },
                  {
                    "text": "Large ganglion cells or multinucleated cells with bizarre appearance in some cases"
                  },
                  {
                    "text": "Pleomorphism does not impact prognosis"
                  },
                  {
                    "text": "No mitotic activity"
                  }
                ],
                "PPTID, WHO Grades 2-3": [
                  {
                    "text": "Dense lobular arrangement"
                  },
                  {
                    "text": "Diffuse proliferation mimicking neurocytoma"
                  },
                  {
                    "text": "Transitional forms with areas of intermediate differentiation combined with pineocytomatous rosettes"
                  },
                  {
                    "text": "Biphasic pattern with pineocytoma admixed with PB, rarest form"
                  },
                  {
                    "text": "Isomorphic cells with round nuclei, stippled chromatin, scant cytoplasm"
                  },
                  {
                    "text": "Pleomorphism does not impact prognosis"
                  },
                  {
                    "text": "Grading criteria proposed by Jouvet et alCriteria for WHO grade 2< 6 mitoses/10 HPFPositive immunoreactivity for neurofilament proteinCriteria for WHO grade 3≥ 6 mitoses/10 HPFor< 6 mitoses but absence of immunoreactivity for neurofilament protein",
                    "sub_points": [
                      "Criteria for WHO grade 2< 6 mitoses/10 HPFPositive immunoreactivity for neurofilament protein",
                      "< 6 mitoses/10 HPF",
                      "Positive immunoreactivity for neurofilament protein",
                      "Criteria for WHO grade 3≥ 6 mitoses/10 HPFor< 6 mitoses but absence of immunoreactivity for neurofilament protein",
                      "≥ 6 mitoses/10 HPFor",
                      "< 6 mitoses but absence of immunoreactivity for neurofilament protein"
                    ]
                  }
                ],
                "PB, WHO Grade 4": [
                  {
                    "text": "Monotonous sheet-like appearance"
                  },
                  {
                    "text": "Small round blue cells, cytologic features similar to other embryonal tumors"
                  },
                  {
                    "text": "Absence ,of large pineocytomatous rosettesMay show Homer Wright or Flexner-Wintersteiner rosettes",
                    "sub_points": [
                      "May show Homer Wright or Flexner-Wintersteiner rosettes"
                    ]
                  },
                  {
                    "text": "Brisk mitotic activity"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Pineocytomatous rosettes are synaptophysin (+)"
                  },
                  {
                    "text": "Cell cytoplasm in pineocytoma and PPTIDSynaptophysin, NSE, chromogranin A (+)GFAP(-)S100(+) in few tumor cells &/or in interspersed reactive astrocytic processesNeurofilament (+) in filament patternCytoplasmic staining may highlight ganglionic differentiation in pineocytoma, PPTIDNeurofilament (+) cells in PPTID prognostically favorable",
                    "sub_points": [
                      "Synaptophysin, NSE, chromogranin A (+)",
                      "GFAP(-)",
                      "S100(+) in few tumor cells &/or in interspersed reactive astrocytic processes",
                      "Neurofilament (+) in filament patternCytoplasmic staining may highlight ganglionic differentiation in pineocytoma, PPTIDNeurofilament (+) cells in PPTID prognostically favorable",
                      "Cytoplasmic staining may highlight ganglionic differentiation in pineocytoma, PPTID",
                      "Neurofilament (+) cells in PPTID prognostically favorable"
                    ]
                  },
                  {
                    "text": "In PBsSynaptophysin and NSE (+/-) and at lower intensityChromogranin A and neurofilament (-) or very little",
                    "sub_points": [
                      "Synaptophysin and NSE (+/-) and at lower intensity",
                      "Chromogranin A and neurofilament (-) or very little"
                    ]
                  },
                  {
                    "text": "Ki-67 proliferation index3-7% for PPTID WHO grade 2High for PBIn one study, mean Ki-67 index significantly different for tumor grades0 in pineocytoma, 5.2 ± 0.4 in PPTID WHO grade 2, 11.2 ± 2.0 in PPTID WHO grade 3, 36.4 ± 6.2 in PBHowever, no statistically significant difference in either overall or disease-free survival with different grade tumors or Ki-67 index; attributed to different clinical management of patients in different centers",
                    "sub_points": [
                      "3-7% for PPTID WHO grade 2",
                      "High for PB",
                      "In one study, mean Ki-67 index significantly different for tumor grades0 in pineocytoma, 5.2 ± 0.4 in PPTID WHO grade 2, 11.2 ± 2.0 in PPTID WHO grade 3, 36.4 ± 6.2 in PBHowever, no statistically significant difference in either overall or disease-free survival with different grade tumors or Ki-67 index; attributed to different clinical management of patients in different centers",
                      "0 in pineocytoma, 5.2 ± 0.4 in PPTID WHO grade 2, 11.2 ± 2.0 in PPTID WHO grade 3, 36.4 ± 6.2 in PB",
                      "However, no statistically significant difference in either overall or disease-free survival with different grade tumors or Ki-67 index; attributed to different clinical management of patients in different centers"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "PPTIDs harbor small in-frame insertions involvingKBTBD4"
                  },
                  {
                    "text": "PBs haveRB1,DICER1,DROSHA, orDGCR8alterations orMYCoverexpression"
                  },
                  {
                    "text": "4 groups of PBs recently identifiedPB-miRNA1, PB-miRNA2, PB-MYC/FOXR2, PB-RB1",
                    "sub_points": [
                      "PB-miRNA1, PB-miRNA2, PB-MYC/FOXR2, PB-RB1"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Papillary Tumor of Pineal Region": [
                  {
                    "text": "Vague epithelial features, cytoplasmic vacuoles"
                  },
                  {
                    "text": "Diffusely (+) for CK8, CK18, CAM5.2 (especially CK18 alone)"
                  }
                ],
                "Germinoma": [
                  {
                    "text": "Germ cells with large prominent nucleoli, vacuolated cytoplasm"
                  },
                  {
                    "text": "Usually accompanied by nonneoplastic CD45(+) lymphocytes"
                  },
                  {
                    "text": "OCT4, SALL4, CD117 (C-kit) (+)"
                  },
                  {
                    "text": "PLAP(+)"
                  }
                ],
                "Metastatic Carcinoma": [
                  {
                    "text": "May have gland formation, more necrosis"
                  },
                  {
                    "text": "Usually immunoreactive for keratins, EMA"
                  }
                ],
                "Pineal Cyst": [
                  {
                    "text": "Glial cyst wall without ependymal or epithelial lining"
                  },
                  {
                    "text": "Gliotic, often with Rosenthal fibers"
                  },
                  {
                    "text": "Nonneoplastic condition"
                  },
                  {
                    "text": "Often biopsies contain accompanying normal pineal glandNormal pineal gland lobularNormal gland intensely synaptophysin IHC(+)Normal gland with interspersed GFAP(+) inter- and intralobular astrocytesKi-67 labeling low",
                    "sub_points": [
                      "Normal pineal gland lobular",
                      "Normal gland intensely synaptophysin IHC(+)",
                      "Normal gland with interspersed GFAP(+) inter- and intralobular astrocytes",
                      "Ki-67 labeling low"
                    ]
                  }
                ],
                "Assessment by DNA Methylation Helpful in Some Cases": [
                  {
                    "text": "In recent study of 93 tumors from multiple referral centers, DNA methylation allowed recalcification of 21/93 submitted examples into 11 germ cell tumors, 5 atypical teratoid/rhabdoid tumors, 2 medulloblastomas. 2 high-grade gliomas, 1 embryonal tumor with multilayered rosettes (ETMR)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Do not mistake PPTs with large ganglion cells for germinoma"
                  },
                  {
                    "text": "Neurocytomas and pineocytomas nearly identical cytologically; differentiate by location"
                  },
                  {
                    "text": "Do not mistake pleomorphism in PPTs for metastatic carcinoma"
                  },
                  {
                    "text": "Do not use pleomorphism as grading criteria"
                  },
                  {
                    "text": "Do not mistake diffuse PPTID, WHO grades 2-3 for PB, WHO grade 4In 1 recent study, pathologic re-review refined classification in 27% of pineal tumor cases, with majority of these being adult patients with pineal tumors originally classified as PBs now reclassified as PPTID",
                    "sub_points": [
                      "In 1 recent study, pathologic re-review refined classification in 27% of pineal tumor cases, with majority of these being adult patients with pineal tumors originally classified as PBs now reclassified as PPTID"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Atypical Teratoid/Rhabdoid Tumor": {
            "name": "Atypical Teratoid/Rhabdoid Tumor",
            "url": "https://app.pathprimer.com/document/b0707bec-a68f-4cc0-8def-ea5fd29e0b43/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Highly malignant CNS neoplasm with poorly differentiated elements and frequent rhabdoid cells occurring in infants and young children"
                  },
                  {
                    "text": "Inactivation ofSMARCB1(INI1)or (rarely)SMARCA4(BRG1)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "GermlineSMARCB1mutations in ~ 1/3 of casesRhabdoid tumor predisposition syndrome",
                    "sub_points": [
                      "Rhabdoid tumor predisposition syndrome"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare: 1-2% of pediatric primary CNS tumors"
                  },
                  {
                    "text": "Generally first 2 years of life"
                  },
                  {
                    "text": "Nearly all intracranial; intraspinal rare"
                  },
                  {
                    "text": "Prognosis poor"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Large, soft, fleshy, and necrotic"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Distinctive, yet nondescript, large, pale cells"
                  },
                  {
                    "text": "Rhabdoid cells highly variable in number"
                  },
                  {
                    "text": "Undifferentiated cells simulating medulloblastoma"
                  },
                  {
                    "text": "Glands, rosettes, or chondroid matrix (uncommon)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Polyimmunophenotypic with variable positivity, often in individual cells or small groupsEMA, cytokeratins, GFAP, S100, SMA, desmin, synaptophysin, chromogranin, neurofilament protein",
                    "sub_points": [
                      "EMA, cytokeratins, GFAP, S100, SMA, desmin, synaptophysin, chromogranin, neurofilament protein"
                    ]
                  },
                  {
                    "text": "Loss of nuclear immunoreactivity for INI1/BAF47 essentially diagnostic and required"
                  },
                  {
                    "text": "Deletions, mutations inSMARCB1(INI1)in almost all cases"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Medulloblastoma, choroid plexus carcinoma, embryonal tumors (formerly supratentorial primitive neuroectodermal tumors)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Atypical teratoid/rhabdoid tumor (AT/RT)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Rhabdoid tumor of CNS"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Highly malignant early pediatric CNS neoplasm with poorly differentiated elements and frequent rhabdoid cells (similar to renal and extrarenal rhabdoid tumor)"
                  },
                  {
                    "text": "Inactivation ofSMARCB1(INI1)or (extremely rarely)SMARCA4(BRG1)"
                  },
                  {
                    "text": "WHO grade 4"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetics": [
                  {
                    "text": "GermlineSMARCB1mutations in ~ 1/3 of casesRhabdoid tumor predisposition syndrome",
                    "sub_points": [
                      "Rhabdoid tumor predisposition syndrome"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare: 1-2% of primary pediatric CNS tumors"
                  }
                ],
                "Age": [
                  {
                    "text": "Generally first 2 years of life (75%)"
                  },
                  {
                    "text": "Rare in adultsOccasionally suprasellarMostly ATRT-MYC subtype",
                    "sub_points": [
                      "Occasionally suprasellar",
                      "Mostly ATRT-MYC subtype"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "M > F (3:2)"
                  }
                ],
                "Site": [
                  {
                    "text": "Nearly all intracranial50-60% infratentorialOften cerebellopontine angle40-50% supratentorialIntracerebralSuprasellar, especially in adults",
                    "sub_points": [
                      "50-60% infratentorialOften cerebellopontine angle",
                      "Often cerebellopontine angle",
                      "40-50% supratentorialIntracerebralSuprasellar, especially in adults",
                      "Intracerebral",
                      "Suprasellar, especially in adults"
                    ]
                  },
                  {
                    "text": "Rare intraspinal (~ 3%)All ATRT-MYC subtype",
                    "sub_points": [
                      "All ATRT-MYC subtype"
                    ]
                  },
                  {
                    "text": "May show CSF dissemination (i.e., drop metastases)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Site-dependent neurologic deficits"
                  },
                  {
                    "text": "Signs of increased ICP"
                  },
                  {
                    "text": "Macrocephaly"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Gross total resection, optimal and prognosticOften not possible",
                    "sub_points": [
                      "Often not possible"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Often rhabdomyosarcoma-like chemotherapy regimen"
                  },
                  {
                    "text": "High-dose chemotherapy + autologous stem cell rescue"
                  },
                  {
                    "text": "Alkylating agents show some response"
                  },
                  {
                    "text": "Potential role of histone deacetylase and EZH2 inhibitors"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Involved field or craniospinal"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Poor; median overall survival: ~ 13 months"
                  },
                  {
                    "text": "Worse overall survival associated withYounger age at diagnosis (< 3 years)CSF seeding at diagnosis (common)Subtotal resectionDelayed radiotherapy, in some series",
                    "sub_points": [
                      "Younger age at diagnosis (< 3 years)",
                      "CSF seeding at diagnosis (common)",
                      "Subtotal resection",
                      "Delayed radiotherapy, in some series"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Large mass"
                  },
                  {
                    "text": "Variably enhancing"
                  },
                  {
                    "text": "Frequent hemorrhage and necrosis"
                  },
                  {
                    "text": "May show CSF dissemination"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Large, soft, fleshy, hemorrhagic, and necrotic"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Heterogeneous, variably textured, disordered, complex architecture"
                  },
                  {
                    "text": "Distinctive, yet nondescript, large pale cells"
                  },
                  {
                    "text": "Undifferentiated, embryonal-like cells (most common)Totally undifferentiated, small round blue cell tumorFlexner-Wintersteiner or Homer Wright rosettes",
                    "sub_points": [
                      "Totally undifferentiated, small round blue cell tumor",
                      "Flexner-Wintersteiner or Homer Wright rosettes"
                    ]
                  },
                  {
                    "text": "Rhabdoid cells, characteristic but not always presentRound eccentric nucleiOpen chromatin patternProminent nucleoliEosinophilic cytoplasmic inclusion (sometimes)Fibrillary or homogeneous",
                    "sub_points": [
                      "Round eccentric nucleiOpen chromatin pattern",
                      "Open chromatin pattern",
                      "Prominent nucleoli",
                      "Eosinophilic cytoplasmic inclusion (sometimes)Fibrillary or homogeneous",
                      "Fibrillary or homogeneous"
                    ]
                  },
                  {
                    "text": "Cords of cellsIn basophilic mucoid matrixResemble chordoma or trabecular pattern of renal rhabdoid tumors",
                    "sub_points": [
                      "In basophilic mucoid matrix",
                      "Resemble chordoma or trabecular pattern of renal rhabdoid tumors"
                    ]
                  },
                  {
                    "text": "Other patterns of differentiation (rare)Epithelial patternsFew small, gland-like spaces/nests or flat epithelial surfacesPrimitive squamous differentiationEpendymal canals or neural tube-like structuresChondroid matrixGanglioglioma-like differentiation",
                    "sub_points": [
                      "Epithelial patternsFew small, gland-like spaces/nests or flat epithelial surfacesPrimitive squamous differentiationEpendymal canals or neural tube-like structures",
                      "Few small, gland-like spaces/nests or flat epithelial surfaces",
                      "Primitive squamous differentiation",
                      "Ependymal canals or neural tube-like structures",
                      "Chondroid matrix",
                      "Ganglioglioma-like differentiation"
                    ]
                  },
                  {
                    "text": "Mitoses (frequent)"
                  },
                  {
                    "text": "Apoptosis (prominent)"
                  },
                  {
                    "text": "Necrosis (common)Often with dystrophic calcification",
                    "sub_points": [
                      "Often with dystrophic calcification"
                    ]
                  },
                  {
                    "text": "Fibrovascular septa"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Large, pale cells"
                  },
                  {
                    "text": "Rhabdoid cells"
                  },
                  {
                    "text": "Small, primitive cells"
                  },
                  {
                    "text": "Abundant apoptosis, mitoses"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Loss of nuclear reactivity for INI1/BAF47 (SMARCB1) essentially diagnostic, and near-required"
                  },
                  {
                    "text": "Rare cases ofSMARCA4alterations show loss of BRG1 expression"
                  },
                  {
                    "text": "Polyimmunophenotypic with variable positivity, often in individual cells or small groupsEMASMAVimentinWidespread IHC(+), little diagnostic valueMay highlight cytoplasmic ball-like inclusionsOther IHC more variableCytokeratinsGFAPS100 proteinDesminSynaptophysinChromograninNeurofilament proteinTrue germ cell markers [CD117 (C-kit), OCT4, PLAP] (-)Claudin-6Role of strong expression in prognosis uncertainIn some studies found to be expressed in variety of other pediatric CNS and soft tissue tumors",
                    "sub_points": [
                      "EMA",
                      "SMA",
                      "VimentinWidespread IHC(+), little diagnostic valueMay highlight cytoplasmic ball-like inclusions",
                      "Widespread IHC(+), little diagnostic value",
                      "May highlight cytoplasmic ball-like inclusions",
                      "Other IHC more variableCytokeratinsGFAPS100 proteinDesminSynaptophysinChromograninNeurofilament protein",
                      "Cytokeratins",
                      "GFAP",
                      "S100 protein",
                      "Desmin",
                      "Synaptophysin",
                      "Chromogranin",
                      "Neurofilament protein",
                      "True germ cell markers [CD117 (C-kit), OCT4, PLAP] (-)",
                      "Claudin-6Role of strong expression in prognosis uncertainIn some studies found to be expressed in variety of other pediatric CNS and soft tissue tumors",
                      "Role of strong expression in prognosis uncertain",
                      "In some studies found to be expressed in variety of other pediatric CNS and soft tissue tumors"
                    ]
                  },
                  {
                    "text": "High Ki-67 labeling index, often > 50%"
                  },
                  {
                    "text": "p53 protein expression often foundUsually noTP53mutationMay be due to deregulation ofCDK2NA(p16INK4A) and (p14ARF) pathway",
                    "sub_points": [
                      "Usually noTP53mutation",
                      "May be due to deregulation ofCDK2NA(p16INK4A) and (p14ARF) pathway"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Deletions or mutations inSMARCB1gene in almost all casesLoss of nuclear INI1 immunostaining",
                    "sub_points": [
                      "Loss of nuclear INI1 immunostaining"
                    ]
                  },
                  {
                    "text": "Mutation inSMARCA4(BRG1)gene (rare)Retained nuclear INI1 and loss of nuclear BRG1 immunostaining",
                    "sub_points": [
                      "Retained nuclear INI1 and loss of nuclear BRG1 immunostaining"
                    ]
                  },
                  {
                    "text": "Loss of all (monosomy) or part (deletion) of chromosome 22; frequent"
                  },
                  {
                    "text": "Gene expression and methylation profiling shows at least 3 subgroupsATRT-TYR (tyrosinase,MITF,BMP4overexpression)Youngest group (median age: 12 months), 90% < 2 yearsMostly posterior fossaInactivatingSMARCB1mutation with loss of 22qGlobal DNA hypermethylationTreatments targetingFGFR2andPDGFRBATRT-SHH (Sonic hedgehog)Overexpression of members of SHH (GLI2,PTCH1, MYCN) and Notch (ASCL1) pathwaysASCL1expression correlates with better prognosisCompound heterozygousSMARCB1point mutationsGlobal DNA hypermethylationBoth supra- and infratentorialATRT-MYC (MYC overexpression without gene amplification)Highest median age (27 months)Most adult tumors are in this groupBroadSMARCB1homozygous deletionsSMARCB1point mutations rare50% supratentorial, 38% posterior fossaAll spinal tumors are in this groupGlobal DNA hypomethylationSimilar methylation profile to renal and extrarenal malignant rhabdoid tumors (MRTs)Increased CD8(+) T-cell infiltration, PD1 and PD-L1 expressionRole of immune checkpoint inhibition",
                    "sub_points": [
                      "ATRT-TYR (tyrosinase,MITF,BMP4overexpression)Youngest group (median age: 12 months), 90% < 2 yearsMostly posterior fossaInactivatingSMARCB1mutation with loss of 22qGlobal DNA hypermethylationTreatments targetingFGFR2andPDGFRB",
                      "Youngest group (median age: 12 months), 90% < 2 years",
                      "Mostly posterior fossa",
                      "InactivatingSMARCB1mutation with loss of 22q",
                      "Global DNA hypermethylation",
                      "Treatments targetingFGFR2andPDGFRB",
                      "ATRT-SHH (Sonic hedgehog)Overexpression of members of SHH (GLI2,PTCH1, MYCN) and Notch (ASCL1) pathwaysASCL1expression correlates with better prognosisCompound heterozygousSMARCB1point mutationsGlobal DNA hypermethylationBoth supra- and infratentorial",
                      "Overexpression of members of SHH (GLI2,PTCH1, MYCN) and Notch (ASCL1) pathwaysASCL1expression correlates with better prognosis",
                      "ASCL1expression correlates with better prognosis",
                      "Compound heterozygousSMARCB1point mutations",
                      "Global DNA hypermethylation",
                      "Both supra- and infratentorial",
                      "ATRT-MYC (MYC overexpression without gene amplification)Highest median age (27 months)Most adult tumors are in this groupBroadSMARCB1homozygous deletionsSMARCB1point mutations rare50% supratentorial, 38% posterior fossaAll spinal tumors are in this groupGlobal DNA hypomethylationSimilar methylation profile to renal and extrarenal malignant rhabdoid tumors (MRTs)Increased CD8(+) T-cell infiltration, PD1 and PD-L1 expressionRole of immune checkpoint inhibition",
                      "Highest median age (27 months)Most adult tumors are in this group",
                      "Most adult tumors are in this group",
                      "BroadSMARCB1homozygous deletionsSMARCB1point mutations rare",
                      "SMARCB1point mutations rare",
                      "50% supratentorial, 38% posterior fossaAll spinal tumors are in this group",
                      "All spinal tumors are in this group",
                      "Global DNA hypomethylation",
                      "Similar methylation profile to renal and extrarenal malignant rhabdoid tumors (MRTs)",
                      "Increased CD8(+) T-cell infiltration, PD1 and PD-L1 expressionRole of immune checkpoint inhibition",
                      "Role of immune checkpoint inhibition"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Rhabdoid cell cytoplasmSpherical, paranuclear, cytoplasmic inclusionsTight, compact, whorled intermediate filamentsUltrastructural variation with other cell types",
                    "sub_points": [
                      "Spherical, paranuclear, cytoplasmic inclusionsTight, compact, whorled intermediate filamentsUltrastructural variation with other cell types",
                      "Tight, compact, whorled intermediate filaments",
                      "Ultrastructural variation with other cell types"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Medulloblastoma": [
                  {
                    "text": "Especially anaplastic/large cell variant"
                  },
                  {
                    "text": "More cell-cell wrapping, nuclear molding"
                  },
                  {
                    "text": "Coarser, more atypical, hyperchromatic nuclei"
                  },
                  {
                    "text": "Diffusely synaptophysin (+)"
                  },
                  {
                    "text": "Reticulin-defined nodules in desmoplastic/nodular variant"
                  },
                  {
                    "text": "Retained nuclear INI1 immunostaining"
                  }
                ],
                "CNS Embryonal Tumors": [
                  {
                    "text": "Formerly called supratentorial primitive neuroectodermal tumor (PNET); terminology no longer recommended"
                  },
                  {
                    "text": "More monomorphous histology; no rhabdoid cells"
                  },
                  {
                    "text": "Diffusely synaptophysin (+)"
                  },
                  {
                    "text": "Retained nuclear INI1 immunostaining"
                  }
                ],
                "Malignant Glioma": [
                  {
                    "text": "GFAP(+) but may be focal"
                  },
                  {
                    "text": "Retained nuclear INI1 immunostaining"
                  }
                ],
                "Choroid Plexus Carcinoma": [
                  {
                    "text": "EMA(-) or focalOften reactive for cytokeratins but only uncommonly EMA(+)",
                    "sub_points": [
                      "Often reactive for cytokeratins but only uncommonly EMA(+)"
                    ]
                  },
                  {
                    "text": "Retained nuclear INI1 staining"
                  },
                  {
                    "text": "AT/RTs not diffusely infiltrating tumors but may trap choroid plexus in some cases; do not mistake for choroid plexus carcinoma"
                  }
                ],
                "Rhabdoid Meningioma": [
                  {
                    "text": "Very rare in infants"
                  },
                  {
                    "text": "Retained nuclear INI1 immunostaining"
                  }
                ],
                "Germinoma": [
                  {
                    "text": "Pineal and suprasellar locations most frequent"
                  },
                  {
                    "text": "More uniform large tumor cells ± inflammatory cells"
                  },
                  {
                    "text": "No rhabdoid inclusions"
                  },
                  {
                    "text": "Occasional noncaseating granulomas"
                  },
                  {
                    "text": "Glycogen-rich cells"
                  },
                  {
                    "text": "Immunoreactivity for CD117 (C-kit), OCT4, PLAP"
                  },
                  {
                    "text": "Retained INI1 nuclear immunostaining"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Consider possibility of AT/RT in any hypercellular, poorly differentiated tumor in infants, including embryonal tumors (formerly PNETs), medulloblastomas, choroid plexus carcinomasMany AT/RTs show paucity of rhabdoid cells",
                    "sub_points": [
                      "Many AT/RTs show paucity of rhabdoid cells"
                    ]
                  },
                  {
                    "text": "Employ immunostaining for INI1 for all CNS pediatric small blue cell/embryonal tumorsAT/RTs show diffuse loss of INI1 immunostaining in all tumor cellsDo not incorrectly interpret entrapped nontumor cells that retain INI1Check fidelity of immunostainingEndothelial cells of blood vessels are internal positive control",
                    "sub_points": [
                      "AT/RTs show diffuse loss of INI1 immunostaining in all tumor cellsDo not incorrectly interpret entrapped nontumor cells that retain INI1",
                      "Do not incorrectly interpret entrapped nontumor cells that retain INI1",
                      "Check fidelity of immunostainingEndothelial cells of blood vessels are internal positive control",
                      "Endothelial cells of blood vessels are internal positive control"
                    ]
                  },
                  {
                    "text": "Small subset of AT/RTs do not show loss of nuclear INI1SMARCA4gene mutation, leading loss of BRG1 nuclear stainingMost patients have inherited, germline mutationsWorse prognosis than with AT/RT withSMARCB1mutation",
                    "sub_points": [
                      "SMARCA4gene mutation, leading loss of BRG1 nuclear staining",
                      "Most patients have inherited, germline mutations",
                      "Worse prognosis than with AT/RT withSMARCB1mutation"
                    ]
                  },
                  {
                    "text": "Not all tumors with INI1 loss/mutation inSMARCB1gene are automatically AT/RTOther pediatric CNS tumors have diffuse loss of INI1 immunostainingCribriform neuroepithelial tumor (CRINET), rareDNA methylation similar to ATRT-TYR subtypePediatric non-CNS tumors with loss of INI1 immunostainingRenal/extrarenal MRTsRenal medullary carcinomaPoorly differentiated chordomaAdult CNS tumors with loss of INI1 immunostainingAdult sellar AT/RTDesmoplastic myxoid tumor in pineal regionAdult non-CNS tumors with loss of INI1 immunostainingEpithelioid sarcomasExtraskeletal myxoid chondrosarcomasEpithelioid malignant peripheral nerve sheath tumorsRare rhabdoid carcinomas of gastroenteropancreatic, sinonasal, genitourinary tractRare CNS tumors can develop subset of cells with loss of INI1Pleomorphic xanthoastrocytomasGangliogliomasDiffuse gliomas/glioblastomasLikely clones of tumor cells withSMARCB1mutations evolve as late mutational event",
                    "sub_points": [
                      "Other pediatric CNS tumors have diffuse loss of INI1 immunostainingCribriform neuroepithelial tumor (CRINET), rareDNA methylation similar to ATRT-TYR subtype",
                      "Cribriform neuroepithelial tumor (CRINET), rareDNA methylation similar to ATRT-TYR subtype",
                      "DNA methylation similar to ATRT-TYR subtype",
                      "Pediatric non-CNS tumors with loss of INI1 immunostainingRenal/extrarenal MRTsRenal medullary carcinomaPoorly differentiated chordoma",
                      "Renal/extrarenal MRTs",
                      "Renal medullary carcinoma",
                      "Poorly differentiated chordoma",
                      "Adult CNS tumors with loss of INI1 immunostainingAdult sellar AT/RTDesmoplastic myxoid tumor in pineal region",
                      "Adult sellar AT/RT",
                      "Desmoplastic myxoid tumor in pineal region",
                      "Adult non-CNS tumors with loss of INI1 immunostainingEpithelioid sarcomasExtraskeletal myxoid chondrosarcomasEpithelioid malignant peripheral nerve sheath tumorsRare rhabdoid carcinomas of gastroenteropancreatic, sinonasal, genitourinary tract",
                      "Epithelioid sarcomas",
                      "Extraskeletal myxoid chondrosarcomas",
                      "Epithelioid malignant peripheral nerve sheath tumors",
                      "Rare rhabdoid carcinomas of gastroenteropancreatic, sinonasal, genitourinary tract",
                      "Rare CNS tumors can develop subset of cells with loss of INI1Pleomorphic xanthoastrocytomasGangliogliomasDiffuse gliomas/glioblastomasLikely clones of tumor cells withSMARCB1mutations evolve as late mutational event",
                      "Pleomorphic xanthoastrocytomas",
                      "Gangliogliomas",
                      "Diffuse gliomas/glioblastomas",
                      "Likely clones of tumor cells withSMARCB1mutations evolve as late mutational event"
                    ]
                  },
                  {
                    "text": "Not all tumors withSMARCB1mutations follow highly aggressive clinical courseCRINET and AT/RT with ASCL1 expression: Better prognosis",
                    "sub_points": [
                      "CRINET and AT/RT with ASCL1 expression: Better prognosis"
                    ]
                  },
                  {
                    "text": "Rare examples of AT/RTs without INI1 protein loss or mutation inSMARCA4(BRG1) geneDiagnosis should be made with cautionRequires extensive additional testing, often by research methodologies",
                    "sub_points": [
                      "Diagnosis should be made with caution",
                      "Requires extensive additional testing, often by research methodologies"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Solitary Fibrous Tumor": {
            "name": "Solitary Fibrous Tumor",
            "url": "https://app.pathprimer.com/document/5418b528-e955-4a7e-bffa-10abea3ac7fd/lesson/47318829-66a5-4fdf-94f4-2d062f91a98f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Fibroblastic tumor with prominent branching, staghorn-shaped vessels harboringNAB2::STAT6fusion"
                  },
                  {
                    "text": "Solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) were considered to exist in a spectrum, but HPC terminology is no longer used"
                  },
                  {
                    "text": "Tumors previously considered under HPC are currently classified as SFT according to the 2021 WHO Classification of CNS Tumors, 5th Edition"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Dural based, rarely parenchymal or intraventricular"
                  },
                  {
                    "text": "Favorable prognosis with gross total resection but tend to recur if incompletely excised"
                  },
                  {
                    "text": "Higher WHO grade correlates with increased risk for recurrence and systemic metastasis"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Circumscribed, usually dural based with dural tail"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Compact, noninfiltrating unless anaplastic"
                  },
                  {
                    "text": "Bands of brightly eosinophilic wire-like collagen (SFT morphology)"
                  },
                  {
                    "text": "Patternless pattern, jumbled appearance with branching, staghorn vessels (HPC morphology)"
                  },
                  {
                    "text": "Biphasic, alternating paucicellular and hypercellular areas"
                  },
                  {
                    "text": "WHO grade based on mitoses (< 5 or ≥ 5 mitoses per 10 HPF) and necrosis"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "STAT6(+), nuclear"
                  },
                  {
                    "text": "CD34(+) but may be reduced or negative in high grade"
                  },
                  {
                    "text": "BCL2(+), CD99(+), S100(-), SSTR2A(-)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Fibrous meningioma"
                  },
                  {
                    "text": "Schwannoma"
                  },
                  {
                    "text": "Melanocytic neoplasm"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Solitary fibrous tumor (SFT)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Hemangiopericytoma (HPC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Fibroblastic tumor with prominent branching, gaping, staghorn-shaped (HPC-like) vesselsTumors previously considered under HPC are currently classified as SFT according to the WHO Classification of CNS Tumors, 5th ed.",
                    "sub_points": [
                      "Tumors previously considered under HPC are currently classified as SFT according to the WHO Classification of CNS Tumors, 5th ed."
                    ]
                  },
                  {
                    "text": "SFT harbors the diagnosticNAB2::STAT6fusion"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Uncommon; HPC morphology more common than SFT morphology in CNS"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean: ~ 50 years"
                  }
                ],
                "Site": [
                  {
                    "text": "Typically dural basedUsually falx cerebri or tentorium cerebelliSpinal cord, less common (~ 10%), better prognosisIntraventricular, rare",
                    "sub_points": [
                      "Usually falx cerebri or tentorium cerebelli",
                      "Spinal cord, less common (~ 10%), better prognosis",
                      "Intraventricular, rare"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Depending on tumor locationHeadaches, seizures, focal deficits",
                    "sub_points": [
                      "Headaches, seizures, focal deficits"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Gross total resection"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Low-grade tumors with classic SFT pattern have favorable prognosis after gross total resection"
                  },
                  {
                    "text": "Intermediate prognosis for more mitotically active lesions"
                  },
                  {
                    "text": "Unfavorable for malignant or high-grade examples"
                  },
                  {
                    "text": "Potential for progression from low-grade to high-grade"
                  },
                  {
                    "text": "Some studies suggest tumors with SFT morphology have better prognosis than those with HPC morphology, which maybe due to overrepresentation of SFT morphology among WHO grade 1 tumors"
                  },
                  {
                    "text": "Higher WHO grade and positive surgical margins are associated with recurrence"
                  },
                  {
                    "text": "Higher WHO grade and prior recurrence are associated with systemic metastasis"
                  },
                  {
                    "text": "Systemic metastasesLung, liver, and bone metastases",
                    "sub_points": [
                      "Lung, liver, and bone metastases"
                    ]
                  },
                  {
                    "text": "Cerebrospinal/leptomeningeal spread, rare"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Circumscribed, usually dural basedDural tail (some)",
                    "sub_points": [
                      "Dural tail (some)"
                    ]
                  },
                  {
                    "text": "Isointense to gray matter on T1WI"
                  },
                  {
                    "text": "Variable and mixed areas of hypo- and hyperintense areas on T2WILow signal in collagen-rich areas",
                    "sub_points": [
                      "Low signal in collagen-rich areas"
                    ]
                  },
                  {
                    "text": "Avid, heterogeneous contrast enhancement"
                  },
                  {
                    "text": "Variable peritumoral edema &/or mass effect"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "White-tan, firm, and rubbery"
                  },
                  {
                    "text": "Smooth or bosselated, unencapsulated surface"
                  },
                  {
                    "text": "Vascular spaces and hemorrhage on cut section"
                  },
                  {
                    "text": "Cysts, rare"
                  },
                  {
                    "text": "Traps regional vessels and nerves"
                  },
                  {
                    "text": "Compresses surrounding CNS parenchyma without gross invasion"
                  },
                  {
                    "text": "Parenchymal invasion in anaplastic examples, rare"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "2 major histologic patternsClassic SFT morphologyLow to moderate cellularityNoninfiltrative, discrete bordersPatternless patternAbundant, brightly eosinophilic collagen invested in strips in between tumor cellsRarely keloid-like or amianthoid fibersBiphasic: hyalinized paucicellular and cellular areasOccasionally fascicular or storiform architectureLoose, spongy tissue with occasional myxoid changeDelicate and thin-walled vesselsSlit-like vessels with bland endothelial cellsFocally thick-walled, hyalinized vessels, especially in low cellularity areasHPC-like vessels, focalUsually low mitotic rateHPC morphologyHighly cellular tumor, jumbled patternRound oval nucleiDelicate and prominent HPC-like staghorn vesselsCollagen bundles focally present",
                    "sub_points": [
                      "Classic SFT morphologyLow to moderate cellularityNoninfiltrative, discrete bordersPatternless patternAbundant, brightly eosinophilic collagen invested in strips in between tumor cellsRarely keloid-like or amianthoid fibersBiphasic: hyalinized paucicellular and cellular areasOccasionally fascicular or storiform architectureLoose, spongy tissue with occasional myxoid changeDelicate and thin-walled vesselsSlit-like vessels with bland endothelial cellsFocally thick-walled, hyalinized vessels, especially in low cellularity areasHPC-like vessels, focalUsually low mitotic rate",
                      "Low to moderate cellularity",
                      "Noninfiltrative, discrete borders",
                      "Patternless pattern",
                      "Abundant, brightly eosinophilic collagen invested in strips in between tumor cellsRarely keloid-like or amianthoid fibers",
                      "Rarely keloid-like or amianthoid fibers",
                      "Biphasic: hyalinized paucicellular and cellular areas",
                      "Occasionally fascicular or storiform architecture",
                      "Loose, spongy tissue with occasional myxoid change",
                      "Delicate and thin-walled vesselsSlit-like vessels with bland endothelial cellsFocally thick-walled, hyalinized vessels, especially in low cellularity areasHPC-like vessels, focal",
                      "Slit-like vessels with bland endothelial cells",
                      "Focally thick-walled, hyalinized vessels, especially in low cellularity areas",
                      "HPC-like vessels, focal",
                      "Usually low mitotic rate",
                      "HPC morphologyHighly cellular tumor, jumbled patternRound oval nucleiDelicate and prominent HPC-like staghorn vesselsCollagen bundles focally present",
                      "Highly cellular tumor, jumbled pattern",
                      "Round oval nuclei",
                      "Delicate and prominent HPC-like staghorn vessels",
                      "Collagen bundles focally present"
                    ]
                  },
                  {
                    "text": "Anaplastic features (uncommon with classic SFT morphology)Mitoses ≥ 5/10 HPFNecrosisHigh cellularity and marked nuclear pleomorphismFascicular, sometimes herringbone architecture",
                    "sub_points": [
                      "Mitoses ≥ 5/10 HPF",
                      "Necrosis",
                      "High cellularity and marked nuclear pleomorphism",
                      "Fascicular, sometimes herringbone architecture"
                    ]
                  }
                ],
                "Grading (CNS WHO, 5th edition)": [
                  {
                    "text": "Grade 1: Any morphology, < 5 mitoses per 10 HPF, ± necrosisMost have classic SFT morphology",
                    "sub_points": [
                      "Most have classic SFT morphology"
                    ]
                  },
                  {
                    "text": "Grade 2: Any morphology, ≥ 5 mitoses per 10 HPF, no necrosisMixture of SFT and HPC morphology",
                    "sub_points": [
                      "Mixture of SFT and HPC morphology"
                    ]
                  },
                  {
                    "text": "Grade 3: Any morphology, ≥ 5 mitoses per 10 HPF, with necrosisMost have HPC morphology",
                    "sub_points": [
                      "Most have HPC morphology"
                    ]
                  },
                  {
                    "text": "SFT morphology is overrepresented among grade 1, but HPC morphology alone is not sufficient to assign higher grade"
                  },
                  {
                    "text": "Tumors outside of CNS can be graded using 2020 WHO classification of soft tissue and bone tumors (5th edition)SFT: Any morphology with < 5 mitoses per 10 HPFMalignant SFT: Any morphology with ≥ 5 mitoses per 10 HPF",
                    "sub_points": [
                      "SFT: Any morphology with < 5 mitoses per 10 HPF",
                      "Malignant SFT: Any morphology with ≥ 5 mitoses per 10 HPF"
                    ]
                  },
                  {
                    "text": "Risk stratification system (including patient age, tumor size, mitotic count and necrosis) used to determine metastatic risk for SFTs outside of CNS does not apply to CNS SFTs"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Bland, oval cells with dark homogeneous chromatinMore hyperchromatic than meningioma",
                    "sub_points": [
                      "More hyperchromatic than meningioma"
                    ]
                  },
                  {
                    "text": "Scant cytoplasm, less than meningioma"
                  },
                  {
                    "text": "Nucleoli usually inconspicuous"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "Reticulin surrounding individual or small clusters of cellsProminent in tumors with HPC morphology and patchy in tumors with SFT morphology",
                    "sub_points": [
                      "Prominent in tumors with HPC morphology and patchy in tumors with SFT morphology"
                    ]
                  },
                  {
                    "text": "Trichrome staining collagen SFT morphology > HPC morphology"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "STAT6(+), nuclear"
                  },
                  {
                    "text": "CD34Diffusely positive in tumors with SFT morphologyOften limited to vessels in tumors with HPC morphology",
                    "sub_points": [
                      "Diffusely positive in tumors with SFT morphology",
                      "Often limited to vessels in tumors with HPC morphology"
                    ]
                  },
                  {
                    "text": "BCL2 variably positive"
                  },
                  {
                    "text": "CD99(+)"
                  },
                  {
                    "text": "Collagen IV, pericellularMore prominent in tumors with SFT morphologyFocal in tumors with HPC morphology",
                    "sub_points": [
                      "More prominent in tumors with SFT morphology",
                      "Focal in tumors with HPC morphology"
                    ]
                  },
                  {
                    "text": "S100, desmin, EMA, most keratins, claudins (-)"
                  },
                  {
                    "text": "FXIIIA, variable, may be negative"
                  },
                  {
                    "text": "Mostly low Ki-67 rate (1-4%) but higher (> 10%) in high grade tumors"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "NAB2::STAT6fusion recognized as molecular signature of these tumorsDifferent fusion types identified in both CNS and soft tissue tumorsExon6-exon16/17 fusion is common in tumors with HPC morphology and higher-grade than exon4-exon2 fusion",
                    "sub_points": [
                      "Different fusion types identified in both CNS and soft tissue tumors",
                      "Exon6-exon16/17 fusion is common in tumors with HPC morphology and higher-grade than exon4-exon2 fusion"
                    ]
                  },
                  {
                    "text": "TERTpromoter hotspot mutations, ~ 30%Associated with poor prognosis in soft tissueNo association with fusion type, grade, or prognosis in CNS",
                    "sub_points": [
                      "Associated with poor prognosis in soft tissue",
                      "No association with fusion type, grade, or prognosis in CNS"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Fibroblastic features, no cell junctions or basal lamina"
                  },
                  {
                    "text": "Abundant, rough endoplasmic reticulum"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Fibrous Meningioma": [
                  {
                    "text": "Whorls and psammoma bodies but may be scant or absent in this subtype"
                  },
                  {
                    "text": "Nuclear pseudoinclusions but often scant or absent"
                  },
                  {
                    "text": "Stromal calcifications, common"
                  },
                  {
                    "text": "EMA(+), SSTR2A(+), nuclear STAT6(-), CD34 only in vessels"
                  },
                  {
                    "text": "Progesterone receptor (+), E-cadherin (+) in some cases"
                  }
                ],
                "Schwannoma": [
                  {
                    "text": "Relation to peripheral nerve"
                  },
                  {
                    "text": "Antoni A and Antoni B regions"
                  },
                  {
                    "text": "S100, CD57, collagen IV, nuclear SOX10 all diffusely positive"
                  }
                ],
                "Melanocytic Neoplasms": [
                  {
                    "text": "Uniformly hypercellular, nested pattern"
                  },
                  {
                    "text": "Cells more epithelioid"
                  },
                  {
                    "text": "Prominent nucleoli and intranuclear inclusions"
                  },
                  {
                    "text": "Melanin but may be scarce or absent"
                  },
                  {
                    "text": "Less collagen"
                  },
                  {
                    "text": "MiTF, HMB-45, Melan-A, S100 (+)"
                  }
                ],
                "Gliosarcoma": [
                  {
                    "text": "Glial component without reticulin"
                  },
                  {
                    "text": "More anaplasia and often parenchymal infiltration in glial component"
                  },
                  {
                    "text": "Microvascular proliferation"
                  },
                  {
                    "text": "Necrosis common"
                  },
                  {
                    "text": "Often p53(+) and always nuclear STAT6(-)"
                  },
                  {
                    "text": "GFAP(+) at least focally, S100(+)"
                  }
                ],
                "Fibrosarcoma": [
                  {
                    "text": "Herringbone pattern"
                  },
                  {
                    "text": "Cytologic monomorphism"
                  },
                  {
                    "text": "Little vessel hyalinization"
                  },
                  {
                    "text": "Only vessels CD34(+), nuclear STAT6(-)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Use STAT6, EMA, and CD34 to distinguish from fibrous meningioma"
                  },
                  {
                    "text": "High mitotic rate and necrosis are poor prognostic factors"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "CNS Neoplasms: Syndromes": {
        "name": "CNS Neoplasms: Syndromes",
        "url": "https://app.pathprimer.com/lesson/a121c01f-b8bb-43f0-a596-46ba73ea4ed4",
        "topics": {
          "Neurofibromatosis Type 1": {
            "name": "Neurofibromatosis Type 1",
            "url": "https://app.pathprimer.com/document/61330020-dfe9-4196-b27a-c2876df855df/lesson/a121c01f-b8bb-43f0-a596-46ba73ea4ed4",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "~ 1/3,000"
                  },
                  {
                    "text": "Autosomal dominant"
                  },
                  {
                    "text": "50% sporadic occurrence"
                  },
                  {
                    "text": "Mutations inNF1gene (at 17q11.2)"
                  },
                  {
                    "text": "Functions as tumor suppressor, plays role in cell proliferation and differentiation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Manifestations usually evident in childhood"
                  },
                  {
                    "text": "≥ 2 of criteria≥ 6 café au lait spots≥ 2 neurofibromas≥ 1 plexiform neurofibromaFreckling in axilla and groinOptic nerve glioma (pilocytic astrocytoma)≥ 2 Lisch nodulesDistinctive bony lesion(s)1st-degree relative with neurofibromatosis type 1",
                    "sub_points": [
                      "≥ 6 café au lait spots",
                      "≥ 2 neurofibromas",
                      "≥ 1 plexiform neurofibroma",
                      "Freckling in axilla and groin",
                      "Optic nerve glioma (pilocytic astrocytoma)",
                      "≥ 2 Lisch nodules",
                      "Distinctive bony lesion(s)",
                      "1st-degree relative with neurofibromatosis type 1"
                    ]
                  },
                  {
                    "text": "Neurogenic-associated neoplasmsNeurofibromasMalignant peripheral nerve sheath tumorOptic glioma (pilocytic astrocytoma)Diffusely infiltrating astrocytomas of all grades",
                    "sub_points": [
                      "Neurofibromas",
                      "Malignant peripheral nerve sheath tumor",
                      "Optic glioma (pilocytic astrocytoma)",
                      "Diffusely infiltrating astrocytomas of all grades"
                    ]
                  },
                  {
                    "text": "Nonneurogenic-associated neoplasmsRhabdomyosarcomaJuvenile myelomonocytic leukemiaPheochromocytoma",
                    "sub_points": [
                      "Rhabdomyosarcoma",
                      "Juvenile myelomonocytic leukemia",
                      "Pheochromocytoma"
                    ]
                  },
                  {
                    "text": "CNS nontumoral manifestationsOccasionally neuroglial hamartomas (e.g., gliofibrillary nodules)Aqueductal stenosis, hydrocephalusMacrocephalyIntellectual impairment commonUnknown bright objects: Asymptomatic focal areas of increased T2 signal on MR",
                    "sub_points": [
                      "Occasionally neuroglial hamartomas (e.g., gliofibrillary nodules)",
                      "Aqueductal stenosis, hydrocephalus",
                      "Macrocephaly",
                      "Intellectual impairment common",
                      "Unknown bright objects: Asymptomatic focal areas of increased T2 signal on MR"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Neurofibromatosis Type 1 (NF1)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Peripheral neurofibromatosis"
                  },
                  {
                    "text": "von Recklinghausen disease"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Cancer predisposition syndrome due to genetic alterations ofNF1"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Inheritance": [
                  {
                    "text": "Autosomal dominant"
                  }
                ],
                "Nonhereditary Incidence": [
                  {
                    "text": "50% sporadic occurrence"
                  }
                ],
                "Chromosomal Alterations": [
                  {
                    "text": "Mutations at 17q11.2Encoded protein: NeurofibrominFunctions as tumor suppressor, plays role in cell proliferation and differentiation",
                    "sub_points": [
                      "Encoded protein: NeurofibrominFunctions as tumor suppressor, plays role in cell proliferation and differentiation",
                      "Functions as tumor suppressor, plays role in cell proliferation and differentiation"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 1/3,000"
                  }
                ],
                "Age": [
                  {
                    "text": "Manifestations usually evident in childhood"
                  }
                ],
                "Sex": [
                  {
                    "text": "M = F"
                  }
                ],
                "Presentation": [
                  {
                    "text": "≥ 2 criteria≥ 6 café au lait spots; earliest manifestationPost pubertal: ≥ 1.5 cm; prepubertal: ≥ 0.5 cm≥ 2 neurofibromas≥ 1 plexiform neurofibromaFreckling in axilla and groinPigmentation of intertriginous skinOptic nerve glioma (pilocytic astrocytoma)≥ 2 Lisch nodulesPigmented iris hamartomasDistinctive bony lesion(s)Dysplasia of sphenoid boneDysplasia or thinning of long bone cortex1st-degree relative with NF1",
                    "sub_points": [
                      "≥ 6 café au lait spots; earliest manifestationPost pubertal: ≥ 1.5 cm; prepubertal: ≥ 0.5 cm",
                      "Post pubertal: ≥ 1.5 cm; prepubertal: ≥ 0.5 cm",
                      "≥ 2 neurofibromas",
                      "≥ 1 plexiform neurofibroma",
                      "Freckling in axilla and groinPigmentation of intertriginous skin",
                      "Pigmentation of intertriginous skin",
                      "Optic nerve glioma (pilocytic astrocytoma)",
                      "≥ 2 Lisch nodulesPigmented iris hamartomas",
                      "Pigmented iris hamartomas",
                      "Distinctive bony lesion(s)Dysplasia of sphenoid boneDysplasia or thinning of long bone cortex",
                      "Dysplasia of sphenoid bone",
                      "Dysplasia or thinning of long bone cortex",
                      "1st-degree relative with NF1"
                    ]
                  },
                  {
                    "text": "Revised criteria for NF1 have been recently proposed, which incorporates genetic testing and aims to separate NF1 from Legius syndrome"
                  },
                  {
                    "text": "Localized NF11 limb or single dermatomeLocal somatic mutationNo genetic transmission",
                    "sub_points": [
                      "1 limb or single dermatome",
                      "Local somatic mutation",
                      "No genetic transmission"
                    ]
                  },
                  {
                    "text": "Neurogenic-associated neoplasmsNeurofibromasLocalized cutaneousDiffuse cutaneousLocalized intraneuralPlexiformMassive soft tissueVisceral, mainly gastrointestinalMalignant peripheral nerve sheath tumor (MPNST)Ganglioneuromatosis: GastrointestinalNot specific, also feature of other syndromes (multiple endocrine neoplasia type 2B, Cowden)Optic gliomaBilateral examples only in NF180% diagnosed by age 11Diffusely infiltrating astrocytomas of any grade",
                    "sub_points": [
                      "NeurofibromasLocalized cutaneousDiffuse cutaneousLocalized intraneuralPlexiformMassive soft tissueVisceral, mainly gastrointestinal",
                      "Localized cutaneous",
                      "Diffuse cutaneous",
                      "Localized intraneural",
                      "Plexiform",
                      "Massive soft tissue",
                      "Visceral, mainly gastrointestinal",
                      "Malignant peripheral nerve sheath tumor (MPNST)",
                      "Ganglioneuromatosis: GastrointestinalNot specific, also feature of other syndromes (multiple endocrine neoplasia type 2B, Cowden)",
                      "Not specific, also feature of other syndromes (multiple endocrine neoplasia type 2B, Cowden)",
                      "Optic gliomaBilateral examples only in NF180% diagnosed by age 11",
                      "Bilateral examples only in NF1",
                      "80% diagnosed by age 11",
                      "Diffusely infiltrating astrocytomas of any grade"
                    ]
                  },
                  {
                    "text": "Nonneurogenic-associated neoplasmsRhabdomyosarcoma, juvenile myelomonocytic leukemia, juvenile xanthogranuloma, gastrointestinal stromal tumor, glomus tumor, pheochromocytoma, DICER1-associated primary intracranial sarcomas (rare)",
                    "sub_points": [
                      "Rhabdomyosarcoma, juvenile myelomonocytic leukemia, juvenile xanthogranuloma, gastrointestinal stromal tumor, glomus tumor, pheochromocytoma, DICER1-associated primary intracranial sarcomas (rare)"
                    ]
                  },
                  {
                    "text": "CNS nontumoral manifestationsUnknown bright objects: Asymptomatic focal areas of increase T2 signal on MROccasionally neuroglial hamartomas (e.g., gliofibrillary nodules)Aqueductal stenosis, hydrocephalus, macrocephaly, learning impairment",
                    "sub_points": [
                      "Unknown bright objects: Asymptomatic focal areas of increase T2 signal on MR",
                      "Occasionally neuroglial hamartomas (e.g., gliofibrillary nodules)",
                      "Aqueductal stenosis, hydrocephalus, macrocephaly, learning impairment"
                    ]
                  },
                  {
                    "text": "Miscellaneous associated lesionsSkeletal dysplasiasScalloping of vertebral bodies, kyphoscoliosis, overgrowth of long bones, pseudoarthroses, bone cyst, lower thoracic acute angular scoliosis, facial asymmetryCardiovascularArterial intimal fibrosis, vascular stenosis, moyamoya, aneurysms, hypertrophic cardiomyopathy",
                    "sub_points": [
                      "Skeletal dysplasiasScalloping of vertebral bodies, kyphoscoliosis, overgrowth of long bones, pseudoarthroses, bone cyst, lower thoracic acute angular scoliosis, facial asymmetry",
                      "Scalloping of vertebral bodies, kyphoscoliosis, overgrowth of long bones, pseudoarthroses, bone cyst, lower thoracic acute angular scoliosis, facial asymmetry",
                      "CardiovascularArterial intimal fibrosis, vascular stenosis, moyamoya, aneurysms, hypertrophic cardiomyopathy",
                      "Arterial intimal fibrosis, vascular stenosis, moyamoya, aneurysms, hypertrophic cardiomyopathy"
                    ]
                  },
                  {
                    "text": "Ocular manifestationsLisch nodules, neurofibroma/ganglioneuroma of choroid, retinal vasoproliferative tumors/massive retinal gliosis",
                    "sub_points": [
                      "Lisch nodules, neurofibroma/ganglioneuroma of choroid, retinal vasoproliferative tumors/massive retinal gliosis"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Selumetinib and other MEK1/2 inhibitors are active in subset of gliomas in NF1 patients and currently being explored in clinical trials"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Risk of malignant neoplasm 10x > normal population"
                  },
                  {
                    "text": "Increased risk of subsequent neoplasms after irradiation"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "T2WI: Unidentified bright objects"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "PET/CT: Helpful to detect malignant transition of plexiform neurofibroma"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Constitutional Mismatch Repair DeficiencySyndrome": [
                  {
                    "text": "Autosomal recessive"
                  },
                  {
                    "text": "Biallelic germline mutations in 1 of 4 mismatch repair genes (MLH1,PMS2,MSH2, andMSH6)"
                  },
                  {
                    "text": "Café au lait spots may be present, but other manifestations of NF1 usually absent"
                  },
                  {
                    "text": "Hypermutated gliomas, hematolymphoid malignancies, colorectal cancer"
                  }
                ],
                "Neurofibromatosis Type 2": [
                  {
                    "text": "Schwannomas (rather than neurofibromas), meningiomas and ependymomas (rather than astrocytomas), neurofibromatosis type 2-associated neoplasms"
                  }
                ],
                "Other RASopathies": [
                  {
                    "text": "Expanding group of syndromes (Noonan, Legius syndrome), but multiple neurofibromas not common"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Neurofibromatosis Type 2": {
            "name": "Neurofibromatosis Type 2",
            "url": "https://app.pathprimer.com/document/3be12b02-3dcd-4d8a-8b6d-0a5b5ed15915/lesson/a121c01f-b8bb-43f0-a596-46ba73ea4ed4",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autosomal dominant or sporadic"
                  },
                  {
                    "text": "Mutations at 22q12,NF2gene"
                  },
                  {
                    "text": "Sporadic occurrence (50%)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Incidence: 1/50,000"
                  },
                  {
                    "text": "2nd or 3rd decade"
                  },
                  {
                    "text": "SchwannomaBilateral vestibular schwannomas, hallmarkSimilar histologic features as sporadic tumorsFeatures occurring more frequently in neurofibromatosis type 2 (NF2)-associated schwannomas include whorl formation, multiple tumors involving single nerve, and juxtaposition to meningioma",
                    "sub_points": [
                      "Bilateral vestibular schwannomas, hallmark",
                      "Similar histologic features as sporadic tumors",
                      "Features occurring more frequently in neurofibromatosis type 2 (NF2)-associated schwannomas include whorl formation, multiple tumors involving single nerve, and juxtaposition to meningioma"
                    ]
                  },
                  {
                    "text": "Meningioma, often multiple; ependymoma, intraspinal; juvenile posterior subcapsular lenticular opacities/juvenile cortical cataract"
                  },
                  {
                    "text": "Meningiomas not higher grade than sporadic lesions"
                  },
                  {
                    "text": "EpendymomaCervical cord and cervicomedullary junction are favored sites in NF2Majority of NF2-associated ependymomas are low grade and asymptomatic",
                    "sub_points": [
                      "Cervical cord and cervicomedullary junction are favored sites in NF2",
                      "Majority of NF2-associated ependymomas are low grade and asymptomatic"
                    ]
                  },
                  {
                    "text": "Mortality due to CNS complicationsIncreased risk of mortality with early-onset disease",
                    "sub_points": [
                      "Increased risk of mortality with early-onset disease"
                    ]
                  },
                  {
                    "text": "Associated nonneoplastic CNS lesionsMeningioangiomatosisS100(+) glial microhamartomasIntramedullary schwannosis",
                    "sub_points": [
                      "Meningioangiomatosis",
                      "S100(+) glial microhamartomas",
                      "Intramedullary schwannosis"
                    ]
                  },
                  {
                    "text": "Associated nonneoplastic peripheral manifestationsPosterior subcapsular lens opacityMononeuropathy/polyneuropathy",
                    "sub_points": [
                      "Posterior subcapsular lens opacity",
                      "Mononeuropathy/polyneuropathy"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Neurofibromatosis 2 (NF2)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Central neurofibromatosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Cancer predisposition syndrome due to genetic alterations inNF2gene"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Inheritance": [
                  {
                    "text": "Autosomal dominant"
                  }
                ],
                "Nonhereditary Incidence": [
                  {
                    "text": "50% sporadic occurrence"
                  }
                ],
                "Chromosomal Alterations": [
                  {
                    "text": "Mutations inNF2gene at 22q12Encoded protein (merlin, schwannomin) functions as tumor suppressor, mediates communication between extracellular milieu and cytoskeleton",
                    "sub_points": [
                      "Encoded protein (merlin, schwannomin) functions as tumor suppressor, mediates communication between extracellular milieu and cytoskeleton"
                    ]
                  },
                  {
                    "text": "~ 30% of de novo NF2 patients have mosaic genetic alterations"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1/50,000"
                  }
                ],
                "Age": [
                  {
                    "text": "2nd or 3rd decade"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Diagnostic criteria for NF2 (Manchester criteria, 1992)Bilateral vestibular schwannomas,or1st-degree relative with NF2 and unilateral vestibular schwannoma, or any 2 of meningioma, glioma, schwannoma, or juvenile posterior subcapsular lenticular opacities/juvenile cortical cataract,orUnilateral vestibular schwannoma and any 2 of neurofibroma, meningioma, glioma, schwannoma, or posterior subcapsular lens opacity,or≥ 2 meningiomas + unilateral vestibular schwannoma, or any 2 of neurofibroma, glioma, schwannoma, or cataract",
                    "sub_points": [
                      "Bilateral vestibular schwannomas,or",
                      "1st-degree relative with NF2 and unilateral vestibular schwannoma, or any 2 of meningioma, glioma, schwannoma, or juvenile posterior subcapsular lenticular opacities/juvenile cortical cataract,or",
                      "Unilateral vestibular schwannoma and any 2 of neurofibroma, meningioma, glioma, schwannoma, or posterior subcapsular lens opacity,or",
                      "≥ 2 meningiomas + unilateral vestibular schwannoma, or any 2 of neurofibroma, glioma, schwannoma, or cataract"
                    ]
                  },
                  {
                    "text": "Baser criteria (2011) incorporate genetic information to clinical information"
                  },
                  {
                    "text": "NF2 with rapid disease courseEarly onsetMultiple tumors in addition to bilateral vestibular schwannomas",
                    "sub_points": [
                      "Early onset",
                      "Multiple tumors in addition to bilateral vestibular schwannomas"
                    ]
                  },
                  {
                    "text": "Features of associated neoplasmsSchwannomaBilateral vestibular schwannomas are hallmarkCutaneous and spinal schwannomas commonPlexiform schwannomas (but not specific to syndrome)Multifocal within nerve with prominent myxoid changeSimilar histologic features as sporadic tumorsFeatures occurring more frequently in NF2-associated schwannomas include whorl formation, multiple tumors involving single nerve, and juxtaposition to meningiomaMeningiomaMultipleMeningiomatosis, when multifocal involves both cranial and spinal meningesIntraventricular, uncommonEpendymomaCervical cord and cervicomedullary junction are favored sites in NF2Majority of NF2-associated ependymomas are low grade and asymptomaticAdmixture of schwannoma and meningiomaIntraneural and soft tissue perineurioma (rare)",
                    "sub_points": [
                      "SchwannomaBilateral vestibular schwannomas are hallmarkCutaneous and spinal schwannomas commonPlexiform schwannomas (but not specific to syndrome)Multifocal within nerve with prominent myxoid changeSimilar histologic features as sporadic tumorsFeatures occurring more frequently in NF2-associated schwannomas include whorl formation, multiple tumors involving single nerve, and juxtaposition to meningioma",
                      "Bilateral vestibular schwannomas are hallmark",
                      "Cutaneous and spinal schwannomas common",
                      "Plexiform schwannomas (but not specific to syndrome)",
                      "Multifocal within nerve with prominent myxoid change",
                      "Similar histologic features as sporadic tumors",
                      "Features occurring more frequently in NF2-associated schwannomas include whorl formation, multiple tumors involving single nerve, and juxtaposition to meningioma",
                      "MeningiomaMultipleMeningiomatosis, when multifocal involves both cranial and spinal meningesIntraventricular, uncommon",
                      "Multiple",
                      "Meningiomatosis, when multifocal involves both cranial and spinal meninges",
                      "Intraventricular, uncommon",
                      "EpendymomaCervical cord and cervicomedullary junction are favored sites in NF2Majority of NF2-associated ependymomas are low grade and asymptomatic",
                      "Cervical cord and cervicomedullary junction are favored sites in NF2",
                      "Majority of NF2-associated ependymomas are low grade and asymptomatic",
                      "Admixture of schwannoma and meningioma",
                      "Intraneural and soft tissue perineurioma (rare)"
                    ]
                  },
                  {
                    "text": "Associated nonneoplastic CNS lesionsMeningioangiomatosis, S100(+) glial microhamartomas, cellular ependymal ectopias, intramedullary schwannosis, syringomyeliaCerebral, cerebellar, periventricular, choroid plexus calcifications",
                    "sub_points": [
                      "Meningioangiomatosis, S100(+) glial microhamartomas, cellular ependymal ectopias, intramedullary schwannosis, syringomyelia",
                      "Cerebral, cerebellar, periventricular, choroid plexus calcifications"
                    ]
                  },
                  {
                    "text": "Associated nonneoplastic peripheral manifestationsPosterior subcapsular lens opacityMononeuropathy/polyneuropathy",
                    "sub_points": [
                      "Posterior subcapsular lens opacity",
                      "Mononeuropathy/polyneuropathy"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treatment predominantly surgical"
                  },
                  {
                    "text": "Bevacizumab useful in subsets of patients with progressive vestibular schwannoma"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Vestibular schwannomas benign but may progress"
                  },
                  {
                    "text": "Meningiomas not higher grade than sporadic lesions"
                  },
                  {
                    "text": "Increased risk of mortality with early-onset disease"
                  },
                  {
                    "text": "Mortality due to CNS complications"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Demonstration of vestibular schwannomas may require thin slices"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "NF2 frequently undiagnosed in children; therefore, further assessment for NF2 features may be recommended in children presenting with meningiomas"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Schwannomatosis": {
            "name": "Schwannomatosis",
            "url": "https://app.pathprimer.com/document/661e0df9-0d30-40ac-9901-eb1d28e159e3/lesson/a121c01f-b8bb-43f0-a596-46ba73ea4ed4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Neurofibromatosis with multiple nonvestibular schwannomas"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "75-85% sporadic, 15-25% inherited"
                  },
                  {
                    "text": "Alterations in chromosome 22qBiallelic somatic inactivation ofNF2geneGermline mutations ofSMARCB1/INI1 geneGermline mutations inLZTR1in subset",
                    "sub_points": [
                      "Biallelic somatic inactivation ofNF2gene",
                      "Germline mutations ofSMARCB1/INI1 gene",
                      "Germline mutations inLZTR1in subset"
                    ]
                  },
                  {
                    "text": "Germline mutations of eitherSMARCB1orLZTR1in 69-86% of familial schwannomatosis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "1:40,000"
                  },
                  {
                    "text": "2nd and 3rd decades"
                  },
                  {
                    "text": "Pain (may be disabling)"
                  },
                  {
                    "text": "Less frequently associated with meningiomas"
                  },
                  {
                    "text": "Rare examples with malignant rhabdoid tumor"
                  },
                  {
                    "text": "Diagnostic criteriaSeveral clinical criteria proposed to distinguish schwannomatosis from neurofibromatosis type 2 (NF2)Lack of bilateral vestibular schwannoma; lack of NF2 in 1st-degree relative; lack of germlineNF2mutationRecent proposals incorporate molecular testing",
                    "sub_points": [
                      "Several clinical criteria proposed to distinguish schwannomatosis from neurofibromatosis type 2 (NF2)",
                      "Lack of bilateral vestibular schwannoma; lack of NF2 in 1st-degree relative; lack of germlineNF2mutation",
                      "Recent proposals incorporate molecular testing"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "SchwannomaSchwannomas with classic featuresProminent myxoid changePeritumoral edema",
                    "sub_points": [
                      "Schwannomas with classic features",
                      "Prominent myxoid change",
                      "Peritumoral edema"
                    ]
                  },
                  {
                    "text": "Tumors with hybrid neurofibroma/schwannoma features overrepresented in syndrome-associated peripheral nerve tumors, particularly in schwannomatosis"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Mosaicism for INI1 IHC in 93% of tumors from familial schwannomatosis, only 55% of sporadic schwannomatosisVariable in practice, does not distinguish NF2 from schwannomatosis-associated schwannomas",
                    "sub_points": [
                      "Variable in practice, does not distinguish NF2 from schwannomatosis-associated schwannomas"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Tumor syndrome, usually sporadic, characterized by multiple nonvestibular schwannomas and only rarely meningiomas"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Chromosomal Alterations": [
                  {
                    "text": "Germline mutations ofSMARCB1/INI1 gene40-50% of familial cases, 8-10% of sporadic cases4-hit hypothesis: (1) GermlineSMARCB1mutation → loss of Chr 22 with remaining, (2)SMARCB1allele, and (3)NF2gene → loss of remaining (4)NF2allele",
                    "sub_points": [
                      "40-50% of familial cases, 8-10% of sporadic cases",
                      "4-hit hypothesis: (1) GermlineSMARCB1mutation → loss of Chr 22 with remaining, (2)SMARCB1allele, and (3)NF2gene → loss of remaining (4)NF2allele"
                    ]
                  },
                  {
                    "text": "Germline mutations inLZTR1in subset (40% of familial and 25% of sporadic cases withoutSMARCB1mutations)"
                  },
                  {
                    "text": "ERBB2mutations found in schwannomatosis-associated hybrid neurofibroma-schwannoma nerve sheath tumors"
                  }
                ],
                "Inheritance": [
                  {
                    "text": "75-85% sporadic, 15-25% inherited"
                  },
                  {
                    "text": "Germline mutations of eitherSMARCB1orLZTR1in 69-86% of familial schwannomatosis"
                  },
                  {
                    "text": "DGCR8microprocessor defect in family with multinodular goiter with schwannomatosis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1:40,000"
                  }
                ],
                "Age": [
                  {
                    "text": "2nd and 3rd decades"
                  }
                ],
                "Site": [
                  {
                    "text": "Multiple schwannomas of spinal (75%), subcutaneous (15%), and cranial nerves (10%)"
                  },
                  {
                    "text": "Segmental in 30% cases"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Pain (may be disabling)"
                  },
                  {
                    "text": "Rarely associated with meningiomas"
                  },
                  {
                    "text": "Infrequently with superficial neurofibromas"
                  },
                  {
                    "text": "Rare examples with malignant rhabdoid tumor"
                  },
                  {
                    "text": "No nonneoplastic manifestations"
                  },
                  {
                    "text": "Diagnostic criteriaSeveral clinical criteria proposed to distinguish schwannomatosis from NF2Lack of bilateral vestibular schwannoma; lack of NF2 in 1st-degree relative; lack of germlineNF2mutationRecent proposals incorporate molecular testing",
                    "sub_points": [
                      "Several clinical criteria proposed to distinguish schwannomatosis from NF2",
                      "Lack of bilateral vestibular schwannoma; lack of NF2 in 1st-degree relative; lack of germlineNF2mutation",
                      "Recent proposals incorporate molecular testing"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgery and pain management"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Good; anaplastic transformation rare"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Plexiform/multinodular lesions common"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Schwannomas vary from globular, multiple in fascicles, to plexiform"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "SchwannomaSchwannomas with classic featuresProminent myxoid change and peritumoral edema",
                    "sub_points": [
                      "Schwannomas with classic features",
                      "Prominent myxoid change and peritumoral edema"
                    ]
                  },
                  {
                    "text": "Tumors with hybrid neurofibroma/schwannoma features overrepresented in syndrome-associated peripheral nerve tumors, particularly in schwannomatosis"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Schwannomas positive for S100, collagen IV, SOX10; negative for EMA"
                  },
                  {
                    "text": "Schwannomas with mosaic pattern of INI1 staining93% of familial, 55% of sporadic schwannomatosisVariable in practice, does not distinguish NF2 from schwannomatosis-associated schwannomas",
                    "sub_points": [
                      "93% of familial, 55% of sporadic schwannomatosis",
                      "Variable in practice, does not distinguish NF2 from schwannomatosis-associated schwannomas"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Neurofibromatosis Type 2": [
                  {
                    "text": "Multiple schwannomas with bilateral vestibular schwannomas"
                  },
                  {
                    "text": "Meningiomas more common, and ependymoma may be present"
                  },
                  {
                    "text": "May also have mosaic pattern of INI1 staining (83%), except for vestibular schwannomas"
                  }
                ],
                "Neurofibromatosis Type 1": [
                  {
                    "text": "Multiple neurofibromasProminent myxoid change, painless, < S100 positivity",
                    "sub_points": [
                      "Prominent myxoid change, painless, < S100 positivity"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "von Hippel-Lindau Syndrome": {
            "name": "von Hippel-Lindau Syndrome",
            "url": "https://app.pathprimer.com/document/a90276e8-a896-45cc-934e-7c5f8ce1699f/lesson/a121c01f-b8bb-43f0-a596-46ba73ea4ed4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Autosomal dominant, germline mutation ofVHLlocated on chromosome 3p25-p26"
                  },
                  {
                    "text": "Incidence ~ 1:40,000 population; > 90% penetrance by 65 years"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "80% of individuals with von Hippel-Lindau (VHL) syndrome have affected parent"
                  },
                  {
                    "text": "Molecular genetic testing indicated in all suspected individuals"
                  },
                  {
                    "text": "Poorer prognosis with renal cell carcinoma"
                  },
                  {
                    "text": "Clinical criteria for diagnosisKnown family history: Single retinal or CNS hemangioblastoma, clear cell renal cell carcinoma (CCRCC), or pheochromocytomaNo family history: ≥ 2 retinal or CNS hemangioblastomas; or single hemangioblastoma and additional characteristic lesionCCRCC, endolymphatic sac tumor, pheochromocytoma, epididymal cystadenoma, renal cysts, pancreatic cysts, pancreatic neuroendocrine tumor",
                    "sub_points": [
                      "Known family history: Single retinal or CNS hemangioblastoma, clear cell renal cell carcinoma (CCRCC), or pheochromocytoma",
                      "No family history: ≥ 2 retinal or CNS hemangioblastomas; or single hemangioblastoma and additional characteristic lesion",
                      "CCRCC, endolymphatic sac tumor, pheochromocytoma, epididymal cystadenoma, renal cysts, pancreatic cysts, pancreatic neuroendocrine tumor"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Hemangioblastomas"
                  },
                  {
                    "text": "Endolymphatic sac tumorBone-destructive, papillary, and well-differentiated adenocarcinoma with low mitotic rateBland, often single-layered atypical epithelium with sclerotic and cystic componentsTypically cytokeratin (+), EMA(+), GFAP(+), S100(+)",
                    "sub_points": [
                      "Bone-destructive, papillary, and well-differentiated adenocarcinoma with low mitotic rate",
                      "Bland, often single-layered atypical epithelium with sclerotic and cystic components",
                      "Typically cytokeratin (+), EMA(+), GFAP(+), S100(+)"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Biallelic inactivation ofVHLin all tumors in all types"
                  },
                  {
                    "text": "Close correlation between type of germline mutations and spectrum of clinical manifestations"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "von Hippel-Lindau (VHL) syndrome"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Germline mutation ofVHLon chromosome 3p25-p26"
                  },
                  {
                    "text": "Autosomal dominant"
                  },
                  {
                    "text": "Diagnosis based on CNS hemangioblastoma (HBL) and 1 other VHL-associated tumor or previous family history"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 1:40,000 population"
                  },
                  {
                    "text": "> 90% penetrance by age 65"
                  },
                  {
                    "text": "80% of individuals with VHL syndrome have affected parent"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean age: 26 years but range from infancy to 7th decade"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Visual loss due to retinal HBL"
                  },
                  {
                    "text": "Nausea, vomiting, and ataxia due to cerebellar HBL"
                  },
                  {
                    "text": "Deafness, vertigo, or tinnitus due to endolymphatic sac tumors"
                  },
                  {
                    "text": "Myelopathy with spinal cord tumors"
                  },
                  {
                    "text": "Presentation with kidney or adrenal tumor is rare"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Molecular genetic testing is indicated in all suspected individuals"
                  },
                  {
                    "text": "Sequence analysis of all 3 exons ofVHL"
                  },
                  {
                    "text": "Measurement of urinary catecholamine metabolites"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "CNS neoplasms: Gross total resection is goal"
                  },
                  {
                    "text": "Early detection and removal of renal, adrenal tumors as well as endolymphatic sac tumors, regardless of symptoms"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Rare, unresectable pheochromocytomas may be treated with tyrosine kinase inhibitors"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Local radiation for inoperable or subtotally resected tumors"
                  },
                  {
                    "text": "Laser photocoagulation for retinal tumors"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Leading cause of death is CNS HBL"
                  },
                  {
                    "text": "Poorer with renal cell carcinoma"
                  },
                  {
                    "text": "Multiple recurrent and new tumorsAverage of 7 VHL-related lesions at age 60 years",
                    "sub_points": [
                      "Average of 7 VHL-related lesions at age 60 years"
                    ]
                  },
                  {
                    "text": "Potential for CSF spread, uncommon"
                  },
                  {
                    "text": "Paraplegia may complicate management of spinal tumors"
                  }
                ],
                "Diagnostic Criteria": [
                  {
                    "text": "Family history of VHL syndromeSingle HBL or clear cell renal cell carcinoma (CCRCC) or pheochromocytoma",
                    "sub_points": [
                      "Single HBL or clear cell renal cell carcinoma (CCRCC) or pheochromocytoma"
                    ]
                  },
                  {
                    "text": "No family history of VHL≥ 2 HBLs in CNS or retina1 HBL and other VHL-associated tumorsCCRCCEndolymphatic sac tumorPheochromocytomaEpididymal cystadenomaPancreatic neuroendocrine tumor",
                    "sub_points": [
                      "≥ 2 HBLs in CNS or retina",
                      "1 HBL and other VHL-associated tumorsCCRCCEndolymphatic sac tumorPheochromocytomaEpididymal cystadenomaPancreatic neuroendocrine tumor",
                      "CCRCC",
                      "Endolymphatic sac tumor",
                      "Pheochromocytoma",
                      "Epididymal cystadenoma",
                      "Pancreatic neuroendocrine tumor"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "HBLRetina, spinal cord, cerebellum, medullaRarely supratentorial and extraneuroaxialDiscrete, sometimes cystic massHighly vascular, flow voids",
                    "sub_points": [
                      "Retina, spinal cord, cerebellum, medulla",
                      "Rarely supratentorial and extraneuroaxial",
                      "Discrete, sometimes cystic mass",
                      "Highly vascular, flow voids"
                    ]
                  },
                  {
                    "text": "Endolymphatic sac tumorTemporal boneOften erosive, sometimes bilateralHypervascular, contrast enhancingMay be hyperintense on noncontrast T1WI",
                    "sub_points": [
                      "Temporal bone",
                      "Often erosive, sometimes bilateral",
                      "Hypervascular, contrast enhancing",
                      "May be hyperintense on noncontrast T1WI"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Syndromic HBLs and endolymphatic sac tumors are macroscopically indistinguishable from sporadic examples"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Please refer to chapter in Hemangioblastoma for this tumor": []
              },
              "ANCILLARY TESTS": {
                "Genetic Testing": [
                  {
                    "text": "4 molecular subtypes recognizedType 1: Without pheochromocytomaType 2: With pheochromocytomaType 2a: With HBL without CCRCCType 2b: With HBL and CCRCCType 2c: Pheochromocytoma only",
                    "sub_points": [
                      "Type 1: Without pheochromocytoma",
                      "Type 2: With pheochromocytomaType 2a: With HBL without CCRCCType 2b: With HBL and CCRCCType 2c: Pheochromocytoma only",
                      "Type 2a: With HBL without CCRCC",
                      "Type 2b: With HBL and CCRCC",
                      "Type 2c: Pheochromocytoma only"
                    ]
                  },
                  {
                    "text": "Biallelic inactivation ofVHLin all tumors in all types"
                  },
                  {
                    "text": "Close correlation between type of germline mutations and spectrum of clinical manifestations"
                  },
                  {
                    "text": "Missense mutation most common in all subtypes"
                  },
                  {
                    "text": "HIF-α inhibition (truncating mutations and missense mutations in HIF-α binding site) is associated with CNS HBL and CCRCC"
                  },
                  {
                    "text": "Missense mutations in non-HIF-α binding site are associated with pheochromocytoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Tuberous Sclerosis Complex": {
            "name": "Tuberous Sclerosis Complex",
            "url": "https://app.pathprimer.com/document/ecd28d51-10aa-4f0b-b97e-bdeb59f3c758/lesson/a121c01f-b8bb-43f0-a596-46ba73ea4ed4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Autosomal dominant; mutations inTSC1orTSC2"
                  },
                  {
                    "text": "Hamartomatous lesions in CNS, skin, kidney, and heart"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Major featuresCortical tubers and white matter migration linesSubependymal nodule (SEN)Subependymal giant cell astrocytoma (SEGA)Retinal astrocytic proliferations (hamartomas)Non-CNS: Facial angiofibroma, periungual fibroma, hypomelanotic macules, Shagreen patch, cardiac rhabdomyoma, renal angiomyolipoma, lymphangioleiomyomatosis",
                    "sub_points": [
                      "Cortical tubers and white matter migration lines",
                      "Subependymal nodule (SEN)",
                      "Subependymal giant cell astrocytoma (SEGA)",
                      "Retinal astrocytic proliferations (hamartomas)",
                      "Non-CNS: Facial angiofibroma, periungual fibroma, hypomelanotic macules, Shagreen patch, cardiac rhabdomyoma, renal angiomyolipoma, lymphangioleiomyomatosis"
                    ]
                  },
                  {
                    "text": "Promising results with mTOR inhibitors"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Early cortical tubers are hypointense on T1WI"
                  },
                  {
                    "text": "White matter migration lines are hyperintense on FLAIR"
                  },
                  {
                    "text": "SEGA and subependymal nodules enhance"
                  }
                ],
                "Molecular": [
                  {
                    "text": "TSC1(hamartin, chr 9q34),TSC2(tuberin, chr 16p13)"
                  },
                  {
                    "text": "TSC1 and TSC2 proteins form functional complex to suppress mTOR activity"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Dysmorphic neurons and giant (balloon) cells in cortical tubers"
                  },
                  {
                    "text": "Elongate glial cells and epithelioid \"giant\" cells in SEGA"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Giant (balloon) cells have mixed neuronal glial phenotype"
                  },
                  {
                    "text": "Variable staining with vimentin, S100 protein, GFAP, class III β-tubulin, neurofilament, synaptophysin, nestin, MAP2"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Tuberous sclerosis complex (TSC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Autosomal dominant; mutations inTSC1orTSC22/3 of patients with spontaneous mutations",
                    "sub_points": [
                      "2/3 of patients with spontaneous mutations"
                    ]
                  },
                  {
                    "text": "Hamartomatous lesions in CNS, skin, kidney, and heart"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "2nd most common neurocutaneous disorder"
                  },
                  {
                    "text": "1:8,000 in general population"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Most common presentation within 1st decade of life"
                  },
                  {
                    "text": "80-90% of patients have seizures at presentationFocal seizures (60%) or infantile spasms (40%)",
                    "sub_points": [
                      "Focal seizures (60%) or infantile spasms (40%)"
                    ]
                  },
                  {
                    "text": "Cognitive impairment and autism spectrum disorder"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Promising results with mTOR inhibitorsNot all lesions of TSC regress under mTOR inhibitors",
                    "sub_points": [
                      "Not all lesions of TSC regress under mTOR inhibitors"
                    ]
                  }
                ],
                "Diagnostic Criteria": [
                  {
                    "text": "Definitive: 2 major or 1 major and 2 minor features"
                  },
                  {
                    "text": "Probable: 1 major and 1 minor feature"
                  },
                  {
                    "text": "Possible: 1 major or ≥ 2 minor featuresMajor featuresCortical tubers and white matter migration linesSubependymal nodule (SEN)Subependymal giant cell astrocytoma (SEGA)Retinal astrocytic proliferations (hamartomas)Non-CNS: Facial angiofibroma, ungual/periungual fibroma, > 3 hypomelanotic macules, Shagreen patch, cardiac rhabdomyoma, renal angiomyolipoma, lymphangioleiomyomatosisMinor featuresRetinal achromic patchNon-CNS: Gingival fibroma, dental enamel pits, confetti skin lesions, renal cysts, nonrenal hamartoma",
                    "sub_points": [
                      "Major featuresCortical tubers and white matter migration linesSubependymal nodule (SEN)Subependymal giant cell astrocytoma (SEGA)Retinal astrocytic proliferations (hamartomas)Non-CNS: Facial angiofibroma, ungual/periungual fibroma, > 3 hypomelanotic macules, Shagreen patch, cardiac rhabdomyoma, renal angiomyolipoma, lymphangioleiomyomatosis",
                      "Cortical tubers and white matter migration lines",
                      "Subependymal nodule (SEN)",
                      "Subependymal giant cell astrocytoma (SEGA)",
                      "Retinal astrocytic proliferations (hamartomas)",
                      "Non-CNS: Facial angiofibroma, ungual/periungual fibroma, > 3 hypomelanotic macules, Shagreen patch, cardiac rhabdomyoma, renal angiomyolipoma, lymphangioleiomyomatosis",
                      "Minor featuresRetinal achromic patchNon-CNS: Gingival fibroma, dental enamel pits, confetti skin lesions, renal cysts, nonrenal hamartoma",
                      "Retinal achromic patch",
                      "Non-CNS: Gingival fibroma, dental enamel pits, confetti skin lesions, renal cysts, nonrenal hamartoma"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Calcified subependymal nodules: Classic appearance"
                  },
                  {
                    "text": "Early-stage cortical tubers are T2 hypointense and later become hyperintense (myelin maturation)"
                  },
                  {
                    "text": "Streaky hyperintense white matter lesions on FLAIR"
                  },
                  {
                    "text": "SEGA and SENs enhance"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Cortical Tubers (80-90% of Cases)": [
                  {
                    "text": "Firm, nodular gray matter lesions, typically multiple"
                  },
                  {
                    "text": "Typically in cerebral cortex, occasionally in cerebellar cortex"
                  }
                ],
                "Subependymal Nodules (80-90% of Cases)": [
                  {
                    "text": "Nodular protrusions of ventricular walls"
                  },
                  {
                    "text": "Along caudate-thalamic groove (candle guttering)"
                  }
                ],
                "Subependymal Giant Cell Astrocytoma (25% of Cases)": [
                  {
                    "text": "Well-circumscribed enlarging mass near foramen of Monro"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Dysmorphic neurons and giant (balloon) cells in cortical tubers"
                  },
                  {
                    "text": "Elongate glial cells and epithelioid \"giant\" cells in SEGA"
                  }
                ],
                "Cortical Tubers": [
                  {
                    "text": "Irregular cortical lamination pattern"
                  },
                  {
                    "text": "Dysmorphic neurons have irregular shapes and prominent Nissl substance"
                  },
                  {
                    "text": "Giant cells (balloon cells) have abundant glassy cytoplasm and prominent nucleoli"
                  },
                  {
                    "text": "Calcifications"
                  }
                ],
                "Subependymal Nodules and Subependymal Giant Cell Astrocytoma": [
                  {
                    "text": "Elongate cells with streaming eosinophilic cytoplasm, arranged in fascicles"
                  },
                  {
                    "text": "Epithelioid cells with eosinophilic cytoplasm (referred as giant although usually not large)"
                  },
                  {
                    "text": "Giant cells have both astrocytic and neuronal differentiation"
                  },
                  {
                    "text": "Occasional microcalcifications"
                  },
                  {
                    "text": "Mitoses, microvascular proliferation or necrosis are rare but do not conform aggressive behavior"
                  }
                ],
                "Retinal Astrocytic Proliferations (Hamartomas)": [
                  {
                    "text": "Identical to subependymal nodules or SEGA"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Giant (balloon) cells have mixed neuronal glial phenotype"
                  },
                  {
                    "text": "Variable staining with vimentin, S100 protein, GFAP, class III β-tubulin, neurofilament, synaptophysin, nestin, MAP2"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "TSC1(hamartin), located on chromosome 9q34Most are truncating mutations",
                    "sub_points": [
                      "Most are truncating mutations"
                    ]
                  },
                  {
                    "text": "TSC2(tuberin), located on chromosome 16p13Small indels (38%), missense (25%), nonsense (15%), splice site variants (17%), gene deletions (5%)",
                    "sub_points": [
                      "Small indels (38%), missense (25%), nonsense (15%), splice site variants (17%), gene deletions (5%)"
                    ]
                  },
                  {
                    "text": "TSC2in 2/3 of cases,TSC1in 1/3 of cases"
                  },
                  {
                    "text": "TSC1 and TSC2 proteins form functional complex to suppress mTOR activity"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Focal Cortical Dysplasia Type IIB": [
                  {
                    "text": "Tubers are more commonly multifocal and calcified"
                  },
                  {
                    "text": "Balloon cells predominate in tubers"
                  }
                ],
                "Diffuse Astrocytoma": [
                  {
                    "text": "SEGA are well circumscribed, noninfiltrative"
                  },
                  {
                    "text": "SEGA typically have mixed glial neuronal immunophenotype unlike gemistocytic cells"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Turcot Syndrome": {
            "name": "Turcot Syndrome",
            "url": "https://app.pathprimer.com/document/30f5b4aa-2fd1-4155-8e0a-84ab584fa568/lesson/a121c01f-b8bb-43f0-a596-46ba73ea4ed4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Germline mutations characterized by gastrointestinal and central nervous system neoplasms"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Type 1Glioblastoma (presentation earlier than peak incidence in general population)Small and large intestinal polyps and colorectal cancerOften autosomal recessiveDistinction from constitutional mismatch repair deficiency syndrome may not be possible",
                    "sub_points": [
                      "Glioblastoma (presentation earlier than peak incidence in general population)",
                      "Small and large intestinal polyps and colorectal cancer",
                      "Often autosomal recessive",
                      "Distinction from constitutional mismatch repair deficiency syndrome may not be possible"
                    ]
                  },
                  {
                    "text": "Type 2Medulloblastoma (presentation later than peak incidence in general population)Numerous intestinal polyps with family history of polyposisOften autosomal dominant",
                    "sub_points": [
                      "Medulloblastoma (presentation later than peak incidence in general population)",
                      "Numerous intestinal polyps with family history of polyposis",
                      "Often autosomal dominant"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Type 1: Germline mutations of mismatch repair genesMLH1(chr 3p22.2)MSH2(chr 2p21-p16.3)Less commonly,MSH6(chr 2p16.3),PMS2(chr 7p22.1)Rarely,MSH3(chr 5q11),PMS1(chr 2q32.2)",
                    "sub_points": [
                      "MLH1(chr 3p22.2)",
                      "MSH2(chr 2p21-p16.3)",
                      "Less commonly,MSH6(chr 2p16.3),PMS2(chr 7p22.1)",
                      "Rarely,MSH3(chr 5q11),PMS1(chr 2q32.2)"
                    ]
                  },
                  {
                    "text": "Type 2: Germline mutations inAPC(chr 5q21)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Li-Fraumeni syndrome"
                  },
                  {
                    "text": "Constitutional mismatch repair deficiency syndromeMay not be easily distinguishable from type 1Café au lait spots, especially without other stigmata of NF1 syndrome",
                    "sub_points": [
                      "May not be easily distinguishable from type 1",
                      "Café au lait spots, especially without other stigmata of NF1 syndrome"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Hereditary disorders characterized by gastrointestinal and CNS neoplasmsType 1 hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) and glioblastomaType 2 familial adenomatous polyposis (FAP) and medulloblastomaIn addition: Skin lesions such as epidermoid cysts, craniofacial exostosis",
                    "sub_points": [
                      "Type 1 hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) and glioblastoma",
                      "Type 2 familial adenomatous polyposis (FAP) and medulloblastomaIn addition: Skin lesions such as epidermoid cysts, craniofacial exostosis",
                      "In addition: Skin lesions such as epidermoid cysts, craniofacial exostosis"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Germline Mutation in DNA Mismatch Repair or Tumor Suppressor Genes": [
                  {
                    "text": "Type 1: DNA mismatch repair genes (MLH1,MSH2,PMS2)"
                  },
                  {
                    "text": "Type 2: Adenomatous polyposis coli (APC)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Glioblastoma (in type 1): Presentation earlier than peak incidence in general populationMedian age: 18 years",
                    "sub_points": [
                      "Median age: 18 years"
                    ]
                  },
                  {
                    "text": "Medulloblastoma (in type 2): Presentation later than peak incidence in general populationMedian age: 15 years",
                    "sub_points": [
                      "Median age: 15 years"
                    ]
                  },
                  {
                    "text": "No family history of polyposis in type 1, frequent family history of polyposis in type 2"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Presentation of CNS tumors at younger age = poor prognostic sign"
                  }
                ],
                "Diagnostic Criteria": [
                  {
                    "text": "Type 1GlioblastomaSmall and large intestinal polyps and colorectal cancerOften autosomal recessive",
                    "sub_points": [
                      "Glioblastoma",
                      "Small and large intestinal polyps and colorectal cancer",
                      "Often autosomal recessive"
                    ]
                  },
                  {
                    "text": "Type 2MedulloblastomaNumerous intestinal polyps with family history of polyposisOften autosomal dominant",
                    "sub_points": [
                      "Medulloblastoma",
                      "Numerous intestinal polyps with family history of polyposis",
                      "Often autosomal dominant"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "Colorectal Lesions": [
                  {
                    "text": "Type 1: Small number of polyps with occasional large (> 3 cm) polyps"
                  },
                  {
                    "text": "Type 2: Innumerable small polyps"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Type 1Anaplastic astrocytoma or glioblastoma, sometimes with oligodendroglioma qualitiesOther types such as oligodendroglioma, ependymoma, glioneuronal tumors (all rare)",
                    "sub_points": [
                      "Anaplastic astrocytoma or glioblastoma, sometimes with oligodendroglioma qualities",
                      "Other types such as oligodendroglioma, ependymoma, glioneuronal tumors (all rare)"
                    ]
                  },
                  {
                    "text": "Type 2MedulloblastomaClassic (nonnodular) histologic type, nuclear β-catenin positive",
                    "sub_points": [
                      "MedulloblastomaClassic (nonnodular) histologic type, nuclear β-catenin positive",
                      "Classic (nonnodular) histologic type, nuclear β-catenin positive"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Genetic Testing": [
                  {
                    "text": "Type 1Germline mutations of mismatch repair genesMost commonly,MLH1(chr 3p22.2) orMSH2(chr 2p21-p16.3)Less commonlyMSH6(chr 2p16.3),PMS2(chr 7p22.1)Rarely,MSH3(chr 5q11),PMS1(chr 2q32.2)None of genes commonly implicated in sporadic glioblastomas",
                    "sub_points": [
                      "Germline mutations of mismatch repair genesMost commonly,MLH1(chr 3p22.2) orMSH2(chr 2p21-p16.3)Less commonlyMSH6(chr 2p16.3),PMS2(chr 7p22.1)Rarely,MSH3(chr 5q11),PMS1(chr 2q32.2)None of genes commonly implicated in sporadic glioblastomas",
                      "Most commonly,MLH1(chr 3p22.2) orMSH2(chr 2p21-p16.3)",
                      "Less commonlyMSH6(chr 2p16.3),PMS2(chr 7p22.1)",
                      "Rarely,MSH3(chr 5q11),PMS1(chr 2q32.2)",
                      "None of genes commonly implicated in sporadic glioblastomas"
                    ]
                  },
                  {
                    "text": "Type 2APC(chr 5q21)APCalso mutated in some sporadic medulloblastomas of classic (nonnodular/desmoplastic) type",
                    "sub_points": [
                      "APC(chr 5q21)",
                      "APCalso mutated in some sporadic medulloblastomas of classic (nonnodular/desmoplastic) type"
                    ]
                  },
                  {
                    "text": "Some patients have neitherAPCnor mismatch repair gene mutations"
                  },
                  {
                    "text": "Other genes associated with familial polyposis syndromes (i.e.,MUTYHandNTHL1) may also have increased risk for CNS neoplasms"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Li-Fraumeni Syndrome": [
                  {
                    "text": "Colorectal and CNS tumors can also occur"
                  },
                  {
                    "text": "Choroid plexus tumors, especially carcinomas, common"
                  },
                  {
                    "text": "GermlineTP53mutations"
                  },
                  {
                    "text": "NoAPCor mismatch repair gene mutations"
                  },
                  {
                    "text": "Colorectal tumors typically carcinomas, not polyps"
                  }
                ],
                "Constitutional Mismatch Repair Deficiency Syndrome": [
                  {
                    "text": "Distinct childhood cancer predisposition syndrome due to biallelic germline mutations in mismatch repair genesMLH1,MSH2,MSH6,PMS2",
                    "sub_points": [
                      "MLH1,MSH2,MSH6,PMS2"
                    ]
                  },
                  {
                    "text": "May be associated with consanguinity"
                  },
                  {
                    "text": "Most patients have high-grade gliomas, and some have colonic carcinomas"
                  },
                  {
                    "text": "May not be easily distinguishable from Turcot type 1"
                  },
                  {
                    "text": "Café au lait spots, especially without other stigmata of neurofibromatosis 1 syndrome"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "PNS Neoplasms": {
        "name": "PNS Neoplasms",
        "url": "https://app.pathprimer.com/lesson/8662e5df-9cdd-4d09-9d11-e109f7a80303",
        "topics": {
          "Conventional Schwannoma": {
            "name": "Conventional Schwannoma",
            "url": "https://app.pathprimer.com/document/f628d385-8b53-46bc-97d8-8d0fdbadd4fc/lesson/8662e5df-9cdd-4d09-9d11-e109f7a80303",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign nerve sheath tumor of Schwann cells"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "NF2, schwannomatosis association (when multiple)"
                  },
                  {
                    "text": "Head, neck, flexor extremities common locations"
                  },
                  {
                    "text": "Gross total removal curative"
                  },
                  {
                    "text": "Malignant transformation extremely rare"
                  }
                ],
                "Imaging": [
                  {
                    "text": "MR: Circumscribed, heterogeneous enhancement"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Often solitary; nodular, encapsulated"
                  },
                  {
                    "text": "Cystic change, yellow discoloration"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Capsule of perineurium and epineurial collagen"
                  },
                  {
                    "text": "Compact spindle cells ± Verocay bodies (Antoni A)"
                  },
                  {
                    "text": "Loose-textured cell processes (Antoni B)"
                  },
                  {
                    "text": "Hyalinized vessels, mucin deposition"
                  },
                  {
                    "text": "Degenerative nuclear atypia (ancient schwannoma)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "S100 proteinTumoral Schwann cells",
                    "sub_points": [
                      "Tumoral Schwann cells"
                    ]
                  },
                  {
                    "text": "EMACapsular perineurial cells",
                    "sub_points": [
                      "Capsular perineurial cells"
                    ]
                  },
                  {
                    "text": "Collagen IVPericellular basal lamina",
                    "sub_points": [
                      "Pericellular basal lamina"
                    ]
                  },
                  {
                    "text": "Electron microscopyContinuous pericellular basal lamina, long-spacing collagen",
                    "sub_points": [
                      "Continuous pericellular basal lamina, long-spacing collagen"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Neurofibroma"
                  },
                  {
                    "text": "Nerve sheath myxoma"
                  },
                  {
                    "text": "Leiomyoma"
                  },
                  {
                    "text": "Malignant peripheral nerve sheath tumor (MPNST)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Neurilemmoma, neurinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign, typically encapsulated, nonmelanotic nerve sheath tumor composed of neoplastic Schwann cells"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Irradiation predisposing factor"
                  }
                ],
                "Chromosomal Alterations": [
                  {
                    "text": "Majority show aberrations of neurofibromatosis 2 (NF2)gene located in chromosome region 22q12.2"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most schwannomas are sporadic (asyndromic)"
                  },
                  {
                    "text": "NF2 associationBilateral vestibular schwannomasMultiple schwannomas",
                    "sub_points": [
                      "Bilateral vestibular schwannomas",
                      "Multiple schwannomas"
                    ]
                  },
                  {
                    "text": "Schwannomatosis associationSporadic (85%), hereditary (15%)No vestibular nerve tumors",
                    "sub_points": [
                      "Sporadic (85%), hereditary (15%)",
                      "No vestibular nerve tumors"
                    ]
                  },
                  {
                    "text": "Neurofibromatosis type 1 (NF1) association very rareSolitary, but possibility of neurofibroma with Schwann cell nodules must be entertained",
                    "sub_points": [
                      "Solitary, but possibility of neurofibroma with Schwann cell nodules must be entertained"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "All affected; peak incidence 3rd-6th decades"
                  }
                ],
                "Sex": [
                  {
                    "text": "No predilection overall"
                  },
                  {
                    "text": "Female predominance in central nervous system examples"
                  },
                  {
                    "text": "Male predominance in radiation-induced tumors"
                  },
                  {
                    "text": "Latency (mean: 20 years)"
                  }
                ],
                "Site": [
                  {
                    "text": "Head and neck"
                  },
                  {
                    "text": "Flexor surface of extremities"
                  },
                  {
                    "text": "Cranial and spinal nerve rootsSensory (vestibular root affected)",
                    "sub_points": [
                      "Sensory (vestibular root affected)"
                    ]
                  },
                  {
                    "text": "Mediastinal, retroperitoneal tumors often massive"
                  },
                  {
                    "text": "Autonomic nerves uncommonly involved"
                  },
                  {
                    "text": "IntraparenchymalSpinal cord > brain examples (rare)",
                    "sub_points": [
                      "Spinal cord > brain examples (rare)"
                    ]
                  },
                  {
                    "text": "Intraosseous schwannomas (rare)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic mass in most cases"
                  },
                  {
                    "text": "Slow growing"
                  },
                  {
                    "text": "Size varies from microscopic (intrafascicular) to large, compressive, bone-erosive tumors"
                  },
                  {
                    "text": "Paraspinous: Sensory symptoms"
                  },
                  {
                    "text": "Intraspinal: Cord compression with motor signs"
                  },
                  {
                    "text": "Pain in schwannomatosis-associated tumors"
                  },
                  {
                    "text": "Rare examples act as host for metastases of various malignant tumors (breast, lung, etc.)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Excision of tumor, parent nerve preserved when possible"
                  },
                  {
                    "text": "Gamma knife radiosurgery frequent option for vestibular schwannomas"
                  },
                  {
                    "text": "Bevacizumab (Avastin) option for progressive NF2-associated vestibular schwannomas"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Site relatedGross total removal curativeSubtotal removal, slow recurrenceCranial, spinal, and giant sacral schwannomaMalignant transformation extremely rare",
                    "sub_points": [
                      "Gross total removal curative",
                      "Subtotal removal, slow recurrenceCranial, spinal, and giant sacral schwannoma",
                      "Cranial, spinal, and giant sacral schwannoma",
                      "Malignant transformation extremely rare"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Conventional x-ray: Sharply circumscribed, focal calcification occasional"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Circumscribed, heterogeneous enhancement, high T2 signal; cystic change"
                  },
                  {
                    "text": "Remodeling of boneVestibular: Auditory canalSpinal: Foraminal, dumbbell configurationGiant sacral schwannoma: Compressive bone destruction",
                    "sub_points": [
                      "Vestibular: Auditory canal",
                      "Spinal: Foraminal, dumbbell configuration",
                      "Giant sacral schwannoma: Compressive bone destruction"
                    ]
                  },
                  {
                    "text": "Brain displacement in intracranial examples"
                  },
                  {
                    "text": "Imaging characteristics related to proportions of Antoni A and B areas and degenerative changes"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Circumscribed, low attenuation, enhancement, cystic change/focal calcification"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solitary: Multifocality in nerve is rare (NF2 and schwannomatosis association)"
                  },
                  {
                    "text": "Nodular, smooth contoured"
                  },
                  {
                    "text": "Encapsulation: Lacking in mucosal, visceral, and intraparenchymal tumors, scant in some intradural examples"
                  },
                  {
                    "text": "Eccentric growth relative to parent nerve"
                  },
                  {
                    "text": "Cystic change common"
                  },
                  {
                    "text": "Yellow discoloration due to lipidization"
                  },
                  {
                    "text": "Hemorrhage ± infarct-like necrosis"
                  },
                  {
                    "text": "Calcification focal but rarely extensive"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Capsule of perineurium and epineurial collagenMay contain parent nerve or nearby ganglion",
                    "sub_points": [
                      "May contain parent nerve or nearby ganglion"
                    ]
                  },
                  {
                    "text": "Schwann cells (exclusive component)Antoni A arrangementCompact spindle cells ± Verocay bodies of alternating, aligned nuclei and processesVerocay bodies uncommon in 8th nerve examplesWhorl formation or tight cell clusters (occasional)Rosetted cells with centrally directed processes (neuroblastoma-like schwannoma)Predominates in spinal canal tumorsAntoni B arrangementMultipolar, loose-textured, haphazardly arranged cell processes, pseudogland formationDegenerative nuclear atypia (ancient schwannoma)Plump cells in rare epithelioid schwannomaGranular cell change uncommon and patchy",
                    "sub_points": [
                      "Antoni A arrangementCompact spindle cells ± Verocay bodies of alternating, aligned nuclei and processesVerocay bodies uncommon in 8th nerve examplesWhorl formation or tight cell clusters (occasional)Rosetted cells with centrally directed processes (neuroblastoma-like schwannoma)Predominates in spinal canal tumors",
                      "Compact spindle cells ± Verocay bodies of alternating, aligned nuclei and processes",
                      "Verocay bodies uncommon in 8th nerve examples",
                      "Whorl formation or tight cell clusters (occasional)",
                      "Rosetted cells with centrally directed processes (neuroblastoma-like schwannoma)",
                      "Predominates in spinal canal tumors",
                      "Antoni B arrangementMultipolar, loose-textured, haphazardly arranged cell processes, pseudogland formationDegenerative nuclear atypia (ancient schwannoma)",
                      "Multipolar, loose-textured, haphazardly arranged cell processes, pseudogland formation",
                      "Degenerative nuclear atypia (ancient schwannoma)",
                      "Plump cells in rare epithelioid schwannoma",
                      "Granular cell change uncommon and patchy"
                    ]
                  },
                  {
                    "text": "MiscellaneousNonpalisading infarct-like necrosis in large examplesNo prognostic significanceLipid-rich, histiocyte infiltrates, perivascular or patchyChondroosseous or adipose metaplasiaRare mitotic figuresHyalinized vessels with associated hemosiderin depositionVascular ectasia ± thrombosis, recanalizationNecrotic debris ± cholesterol crystalsDiffuse hyalinizationMucin deposition rarely widespreadScant intratumoral axonsCutaneous adnexal entrapmentAssociated arachnoidal cell reaction rare and NF2 associated (mixed schwannoma-meningioma)Lipofuscin commonly seenGastrointestinal schwannomas show peripheral cuff-like lymphoid aggregates",
                    "sub_points": [
                      "Nonpalisading infarct-like necrosis in large examplesNo prognostic significance",
                      "No prognostic significance",
                      "Lipid-rich, histiocyte infiltrates, perivascular or patchy",
                      "Chondroosseous or adipose metaplasia",
                      "Rare mitotic figures",
                      "Hyalinized vessels with associated hemosiderin deposition",
                      "Vascular ectasia ± thrombosis, recanalization",
                      "Necrotic debris ± cholesterol crystals",
                      "Diffuse hyalinization",
                      "Mucin deposition rarely widespread",
                      "Scant intratumoral axons",
                      "Cutaneous adnexal entrapment",
                      "Associated arachnoidal cell reaction rare and NF2 associated (mixed schwannoma-meningioma)",
                      "Lipofuscin commonly seen",
                      "Gastrointestinal schwannomas show peripheral cuff-like lymphoid aggregates"
                    ]
                  },
                  {
                    "text": "Some tumors may show hybrid features of schwannoma and other peripheral nerve sheath tumors, particularly perineurioma"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Elongate to plump nuclei"
                  },
                  {
                    "text": "Inconspicuous nucleoli"
                  },
                  {
                    "text": "Intranuclear cytoplasmic pseudoinclusions"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Periodic acid-Schiff: Pericellular basal lamina, debris-containing histiocytes"
                  },
                  {
                    "text": "Reticulin: Pericellular basal lamina"
                  },
                  {
                    "text": "Trichrome: Capsular, perivascular, and patchy stromal collagen deposits"
                  },
                  {
                    "text": "Oil red O: Lipid-laden histiocytes"
                  },
                  {
                    "text": "Alcian blue: Mucin accumulation (Antoni B > Antoni A), rarely diffuse and abundant"
                  },
                  {
                    "text": "Bodian and Bielschowsky: Intratumoral axons and in peritumoral nerve fascicles"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "CD57, S100, and SOX10 protein: Neoplastic Schwann cells"
                  },
                  {
                    "text": "Neurofilament protein: Scattered axons often peripherally located, also in peritumoral fascicles"
                  },
                  {
                    "text": "Epithelial membrane antigen: Capsular perineurial cells"
                  },
                  {
                    "text": "Collagen IV: Pericellular basal lamina of Schwann cells"
                  },
                  {
                    "text": "GFAP: Variably positive in some schwannomasMore common in retroperitoneal schwannomas",
                    "sub_points": [
                      "More common in retroperitoneal schwannomas"
                    ]
                  },
                  {
                    "text": "CD68: Histiocytes and granular cells"
                  },
                  {
                    "text": "CD34: Scant in perivascular region of Antoni B tissue"
                  },
                  {
                    "text": "Keratin: May be positive in some examplesCross reaction of antibody with GFAP",
                    "sub_points": [
                      "Cross reaction of antibody with GFAP"
                    ]
                  },
                  {
                    "text": "Mosaic pattern of SMARCB1/INI1 immunostaining more frequent in syndrome-associated (NF2, schwannomatosis) schwannomas"
                  },
                  {
                    "text": "SMARCB1/INI1 loss in ~ 42% of epithelioid schwannomas"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Somatic inactivation ofNF2tumor suppressor gene common genetic alteration"
                  },
                  {
                    "text": "Recurrent mutations inARID1A,ARID1B, andDDR1, as well asSH3PXD2A::HTRA1fusion in subsets"
                  },
                  {
                    "text": "GermlineNF2gene mutation in NF2 patients"
                  },
                  {
                    "text": "Germline alteration in schwannomatosis-associated cases unknown in most casesSMARCB1orLZTR1germline mutations in subset",
                    "sub_points": [
                      "SMARCB1orLZTR1germline mutations in subset"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Scant organelles: Golgi, rough endoplasmic reticulum, mitochondria, lysosomes, lipid droplets"
                  },
                  {
                    "text": "Rudimentary junctions"
                  },
                  {
                    "text": "Pericellular continuous basal lamina"
                  },
                  {
                    "text": "Long-spacing collagen in stroma"
                  },
                  {
                    "text": "Antoni A tissueCompact, apposed cellsLong, thin, entwined processes and intervening collagen",
                    "sub_points": [
                      "Compact, apposed cells",
                      "Long, thin, entwined processes and intervening collagen"
                    ]
                  },
                  {
                    "text": "Antoni B tissueLoosely disposed cells and processesIntervening collagen and electron lucent matrix",
                    "sub_points": [
                      "Loosely disposed cells and processes",
                      "Intervening collagen and electron lucent matrix"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Neurofibroma": [
                  {
                    "text": "May resemble Antoni B tissue of schwannoma"
                  },
                  {
                    "text": "Lacks thick capsule"
                  },
                  {
                    "text": "S100, SOX10: Partial staining"
                  },
                  {
                    "text": "Neurofilament protein immunoreactive axons often grouped/aligned"
                  },
                  {
                    "text": "Caveat: Large neurofibromas may have Schwann cell nodules"
                  }
                ],
                "Nerve Sheath Myxoma": [
                  {
                    "text": "Unencapsulated, superficially located"
                  },
                  {
                    "text": "Also composed of Schwann cells"
                  },
                  {
                    "text": "No Antoni A/B areas"
                  },
                  {
                    "text": "No Verocay bodies"
                  }
                ],
                "Malignant Peripheral Nerve Sheath Tumors": [
                  {
                    "text": "Malignant cytologic featuresUnlike degenerative atypia (bizarre hyperchromatic cells, intranuclear cytoplasmic inclusions) of schwannomas",
                    "sub_points": [
                      "Unlike degenerative atypia (bizarre hyperchromatic cells, intranuclear cytoplasmic inclusions) of schwannomas"
                    ]
                  },
                  {
                    "text": "Necrosis often with palisading cells"
                  },
                  {
                    "text": "Loss of Schwann cell markers (S100) and loss of H3K27 trimethylation"
                  }
                ],
                "Leiomyoma": [
                  {
                    "text": "Lacks thick hyaline capsule"
                  },
                  {
                    "text": "Blunted nuclei rather than tapered"
                  },
                  {
                    "text": "More dense eosinophilic cytoplasm, distinct cell borders"
                  },
                  {
                    "text": "Nuclear palisading may be seen"
                  },
                  {
                    "text": "S100(-)"
                  },
                  {
                    "text": "Reactive for myogenic markers (SMA, desmin)"
                  }
                ],
                "Ganglioneuroma": [
                  {
                    "text": "Should be differentiated from schwannoma affecting dorsal root ganglia"
                  },
                  {
                    "text": "Haphazardly arranged, cytologically dysmorphic ganglion cells"
                  },
                  {
                    "text": "Spindle cell component less cellular; axon-containing throughout"
                  }
                ],
                "Palisaded Myofibroblastoma": [
                  {
                    "text": "Typically involves lymph nodes"
                  },
                  {
                    "text": "S100(-)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Plexiform Schwannoma": {
            "name": "Plexiform Schwannoma",
            "url": "https://app.pathprimer.com/document/511debd1-f5d5-492c-93b0-9b66826b5371/lesson/8662e5df-9cdd-4d09-9d11-e109f7a80303",
            "content": {
              "KEY FACTS": {
                "Clinical Issues": [
                  {
                    "text": "Dermal-subcutaneous (90%)"
                  },
                  {
                    "text": "Prognosis excellent with simple excision"
                  },
                  {
                    "text": "Sporadic (90%)"
                  },
                  {
                    "text": "NF2 associated (~ 5%)"
                  },
                  {
                    "text": "Schwannomatosis associated (~ 5%)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Circumscribed lesion(s) but may be extensive"
                  },
                  {
                    "text": "Plexiform to multinodular expanded fascicle(s)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Antoni A > B tissue"
                  },
                  {
                    "text": "Scant mitoses (except in cellular tumors)"
                  },
                  {
                    "text": "Peripheral perineurial ensheathment"
                  },
                  {
                    "text": "Multiple (2-50) nodules"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Reticulin (+) around individual cells"
                  },
                  {
                    "text": "S100 diffusely (+), SOX10(+)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Plexiform neurofibromaSmaller cellsFrequent interfascicular diffuse neurofibroma elementAbundant stromal mucinS100 partially (+)",
                    "sub_points": [
                      "Smaller cells",
                      "Frequent interfascicular diffuse neurofibroma element",
                      "Abundant stromal mucin",
                      "S100 partially (+)"
                    ]
                  },
                  {
                    "text": "Palisaded encapsulated neuromaAbundant axons",
                    "sub_points": [
                      "Abundant axons"
                    ]
                  },
                  {
                    "text": "Traumatic neuromaLacks circumscriptionNumerous microfascicles",
                    "sub_points": [
                      "Lacks circumscription",
                      "Numerous microfascicles"
                    ]
                  },
                  {
                    "text": "Cutaneous leiomyomaS100(-), SOX10(-)SMA and desmin (+)",
                    "sub_points": [
                      "S100(-), SOX10(-)",
                      "SMA and desmin (+)"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Multinodular schwannoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Tumor of Schwann cells with plexiform or multinodular growth"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Sporadic (90%)"
                  },
                  {
                    "text": "NF2 associated (~ 5%)"
                  },
                  {
                    "text": "Schwannomatosis associated (~ 5%)"
                  },
                  {
                    "text": "Solitary; occasionally multiple in NF2 and schwannomatosisAsymptomatic > painful or tender (schwannomatosis)",
                    "sub_points": [
                      "Asymptomatic > painful or tender (schwannomatosis)"
                    ]
                  },
                  {
                    "text": "Location variesDermal/subcutaneous (90%)Extremity, trunk, head and neckMucosal sitesVisceral rare",
                    "sub_points": [
                      "Dermal/subcutaneous (90%)",
                      "Extremity, trunk, head and neck",
                      "Mucosal sites",
                      "Visceral rare"
                    ]
                  },
                  {
                    "text": "Rare examples of conventional schwannoma contiguous with deep plexiform component"
                  }
                ],
                "Age": [
                  {
                    "text": "Children to elderly (mean: ~ 35 years)Rarely congenital",
                    "sub_points": [
                      "Rarely congenital"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "No predilection"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "AdultsExcellent with simple excisionInfrequent recurrence of large, cellular, &/or mitotically active examples",
                    "sub_points": [
                      "Excellent with simple excision",
                      "Infrequent recurrence of large, cellular, &/or mitotically active examples"
                    ]
                  },
                  {
                    "text": "ChildrenRecurrence (50%) if infiltrative or poorly circumscribedNo deaths of disease or metastases",
                    "sub_points": [
                      "Recurrence (50%) if infiltrative or poorly circumscribed",
                      "No deaths of disease or metastases"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Few grossly obvious; rarely > 10 cmBone erosion infrequentSoft tissue infiltration uncommon (childhood)",
                    "sub_points": [
                      "Bone erosion infrequent",
                      "Soft tissue infiltration uncommon (childhood)"
                    ]
                  },
                  {
                    "text": "Circumscribed"
                  },
                  {
                    "text": "Plexiform to multinodular expanded fascicle(s)"
                  },
                  {
                    "text": "No necrosis or hemorrhage"
                  },
                  {
                    "text": "Cut surface may be yellow due to lipid accumulation"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Round to oval contours of schwannoma-affected nerve fascicle(s)"
                  },
                  {
                    "text": "Multiple (2-50) nodules or foci of fascicular expansion"
                  },
                  {
                    "text": "Occasional cellular-type schwannomaHypercellularityMitotically activeTendency for local recurrence",
                    "sub_points": [
                      "Hypercellularity",
                      "Mitotically active",
                      "Tendency for local recurrence"
                    ]
                  },
                  {
                    "text": "Antoni A > B tissueSome nodules entirely Antoni AArrays of palisaded nuclei more common than well-formed Verocay bodies",
                    "sub_points": [
                      "Some nodules entirely Antoni A",
                      "Arrays of palisaded nuclei more common than well-formed Verocay bodies"
                    ]
                  },
                  {
                    "text": "Minor degenerative atypia"
                  },
                  {
                    "text": "Scant mitoses (except in cellular tumors)"
                  },
                  {
                    "text": "Peripheral perineurial ensheathment"
                  },
                  {
                    "text": "Occasional scattered or displaced intratumoral axons"
                  },
                  {
                    "text": "Large nodules show thickened capsule"
                  },
                  {
                    "text": "Necrosis absent"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Typical schwannoma featuresSpindle cells with tapered nuclei",
                    "sub_points": [
                      "Spindle cells with tapered nuclei"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Reticulin (+) around individual cells"
                  },
                  {
                    "text": "Occasional Bodian or Bielschowsky (+) axons, with LFB/PAS(+) Schwann cell sheaths"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "S100 diffusely (+), SOX10(+)"
                  },
                  {
                    "text": "GFAP(+) in most cases"
                  },
                  {
                    "text": "Neurofilament protein (+) residual axons"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Features of typical Schwann cellsCytoplasmic intermediate filamentsProcesses covered by basement membraneScant junctions",
                    "sub_points": [
                      "Cytoplasmic intermediate filaments",
                      "Processes covered by basement membrane",
                      "Scant junctions"
                    ]
                  },
                  {
                    "text": "Long-spacing collagen (Luse bodies)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Plexiform Neurofibroma": [
                  {
                    "text": "Spindled smaller nuclei"
                  },
                  {
                    "text": "Thick collagen bundles"
                  },
                  {
                    "text": "Abundant mucinous matrix"
                  },
                  {
                    "text": "S100 subtotally (+)"
                  },
                  {
                    "text": "Frequent interfascicular diffuse element"
                  }
                ],
                "Palisaded Encapsulated Neuroma": [
                  {
                    "text": "Uni- and occasionally multinodularity"
                  },
                  {
                    "text": "Relatively abundant axons"
                  },
                  {
                    "text": "Apical irregular loss of perineurial capsule"
                  },
                  {
                    "text": "Deep nerve entry zone"
                  }
                ],
                "Traumatic Neuroma": [
                  {
                    "text": "Lacks circumscription"
                  },
                  {
                    "text": "Parent nerve obvious"
                  },
                  {
                    "text": "Abundant microfascicles"
                  }
                ],
                "Cutaneous Leiomyoma": [
                  {
                    "text": "Blunt-ended nuclei"
                  },
                  {
                    "text": "S100 minor staining at best; SOX10(-)"
                  },
                  {
                    "text": "Smooth muscle actin and desmin (+)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Malignant Peripheral Nerve Sheath Tumor": {
            "name": "Malignant Peripheral Nerve Sheath Tumor",
            "url": "https://app.pathprimer.com/document/ca55f706-adf2-4f69-944c-5519c28d4f1d/lesson/8662e5df-9cdd-4d09-9d11-e109f7a80303",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant neoplasm originating from, or demonstrating differentiation toward, nerve sheath elements"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Ionizing radiation"
                  },
                  {
                    "text": "2-3% of patients with NF1 have MPNST"
                  },
                  {
                    "text": "50% of MPNST occur in NF1"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Young adults; rarely pediatric"
                  },
                  {
                    "text": "Buttock, thigh, brachial plexus, upper arm, paraspinal"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Infiltrative, heterogeneously enhancing mass"
                  },
                  {
                    "text": "Quantitative FDG PET/CT and DWI/ADC mapping high sensitivity and specificity for MPNST in NF1"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Mitoses high (usually > 4/10 HPF)"
                  },
                  {
                    "text": "Geographic necrosis ± pseudopalisading"
                  },
                  {
                    "text": "Heterologous elements (10% of cases)Epithelial glandular, squamous, neuroendocrine, rhabdomyoblastic, cartilage, bone",
                    "sub_points": [
                      "Epithelial glandular, squamous, neuroendocrine, rhabdomyoblastic, cartilage, bone"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "S100, SOX10, CD57 (+); EMA(+) with perineurial differentiation; BRAF VE1(+) in subset"
                  },
                  {
                    "text": "Frequent inactivating mutations in components of polycomb repressive complex (PRC2),EED, orSUZ12, in majority of casesMutations result in loss of H3K27me3",
                    "sub_points": [
                      "Mutations result in loss of H3K27me3"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Neurofibroma"
                  },
                  {
                    "text": "Cellular schwannoma"
                  },
                  {
                    "text": "Fibrosarcoma"
                  },
                  {
                    "text": "Synovial sarcoma"
                  },
                  {
                    "text": "Melanoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Malignant peripheral nerve sheath tumor (MPNST)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Antiquated termsNeurogenic sarcomaNeurofibrosarcomaMalignant schwannoma",
                    "sub_points": [
                      "Neurogenic sarcoma",
                      "Neurofibrosarcoma",
                      "Malignant schwannoma"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant tumor of nerve sheath elements (schwannian or perineurial cell differentiation)Originating in nerveArising in transition from benign peripheral nerve sheath tumor (neurofibroma much more common than schwannoma) or de novoArising in transition from other neuroectodermal tumors (ganglioneuroma/ganglioneuroblastoma or pheochromocytoma)Developing in setting of neurofibromatosis type 1 (NF1) (von Recklinghausen disease)Developing sporadically, unassociated with nerve or precursor but with histologic, immunohistochemical, &/or ultrastructural features of MPNST",
                    "sub_points": [
                      "Originating in nerve",
                      "Arising in transition from benign peripheral nerve sheath tumor (neurofibroma much more common than schwannoma) or de novo",
                      "Arising in transition from other neuroectodermal tumors (ganglioneuroma/ganglioneuroblastoma or pheochromocytoma)",
                      "Developing in setting of neurofibromatosis type 1 (NF1) (von Recklinghausen disease)",
                      "Developing sporadically, unassociated with nerve or precursor but with histologic, immunohistochemical, &/or ultrastructural features of MPNST"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Radiation": [
                  {
                    "text": "Ionizing radiation underlies ~ 10% of MPNSTReported mean latency: 15-18 years",
                    "sub_points": [
                      "Reported mean latency: 15-18 years"
                    ]
                  }
                ],
                "Chemical Carcinogens": [
                  {
                    "text": "No apparent association"
                  }
                ],
                "Associated Syndromes": [
                  {
                    "text": "~ 50% of MPNST occur in NF1"
                  },
                  {
                    "text": "2-3% of patients with NF1 develop MPNST"
                  },
                  {
                    "text": "All reported multiple MPNSTs occur in NF1"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "0.0001% of general population"
                  },
                  {
                    "text": "~ 5% of all soft tissue tumors"
                  }
                ],
                "Age": [
                  {
                    "text": "Adulthood (20-50 years)Mean ageSporadic tumors: 40-44 yearsNF1-associated tumors: 20-35 years",
                    "sub_points": [
                      "Mean ageSporadic tumors: 40-44 yearsNF1-associated tumors: 20-35 years",
                      "Sporadic tumors: 40-44 years",
                      "NF1-associated tumors: 20-35 years"
                    ]
                  },
                  {
                    "text": "Pediatric tumors (rare)NF1 associated in 50-60%",
                    "sub_points": [
                      "NF1 associated in 50-60%"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "Slight female predominance"
                  }
                ],
                "Site": [
                  {
                    "text": "Large and medium-sized nervesSciatic most frequently affected",
                    "sub_points": [
                      "Sciatic most frequently affected"
                    ]
                  },
                  {
                    "text": "Common sites includeButtockThighBrachial plexusUpper armParaspinal",
                    "sub_points": [
                      "Buttock",
                      "Thigh",
                      "Brachial plexus",
                      "Upper arm",
                      "Paraspinal"
                    ]
                  },
                  {
                    "text": "Cranial nerves and visceral examples rare"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Rapidly growing mass"
                  },
                  {
                    "text": "Pain, motor weakness, sensory loss"
                  },
                  {
                    "text": "Sudden enlargement of preexisting neurofibroma"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Wide en bloc resection"
                  }
                ],
                "Adjuvant therapy": [
                  {
                    "text": "No effective chemotherapeutic regimen"
                  }
                ],
                "Radiation": [
                  {
                    "text": "Restricts and reduces incidence of local recurrence"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Recurrence frequent (40-70%)"
                  },
                  {
                    "text": "Overall rate of metastasis: 30-45%Higher at particular sitesButtockLower extremityParaspinalHigher in NF1 patients",
                    "sub_points": [
                      "Higher at particular sitesButtockLower extremityParaspinal",
                      "Buttock",
                      "Lower extremity",
                      "Paraspinal",
                      "Higher in NF1 patients"
                    ]
                  },
                  {
                    "text": "Common metastatic sites includeLungBonePleuraSoft tissueLiverBrain",
                    "sub_points": [
                      "Lung",
                      "Bone",
                      "Pleura",
                      "Soft tissue",
                      "Liver",
                      "Brain"
                    ]
                  },
                  {
                    "text": "~ 70% die of tumor"
                  },
                  {
                    "text": "5-year survival rate: 53-50%"
                  },
                  {
                    "text": "10-year survival rate: ~ 30%"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Large, infiltrative, heterogeneous (viable/necrotic) mass"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Architecture best seen in longitudinal axis"
                  },
                  {
                    "text": "T1 with contrastMarked enhancement",
                    "sub_points": [
                      "Marked enhancement"
                    ]
                  },
                  {
                    "text": "T1WIIsointense compared to muscle",
                    "sub_points": [
                      "Isointense compared to muscle"
                    ]
                  },
                  {
                    "text": "T2WIHyperintense compared to fat",
                    "sub_points": [
                      "Hyperintense compared to fat"
                    ]
                  },
                  {
                    "text": "Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mappingHigh sensitivity and specificity for MPNST in context of NF1",
                    "sub_points": [
                      "High sensitivity and specificity for MPNST in context of NF1"
                    ]
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Soft tissue mass hypodense to muscle"
                  },
                  {
                    "text": "Heterogeneous areas corresponding to hemorrhage and necrosis"
                  }
                ],
                "Quantitative FDG PET/CT": [
                  {
                    "text": "High sensitivity (89-95%) and specificity (72-95%) for malignancy in peripheral nerve sheath tumors"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Tumors involving nerveFusiform",
                    "sub_points": [
                      "Fusiform"
                    ]
                  },
                  {
                    "text": "Tumors unassociated with nerveGloboid",
                    "sub_points": [
                      "Globoid"
                    ]
                  },
                  {
                    "text": "Arising from neurofibromaIntraneural, plexiform neurofibroma or diffuse (rare)MPNST often focal; multiple sections recommended",
                    "sub_points": [
                      "Intraneural, plexiform neurofibroma or diffuse (rare)MPNST often focal; multiple sections recommended",
                      "MPNST often focal; multiple sections recommended"
                    ]
                  },
                  {
                    "text": "Cut surface firm, gray-tan"
                  },
                  {
                    "text": "Pseudocapsule"
                  },
                  {
                    "text": "Necrosis and hemorrhage common"
                  }
                ],
                "Size": [
                  {
                    "text": "Majority > 5 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Associated nerve or neurofibroma (50%)"
                  },
                  {
                    "text": "Hypercellular, mainly spindle cells"
                  },
                  {
                    "text": "Herringbone, storiform, tissue culture-like patterns"
                  },
                  {
                    "text": "Fibrous or myxoid stroma"
                  },
                  {
                    "text": "Nuclear palisading (rare)"
                  },
                  {
                    "text": "Hyperchromatic, crowded nuclei; mitoses (usually > 4/10 HPF)"
                  },
                  {
                    "text": "Geographic necrosis ± pseudopalisading"
                  },
                  {
                    "text": "Perivascular aggregation of viable tumor cells"
                  },
                  {
                    "text": "Multinucleated, large, pleomorphic cells (occasional)"
                  },
                  {
                    "text": "Malignant heterologous elements in 10% of casesSkeletal muscle, smooth muscle, cartilage, boneEpithelial glandular, squamous, neuroendocrine",
                    "sub_points": [
                      "Skeletal muscle, smooth muscle, cartilage, bone",
                      "Epithelial glandular, squamous, neuroendocrine"
                    ]
                  },
                  {
                    "text": "Histologic variantsMPNST with epithelial differentiationMPNST with rhabdomyoblastic (Triton tumor) or osteocartilaginous differentiationMPNST with angiosarcomaEpithelioid MPNSTDistinctive variant of MPNST usually arising in superficial sitesUsually not NF1 associatedRound or polygonal cells with voluminous cytoplasm, well-defined borders, vesicular nuclei, and macronucleoliMultilobular growth pattern1 of morphologic forms of MPNST developing in schwannomaStrong expression of schwannian markers (unlike conventional MPNST), including S100, SOX10, collagen IVINI1 loss in subsetMPNST with perineurial differentiationWhorl formation characteristicEMA expression",
                    "sub_points": [
                      "MPNST with epithelial differentiation",
                      "MPNST with rhabdomyoblastic (Triton tumor) or osteocartilaginous differentiation",
                      "MPNST with angiosarcoma",
                      "Epithelioid MPNSTDistinctive variant of MPNST usually arising in superficial sitesUsually not NF1 associatedRound or polygonal cells with voluminous cytoplasm, well-defined borders, vesicular nuclei, and macronucleoliMultilobular growth pattern1 of morphologic forms of MPNST developing in schwannomaStrong expression of schwannian markers (unlike conventional MPNST), including S100, SOX10, collagen IVINI1 loss in subset",
                      "Distinctive variant of MPNST usually arising in superficial sites",
                      "Usually not NF1 associated",
                      "Round or polygonal cells with voluminous cytoplasm, well-defined borders, vesicular nuclei, and macronucleoli",
                      "Multilobular growth pattern",
                      "1 of morphologic forms of MPNST developing in schwannoma",
                      "Strong expression of schwannian markers (unlike conventional MPNST), including S100, SOX10, collagen IV",
                      "INI1 loss in subset",
                      "MPNST with perineurial differentiationWhorl formation characteristicEMA expression",
                      "Whorl formation characteristic",
                      "EMA expression"
                    ]
                  },
                  {
                    "text": "Low-grade tumors: Less cellular, lower mitotic activity, no necrosisCell crowding, nuclear enlargement, hyperchromasia are essential diagnostic features",
                    "sub_points": [
                      "Cell crowding, nuclear enlargement, hyperchromasia are essential diagnostic features"
                    ]
                  },
                  {
                    "text": "MPNST ex-schwannoma rareUsually in form of epithelioid change, primitive round blue cell tumor, or angiosarcoma",
                    "sub_points": [
                      "Usually in form of epithelioid change, primitive round blue cell tumor, or angiosarcoma"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Highly varied, none diagnostic"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "S100 and CD57 (+) both ~ 1/2, may be focal"
                  },
                  {
                    "text": "SOX10(+) frequent but not positive in all tumors and usually positive in subset of tumor cells"
                  },
                  {
                    "text": "Collagen IV variably (+); negative in high-grade examples"
                  },
                  {
                    "text": "EMA(+) with perineurial differentiation"
                  },
                  {
                    "text": "Neurofilament protein identifies associated axons, if any"
                  },
                  {
                    "text": "TLE1 weak and focal positivity"
                  },
                  {
                    "text": "Desmin (+) with rhabdomyoblastic differentiation"
                  },
                  {
                    "text": "Cytokeratin, CEA (+) with glandular differentiation"
                  },
                  {
                    "text": "Chromogranin (+) with neuroendocrine differentiation"
                  },
                  {
                    "text": "Ki-67 labeling index: Moderate to high"
                  },
                  {
                    "text": "p53(+), p27 often (-)"
                  },
                  {
                    "text": "Loss of neurofibromin reactivity using specific antibody helps differentiate from similar spindle cell neoplasms"
                  },
                  {
                    "text": "EGFR immunoreactivity and p16 loss frequent"
                  },
                  {
                    "text": "Loss of H3K27me3 in majority of tumors"
                  },
                  {
                    "text": "ATRX loss in small proportion"
                  },
                  {
                    "text": "BRAF VE1 (+) in ~ 20% of sporadic MPNST"
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Aneuploidy common"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "CDKN2Adeletion may be helpful in identifying early transition to MPNST in neurofibromas"
                  },
                  {
                    "text": "EGFRamplification in subset"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Frequent inactivating mutations in components of polycomb repressive complex (PRC2),EED, orSUZ12, in majority of casesMutations result in loss of histone H3 lysine 27 trimethylation (H3K27me3)",
                    "sub_points": [
                      "Mutations result in loss of histone H3 lysine 27 trimethylation (H3K27me3)"
                    ]
                  },
                  {
                    "text": "Frequent alterations inCDKN2AandNF1tumor suppressors"
                  },
                  {
                    "text": "BRAF(V600E) mutation present in subset of sporadic MPNST (up to 20%), but very rare in NF1-associated MPNST"
                  },
                  {
                    "text": "Subset of tumors may haveATRXorDAXXmutations, associated with alternative lengthening of telomeres (ALT) phenotype"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Variable differentiation (basal lamina) or undifferentiated cells"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Cellular Neurofibroma": [
                  {
                    "text": "Small cells, 1/3 size of MPNST"
                  },
                  {
                    "text": "Mitotic indices usually not higher than 4/10 HPF"
                  },
                  {
                    "text": "No necrosis"
                  }
                ],
                "Neurofibroma": [
                  {
                    "text": "Degenerative atypia (bizarre giant cells) with nuclear pseudoinclusions, smudgy chromatin may be present but lack prognostic significance"
                  },
                  {
                    "text": "Mitotic activity usually not higher than 4/10 HPF"
                  },
                  {
                    "text": "No necrosis"
                  }
                ],
                "Atypical Neurofibromatous Neoplasms of Uncertain Biologic Potential": [
                  {
                    "text": "Consensus conference (2016) recommending this term to tumors displaying at least 2 featuresNuclear atypia, loss of neurofibroma architecture, hypercellularity, mitotic activity > 1/50 but < 3/10 HPF",
                    "sub_points": [
                      "Nuclear atypia, loss of neurofibroma architecture, hypercellularity, mitotic activity > 1/50 but < 3/10 HPF"
                    ]
                  }
                ],
                "Cellular Schwannoma": [
                  {
                    "text": "Collagenous capsule and vessels, Antoni A pattern dominant"
                  },
                  {
                    "text": "Collagen IV and S100 diffusely (+)"
                  },
                  {
                    "text": "Neurofibromin and H3K27me3 usually preserved"
                  }
                ],
                "Perineurioma": [
                  {
                    "text": "Bland nuclear features, mitoses absent or rare"
                  },
                  {
                    "text": "Elongate narrow processes"
                  },
                  {
                    "text": "EMA(+), collagen IV (+); S100(-)"
                  }
                ],
                "Fibrosarcoma": [
                  {
                    "text": "S100(-), lack of nerve association"
                  }
                ],
                "Leiomyosarcoma": [
                  {
                    "text": "SMA(+), desmin (+), S100 (minor positivity)"
                  }
                ],
                "Synovial Sarcoma": [
                  {
                    "text": "SS18::SSX1orSS18::SSX2fusions usually resulting from t(X;18) translocation are diagnostic"
                  },
                  {
                    "text": "TLE1 diffuse, strong nuclear positivity; minor S100 positivity (20%)"
                  },
                  {
                    "text": "Keratin and EMA (+) in 20%"
                  }
                ],
                "Melanoma": [
                  {
                    "text": "Desmoplastic melanoma and so-called \"neurotropic\" melanoma, particularly problematic"
                  },
                  {
                    "text": "Cutaneous, head and neck, and other superficial locations"
                  },
                  {
                    "text": "S100 and SOX10 expression to greater extent"
                  }
                ],
                "Epithelioid Sarcoma": [
                  {
                    "text": "EMA(+), keratin (+), S100(-)"
                  },
                  {
                    "text": "INI1 loss of nuclear staining"
                  }
                ],
                "Gastrointestinal Stromal Tumor": [
                  {
                    "text": "CD117(+)"
                  }
                ],
                "Ossifying Fibromyxoid Tumor of Soft Parts": [
                  {
                    "text": "Shares S100 expression with Schwann cell neoplasms"
                  },
                  {
                    "text": "Usually develop in superficial locations"
                  },
                  {
                    "text": "Peripheral bony shell in most cases"
                  },
                  {
                    "text": "Desmin expression in subset and mosaic pattern of INI1 loss"
                  }
                ],
                "Irradiation-Induced Atypia in Normal Nerve": [
                  {
                    "text": "No proliferative activity"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Always think of MPNST when encountering cellular spindle cell neoplasms in patients with NF1"
                  },
                  {
                    "text": "Sudden enlargement or pain in large NF1-associated neurofibroma is always alarming clinical sign"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Important to sample large/plexiform neurofibromas since malignant change may be focal and difficult to recognize"
                  },
                  {
                    "text": "Partial S100 expression in most MPNSTs contrasts with diffuse expression in cellular schwannomaUnlike conventional MPNST, epithelioid variant demonstrates consistently strong, uniform S100 expression",
                    "sub_points": [
                      "Unlike conventional MPNST, epithelioid variant demonstrates consistently strong, uniform S100 expression"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "CNS WHO 2021": {
        "name": "CNS WHO 2021",
        "url": "https://app.pathprimer.com/lesson/ea2afda3-ba82-4880-b988-92208a608d8e",
        "topics": {}
      }
    }
  }
}